id subject predicate object category relation description has_attribute source uuid:b8cd0264-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b8cd354a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:b8cd5ee4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:b8cd8414-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:b8cda944-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.707']} DrugCentral uuid:b8cdd310-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:b8cdf80e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:b8ce2162-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) DrugCentral uuid:b8ce4a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b8ce4a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b8ce7e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:b8cea79a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b8ced10c-94cc-11ec-8aec-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8cefae2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8cf2454-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8cf4dd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:b8cf72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:13 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levdobutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:b8cf9844-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b8cfc120-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b8cfe9de-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8d012a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P48760 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Folylpoly-gamma-glutamate synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:b8d03c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b8d06562-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:b8d08df8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:b8d0b6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:b8d0df9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:b8d109f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:25 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b8d132bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:25 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:b8d1572e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:b8d17bbe-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:b8d1a01c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96J66 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Transporter (ATP-binding cassette sub-family C member 11) DrugCentral uuid:b8d1c498-94cc-11ec-8aec-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b8d1ed10-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8F0 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Enzyme (Uracil phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b8d216e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O26232 biolink:molecularly_interacts_with DrugCentral:27 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b8d23f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03962 biolink:molecularly_interacts_with DrugCentral:27 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:b8d2689e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:b8d2912a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:b8d2bb6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:b8d2e3fa-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:b8d30c90-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:b8d33580-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.276']} DrugCentral uuid:b8d35e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:b8d38684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:b8d3af38-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:35 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.49']} DrugCentral uuid:b8d3e124-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b8d3e124-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b8d3e124-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d430a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:b8d490ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.697']} DrugCentral uuid:b8d4b978-94cc-11ec-8aec-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose is inhibitor of Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:b8d4ddc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8d5069e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b8d52f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b8d55806-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:b8d58150-94cc-11ec-8aec-0242ac110003 UniProtKB:P94451 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:b8d5abc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P53051 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Oligo-1,6-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b8d5d47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00690 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:b8d5fd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:b8d625a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b8d64ea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b8d67718-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:b8d69fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:b8d6c858-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b8d6f13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.227']} DrugCentral uuid:b8d719f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:b8d73e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:b8d767a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:b8d79346-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:b8d7bd3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:b8d7e2a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:b8d806fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b8d83580-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:48 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acenocoumarol is inhibitor of Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:b8d85e02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:48 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acenocoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.114']} DrugCentral uuid:b8d88684-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:49 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:b8d8b06e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:50 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceprometazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b8d8d4b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:b8d8fd44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:b8d9217a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:b8d945c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b8d971de-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:b8d99a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:b8d9c31e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:b8d9ec22-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:b8da14a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b8da3d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:b8da65a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:b8da8ea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:b8dab724-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.547']} DrugCentral uuid:b8dadfb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:b8db0850-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:b8db32da-94cc-11ec-8aec-0242ac110003 UniProtKB:P02144 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Unclassified (Myoglobin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:b8db5b3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is agonist of GPCR (Cannabinoid receptor 1) DrugCentral uuid:b8db7fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:54 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetanilide targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:b8dba83c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:b8dbd12c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:b8dbf9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:b8dc2280-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8dc4b20-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8dc7410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:b8dc9cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:b8dcc604-94cc-11ec-8aec-0242ac110003 UniProtKB:P29972 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Transporter (Aquaporin-1) DrugCentral uuid:b8dcea3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:b8dd165e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:b8dd4016-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:b8dd6898-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b8dd9160-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:b8ddb9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8dde41c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:b8de0cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b8de35e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:b8de5e56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERQ8 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8de86ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:b8deaf64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:b8ded908-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:b8df018a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:b8df2a16-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:b8df52a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b8df7bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8dfa5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8dfce62-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8dff6d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:b8e01fac-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:b8e04838-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b8e070b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:b8e0993c-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:b8e0c56a-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:b8e0f26a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:b8e11b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:b8e1447c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e19756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b8e24656-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8e24656-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8e24656-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8e24656-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b8e29890-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:b8e29890-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:b8e2cc34-94cc-11ec-8aec-0242ac110003 UniProtKB:P46510 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:b8e2f4ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.08']} DrugCentral uuid:b8e31da6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:b8e3460a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HVB9 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:b8e36e78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:b8e397c2-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:b8e3c10c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75493 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase-related protein 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:b8e3ed94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:b8e3ed94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:b8e4212e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:b8e45310-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:b8e45310-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:b8e45310-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:b8e48ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:b8e4b30a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0PXQ5 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Urease subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:b8e4db64-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:59 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetophenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:b8e5006c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:59 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetophenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b8e528da-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:b8e5515c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril is inhibitor of Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b8e579c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:b8e5a288-94cc-11ec-8aec-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:b8e5cab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08049 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b8e5f2f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19621 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:b8e61b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42892 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Endothelin-converting enzyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b8e64472-94cc-11ec-8aec-0242ac110003 UniProtKB:P00800 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Thermolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:b8e66cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:b8e69508-94cc-11ec-8aec-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:b8e6be98-94cc-11ec-8aec-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:b8e6e6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b8e70f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b8e7374c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b8e76168-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:b8e7899a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:b8e7b208-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:b8e7db5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b8e805d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b8e830b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b8e85910-94cc-11ec-8aec-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:b8e88174-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:b8e8aa82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:b8e8d6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8e8d6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b8e90e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:b8e90e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:b8e94604-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:b8e94604-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:b8e97d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:b8e97d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:b8e9b544-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:b8e9b544-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:b8e9efaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b8e9efaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b8ea323a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8ea323a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8ea323a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8ea323a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8ea323a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b8ea8898-94cc-11ec-8aec-0242ac110003 UniProtKB:H6TY12 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Nicotinic acetylcholine receptor alpha8 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:b8eab0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P99999 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Enzyme (Cytochrome c) DrugCentral uuid:b8ead4d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Secreted (Vascular endothelial growth factor A) DrugCentral uuid:b8eaf8dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04179 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Enzyme (Superoxide dismutase [Mn], mitochondrial) DrugCentral uuid:b8eb1d62-94cc-11ec-8aec-0242ac110003 UniProtKB:P48637 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine is modulator of Enzyme (Glutathione synthetase) DrugCentral uuid:b8eb422e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine is modulator of Transporter (Cystine/glutamate transporter) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8eb8194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:b8ebed14-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:b8ec115e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:b8ec3594-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b8ec5e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b8ec86ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:b8ecaf06-94cc-11ec-8aec-0242ac110003 UniProtKB:P60045 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Acidic phospholipase A2 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:b8ecd7ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P19440 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:b8ed0014-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b8ed28c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:b8ed5104-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:b8ed7a9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b8eda334-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b8edcc9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:76 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acipimox is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b8edf4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:b8ee19fe-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:b8ee4244-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) DrugCentral uuid:b8ee6666-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:b8ee8eac-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:b8eeb76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b8eedfba-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:b8ef07c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:b8ef07c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:b8ef45f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:b8ef45f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:b8ef45f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:b8ef45f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:b8ef45f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:b8ef90ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b8efb4da-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:b8efddb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b8f006b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:b8f02ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Kinase (Thymidine kinase) DrugCentral uuid:b8f05318-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:b8f07b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:b8f0a412-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:b8f0c816-94cc-11ec-8aec-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:b8f0ec56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:b8f110a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04407 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:b8f13738-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b8f15f88-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b8f18814-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:b8f1b190-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:b8f1da76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil is inhibitor of Polyprotein (Protein P) DrugCentral uuid:b8f1fe84-94cc-11ec-8aec-0242ac110003 UniProtKB:P54098 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil targets Enzyme (DNA polymerase subunit gamma-1) DrugCentral uuid:b8f222b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:b8f24ad8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b8f27f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:b8f27f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:b8f27f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:b8f27f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:b8f2c864-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:b8f2f212-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.509']} DrugCentral uuid:b8f31a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:b8f3428a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:b8f36ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8f39366-94cc-11ec-8aec-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:b8f3bbac-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:b8f3e41a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b8f40c74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b8f43514-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9TVW2 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:b8f45d78-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:b8f485be-94cc-11ec-8aec-0242ac110003 UniProtKB:P23526 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.796']} DrugCentral uuid:b8f4b214-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b8f4b214-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b8f4e964-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BTU6 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b8f511aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCG2 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b8f539d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04406 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Glyceraldehyde-3-phosphate dehydrogenase liver) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:b8f56ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:b8f56ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:b8f56ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:b8f56ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:b8f5b916-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TEK3 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Histone-lysine N-methyltransferase, H3 lysine-79 specific) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b8f5e148-94cc-11ec-8aec-0242ac110003 UniProtKB:P49652 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:b8f60ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:b8f63378-94cc-11ec-8aec-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:b8f65cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b8f6856c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:b8f6af24-94cc-11ec-8aec-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b8f6d774-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:b8f6ffb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b8f72800-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b8f750dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41148 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Membrane other (Endoplasmin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:b8f77922-94cc-11ec-8aec-0242ac110003 UniProtKB:P49137 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (MAP kinase-activated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:b8f7a17c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:b8f7c9e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b8f7f2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:b8f81ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.836']} DrugCentral uuid:b8f84370-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12931 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock protein 75 kDa, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:b8f86bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:b8f89550-94cc-11ec-8aec-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:b8f8bd8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b8f8e5d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b8f90f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:b8f937d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJX6 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8f95ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b8f9882a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b8f9b0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P51579 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8f9d8fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8fa012e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b8fa2960-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b8fa53d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P09467 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:b8fa7c26-94cc-11ec-8aec-0242ac110003 UniProtKB:P00636 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b8faa44e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:b8facc94-94cc-11ec-8aec-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:b8faf552-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:b8fb1da2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:b8fb49e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b8fb49e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b8fb7de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.19']} DrugCentral uuid:b8fba646-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A9J4 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Ketopantoate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.2']} DrugCentral uuid:b8fbcea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:b8fbf812-94cc-11ec-8aec-0242ac110003 UniProtKB:O43598 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:b8fc2224-94cc-11ec-8aec-0242ac110003 UniProtKB:O35820 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:b8fc4a74-94cc-11ec-8aec-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fca0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:b8fd3a42-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b8fd725a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:b8fd725a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:b8fd725a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:b8fd725a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:b8fd725a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:b8fdc700-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b8fdf0e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:b8fe1d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:b8fe1d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:b8fe5896-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:b8fe5896-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:b8fe5896-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:b8fe9752-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:b8febfc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:b8fee838-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:b8ff1088-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:b8ff34f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b8ff5e12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:b8ff8662-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b8ffae9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alacepril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:b8ffd93c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:b8ffd93c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:b9000c7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:b9000c7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:b9003a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole targets Structural (Tubulin alpha chain) DrugCentral uuid:b900669a-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900669a-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900669a-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b900b4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:b9011414-94cc-11ec-8aec-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:104 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole sulfoxide targets Structural (Tubulin alpha chain) DrugCentral uuid:b9013818-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.613']} DrugCentral uuid:b9016072-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:b90188c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:b901b298-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:b901dafc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:b901feec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclofenac targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:b902230e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:b9024bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.9']} DrugCentral uuid:b902743a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b9029c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b902c4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.721']} DrugCentral uuid:b902eeb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:b90316d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9034680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:b9034680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:b9034680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:b9038258-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:b9038258-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:b903b598-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:b903dd98-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:b904067e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:b9042eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:b90456ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:b9048054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b904a8f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Protein farnesyltransferase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:b904d112-94cc-11ec-8aec-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:b904f926-94cc-11ec-8aec-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:b905213a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b9054b38-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:b9057388-94cc-11ec-8aec-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:b9059bce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WUK0 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine is inhibitor of Enzyme (Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:b905c3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:b905ed68-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.951']} DrugCentral uuid:b9061586-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b9063dc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:b906715c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b906715c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b906715c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b906715c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b906bc66-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b906e4c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:b9070d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:b90738bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:b9076332-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:b9078b6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:b907b454-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:b907dc86-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.61']} DrugCentral uuid:b90804ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:b9082d58-94cc-11ec-8aec-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:b90855bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9TSZ1 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9087dda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DLS0 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b908a65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08424 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b908ce84-94cc-11ec-8aec-0242ac110003 UniProtKB:P06281 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:b908f7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7M3D2 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b9091fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:b90947d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DLW5 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:b9096ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:b90998c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b909c104-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b909e954-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:b90a12a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:b90a371a-94cc-11ec-8aec-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:b90a5f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:b90a8896-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9FBI2 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Unclassified (Shiga toxin subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:b90ab0dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b90adc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b90b047e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b90b2cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:b90b54ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:b90b7e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b90ba654-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.218']} DrugCentral uuid:b90bce86-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfacalcidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:b90bf744-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfacalcidol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:b90c1b52-94cc-11ec-8aec-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Transporter (Sodium- and chloride-dependent GABA transporter 1) DrugCentral uuid:b90c4712-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b90c4712-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b90c4712-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90cc03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b90d97f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b90d97f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b90d97f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b90dd686-94cc-11ec-8aec-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b90dfea4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b90e280c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90e8c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b90f5c18-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:b90f844a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Unclassified (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b90fad30-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem is partial agonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) DrugCentral uuid:b90fd116-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:b90ff934-94cc-11ec-8aec-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.457']} DrugCentral uuid:b91021c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:b9104ace-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.61']} DrugCentral uuid:b9107ac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:b9107ac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:b9107ac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:b910c0d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:b910c0d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:b910c0d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:b9110752-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:b9110752-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:b9110752-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:b9114d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b9114d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b9114d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b9118c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:b911b454-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:b911ddbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:b91206de-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:b9123208-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:b9125a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:b9128258-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:b912aaa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.678']} DrugCentral uuid:b912d366-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.658']} DrugCentral uuid:b912fb98-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:b91323a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9134c10-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b913741a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b9139c42-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:b913c438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b913ed8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:b91415f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:b9143e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b9146622-94cc-11ec-8aec-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:b9148f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b914b762-94cc-11ec-8aec-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:b914df9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b91507a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b91530ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b91558c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b91580b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b915a8de-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.35']} DrugCentral uuid:b915d3a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b915fe7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 altretamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:b91626b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:b9164eec-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9167868-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b916a09a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b916c8e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:b916f144-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b917199e-94cc-11ec-8aec-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is inhibitor of Ion channel (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b91758d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:b917c98e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q20MD5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:b917f1de-94cc-11ec-8aec-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:b9181a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:b91842e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:b91866d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.34']} DrugCentral uuid:b9188ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:b918b736-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:b918dfcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.254']} DrugCentral uuid:b91907d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:b9192be4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:b9195402-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:b9198288-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:b9198288-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:b9198288-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:b919c860-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:b919c860-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:b919c860-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:b91a074e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifostine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:b91a2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifostine targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) DrugCentral uuid:b91a5352-94cc-11ec-8aec-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amikacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.201']} DrugCentral uuid:b91a7b84-94cc-11ec-8aec-0242ac110003 UniProtKB:P37088 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Amiloride-sensitive sodium channel subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:b91aa3f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:b91acc06-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:b91af442-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.408']} DrugCentral uuid:b91b1c92-94cc-11ec-8aec-0242ac110003 UniProtKB:P19634 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b91b45dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:b91b6e18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:b91b962c-94cc-11ec-8aec-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b91bbe54-94cc-11ec-8aec-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:b91be7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:b91c17be-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b91c17be-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b91c17be-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b91c560c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9W6Q1 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:b91c7fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14940 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:b91ca80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26431 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:b91cd12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50482 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:b91cf972-94cc-11ec-8aec-0242ac110003 UniProtKB:P06869 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:b91d23ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P55926 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:b91d4be8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:b91d741a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b91d9c56-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:b91dc546-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amineptine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b91ded78-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminocaproic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:b91e15aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminocaproic acid is inhibitor of Enzyme (Tissue-type plasminogen activator) DrugCentral uuid:b91e399a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:b91e623a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:b91e8a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:b91eae70-94cc-11ec-8aec-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:b91ed698-94cc-11ec-8aec-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:b91effec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:b91f281e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:b91f5078-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:b91f7454-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:b91f9916-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:b91fc148-94cc-11ec-8aec-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopicoline is inhibitor of Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b91fe970-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b920118e-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:b9203a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b9206256-94cc-11ec-8aec-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:b9208a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:b920b2ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b920dea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:b92106d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:b9212f10-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.177']} DrugCentral uuid:b921588c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b92180aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b921a8d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:b921d0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:b921fa26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9222258-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:b9224bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:b92273f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b9229e22-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:b922c65e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:b922eea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.989']} DrugCentral uuid:b92316e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:b9233fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.674']} DrugCentral uuid:b9236802-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.045']} DrugCentral uuid:b923905c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:b923b884-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:b923e1e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.984']} DrugCentral uuid:b9240a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:b924323c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:b9245afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.168']} DrugCentral uuid:b924853e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.296']} DrugCentral uuid:b924ad70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.968']} DrugCentral uuid:b924d692-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.498']} DrugCentral uuid:b924ff6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:b925278c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.004']} DrugCentral uuid:b9254fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:b92577e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.176']} DrugCentral uuid:b925a0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.549']} DrugCentral uuid:b925c8c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:b925f0c2-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.284']} DrugCentral uuid:b92618ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.791']} DrugCentral uuid:b92642d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:b9266b10-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:b9269338-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.039']} DrugCentral uuid:b926bb4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P37268 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b926e40a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.368']} DrugCentral uuid:b9270c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:b927348c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:b9275cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:b927852c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.347']} DrugCentral uuid:b927ad2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b927d5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.407']} DrugCentral uuid:b927fe12-94cc-11ec-8aec-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:b928296e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.879']} DrugCentral uuid:b9285588-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:b9287dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:b928a6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.943']} DrugCentral uuid:b928cff4-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.932']} DrugCentral uuid:b928f844-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:b929208a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b9294916-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:b9297134-94cc-11ec-8aec-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b929995c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75151 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase PHF2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:b929c18e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b929eb0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZMT4 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:b92a1314-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.953']} DrugCentral uuid:b92a3b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:b92a6346-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:b92a8c0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.382']} DrugCentral uuid:b92ab436-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:b92adc36-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.758']} DrugCentral uuid:b92b044a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:b92b2ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:b92b54f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:b92b7d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b92ba558-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:b92bcff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:b92bf896-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b92c2082-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:b92c48a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:b92c719a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:b92c99c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:b92cc2d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b92ceb70-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.367']} DrugCentral uuid:b92d13a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.456']} DrugCentral uuid:b92d3bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:b92d63d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b92d8d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b92db528-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b92ddd64-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:b92e058c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b92e2fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:b92e591a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b92e81c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:b92eaa00-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:b92ed30e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b92efb40-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:b92f2372-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:b92f4eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.83']} DrugCentral uuid:b92f79c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b92fa1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:b92fca3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:b92ff266-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b9301b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:b9304392-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.066']} DrugCentral uuid:b9306bba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:b93094aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b930be94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b930e6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:b9310eee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b93137e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b931601a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b9318842-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:b931b07e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:b931d914-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:b932011e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b9322928-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:b932545c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b9327d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b932a56a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b932cdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b932f60a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b933212a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:b933493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b9337170-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:b933a96a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b933a96a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b933a96a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b933a96a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b933a96a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b933ffa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b934282c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptylinoxide targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b93451da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9347a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b934a5fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b934dcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:b934dcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:b934dcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:b934dcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:b9351dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.646']} DrugCentral uuid:b9354608-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:b9356eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:b935977a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:b935bf84-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:b935e7ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.358']} DrugCentral uuid:b9360fca-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b936389c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b93660e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b9368932-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:b936ad18-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:b936d464-94cc-11ec-8aec-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b936fcaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b93724e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.507']} DrugCentral uuid:b9374d90-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b93775b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9379e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:b937c6a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:b937ef66-94cc-11ec-8aec-0242ac110003 UniProtKB:P50135 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:b9381914-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y251 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Enzyme (Heparanase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.28']} DrugCentral uuid:b9384128-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b9386950-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:b9389330-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:b938bb80-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:b938e38a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b9390798-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:b9393042-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:b93959c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:b9398204-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:b939aa40-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.182']} DrugCentral uuid:b939d312-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b939fb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b93a238a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b93a4bda-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:b93a76b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.734']} DrugCentral uuid:b93a9edc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:b93ac70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.542']} DrugCentral uuid:b93aef4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:b93b17ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:b93b408a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.616']} DrugCentral uuid:b93b68c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.211']} DrugCentral uuid:b93b91c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:b93bb9fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.365']} DrugCentral uuid:b93be238-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b93c0a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:b93c349a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:b93c5cd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:b93c84fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y345 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Sodium- and chloride-dependent glycine transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:b93cad1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:b93cd602-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:b93cfe16-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:b93d263e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b93d4e66-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b93d76fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:b93da6ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b93da6ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b93da6ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b93ddeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:b93e0806-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b93e301a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b93e5824-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93e932a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b93ef342-94cc-11ec-8aec-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amperozide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:b93f1b56-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amperozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:b93f43e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:b93f67d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.753']} DrugCentral uuid:b93f900e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:b93fb4e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:b93fd9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:b940026e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:b9402668-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:b9404e7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:b9407794-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9409fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b940c7f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:b940f020-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b94149f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b942166c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b942166c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b942166c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b942166c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b94269f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:b94269f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:b94269f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:b942aa1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:b942d21e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:b942f67c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.09']} DrugCentral uuid:b9431f44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9435e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b943c2d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b943ec44-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:b944103e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.172']} DrugCentral uuid:b9443906-94cc-11ec-8aec-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:b9446138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:b9448960-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:b944b17e-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:b944da32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:b9450264-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:b9452a96-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:b94552be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:b945891e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b945891e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b945891e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b945891e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b945d356-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:b945fbf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b9462428-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9464c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:b9467478-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:b9469cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b946c504-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b946f0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:b946f0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:b9472436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagrelide is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:b947500a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagrelide targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:b9477850-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anastrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:b947a19a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androisoxazole targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:b947c620-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b947ee52-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:b9481670-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b9483e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:b94866f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.17']} DrugCentral uuid:b9488f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:b948b76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b948dfa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:b9490922-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:b9493244-94cc-11ec-8aec-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:b9495a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b9498276-94cc-11ec-8aec-0242ac110003 UniProtKB:O54939 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:b949ab5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anecortave targets Secreted (Plasminogen activator inhibitor 1) DrugCentral uuid:b949cf56-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b949f350-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:b94a1740-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:b94a3b80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:b94a5f66-94cc-11ec-8aec-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Structural (Tubulin beta-4B chain) DrugCentral uuid:b94a836a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anileridine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:b94aa76e-94cc-11ec-8aec-0242ac110003 UniProtKB:P38435 biolink:molecularly_interacts_with DrugCentral:222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anisindione is inhibitor of Enzyme (Vitamin K-dependent gamma-carboxylase) DrugCentral uuid:b94acb54-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anisindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b94af61a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:b94b1a32-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:b94b3e5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 antazoline is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b94b624e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 antazoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:b94b8b20-94cc-11ec-8aec-0242ac110003 UniProtKB:O75342 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Arachidonate 12-lipoxygenase, 12R-type) DrugCentral uuid:b94baf1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:b94bd74c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:b94bffc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:b94c28b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:b94c50b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:b94c78f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:b94ca186-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:b94ccb0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:b94cf35c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:b94d1b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:b94d45a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b94d6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b94d96fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b94dbf4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:b94de802-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b94e1034-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:b94e3866-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:b94e611a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b94e8a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:b94eb2a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:b94edab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:b94f0304-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:b94f2bae-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b94f53c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:b94f7bea-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:b94fa430-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:b94fccda-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:b94ff502-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b9501d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:b95045ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:b95070e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9509b42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b950ceb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b950ceb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b950ceb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b950ceb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9514b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:b9520db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b9520db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b9520db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b9525392-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9525392-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9529604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9529604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9529604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9529604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b9529604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:b952f298-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:b952f298-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:b952f298-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:b9533230-94cc-11ec-8aec-0242ac110003 UniProtKB:P34949 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Enzyme (Mannose-6-phosphate isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:b9535a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b95382d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:b953ab02-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:b953d334-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.938']} DrugCentral uuid:b953fc7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9542802-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:b9545a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b9545a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b9545a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b954997c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:b954bd8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:b954e5d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:b9550e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5DUB1 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:b95536e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:b9555ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:b9557ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.757']} DrugCentral uuid:b955a6e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:b955cf9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32418 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Transporter (Sodium/calcium exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:b955f7fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.359']} DrugCentral uuid:b95627d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:b95627d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:b95627d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:b9566c02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b9566c02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b9569aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:b956bedc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:b956e6fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:b9570f9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:b9573790-94cc-11ec-8aec-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:b9575fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00735 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:b95787ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.851']} DrugCentral uuid:b957b116-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:b957d934-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:b9580166-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:b958298e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.131']} DrugCentral uuid:b9585256-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:b9587a6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:b958a288-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:b958cab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:b958f33c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:b9591b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:b9594378-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:b9596b82-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:b95996ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:b959c226-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:b959ec60-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.991']} DrugCentral uuid:b95a14f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:b95a3d46-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.681']} DrugCentral uuid:b95a6550-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:b95a8d64-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.169']} DrugCentral uuid:b95ab6c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:b95adee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:b95b06f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:b95b2f08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.633']} DrugCentral uuid:b95b5884-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b95b83d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b95bac58-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.421']} DrugCentral uuid:b95bd480-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:b95bfd20-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:b95c26ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.202']} DrugCentral uuid:b95c4eec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.463']} DrugCentral uuid:b95c7714-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:b95c9fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:b95cc7aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b95cefd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b95d18d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:b95d440a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:b95d6e94-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:b95d96a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b95dbf66-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b95de77a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b95e0f70-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:b95e377a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b95e6010-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:b95e882e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b95eb164-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:b95ed98c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arsenic trioxide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:b95f0254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arsenic trioxide is inhibitor of Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:b95f2644-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.312']} DrugCentral uuid:b95f4e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.998']} DrugCentral uuid:b95f7694-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:b95f9f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:b95fc77a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:b95fefa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.741']} DrugCentral uuid:b96017c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:b9604042-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:b9606842-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:b960904c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:b960b860-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:b960e27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:b9610aa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:b96132d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:b9615af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.126']} DrugCentral uuid:b961848e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.027']} DrugCentral uuid:b961acd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:b961d506-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:b961fe46-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:b96226dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:b9624f04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b9627718-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:b962a0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b962c98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:b962f242-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:b9631a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.297']} DrugCentral uuid:b96342e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:b9636aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:b9639300-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:b963bb1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:b963e38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:b9640bb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:b96433be-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:b9645be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:b9648512-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:b964a8ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:b964d86e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b964d86e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b964d86e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b965170c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:b9653f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:b9656752-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:b9658f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:b965b838-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.701']} DrugCentral uuid:b965e042-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.546']} DrugCentral uuid:b9660860-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.883']} DrugCentral uuid:b966307e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:b96659b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b96682b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:b966aaf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:b966d308-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:b966fba8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.673']} DrugCentral uuid:b96723bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.868']} DrugCentral uuid:b9674bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:b9677420-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:b9679ce8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:b967c614-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:b967f1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b967f1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9682622-94cc-11ec-8aec-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:b9684e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b9687668-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9689e90-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.58']} DrugCentral uuid:b968c6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asulacrine targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:b968eab2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:b96912b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:b9693b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:b96963de-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:b9698bf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.575']} DrugCentral uuid:b969b44c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:b969dc88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b96a06a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:b96a2ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b96a56e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.27']} DrugCentral uuid:b96a7fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.12']} DrugCentral uuid:b96aa848-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b96ad066-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:b96af88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:b96b2084-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:b96b49e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:b96b7214-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:b96b9a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:b96bc278-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:b96bedf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.69']} DrugCentral uuid:b96c1606-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:b96c3dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b96c6688-94cc-11ec-8aec-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.282']} DrugCentral uuid:b96c8e92-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:b96cb6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:b96cdece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:b96d0804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b96d341e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:b96d341e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:b96d6b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:b96d6b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:b96da07a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b96dc9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:b96dedb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:b96e15c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:b96e3f30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:b96e674e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b96e8f58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:b96eb76c-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:b96edfee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q1W675 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:b96f07ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:b96f2ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43264 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial) DrugCentral uuid:b96f5474-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02768 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone is inhibitor of Enzyme (Cytochrome b) DrugCentral uuid:b96f79c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:b96fa47e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:b96fccb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:b96ff0aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:b97019b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:b970499c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b970499c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b970499c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b97087d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:b970b0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b970d9a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:b97101ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:b97129ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:b9715350-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:b9717b82-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:b971a3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:b971cbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:b971f530-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:b9721d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:b9724562-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:b9726d80-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:b9729648-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:b972be70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:b972e68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:b9730eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:b9733b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:b97363b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:b9738bde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:b973b3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:b973dc9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:b97404e2-94cc-11ec-8aec-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:b9743c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:b9743c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:b9743c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:b9743c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:b9743c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:b97491f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:b974c1c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b974c1c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b974c1c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b97509d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:b97509d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:b97509d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:b975494c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapropazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:b9756d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapropazone targets Enzyme (Xanthine dehydrogenase/oxidase) DrugCentral uuid:b9759208-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:b975ba44-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azatadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b975de20-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:b9760620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:b9762a56-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:b9764e28-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:b97671f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P63000 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Enzyme (Ras-related C3 botulinum toxin substrate 1) DrugCentral uuid:b97695c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:b976b9a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelaic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) DrugCentral uuid:b976df28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:b9770732-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b9772b22-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9775354-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b9777c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b977a46c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.168']} DrugCentral uuid:b977ccb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:b977f4bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9781d66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:b97846a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b97872a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b97872a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b978a13c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b978c946-94cc-11ec-8aec-0242ac110003 UniProtKB:O08703 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b978f178-94cc-11ec-8aec-0242ac110003 UniProtKB:O70344 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:b979198c-94cc-11ec-8aec-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b979433a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.39']} DrugCentral uuid:b9796b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.7']} DrugCentral uuid:b9799344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:b979bb44-94cc-11ec-8aec-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b979f6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:b97a4a8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:b97a73cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:b97a9dc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.317']} DrugCentral uuid:b97ac5d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:b97aedd4-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b97b1692-94cc-11ec-8aec-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:b97b3f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q83TT7 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Unclassified (AmpC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:b97b675a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:b97b8fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:b97bb818-94cc-11ec-8aec-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:b97be02c-94cc-11ec-8aec-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c1f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b97c83f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:b97cac28-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.716']} DrugCentral uuid:b97cd432-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:b97cfe62-94cc-11ec-8aec-0242ac110003 UniProtKB:P60932 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Unclassified (Undecaprenyl-diphosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:b97d2a54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97d2a54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97d6172-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:b97d6172-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:b97d9520-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97df632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b97ecfa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:b97ef398-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:b97f1788-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:b97f3b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:b97f6080-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:b97f8466-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b97fac66-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.25']} DrugCentral uuid:b97fd498-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:b97ffe00-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b98026aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bamipine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b9804e78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b9804e78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:b9807c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:b980a4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:b980cd30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:b980f652-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9811e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:b9814710-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b9816f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:b98197ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:b981bfc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Y34 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate is agonist of GPCR (Probable G-protein coupled receptor 97) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:b981eb34-94cc-11ec-8aec-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:b982138e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9823bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belotecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.561']} DrugCentral uuid:b982649c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:b9828c92-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b982b488-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:b982dd6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:b98305b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b9832daa-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:b9835596-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:b9837daa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:b983a7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:b983cff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:b983f46a-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.3']} DrugCentral uuid:b9841c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:b98440aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:b98464fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:b9848902-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benoxaprofen is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:b984ace8-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benoxaprofen targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:b984d560-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.57']} DrugCentral uuid:b984fd74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:b985256a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:b9854d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:b98576aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:b9859ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b985c6dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b985eec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:b9861718-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:b9863f18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:b9866740-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:b9868f2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:b986b902-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:b986e206-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:b9870a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:b9873224-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.486']} DrugCentral uuid:b9875d12-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:b9879084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b9879084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b9879084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b987d10c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:b987f6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:b9881ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:b9884a92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:b9884a92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:b9887e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:b988a640-94cc-11ec-8aec-0242ac110003 UniProtKB:P03313 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Unclassified (Genome polyprotein [Cleaved into: P1; Capsid protein VP0) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:b988ce54-94cc-11ec-8aec-0242ac110003 UniProtKB:P52789 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Kinase (Hexokinase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:b988f65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzarone targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:b9891fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b98947ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:b9897002-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:b989983e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:b989c106-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:b989e91a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:b98a112e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:b98a394c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:b98a61ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.908']} DrugCentral uuid:b98a8ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.711']} DrugCentral uuid:b98ab2be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:b98adac8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b98b0444-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.32']} DrugCentral uuid:b98b2c62-94cc-11ec-8aec-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:b98b5476-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:b98b7ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b98ba552-94cc-11ec-8aec-0242ac110003 UniProtKB:O15392 biolink:molecularly_interacts_with DrugCentral:321 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benziodarone targets Unclassified (Baculoviral IAP repeat-containing protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b98bcd7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:321 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benziodarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b98bf58e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:b98c196a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:b98c3dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:b98c62c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:b98c86c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:b98caaa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:b98ccfe0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:b98cf3a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:b98d1798-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01118 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 7 subunit alpha) DrugCentral uuid:b98d3b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['3.495']} DrugCentral uuid:b98d640a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzonatate targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:b98d87dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:b98dabb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:b98dcf80-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:b98df35c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:b98e179c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:b98e3f9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b98e67b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.445']} DrugCentral uuid:b98e8fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:b98ebb0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:b98ee320-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:b98f0b34-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:b98f33f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:b98f5896-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.17']} DrugCentral uuid:b98f8064-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:b98fa422-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:b98fc7f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:b98fec3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:b990145c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:b9903c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:b99064a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:b9908dce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.157']} DrugCentral uuid:b990b60a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:b990de1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:b9910704-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:b9912f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:b9915740-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.654']} DrugCentral uuid:b9917f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:b991a7cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:b991cfe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.636']} DrugCentral uuid:b991f916-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:b9922120-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:b9924b00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:b9927648-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:b992a12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:b992ca58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.253']} DrugCentral uuid:b992f3b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:b9931bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:b99343fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:b9936c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:b9939474-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:b993bc74-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:b993e47e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:b9940c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:b99435b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:b9945dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzyl benzoate targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:b99485d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzyl benzoate targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b994ae90-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepotastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b994d262-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:b994f620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:b9951e2a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:b995465c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.149']} DrugCentral uuid:b9956ede-94cc-11ec-8aec-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:b99596c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b995bec0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:b995e7c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:b9961780-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:b9961780-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:b9961780-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:b996556a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is gating inhibitor of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9967e82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:b996a344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:b996c72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:b996ef2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:b997175c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b9973ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:b997682e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:b9979042-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2Q167 biolink:molecularly_interacts_with DrugCentral:345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betacarotene targets Unclassified (Core protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:b997b9f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betahistine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:b997e56a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betahistine is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:b9980d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:b9983588-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:b9985a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:b9987dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone benzoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:b998a1e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:b998c64c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:b998ee6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:b99912dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:b9993ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:b99962d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:b9998c1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:b999b80e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:b999e23e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:b99a0a2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.53']} DrugCentral uuid:b99a32b6-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:b99a5ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betazole is agonist of GPCR (Histamine H2 receptor) DrugCentral uuid:b99a7e88-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:b99aa782-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:b99ad068-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:b99af886-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:b99b20a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:b99b48c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH27 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol targets GPCR (Muscarinic receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b99b725c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betanidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:b99b962e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bevantolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:b99bba0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:b99be228-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:b99c0aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:b99c32d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:b99c5ae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:b99c82e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b99cab86-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:b99cd3a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:b99cfbae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:b99d23c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b99d4d8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:b99d7584-94cc-11ec-8aec-0242ac110003 UniProtKB:O43174 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:b99d9ea6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR63 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:b99dc6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:b99df05e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:b99e1886-94cc-11ec-8aec-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Enzyme (Lipoprotein lipase) DrugCentral uuid:b99e3c80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:b99e6476-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:b99e8e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:b99eb6e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:b99edf0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:b99f073c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) DrugCentral uuid:b99f2e38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:b99f525a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:b99f7654-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:b99f9a1c-94cc-11ec-8aec-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:b99fbe52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:b99fe242-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:b9a00a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9a03260-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:b9a05ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:b9a083a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:b9a0aba0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:b9a0d3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifemelane targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:b9a0fe7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b9a12666-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:b9a14e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:b9a1767a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:b9a19f92-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bimatoprost targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b9a1c8be-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bimatoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:b9a1f1a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biotin targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b9a21a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.32']} DrugCentral uuid:b9a2433e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:b9a26b48-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:b9a29460-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:b9a2bdbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:b9a2e5be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:b9a309ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:b9a331c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:b9a35be8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9a383f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisantrene targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:b9a3ac24-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:b9a3d438-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:b9a3fd28-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b9a42546-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:b9a44d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:b9a47582-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisulepine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b9a49a94-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bitolterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:b9a4bea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bivalirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:b9a4e6b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:b9a50eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:b9a537b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.854']} DrugCentral uuid:b9a55fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:b9a58800-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:b9a5b014-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:b9a5d94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.014']} DrugCentral uuid:b9a60168-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:b9a629d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.262']} DrugCentral uuid:b9a651c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:b9a67b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:b9a6a424-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:b9a6cc2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:b9a6f44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b9a71d46-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:b9a74550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:b9a76d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:b9a79582-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b9a7beae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:b9a7e6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:b9a80efe-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:b9a83884-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:b9a860c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99460 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Cytosolic other (26S proteasome non-ATPase regulatory subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:b9a888de-94cc-11ec-8aec-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.208']} DrugCentral uuid:b9a8b174-94cc-11ec-8aec-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:b9a8dabe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:b9a902e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:b9a92b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:b9a95458-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:b9a97cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:b9a9a4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:b9a9cd02-94cc-11ec-8aec-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:b9a9f520-94cc-11ec-8aec-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b9aa1f46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:b9aa47c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:b9aa6ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:b9aa9818-94cc-11ec-8aec-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:b9aac1c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:b9aae9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:b9ab11da-94cc-11ec-8aec-0242ac110003 UniProtKB:A5PKW4 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Unclassified (PH and SEC7 domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:b9ab4218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:b9ab4218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:b9ab4218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:b9ab802a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:b9aba848-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IJT1 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:b9abd048-94cc-11ec-8aec-0242ac110003 UniProtKB:P28063 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.78']} DrugCentral uuid:b9abfa5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:b9ac2264-94cc-11ec-8aec-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:b9ac4a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:b9ac6e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:b9ac9690-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:b9acbecc-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b9ace6d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:b9ad0ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q29010 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:b9ad380c-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:b9ad5fee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21451 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9ad87da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:b9adabac-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:b9add2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:b9adf77e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:b9ae1f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:b9ae480a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:b9ae7118-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:b9ae99fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:b9aec208-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:b9aeea44-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:b9af1406-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:b9af3c1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:b9af642e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:b9af958e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9af958e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9af958e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9afdbd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:b9afdbd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:b9afdbd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:b9b01a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:b9b04308-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:b9b06b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:b9b0931c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b9b0bb3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:b9b0e3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:b9b10bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9b133da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9b15c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:b9b184f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:b9b1acfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:b9b1d510-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:b9b1fd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b9b225b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:b9b24ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b9b276fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:b9b29fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:b9b2c7ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:b9b2f012-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b9b3183a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:b9b34166-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:b9b3695c-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:b9b39a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:b9b3c262-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:b9b3eb70-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:b9b41398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:b9b43bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:b9b463ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9b48ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:b9b4b636-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:b9b4de4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:b9b506f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9b530fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06479 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b9b558e8-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:b9b580e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b9b5a974-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:b9b5d17e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:b9b5f992-94cc-11ec-8aec-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:b9b621a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:b9b64b36-94cc-11ec-8aec-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:b9b67336-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:b9b69b18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:b9b6cac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9b6cac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9b6cac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9b70526-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b9b72d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:b9b7590e-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b9b7590e-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b9b78c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:b9b7b4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:b9b7dca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:b9b8049e-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:b9b82d5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.858']} DrugCentral uuid:b9b85566-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:b9b87d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:b9b8a5ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:b9b8d126-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b9b8fc64-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b9b925a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:b9b94e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9b97626-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9b99e26-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:b9b9c630-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9b9eef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:b9ba17fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9ba4132-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9ba695a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b9ba933a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:b9babb3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b9bae33a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:b9bb0b44-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b9bb33bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:b9bb5bda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:b9bb83ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:b9bbac02-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:b9bbd4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:b9bbfcca-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:b9bc24b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b9bc4cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:b9bc7786-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:b9bc9ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:b9bcc7fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9bcf850-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:b9bcf850-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:b9bcf850-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:b9bd463e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9bd463e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9bd463e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9bd463e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9bd463e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9bda07a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:b9bda07a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:b9bdd3a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:b9bdfbb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:b9be23b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:b9be4dc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9be75e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:b9be9df4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:b9bec612-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b9beee9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9bf16b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:b9bf3ed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:b9bf6798-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.745']} DrugCentral uuid:b9bf910a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:b9bfb914-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:b9bfe132-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.319']} DrugCentral uuid:b9c00a0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:b9c03222-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:b9c05a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.218']} DrugCentral uuid:b9c08a06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b9c08a06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b9c08a06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:b9c0c89a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brotizolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:b9c0f0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:b9c11994-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buclizine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:b9c13e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b9c16228-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:b9c18a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:b9c1b1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:b9c1dad2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:b9c20336-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:b9c22b22-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.701']} DrugCentral uuid:b9c25318-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:b9c27ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:b9c2a3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:b9c2cbae-94cc-11ec-8aec-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:b9c2f3ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c3335a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:b9c39d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:b9c3c36a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b9c3eb7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:b9c41388-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:b9c43746-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:b9c45ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:b9c480c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:b9c4a582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:b9c4c972-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:b9c4f212-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:b9c51a1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:b9c54230-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:b9c56602-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.59']} DrugCentral uuid:b9c58ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:b9c5b6fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:b9c5df24-94cc-11ec-8aec-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:b9c6071a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:b9c62f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:b9c65346-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:b9c6770e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:b9c69ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:b9c6bf66-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.399']} DrugCentral uuid:b9c6e784-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.263']} DrugCentral uuid:b9c70f98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:b9c737a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:b9c7613c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:b9c78bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:b9c7b3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:b9c7dbb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b9c8043e-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b9c82c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:b9c85452-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:b9c87cde-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.293']} DrugCentral uuid:b9c8a68c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9c8ce78-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:b9c8f68c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:b9c91e78-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.233']} DrugCentral uuid:b9c949ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:b9c971e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b9c999f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b9c9c1d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z0V1 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:b9c9ea56-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:b9ca124c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:b9ca3a6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b9ca6454-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9ca8c7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:b9cab49a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:b9cadcae-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:b9cb0616-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:b9cb2e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:b9cb56a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:b9cb7eac-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:b9cba710-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:b9cbcfd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:b9cbf7c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b9cc1fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:b9cc48a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.796']} DrugCentral uuid:b9dae31a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:b9db10c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:b9db34e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:b9db5d2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:b9db86d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:b9dbb038-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:b9dbdc7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:b9dbdc7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:b9dc13ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9dc13ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9dc4764-94cc-11ec-8aec-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.569']} DrugCentral uuid:b9dc6faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.52']} DrugCentral uuid:b9dc97c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01776 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:b9dcc072-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:b9dce91c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:b9dd1180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:b9dd3a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:b9dd645a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:b9dd8c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:b9ddb4dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:b9dddd36-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:b9de05f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.435']} DrugCentral uuid:b9de2e4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:b9de568a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:b9de7eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.277']} DrugCentral uuid:b9dea996-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:b9ded2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.471']} DrugCentral uuid:b9defb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9df24a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:b9df4d10-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:b9df757e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:b9df9de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b9dfc6be-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:b9dfef04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b9e0175e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:b9e03fd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9e06876-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:b9e090c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9e0b8f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:b9e0e166-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:b9e10c22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:b9e13472-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:b9e1680c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9e1680c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9e1680c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9e1680c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:b9e1b97e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9e1b97e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9e1b97e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9e20780-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9e20780-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9e20780-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9e20780-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9e20780-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:b9e26536-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:b9e26536-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:b9e26536-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:b9e2ab5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:b9e2ab5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:b9e2ab5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:b9e2ed8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 busulfan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.283']} DrugCentral uuid:b9e31da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9e31da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9e31da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9e35e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b9e35e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b9e35e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:b9e395fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:b9e3be36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:b9e3e708-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:b9e40fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:b9e437f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:b9e46016-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.161']} DrugCentral uuid:b9e4882a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:b9e4ae18-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.805']} DrugCentral uuid:b9e4d690-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:b9e4feb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92206 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.347']} DrugCentral uuid:b9e52802-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:b9e54c92-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:b9e57514-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:b9e59d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:b9e5c5aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:b9e5ee40-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:b9e6167c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.405']} DrugCentral uuid:b9e63e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:b9e6628a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:b9e688a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:b9e6acb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:b9e6d0b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:b9e6f8f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:b9e721ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:b9e749fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9e77256-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:b9e79a9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:b9e7c35a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:b9e7ebc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:b9e81404-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:b9e83c40-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:b9e867a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9e8930c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:b9e8be72-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b9e8eaf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9e9134a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9e93c80-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:b9e964bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:b9e98d70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cadralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:b9e9b174-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cadralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:b9e9d9c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:b9ea0228-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:b9ea2c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:b9ea56b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b9ea7f82-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:b9eaa7dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:b9ead086-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:b9eaf930-94cc-11ec-8aec-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:b9eb2176-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b9eb49da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:b9eb72ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:b9eb9afc-94cc-11ec-8aec-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:b9ebc748-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:b9ebc748-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:b9ec08d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b9ec08d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b9ec08d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b9ec08d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:b9ec5334-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2T3 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Guanine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:b9ec7b84-94cc-11ec-8aec-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:b9eca424-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:b9eccc7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcifediol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:b9ecf190-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:465 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcipotriene is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:b9ed19d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:b9ed3e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b9ed66ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:b9ed8ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02774 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Secreted (Vitamin D-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:b9edb314-94cc-11ec-8aec-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:b9edddee-94cc-11ec-8aec-0242ac110003 UniProtKB:O42392 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.6']} DrugCentral uuid:b9ee085a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28037 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:b9ee308c-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RGC1 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:b9ee5a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9PTN2 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:b9ee82e4-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camphor targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:b9eeab3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camphor is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:b9eed398-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:b9eefc24-94cc-11ec-8aec-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:b9ef24ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:b9ef4d28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01177 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:b9ef7550-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:b9ef9e68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:b9efc9c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:b9eff516-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:b9f02040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:b9f049bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:b9f07202-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:472 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camylofin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:b9f09a2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:b9f0c266-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:b9f0eb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:b9f11464-94cc-11ec-8aec-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:b9f13d72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBT6 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase kappa) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:b9f165ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNA4 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase iota) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:b9f18f8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y253 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase eta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:b9f1b7de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:b9f1e024-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:b9f20874-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:b9f2311e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:b9f2598c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:b9f281e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:b9f2aa40-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:b9f2d2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:b9f2faea-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:b9f3233a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canrenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:b9f34c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capecitabine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:b9f370b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:b9f39932-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b9f3c1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9f3ea72-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:b9f412b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:b9f43c48-94cc-11ec-8aec-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:b9f464a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:b9f48d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9f4b5e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:b9f4de32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:b9f50754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q93T40 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase II) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:b9f531e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:b9f55ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.85']} DrugCentral uuid:b9f58314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:b9f5ab82-94cc-11ec-8aec-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:b9f5d42c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:b9f5fc7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:b9f624ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:b9f64cea-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.94']} DrugCentral uuid:b9f675a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:b9f69de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9f6c620-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9f6ee7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:b9f717e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:b9f7401e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:b9f76846-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:b9f79136-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:b9f7b968-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.577']} DrugCentral uuid:b9f7e190-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:b9f809e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:b9f83438-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:b9f85e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:b9f8865e-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:b9f8aeae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b9f8d816-94cc-11ec-8aec-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:b9f9012e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:b9f929b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:b9f951f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.74']} DrugCentral uuid:b9f97afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:b9f9a7c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:b9f9a7c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:b9f9df04-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b9f9df04-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:b9fa1802-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:b9fa1802-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:b9fa4ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:b9fa4ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:b9fa876a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b9fa876a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:b9fabf96-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:b9fabf96-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:b9fb03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:b9fb03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:b9fb03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:b9fb03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:b9fb03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:b9fb58d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:b9fb7ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.495']} DrugCentral uuid:b9fba53c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.125']} DrugCentral uuid:b9fbcdb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:b9fbf78a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:b9fc1fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:b9fc4b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9fc4b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9fc4b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:b9fc87e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:b9fc87e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:b9fcbbfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H461 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is allosteric modulator of GPCR (Frizzled-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:b9fce514-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:b9fd0e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:b9fd36a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fd7196-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:b9fdd0c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone is inhibitor of Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:b9fdf904-94cc-11ec-8aec-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:b9fe2154-94cc-11ec-8aec-0242ac110003 UniProtKB:P51661 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:b9fe4c06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:b9fe7456-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:b9fe9c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:b9fec50a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:b9feee36-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:b9ff167c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:b9ff3fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:b9ff682a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:b9ff91ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:b9ffba28-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.149']} DrugCentral uuid:b9ffe28c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa is inhibitor of Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:ba00069a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.168']} DrugCentral uuid:ba00300c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:ba005852-94cc-11ec-8aec-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba00808e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbimazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:ba00a8b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbimazole is inhibitor of Enzyme (Thyroid peroxidase) DrugCentral uuid:ba00ce22-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbinoxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:ba00f2b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carboprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:ba011ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:ba011ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0165c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba01c336-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:510 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carubicin targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:ba01e74e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:ba0210a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:ba0238d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P7S1 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:ba026106-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13510 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:ba0289c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:ba02b278-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmustine is inhibitor of Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:ba02db9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:ba02ff94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:ba03287a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:ba035228-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:515 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:ba037a6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18910 biolink:molecularly_interacts_with DrugCentral:515 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:ba03a296-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:ba03c816-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfenazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:ba03ec42-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carpipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:ba041474-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carpipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:ba043cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:ba046596-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:ba048de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:ba04b622-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:ba04de54-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:ba0506d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:ba052fb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carteolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:ba05580c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carteolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:ba05805c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carumonam targets Enzyme (Peptidoglycan synthase FtsI) DrugCentral uuid:ba05a686-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is inhibitor of Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:ba05d0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:ba05f94c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:ba06219c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:ba064a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:ba0672b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:ba069b86-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:ba06c3d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:ba06f1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:ba071a3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.273']} DrugCentral uuid:ba074270-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.476']} DrugCentral uuid:ba076aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:ba0793ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:ba07bbf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:ba07e450-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:ba080cfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:ba083540-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:ba085d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:ba0885a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:ba08ae80-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:ba08d7a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:ba08ffd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.054']} DrugCentral uuid:ba092810-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:ba095254-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:ba097b58-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:ba09a38a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.706']} DrugCentral uuid:ba09cbf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:ba09f498-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:ba0a1ca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:ba0a44d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:ba0a6cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:ba0a95f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:ba0abe28-94cc-11ec-8aec-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:ba0ae72c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:ba0b0f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefacetrile targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba0b3574-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba0b5978-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0b9884-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0bfc7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.14']} DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c3b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0c99e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.09']} DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d3e00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0d79f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0dd996-94cc-11ec-8aec-0242ac110003 UniProtKB:O54286 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Enzyme (Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase) DrugCentral uuid:ba0dfd86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:ba0e2194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0e6122-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0ebfaa-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba0ee9a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:ba0f0dac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q54906 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0f486c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba0fbd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba101d28-94cc-11ec-8aec-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:ba104136-94cc-11ec-8aec-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:ba10651c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:ba108e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba10d04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba112e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19174 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets Enzyme (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba116d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba11cb32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba120692-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba126498-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:ba128eb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:ba12b6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:ba12dee6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1303b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:ba132c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba136b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba13c9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1405a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1467de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba14a4e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba15034c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:ba152b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.512']} DrugCentral uuid:ba1553d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.659']} DrugCentral uuid:ba157d40-94cc-11ec-8aec-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:ba15a586-94cc-11ec-8aec-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba15cdfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.617']} DrugCentral uuid:ba15f702-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:ba1620ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1644d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:ba166d18-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:ba169554-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:ba16bdea-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba16fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba175b9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba177f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:ba17a7b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba17e76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1847c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba186b9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) DrugCentral uuid:ba188fee-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:ba18b834-94cc-11ec-8aec-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:ba18e192-94cc-11ec-8aec-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:ba1909ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19493e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba19c0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1a1eea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefprozil targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1a4316-94cc-11ec-8aec-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:ba1a6bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.522']} DrugCentral uuid:ba1a9406-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:ba1abc56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:ba1ae4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:ba1b0d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:ba1b3596-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5A7N4 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Unclassified (tRNA 2'-phosphotransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:ba1b5df0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.261']} DrugCentral uuid:ba1b862c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.534']} DrugCentral uuid:ba1bb0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:ba1bd8d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q1J5W5 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein) DrugCentral uuid:ba1bfe0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60FU1 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c3a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1c99f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1cbde4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime targets Enzyme (Beta-lactamase) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1cfab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1d5876-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.142']} DrugCentral uuid:ba1d81a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.513']} DrugCentral uuid:ba1daa06-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.744']} DrugCentral uuid:ba1dd256-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.213']} DrugCentral uuid:ba1dfa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba1e2396-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba1e47a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:ba1e6fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:ba1e9826-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1ed84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1f4e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba1fae3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:ba1fd72c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:ba1fffcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:ba20283a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.477']} DrugCentral uuid:ba20508a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:ba207952-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:ba20a1ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.917']} DrugCentral uuid:ba20c9fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:ba20f256-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:ba211bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.856']} DrugCentral uuid:ba214440-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:ba216c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba2194ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:ba21be02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:ba21e648-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:ba220e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba223710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:ba225fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:ba228850-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:ba22b118-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:ba22d972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:ba230528-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:ba232d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:ba2355b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:ba237e04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:ba23a6f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:ba23cf30-94cc-11ec-8aec-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:ba23f776-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:ba24200c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.627']} DrugCentral uuid:ba244870-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.29']} DrugCentral uuid:ba2470ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:ba2498e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:ba24c26e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:ba24eabe-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:ba251304-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:ba253c94-94cc-11ec-8aec-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:ba2565a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:ba258e10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HZR1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:ba25b674-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:ba25deba-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:ba26076e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:ba262fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:ba26580e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:ba26804a-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:ba26a9d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:ba26d20c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:ba26fa7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:ba2723ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:ba274cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:ba2775d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O78750 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba279e30-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:ba27c6da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:ba27efc0-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:ba28189c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:ba28410a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:ba286ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:ba289312-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:ba28bb30-94cc-11ec-8aec-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:ba28e36c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:ba290c66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:ba2934c0-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:ba295d10-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:ba29854c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:ba29adf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:ba29d61e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:ba29f9fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16348 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin targets Transporter (Solute carrier family 15 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2a3a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ab91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2b18b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:ba2b40ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba2b6506-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:ba2b8da6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:ba2bb5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba2bde3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba2c0664-94cc-11ec-8aec-0242ac110003 UniProtKB:P35236 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2c4804-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba2ca5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:ba2cce64-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:ba2cf696-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:ba2d1ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:ba2d4768-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:ba2d6f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:ba2d97ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:ba2dbfe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:ba2de95c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:ba2e151c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba2e3916-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:ba2e612a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:ba2e8998-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:ba2eb1b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:ba2ed9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:ba2f0206-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:ba2f2ad8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:ba2f5422-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:ba2f7c40-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:ba2fa468-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:ba2fce20-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba300d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba306c90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba30908a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:ba30b8b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba30f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba315740-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:ba317b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:ba31a650-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:ba31cec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:ba31f6f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00488 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Coagulation factor XIII A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:ba321fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba324876-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceruletide is agonist of GPCR (Cholecystokinin receptor type A) DrugCentral uuid:ba326c70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:ba3294ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:ba32bd06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:ba32e772-94cc-11ec-8aec-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrorelix targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:ba330b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrorelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:ba3333da-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:ba335bee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.983']} DrugCentral uuid:ba33851a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:ba33ad2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.883']} DrugCentral uuid:ba33d56a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.201']} DrugCentral uuid:ba33ff68-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:ba3427ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.93']} DrugCentral uuid:ba344fd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:ba3477f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:ba34a0da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13443 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Disintegrin and metalloproteinase domain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:ba34c902-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:ba34f12a-94cc-11ec-8aec-0242ac110003 UniProtKB:P62580 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Chloramphenicol acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:ba351952-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:ba35433c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q88N29 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Unclassified (Probable HTH-type transcriptional regulator TtgR) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:ba356cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorcyclizine targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:ba359508-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:ba35bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:ba35e60c-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba360e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:ba3636ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:ba365ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:ba3687f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:ba36b8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:ba36b8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:ba36b8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:ba36ff4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:ba36ff4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:ba36ff4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:ba374b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:ba374b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:ba374b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:ba379146-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:ba379146-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:ba379146-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:ba37d7f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:ba37d7f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:ba37d7f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba385130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba3939ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba399d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba399d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba39d4ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba39d4ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba3a0994-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:ba3a3284-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:ba3a5ac0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:ba3a82fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba3aab56-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:ba3ad6d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:ba3b00d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:ba3b28f6-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba3b518c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:ba3b79dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba3ba222-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:ba3bca7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.764']} DrugCentral uuid:ba3bf3d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:ba3c1c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:ba3c445c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.163']} DrugCentral uuid:ba3c7440-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:ba3c7440-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:ba3c7440-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:ba3caed8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:ba3cd2f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloropyramine targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:ba3cfb40-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:ba3d2444-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:ba3d4ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba3d75ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:ba3d9e10-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:ba3dc886-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:ba3df144-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:ba3e1994-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:ba3e41d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:ba3e6c14-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:ba3e94b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:ba3ebcfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:ba3ee522-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:ba3f0e30-94cc-11ec-8aec-0242ac110003 UniProtKB:P05227 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Cytosolic other (Histidine-rich protein PFHRP-II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:ba3f3658-94cc-11ec-8aec-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:ba3f5e94-94cc-11ec-8aec-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:ba3f86e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:ba3fb056-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:ba3fd8c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N6S8 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Cysteine proteinase falcipain 2a) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:ba4000ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorothiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:ba4024fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['5.43']} DrugCentral uuid:ba404f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorotrianisene targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:ba40734c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorotrianisene is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:ba40975a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:ba40bfdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:ba40e8ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:ba4110ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:ba413930-94cc-11ec-8aec-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:ba416158-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:ba418a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.818']} DrugCentral uuid:ba41b284-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:ba41dbd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:ba4204f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:ba422e1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:ba4257b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:ba428006-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:ba42b0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba42b0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba42b0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba42ef64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:ba4317b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96JM7 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:ba43409a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05BQ5 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (MBT domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:ba4368ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:ba439130-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.842']} DrugCentral uuid:ba43b976-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:ba43e32e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphentermine is substrate of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.471']} DrugCentral uuid:ba440bce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.404']} DrugCentral uuid:ba44343c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:ba445c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.987']} DrugCentral uuid:ba44854a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:ba44adb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.233']} DrugCentral uuid:ba44d608-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:ba44fe8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:ba45278e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:ba454fde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:ba45781a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:ba45a13c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba45ca54-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:ba45f330-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:ba461b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:ba4643bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:ba466c84-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:ba469542-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:ba46bd88-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:ba46e66e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:ba470ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:ba473786-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:ba475fc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:ba478920-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba47b170-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:ba47d9ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.759']} DrugCentral uuid:ba480328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:ba482bdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:ba485422-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.746']} DrugCentral uuid:ba487c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.251']} DrugCentral uuid:ba48a490-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:ba48cd80-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:ba48f62a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:ba491e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:ba494698-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:ba497172-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:ba499cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:ba49c514-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:ba49ed64-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:ba4a171c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:ba4a3f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:ba4a67a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:ba4a90a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:ba4ac0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:ba4ac0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:ba4ac0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:ba4aff2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:ba4b2792-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:ba4b50be-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:ba4b790e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:ba4ba12c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:ba4bc9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.061']} DrugCentral uuid:ba4bf208-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.713']} DrugCentral uuid:ba4c1a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.569']} DrugCentral uuid:ba4c4258-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba4c6b3e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:ba4c937a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.043']} DrugCentral uuid:ba4cbbde-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:ba4ce42e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.797']} DrugCentral uuid:ba4d0df0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:ba4d36ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:ba4d6016-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.835']} DrugCentral uuid:ba4d8870-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:ba4db25a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:ba4ddabe-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.777']} DrugCentral uuid:ba4e030e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:ba4e2b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:ba4e5462-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:ba4e7ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:ba4ea52a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:ba4ecd8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba4ef94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:ba4f2342-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:ba4f4b92-94cc-11ec-8aec-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba4f7478-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:ba4f9cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba4fc59a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:ba4fedf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba502e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba50b14e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba512c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba512c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba512c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba512c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba512c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:ba518574-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:ba518574-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:ba51c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba51c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba51c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba51c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba51c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba522682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:ba522682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:ba522682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:ba526cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:ba526cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:ba526cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba52caba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:ba534224-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:ba536a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba53929c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04925 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Unclassified (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba53bba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:ba53e3f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba541032-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:ba541032-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:ba5443c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:ba546dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:ba549642-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.367']} DrugCentral uuid:ba54bea6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:ba54e71e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:ba55105e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:ba55396c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:ba55619e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:ba5589c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:ba55b252-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:ba55dad4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:ba56040a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:ba562e9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.194']} DrugCentral uuid:ba565702-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:ba567f34-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:ba56a78e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral uuid:ba56d0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:ba56f946-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba57216e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Surface antigen (Major prion protein) DrugCentral uuid:ba574590-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba576e1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.56']} DrugCentral uuid:ba57966c-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:ba57ba84-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:ba57e2d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:ba580cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:ba583554-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:ba585d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:ba5885cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:ba58aed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:ba58d716-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:ba58ff70-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:ba5927d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:ba595092-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:ba5978ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba59a114-94cc-11ec-8aec-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:ba59c932-94cc-11ec-8aec-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba59f416-94cc-11ec-8aec-0242ac110003 UniProtKB:P29474 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, endothelial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:ba5a1c66-94cc-11ec-8aec-0242ac110003 UniProtKB:P29476 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.554']} DrugCentral uuid:ba5a44a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:ba5a6d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is opener of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:ba5a961e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:ba5abe6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:ba5ae6be-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:ba5b0fea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:ba5b384e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:ba5b60b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba5b890c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:ba5bb24c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.31']} DrugCentral uuid:ba5bda92-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:ba5c0404-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:ba5c2c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:ba5c5562-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:ba5c7db2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:ba5ca68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:ba5ccee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:ba5cf7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:ba5d1fce-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.39']} DrugCentral uuid:ba5d4828-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:ba5d7078-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:ba5d9aee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:ba5dc366-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:ba5decb0-94cc-11ec-8aec-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba5e14f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:ba5e3e5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4QEW7 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:ba5e66b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:ba5e8f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:ba5eb802-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:ba5ee052-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:ba5f08ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:ba5f2ca6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:ba5f55f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:ba5f7e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:ba5fa690-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:ba5fcee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:ba5ff79e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:ba601fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:ba60482a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:ba607070-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:ba609910-94cc-11ec-8aec-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:ba60c156-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba60fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:ba616156-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:ba618aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:ba61b318-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox is inhibitor of Unclassified (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:ba61dc08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba620430-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicloprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:ba622c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicloprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:ba6254bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cidofovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:ba627942-94cc-11ec-8aec-0242ac110003 UniProtKB:P16444 biolink:molecularly_interacts_with DrugCentral:640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilastatin is inhibitor of Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:ba62a192-94cc-11ec-8aec-0242ac110003 UniProtKB:P22412 biolink:molecularly_interacts_with DrugCentral:640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilastatin targets Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:ba62c9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilazapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:ba62f232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba632126-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:ba632126-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:ba634ee4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba637720-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba639fca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:ba63c7de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:ba63f02e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:ba641888-94cc-11ec-8aec-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:ba644128-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:ba646a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is inhibitor of Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:ba649272-94cc-11ec-8aec-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:ba64bb30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:ba64e5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:ba650e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:ba6536f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet is allosteric modulator of GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:ba655f40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinalukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:ba65892a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinalukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:ba65ad38-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:ba65d57e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:ba65fdd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:ba662664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:ba664e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:ba6676c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.552']} DrugCentral uuid:ba669f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.208']} DrugCentral uuid:ba66c858-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.987']} DrugCentral uuid:ba66f094-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:ba671a10-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:ba67431e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:ba676b78-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.064']} DrugCentral uuid:ba6793b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:ba67bc04-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:ba67e4ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:ba680cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:ba68353a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:ba685e2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:ba688742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:ba68af6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.242']} DrugCentral uuid:ba68d83c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.299']} DrugCentral uuid:ba690082-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.793']} DrugCentral uuid:ba69294a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:ba695230-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.97']} DrugCentral uuid:ba698304-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:ba698304-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:ba698304-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:ba69c1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:ba69ee20-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:ba69ee20-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:ba6a1c24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:ba6a4460-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:ba6a6e54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q45066 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:ba6a969a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:ba6abecc-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:ba6ae71c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:ba6b0fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6b711e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:ba6c4698-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:ba6c4698-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:ba6c7a14-94cc-11ec-8aec-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:ba6ca278-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:ba6ccb40-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:ba6cf39a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:ba6d1bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:ba6d441c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:ba6d6d16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:ba6d9552-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:ba6dbd98-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:ba6de5de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba6e10d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:ba6e3962-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:ba6e61d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:ba6e8a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba6eb2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.281']} DrugCentral uuid:ba6edafc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:ba6f03d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.947']} DrugCentral uuid:ba6f2c28-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:ba6f54dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:ba6f7e30-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.472']} DrugCentral uuid:ba6fa6a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:ba6fd02e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.063']} DrugCentral uuid:ba6ff900-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:ba702150-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:ba7049c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:ba70725e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:ba709a90-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:ba70c2e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:ba70eb3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:ba711556-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:ba7141a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:ba7141a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:ba7184aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:ba7184aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:ba7184aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:ba7184aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:ba7184aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:ba71ec2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba71ec2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba71ec2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba71ec2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba723dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba723dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba723dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:ba72851c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:ba72851c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:ba72851c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:ba72c3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:ba72f4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:ba72f4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:ba72f4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:ba733354-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:ba735b9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:ba7385ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.935']} DrugCentral uuid:ba73af0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:ba73d764-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:ba73ffd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.931']} DrugCentral uuid:ba74289a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:ba745108-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.456']} DrugCentral uuid:ba7479c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:ba74a22a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:ba74cb10-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:ba74f37e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:ba751c3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:ba754496-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:ba75702e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:ba759aea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:ba75c470-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:ba75ed4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:ba761682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:ba763ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:ba766736-94cc-11ec-8aec-0242ac110003 UniProtKB:Q48255 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba76901c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15474 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:ba76b880-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPK8 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba76e09e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:ba7704c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.441']} DrugCentral uuid:ba772da6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:ba7755f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:ba777e50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:668 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clarithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:ba77a68c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'MPC', 'has_quantitative_value': ['8.719']} DrugCentral uuid:ba77cf36-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.187']} DrugCentral uuid:ba77f7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:ba781fea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba784808-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:ba787102-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:ba789966-94cc-11ec-8aec-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:ba78c1ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:ba78e9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:ba7913dc-94cc-11ec-8aec-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:ba793c04-94cc-11ec-8aec-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:ba796440-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:ba798c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:ba79b508-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:ba79dd30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:ba7a056c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:ba7a2fce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:ba7a580a-94cc-11ec-8aec-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:ba7a8046-94cc-11ec-8aec-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:ba7aa864-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4TVR4 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:ba7ad21c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:ba7afc4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:ba7b2460-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A3M1 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:ba7b4cce-94cc-11ec-8aec-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:ba7b7564-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:ba7b9f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:ba7bc780-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:ba7befda-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:ba7c18de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba7c4138-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:ba7c6992-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:ba7c91ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:ba7cbc58-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:ba7ce4c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:ba7d0d20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:ba7d3d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba7d3d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba7d3d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba7d83a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:ba7d83a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:ba7d83a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:ba7dc210-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:ba7debf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:ba7e1440-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:ba7e3c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:ba7e64e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:ba7e8f74-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:ba7eb7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.036']} DrugCentral uuid:ba7ee01e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:ba7f0878-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:ba7f3140-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:ba7f5990-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:ba7f81e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.604']} DrugCentral uuid:ba7faaee-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:ba7fd352-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:ba7ffb8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:ba8023de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:ba804daa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.084']} DrugCentral uuid:ba8078ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.558']} DrugCentral uuid:ba80a124-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:ba80c99c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:ba80f26e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:ba811ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:ba81444e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:ba816ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:ba81962e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:ba81be56-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:ba81e7aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:ba82100e-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:ba823bba-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:ba826676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:ba828ec6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:ba82b77a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:ba82dfc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN4 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:ba8308ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:ba83310a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:ba835a04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:ba83824a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:ba83ab08-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:ba83d380-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:ba83fd74-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:ba8425ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:ba844e32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:674 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:ba847254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:674 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:ba8496da-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:ba84baf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:ba84e34c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clindamycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:ba850750-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:ba853040-94cc-11ec-8aec-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:ba855886-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:ba8580ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:ba85b10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:ba85b10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:ba85b10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:ba85eb70-94cc-11ec-8aec-0242ac110003 UniProtKB:P05141 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 2) DrugCentral uuid:ba860f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12235 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Transporter (ADP/ATP translocase 1) DrugCentral uuid:ba86338c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12236 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 3) DrugCentral uuid:ba86579a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:ba867c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT1 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid is inhibitor of Transporter (Solute carrier family 17 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:ba86a48e-94cc-11ec-8aec-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:ba86ccfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:ba86f240-94cc-11ec-8aec-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba871b62-94cc-11ec-8aec-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba874394-94cc-11ec-8aec-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:ba876784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HA47 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 1) DrugCentral uuid:ba878c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZX2 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 2) DrugCentral uuid:ba87b298-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:ba87dad4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L2G3 biolink:molecularly_interacts_with DrugCentral:692 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofazimine targets Enzyme (Uncharacterized oxidoreductase CzcO-like) DrugCentral uuid:ba87fee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:692 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofazimine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:ba88273c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:ba884ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:ba887822-94cc-11ec-8aec-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Enzyme (Lipoprotein lipase) DrugCentral uuid:ba889c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba88c462-94cc-11ec-8aec-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:ba88ed66-94cc-11ec-8aec-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clometacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba8915ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.461']} DrugCentral uuid:ba893dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:ba896638-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:ba899234-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.745']} DrugCentral uuid:ba89baa2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:ba89e400-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:ba8a0cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:ba8a3522-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:ba8a5d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.062']} DrugCentral uuid:ba8a85a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:ba8aae94-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:ba8ad6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:ba8aff34-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:ba8b2752-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:ba8b5100-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:ba8b793c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.889']} DrugCentral uuid:ba8ba16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.358']} DrugCentral uuid:ba8bc9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:ba8bf27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:ba8c1acc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.371']} DrugCentral uuid:ba8c431c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.668']} DrugCentral uuid:ba8c6b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:ba8c9470-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba8cbdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:ba8ce632-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:ba8d0f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.979']} DrugCentral uuid:ba8d3aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:ba8d6300-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.778']} DrugCentral uuid:ba8d8b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:ba8db3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:ba8ddd26-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:ba8e0594-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:ba8e2dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:ba8e56d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:ba8e7f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:ba8ea756-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:ba8ecf9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:ba8ef972-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.703']} DrugCentral uuid:ba8f21e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:ba8f4a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:ba8f72ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:ba8f9c10-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:ba8fc488-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:ba8fecb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:ba901514-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:ba903dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.412']} DrugCentral uuid:ba90660e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.007']} DrugCentral uuid:ba908e5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.696']} DrugCentral uuid:ba90b6ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:ba90e232-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:ba910bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:ba913408-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:ba915cee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:ba918566-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.319']} DrugCentral uuid:ba91ad84-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:ba91d692-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:ba91ff32-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:ba922796-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:ba925068-94cc-11ec-8aec-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Glutathione S-transferase P) DrugCentral uuid:ba927476-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:ba929dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:ba92c764-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:ba92f022-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.937']} DrugCentral uuid:ba931912-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:ba93422a-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:ba936a7a-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:ba9392b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:ba93bae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba9414d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:ba94df7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba94df7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba94df7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba94df7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:ba953152-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:ba953152-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:ba953152-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:ba957798-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:ba957798-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:ba957798-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:ba95b668-94cc-11ec-8aec-0242ac110003 UniProtKB:P39051 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:ba95deae-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba960ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:ba960ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:ba960ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba968746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba976a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba980436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:ba98e298-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:ba990c1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:ba99346e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:ba995e26-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:ba998694-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:ba99aed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:ba99d72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:ba9a0146-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:ba9a2996-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:ba9a51b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:ba9a7a0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:ba9aa2cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:ba9acb12-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:ba9af34e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:ba9b1b9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:ba9b4538-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:ba9b6d6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:ba9b95b0-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba9bbf04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:ba9bea88-94cc-11ec-8aec-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:ba9c1314-94cc-11ec-8aec-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:ba9c3c40-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:ba9c64cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:ba9c94ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:ba9c94ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:ba9c94ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:ba9cd362-94cc-11ec-8aec-0242ac110003 UniProtKB:O70507 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:ba9cfc70-94cc-11ec-8aec-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:ba9d24a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonixin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:ba9d4ce8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloperastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:ba9d7542-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.524']} DrugCentral uuid:ba9d9f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:ba9dc790-94cc-11ec-8aec-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:ba9df792-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:ba9df792-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:ba9df792-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:ba9e3e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:ba9e3e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:ba9e3e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:ba9e7eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:ba9e7eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:ba9e7eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:ba9ebe16-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:ba9ebe16-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:ba9ebe16-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:ba9ef5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:ba9f1e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:ba9f476e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:ba9f711c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:ba9f99c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:ba9fd13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:ba9fd13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:ba9fd13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:ba9fd13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:ba9fd13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:baa02e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:baa02e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:baa02e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:baa06cde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:baa0952e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.379']} DrugCentral uuid:baa0bdd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:baa0e5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.136']} DrugCentral uuid:baa10e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:baa1368c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:baa15fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:baa18998-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.351']} DrugCentral uuid:baa1b1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:baa1daba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:baa202ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:baa22bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:baa2544a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.104']} DrugCentral uuid:baa27d58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.995']} DrugCentral uuid:baa2a6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:baa2cf06-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:baa2f7ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:baa32474-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.235']} DrugCentral uuid:baa34cce-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.429']} DrugCentral uuid:baa37668-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:baa39ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.466']} DrugCentral uuid:baa3c7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:baa3f020-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:baa41866-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:baa440c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:baa469ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:baa49214-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:baa4ba50-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.267']} DrugCentral uuid:baa4e2a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:baa50e06-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.106']} DrugCentral uuid:baa5364c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:baa55eba-94cc-11ec-8aec-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:baa5876e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:baa5ab72-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:baa5d3ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.521']} DrugCentral uuid:baa5fc30-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:baa62548-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.598']} DrugCentral uuid:baa64db6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:baa671ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:baa69a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:baa6c4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.712']} DrugCentral uuid:baa6ed7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:baa715de-94cc-11ec-8aec-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.645']} DrugCentral uuid:baa73e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:baa76750-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:baa78faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.159']} DrugCentral uuid:baa7b7fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:baa7e04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.058']} DrugCentral uuid:baa8094e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.089']} DrugCentral uuid:baa83180-94cc-11ec-8aec-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:baa859ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:baa8825c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.497']} DrugCentral uuid:baa8ab7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:baa8d3a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:baa8fc78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:baa924be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:baa94ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:baa976ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.471']} DrugCentral uuid:baa99f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:baa9c838-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.906']} DrugCentral uuid:baa9f0b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:baaa18f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:baaa4132-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.942']} DrugCentral uuid:baaa6a86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:baaa92cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:baaabc52-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:baaae4b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:baab0d88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:baab35ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.99']} DrugCentral uuid:baab5e32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:baab868c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:baabafc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:baabd808-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:baac0044-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPN5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Putative cytochrome P450 130) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:baac288a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:baac53aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:baac7d6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:baaca5bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:baaccdee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:baacf242-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:baad1a74-94cc-11ec-8aec-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:baad42b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:baad6ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:baad93be-94cc-11ec-8aec-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:baadcb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:baadcb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:baadcb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:baadcb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:baadcb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:baae179e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxazolam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:baae3fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:baae688e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.783']} DrugCentral uuid:baae91ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:baaebabe-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:baaee444-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.154']} DrugCentral uuid:baaf0cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:baaf3502-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:baaf5e38-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:baaf86a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:baafaf82-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:baafd818-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bab001d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bab02a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bab0525c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:bab07aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:bab0a34c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bab0cc6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bab0f4c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bab11dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.594']} DrugCentral uuid:bab14612-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bab16ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:bab19766-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bab1c11e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.181']} DrugCentral uuid:bab1e9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bab211f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.591']} DrugCentral uuid:bab23a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:bab262cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.792']} DrugCentral uuid:bab28bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:bab2b452-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bab2dcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bab305ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bab32ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:bab356fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bab37f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bab3a880-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bab3d0d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:bab3f920-94cc-11ec-8aec-0242ac110003 UniProtKB:P22310 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (UDP-glucuronosyltransferase 1-4) {'has_attribute_type': 'IAO:0000004', 'name': 'app Km', 'has_quantitative_value': ['4.208']} DrugCentral uuid:bab42166-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bab44a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bab472b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bab49b00-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.445']} DrugCentral uuid:bab4c54e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bab4edc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bab516ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bab53f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bab568a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bab59186-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:bab5b9e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:bab5e244-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bab60b16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bab6335c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bab65bc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bab68410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bab6ae0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bab6d672-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bab6fec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bab7271c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bab75214-94cc-11ec-8aec-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bab77a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bab7a2be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bab7cb22-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bab7f408-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bab81c6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bab844bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bab86db6-94cc-11ec-8aec-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bab89674-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bab8bece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bab8e728-94cc-11ec-8aec-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bab910d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bab93b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bab963b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bab98c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bab9b4c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bab9dd2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:baba0982-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:baba0982-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:baba4d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:baba4d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:baba4d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:baba4d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:baba4d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:babaafc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:babaafc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:babaafc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:babaafc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:babb0418-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:babb0418-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:babb0418-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:babb469e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:babb469e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:babb89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:babb89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:babb89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:babb89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:babb89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:babbe6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:babbe6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:babbe6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babc410c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:babcc0d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:babcc0d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:babcc0d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:babcff5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:babd27b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:babd5060-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:babd78c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:babda114-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:babdc522-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:babdee26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:babe1658-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:babe3fde-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:babe684c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:babe9204-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:babeba54-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:babee2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:babf0b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:babf33f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:babf5c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:babf8038-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:babfa874-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:babfcd18-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:babff55e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bac01e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bac046a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bac071fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bac09aae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bac0c790-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bac0c790-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bac103d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:bac103d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:bac103d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:bac1424c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27922 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bac16a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GJT6 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bac192d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bac1bbe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bac1e472-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bac21834-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bac21834-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bac21834-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bac21834-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bac26280-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bac28abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.801']} DrugCentral uuid:bac2b30c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bac2d774-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.49']} DrugCentral uuid:bac2ff9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:bac327e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bac35046-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bac378f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bac3a276-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6B856 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin beta-2B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bac3cad0-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine is inhibitor of Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bac3f410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27957 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Unclassified (Tubulin polymerization-promoting protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bac41e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin beta-4B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bac44e38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bac44e38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bac44e38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bac4908c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bac4908c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bac4c46c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08828 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bac4f446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bac4f446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bac4f446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bac532a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bac55b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P19754 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:bac583d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:bac5ac42-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:bac5d4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bac5fe40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bac626a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:bac64ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:bac6778a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:bac69b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bac6c3f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bac6ec1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:bac7156e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:bac74174-94cc-11ec-8aec-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bac74174-94cc-11ec-8aec-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bac77608-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortivazol is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bac79a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cotinine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:bac7bfc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bac7e804-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bac81054-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bac838ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bac8616c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bac8899e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bac8b1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bac8daa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bac90482-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bac92d18-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bac95572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bac97dea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bac9aa2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bac9d54c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bac9fd88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:baca26a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q33BM1 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G protein-coupled receptor GPR35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:baca4ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES90 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:baca770e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bacaa030-94cc-11ec-8aec-0242ac110003 UniProtKB:P25815 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets Cytosolic other (Protein S100-P) DrugCentral uuid:bacac4a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bacaecf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:bacb1556-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bacb3db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bacb68d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bacb93dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bacbbc7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.602']} DrugCentral uuid:bacbe4c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:bacc0db2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:bacc35ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:bacc5e34-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bacc8698-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:baccaf38-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:baccd774-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.235']} DrugCentral uuid:baccffa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:bacd27ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:bacd53de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:bacd7c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.993']} DrugCentral uuid:bacda532-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.353']} DrugCentral uuid:bacdce36-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:bacdf690-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.385']} DrugCentral uuid:bace1ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:bace4730-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.924']} DrugCentral uuid:bace6fee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:bace985c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:bacec0b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.206']} DrugCentral uuid:baceea1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:bacf1412-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:bacf382a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bacf6232-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.728']} DrugCentral uuid:bacf8a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:bacfb390-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:bacfdbfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.541']} DrugCentral uuid:bad004d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.812']} DrugCentral uuid:bad02d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:bad055f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:bad07e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:bad0a692-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.829']} DrugCentral uuid:bad0ced8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bad0f7e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:bad12018-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:bad1485e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:bad1709a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bad1999e-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclofenil targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bad1c1f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclofenil targets Nuclear other (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bad1ea34-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bad212fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:bad23b6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bad263ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bad28c00-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bad2b5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bad2de3a-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:bad306a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclopentolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bad32a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclophosphamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bad35478-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad37c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:bad3a4d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad3cce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad3f586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bad41e26-94cc-11ec-8aec-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad44658-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WQA8 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Enzyme (Alanine racemase) DrugCentral uuid:bad46a52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bad494f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O60391 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad4be6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WP31 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine is inhibitor of Enzyme (D-alanine--D-alanine ligase) DrugCentral uuid:bad4e2a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WQA9 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine is inhibitor of Enzyme (Alanine racemase) DrugCentral uuid:bad506ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bad52f96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad56e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bad5d95a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bad601aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:bad629f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bad6522c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bad67cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bad6a542-94cc-11ec-8aec-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is modulator of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:bad6ce82-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bad6f7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bad71fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bad747ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bad7701c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bad79920-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02790 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bad7c148-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bad7e984-94cc-11ec-8aec-0242ac110003 UniProtKB:P23284 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.01']} DrugCentral uuid:bad811d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bad83b32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bad86364-94cc-11ec-8aec-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bad88ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08752 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bad8b3d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bad8dc86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bad904a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bad92cea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHG7 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:bad95526-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:bad979e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bad9a21a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bad9ca42-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bad9f26a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:bada2af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bada2af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bada2af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bada2af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bada7654-94cc-11ec-8aec-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bada9f08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:badac7d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05412 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Transcription factor (Transcription factor AP-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:badaeff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycrimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:badb13de-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:badb3cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:badb651e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:badb8d64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.855']} DrugCentral uuid:badbb58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:badbdaee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:badc03a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:badc2be8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:badc541a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.419']} DrugCentral uuid:badc7cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.812']} DrugCentral uuid:badca500-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.652']} DrugCentral uuid:badccd3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:badcf55a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:badd1eae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:badd46f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:badd6f26-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:badd976c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:baddc278-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:baddeadc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.185']} DrugCentral uuid:bade1304-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bade3b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bade67d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bade92c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:badebb24-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.559']} DrugCentral uuid:badee3c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:badf0c14-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:badf343c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:badf5d18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:badf8e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:badf8e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:badf8e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:badfc762-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:badfefb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:bae01884-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bae04156-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:bae06988-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:bae091b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:bae0ba3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bae0e26e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bae10aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bae132e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bae15be0-94cc-11ec-8aec-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bae1844e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bae1ac8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bae1e42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bae1e42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bae1e42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bae1e42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bae1e42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bae249f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bae249f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bae249f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bae249f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bae249f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bae2a69e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bae2a69e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bae2a69e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bae2ecbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bae2ecbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bae2ecbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bae32c0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bae3542c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:bae37c72-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bae3a4cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bae3cda8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:bae3f6e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bae41f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.315']} DrugCentral uuid:bae44774-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bae4703c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:769 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cysteine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:bae4988c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15309 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (Prostatic acid phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'GI50', 'has_quantitative_value': ['7']} DrugCentral uuid:bae4c0e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:bae4e918-94cc-11ec-8aec-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (DNA polymerase beta) DrugCentral uuid:bae515f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bae515f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bae515f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bae54e80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bae576bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacarbazine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.255']} DrugCentral uuid:bae59f84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14181 biolink:molecularly_interacts_with DrugCentral:773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacarbazine targets Enzyme (DNA polymerase alpha subunit B) DrugCentral uuid:bae5c3a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P62993 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bae5ebe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bae61446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60631 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bae63d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96IV0 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Enzyme (Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:bae66644-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bae68e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bae6b6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:bae6e02e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bae7086a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bae730a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bae758e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bae7816e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bae7a9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bae7d984-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bae7d984-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bae7d984-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bae818cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bae840fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28731 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Unclassified (Thrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bae86930-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:bae89158-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:bae8bbd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.163']} DrugCentral uuid:bae8e540-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.087']} DrugCentral uuid:bae90d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:bae935ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:bae95fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.976']} DrugCentral uuid:bae98842-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:bae9b088-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.425']} DrugCentral uuid:bae9d8d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.708']} DrugCentral uuid:baea01dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:baea2a18-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:baea5272-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.265']} DrugCentral uuid:baea7bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:baeaa556-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:baeacd92-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:baeaf5e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:baeb1a54-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:baeb3e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:baeb666c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Enzyme (Steryl-sulfatase) DrugCentral uuid:baeb8a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:baebb360-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.053']} DrugCentral uuid:baebdb92-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:baec0446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:baec2ca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.757']} DrugCentral uuid:baec5680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15413 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 3) DrugCentral uuid:baec7b06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:baeca36a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.929']} DrugCentral uuid:baeccbc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.762']} DrugCentral uuid:baecf568-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:baed1dc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:baed4630-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:baed6a3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.279']} DrugCentral uuid:baed9306-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.388']} DrugCentral uuid:baedbb56-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:baede040-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:baee0886-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:baee318a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:baee59bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:baee82ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:baeeab2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone is inhibitor of Enzyme (Dihydropteroate synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:baeed400-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:baeefc1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:baef2446-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:baef498a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:baef720c-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:baef9a5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:baefc2d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q57P83 biolink:molecularly_interacts_with DrugCentral:783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daptomycin targets Transporter (Outer membrane porin protein OmpD) DrugCentral uuid:baefe6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:baf0105e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:baf038b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:baf060e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:baf08926-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:baf0b270-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:baf0daa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:baf103f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:baf12c3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:baf15504-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:baf17d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:baf1a5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:baf1cf7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:baf1f7f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:baf220c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:baf2490a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:baf271c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Breakpoint cluster region protein) DrugCentral uuid:baf295d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:baf2be1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:baf2e676-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:baf30f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:baf3377a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.07']} DrugCentral uuid:baf35fac-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:baf387f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:baf3b1a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:baf3d9c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:baf401f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:baf42a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:baf452fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:baf47b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.33']} DrugCentral uuid:baf4a33a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:baf4cb58-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:baf4f51a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.46']} DrugCentral uuid:baf51d60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:baf546c8-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:baf56f04-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:baf59a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:baf5c2b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:baf5eb00-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:baf613fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:baf63c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:baf6649a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:baf68ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:baf6b5ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:baf6de0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:baf7063e-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:baf72e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.77']} DrugCentral uuid:baf75742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:baf77f74-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:baf7a7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:baf7cfe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:baf7f8d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:baf82104-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:baf8492c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:baf8717c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:baf89a80-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:baf8c29e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:baf8eba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.03']} DrugCentral uuid:baf913d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:baf93d64-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:baf965b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:baf98de6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:baf9b622-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:baf9def4-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:bafa0730-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.35']} DrugCentral uuid:bafa2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bafa5816-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.25']} DrugCentral uuid:bafa8052-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bafaa884-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.16']} DrugCentral uuid:bafad0c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.47']} DrugCentral uuid:bafafa1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bafb2264-94cc-11ec-8aec-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bafb4bcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bafb7412-94cc-11ec-8aec-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bafb9cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bafbc50c-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bafbed3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bafc1566-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bafc3e60-94cc-11ec-8aec-0242ac110003 UniProtKB:P06240 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase LCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.19']} DrugCentral uuid:bafc669c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bafc9036-94cc-11ec-8aec-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bafcb84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:bafce43c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bafd0ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bafd35e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bafd5e26-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bafd86d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bafdaf0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bafdd7de-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bafe011e-94cc-11ec-8aec-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bafe2964-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bafe5196-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bafe79d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bafea2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bafecb26-94cc-11ec-8aec-0242ac110003 UniProtKB:P27037 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bafef34e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:baff1b80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:baff448e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:baff6cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:baff94e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:baffbd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:baffe61e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bb000e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bb003664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bb005eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bb008876-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:bb00b0a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P36894 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bb00d9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bb010242-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb012ad8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bb01544a-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:bb017d58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bb01a59e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bb01cf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bb01f79c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bb021fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:bb02492c-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bb02717c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bb0299c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bb02c212-94cc-11ec-8aec-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb02eab2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.41']} DrugCentral uuid:bb0312f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bb033b3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:bb036384-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bb038c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bb03b4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bb03dce2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bb040546-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bb042fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bb04596a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bb0481ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bb04a9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bb04d372-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bb04fbc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:bb0523ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bb054c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bb057552-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bb059da2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb05c5de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bb05ee9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bb06231c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bb06231c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bb06231c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bb06231c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bb067056-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bb067056-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bb06a80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bb06a80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bb06dcc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01538 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Transcription factor (Myelin transcription factor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bb07050c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bb0729d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:bb074de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bb0771d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bb0795ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:bb07b9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bb07e558-94cc-11ec-8aec-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bb080db2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deanol targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bb0835e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deanol targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bb085f38-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:788 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:bb088396-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:788 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:bb08a7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:bb08d01c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bb08f858-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bb09215c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bb094db2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bb094db2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bb0990d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:bb0990d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:bb0990d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:bb0990d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:bb0990d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:bb09dc46-94cc-11ec-8aec-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bb0a0496-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:bb0a28a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferoxamine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bb0a514e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferoxamine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb0a798a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bb0aa1e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.84']} DrugCentral uuid:bb0aca34-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bb0af324-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GRG7 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bb0b1b88-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bb0b43ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.97']} DrugCentral uuid:bb0b6bec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:bb0b9504-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:bb0bbd36-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bb0be586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb0c0f20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bb0c3888-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb0c6966-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:bb0c6966-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:bb0c6966-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0ce1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bb0db80c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demecarium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:bb0ddc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:bb0e0078-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:bb0e2490-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bb0e4dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denopamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:bb0e75e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bb0e9efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deptropine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb0ec76a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deptropine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bb0ef758-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bb0ef758-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bb0ef758-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bb0f3952-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deserpidine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:bb0f5dce-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:bb0f8204-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:bb0fa644-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:bb0fcad4-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:bb0feed8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:bb101822-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bb101822-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb107fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bb113c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:bb116448-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.631']} DrugCentral uuid:bb118cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bb11b54c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bb11dd92-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.755']} DrugCentral uuid:bb1205e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.081']} DrugCentral uuid:bb122ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.194']} DrugCentral uuid:bb125722-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:bb127f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bb12a786-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bb12d12a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bb12f95c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:bb131d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bb134588-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:bb136e32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bb139704-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bb13bf54-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bb13e790-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:bb141062-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:bb1438bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:bb14621a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:bb148628-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bb14b0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:bb14d92a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bb150260-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bb152aba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:bb15538c-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bb157bb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bb15a3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bb15cc22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16269a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb16f084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bb16f084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bb16f084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bb172f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bb1757a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bb1780e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb17c4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:bb182da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb1856ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:bb187f26-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:bb18a776-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.025']} DrugCentral uuid:bb18cfd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:bb18f88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bb1920e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:bb194942-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:bb197188-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.189']} DrugCentral uuid:bb199a96-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bb19c2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:bb19ebcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bb1a149e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bb1a3d84-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bb1a65c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bb1a8e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb1ab73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bb1adf82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:bb1b08e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:bb1b3126-94cc-11ec-8aec-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.027']} DrugCentral uuid:bb1b59ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P28476 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-2) DrugCentral uuid:bb1b85a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:bb1b85a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:bb1b85a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1bfbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bb1cc180-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bb1ce9da-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:bb1d1220-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bb1d3b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:bb1d643c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bb1d8c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:bb1db4e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bb1dde30-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb1e0680-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bb1e2a98-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bb1e52fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.932']} DrugCentral uuid:bb1e7bb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone targets Cytosolic other (Annexin A1) DrugCentral uuid:bb1e9fc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb1ec818-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:bb1ef05e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.498']} DrugCentral uuid:bb1f1958-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bb1f41a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bb1f69f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:bb1f92c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:bb1fbb74-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bb1fe3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycorticosterone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) DrugCentral uuid:bb200818-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycorticosterone pivalate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:bb2030ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:bb20591c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.88']} DrugCentral uuid:bb208144-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:bb20a534-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:bb20ce1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bb20f624-94cc-11ec-8aec-0242ac110003 UniProtKB:P05112 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytokine (Interleukin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bb211ece-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb21471e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bb2171bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.786']} DrugCentral uuid:bb219a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bb21c2a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.517']} DrugCentral uuid:bb21eb06-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bb22139c-94cc-11ec-8aec-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bb223cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bb2260fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bb228962-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bb22b266-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb22dab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bb230310-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bb232b56-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bb23554a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:bb237d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bb23a5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bb23ce1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bb23f6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb241ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bb24473e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bb246f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bb24986a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:bb24c0a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bb24e8ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexbrompheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bb250d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bb2537ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bb256fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb256fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb256fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb256fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb256fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bb25c49c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:bb25ece2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:bb261514-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:bb263d50-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:bb266636-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bb268e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.607']} DrugCentral uuid:bb26b69a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.384']} DrugCentral uuid:bb26decc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bb270988-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:bb2731d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.257']} DrugCentral uuid:bb275a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bb27843a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bb27ac76-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:bb27d4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:bb27fcee-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:bb2825de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:bb284e10-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bb28764c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.898']} DrugCentral uuid:bb289f1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:bb28ca34-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:bb28f270-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bb291ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:bb294306-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bb296b9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexloxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:bb2993ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bb29bc0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bb29e45a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bb2a0d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bb2a35cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:bb2a5e30-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bb2a8658-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:bb2ab1c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bb2ae22e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:bb2ae22e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:bb2ae22e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:bb2b287e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb2b287e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb2b287e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb2b6776-94cc-11ec-8aec-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bb2b8fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bb2bb492-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bb2bdff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:bb2c082a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bb2c3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2c3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2c3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2c3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2c3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2c9a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bb2cc2e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bb2ceb3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:bb2d13f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bb2d3c40-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bb2d64a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bb2d8cea-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bb2db5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bb2dde02-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.824']} DrugCentral uuid:bb2e0666-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bb2e2eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bb2e5986-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bb2e81d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:bb2eaa94-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:bb2ed2e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:bb2f035e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bb2f035e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bb2f035e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bb2f45a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bb2f45a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bb2f73d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bb2f97ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bb2fc10e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bb2fe94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bb3012b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bb3038be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bb3060fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:bb3084ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:bb30ae02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:bb30d1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.87']} DrugCentral uuid:bb30fa10-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:bb312242-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bb314aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:bb31733c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bb319b46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bb31c38c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb321e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb32d86c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is agonist of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'D2', 'has_quantitative_value': ['6.458']} DrugCentral uuid:bb330094-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:bb33292a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bb335184-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bb3379d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is blocker of Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bb33a210-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bb33cc54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bb33f4ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb343374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bb34a656-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bb34a656-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bb34a656-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bb34e512-94cc-11ec-8aec-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bb350f10-94cc-11ec-8aec-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bb35372e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bb355b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bb357f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bb35ab64-94cc-11ec-8aec-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:bb35d8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:bb35d8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb361de2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bb368926-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dezocine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bb36b19e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dezocine is antagonist of GPCR (Kappa-type opioid receptor) DrugCentral uuid:bb36d660-94cc-11ec-8aec-0242ac110003 UniProtKB:P42574 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (Caspase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bb36fece-94cc-11ec-8aec-0242ac110003 UniProtKB:P55210 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (Caspase-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:bb3726f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q17339 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Unclassified (Female germline-specific tumor suppressor gld-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bb374f50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02083 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (N-acylethanolamine-hydrolyzing acid amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bb378254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb378254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb378254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb37c124-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bb37e988-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bb381296-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is allosteric modulator of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bb383b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bb3863cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bb388c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bb38b6b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:bb38df78-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bb3907d2-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bb39302c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.67']} DrugCentral uuid:bb395958-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bb398194-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bb39a9ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bb39d2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bb39fb56-94cc-11ec-8aec-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:bb3a2c66-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:bb3a2c66-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:bb3a2c66-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:bb3a7400-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bb3a7400-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bb3a7400-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bb3abf46-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:bb3abf46-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:bb3abf46-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:bb3b0686-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb3b0686-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb3b0686-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb3b529e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:bb3b529e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:bb3b529e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:bb3b9a56-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bb3b9a56-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bb3b9a56-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3c1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3cf5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb3d65d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:bb3d65d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:bb3d65d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:bb3dadf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bb3dadf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bb3dadf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bb3df404-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bb3df404-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bb3df404-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3e6826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb3f3684-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb3f3684-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb3f3684-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb3f7d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bb3f7d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bb3f7d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bb3fc392-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:bb3fc392-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:bb3fc392-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:bb400a46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:bb400a46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:bb400a46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:bb405050-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb405050-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb405050-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bb409948-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:bb409948-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:bb409948-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:bb40d94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.64']} DrugCentral uuid:bb41059a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:bb41059a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:bb41398e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is activator of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bb4161b6-94cc-11ec-8aec-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibekacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.921']} DrugCentral uuid:bb418b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bb41af40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:bb41db5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb41db5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb41db5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb4219da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bb42423e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.081']} DrugCentral uuid:bb426c3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15118 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3']} DrugCentral uuid:bb4296f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15119 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.699']} DrugCentral uuid:bb42bf48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15120 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.097']} DrugCentral uuid:bb42e798-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16654 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.301']} DrugCentral uuid:bb431088-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bb4338e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bb436128-94cc-11ec-8aec-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bb438950-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bb43b218-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:bb43da5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bb4402ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:bb442ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bb4455a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bb447e32-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:bb44a664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bb44cf54-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.577']} DrugCentral uuid:bb44f7c2-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:bb452148-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bb4549a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb457256-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bb459aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bb45c2e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bb45eb32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bb46159e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bb463f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:bb4667ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bb469028-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bb46b92c-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bb46e17c-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bb4709c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bb473208-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bb475ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bb47832a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bb47ab5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb47d3a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bb47ff08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:bb4829c4-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:bb485228-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb487b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bb48a368-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bb48cb86-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bb48f3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bb491d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bb49457a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb496e74-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bb499692-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bb49bff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bb49e822-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bb4a104a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bb4a3912-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bb4a61da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bb4a89f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bb4ab23e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bb4ada7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bb4b0342-94cc-11ec-8aec-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bb4b2b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60656 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bb4b53d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAW8 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bb4b7c78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bb4ba7ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bb4bd006-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bb4bf81a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bb4c20c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bb4c4a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bb4c7254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bb4c9662-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:bb4cbef8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:bb4ce734-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bb4d1042-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bb4d479c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bb4d479c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bb4d479c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bb4d479c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bb4d479c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bb4d981e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:bb4dc168-94cc-11ec-8aec-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb4de9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.388']} DrugCentral uuid:bb4e12c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.354']} DrugCentral uuid:bb4e3bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bb4e63f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:bb4e8c60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:bb4eb4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bb4edd32-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WMN1 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (ATP phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bb4f0582-94cc-11ec-8aec-0242ac110003 UniProtKB:P05982 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (NULLD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bb4f2e7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:bb4f573a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:bb4f7f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.773']} DrugCentral uuid:bb4fa7c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:bb4fd0de-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.082']} DrugCentral uuid:bb4ff938-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:bb502188-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:bb5049d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:bb50728c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:bb509af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.079']} DrugCentral uuid:bb50c41c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bb50ec80-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.033']} DrugCentral uuid:bb511674-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.386']} DrugCentral uuid:bb513ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.767']} DrugCentral uuid:bb516796-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.327']} DrugCentral uuid:bb518fe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P70676 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Unclassified (SMR1-alpha2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:bb51ba16-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:bb51e270-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.61']} DrugCentral uuid:bb52127c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bb52127c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bb52127c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bb525174-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 didanosine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bb5279d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dienestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:bb52a21e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dienogest is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bb52c668-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:bb52f07a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bb531460-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:bb533c56-94cc-11ec-8aec-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:bb533c56-94cc-11ec-8aec-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:bb536a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bb538f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:bb53b35c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:bb53dbb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:bb54041a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.252']} DrugCentral uuid:bb542d1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bb545578-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:bb547eb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:bb54a71c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:bb54d2dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:bb54fca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:bb5524f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.439']} DrugCentral uuid:bb554e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:bb557688-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bb559eec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:bb55c73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.223']} DrugCentral uuid:bb55eff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.272']} DrugCentral uuid:bb561854-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:bb5640cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.437']} DrugCentral uuid:bb566912-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:bb5692ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.317']} DrugCentral uuid:bb56bafc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.657']} DrugCentral uuid:bb56e356-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bb570b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:bb5735a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:bb575e08-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:bb57864e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:bb57aeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.739']} DrugCentral uuid:bb57d7ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:bb580006-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:bb582860-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.593']} DrugCentral uuid:bb58509c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bb587ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb58a2fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bb58cbf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.983']} DrugCentral uuid:bb58f538-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.847']} DrugCentral uuid:bb591d92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.361']} DrugCentral uuid:bb5945f6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb596e96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.483']} DrugCentral uuid:bb59d818-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:bb5a04b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bb5a2e1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:bb5a5658-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:bb5a7e94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:bb5aa6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:bb5ad04c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bb5af87e-94cc-11ec-8aec-0242ac110003 UniProtKB:O08580 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb5b20c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 difenoxin is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bb5b44be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bb5b6d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bb5b95ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bb5bbe08-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd1', 'has_quantitative_value': ['7.125']} DrugCentral uuid:bb5be644-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bb5c0f8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:bb5c37ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:bb5c6010-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.648']} DrugCentral uuid:bb5c8842-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:bb5cb376-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bb5cd77a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5cffde-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5d4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb5dba78-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.783']} DrugCentral uuid:bb5de476-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.136']} DrugCentral uuid:bb5e0f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb5e37c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bb5e6022-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5ea4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb5f1be8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51450 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb5f4410-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.007']} DrugCentral uuid:bb5f6c4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:bb5f9488-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.187']} DrugCentral uuid:bb5fbf12-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.526']} DrugCentral uuid:bb5fe762-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bb600f94-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bb6037c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bb60607a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.085']} DrugCentral uuid:bb6088c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:bb60b0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.121']} DrugCentral uuid:bb60d938-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bb610228-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:bb612a6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:bb6152c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.261']} DrugCentral uuid:bb617b22-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.369']} DrugCentral uuid:bb61a430-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bb61cc6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bb61f5de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.299']} DrugCentral uuid:bb621f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bb62473c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:bb626f6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydrocodeine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bb629372-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:bb62bc62-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.462']} DrugCentral uuid:bb62e494-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:bb630db6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.309']} DrugCentral uuid:bb6336ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.127']} DrugCentral uuid:bb635fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bb6387fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.385']} DrugCentral uuid:bb63b022-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.373']} DrugCentral uuid:bb63d84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:bb6400fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:bb64293a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bb645180-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bb6475b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.442']} DrugCentral uuid:bb649e74-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bb64c6c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.605']} DrugCentral uuid:bb64eeec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:bb6512d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bb653c58-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.183']} DrugCentral uuid:bb65648a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:bb65887a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bb65b0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bb65d92e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.896']} DrugCentral uuid:bb660160-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb662988-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.79']} DrugCentral uuid:bb66519c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:bb667a64-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bb66a28c-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:bb66cab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.922']} DrugCentral uuid:bb66f2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.529']} DrugCentral uuid:bb671f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:bb674732-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bb676f78-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.424']} DrugCentral uuid:bb679930-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.644']} DrugCentral uuid:bb67c180-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.364']} DrugCentral uuid:bb67ea34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:bb681338-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.83']} DrugCentral uuid:bb683c32-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bb68645a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bb688854-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.752']} DrugCentral uuid:bb68b11c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:bb68dac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bb6902fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:bb692b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.821']} DrugCentral uuid:bb695360-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:bb697be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:bb699fc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 5A) DrugCentral uuid:bb69c3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bb69ec08-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bb6a14e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.349']} DrugCentral uuid:bb6a3d20-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.416']} DrugCentral uuid:bb6a653e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb6a8d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:bb6ab6c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bb6adeec-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bb6b06f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb6b3004-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bb6b5886-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bb6b80ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bb6bb0e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bb6bb0e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bb6bb0e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bb6bf0fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bb6c14ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:bb6c38b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:bb6c5ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:bb6c81d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:bb6ca5c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bb6cc9be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bb6cf98e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb6cf98e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb6cf98e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb6d3a48-94cc-11ec-8aec-0242ac110003 UniProtKB:O54699 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bb6d6266-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:bb6d8660-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bb6daa50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bb6dcf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:bb6df38e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:bb6e1bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bb6e43fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:bb6e6d00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb6e9596-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bb6ebdc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bb6ee6c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bb6f0f80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:bb6f37bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.017']} DrugCentral uuid:bb6f600c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bb6f891a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:bb6fb142-94cc-11ec-8aec-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:bb6fd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:bb7001b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bb702ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bb705ac0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb705ac0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb705ac0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb70a0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bb70a0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bb70a0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bb70dfb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bb7107f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bb71301c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bb71584e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimemorfan is inhibitor of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bb71813e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.791']} DrugCentral uuid:bb71a97a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.312']} DrugCentral uuid:bb71d1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:bb71face-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:bb72230a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bb724c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.479']} DrugCentral uuid:bb7275da-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:bb729e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bb72c6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:bb72ef10-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.785']} DrugCentral uuid:bb731760-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:bb7340a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:bb7368dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:bb739118-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:bb73b940-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:bb73e244-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:bb740a94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KQK5 biolink:molecularly_interacts_with DrugCentral:902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetacrine targets Unclassified (Apical membrane antigen 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bb7432a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:bb745b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bb748410-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bb74ac4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bb74d474-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bb74fcb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bb752cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bb752cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bb752cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bb756f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:bb756f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:bb759d14-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:bb75c780-94cc-11ec-8aec-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb75f084-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bb7618c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb7641c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bb7669d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bb769214-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bb76ba50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bb76e2dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bb770b18-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bb773354-94cc-11ec-8aec-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bb775c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bb77861a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bb77ae56-94cc-11ec-8aec-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bb77d66a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bb780036-94cc-11ec-8aec-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bb782930-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bb785176-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bb78798a-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb78a1d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:bb78ca8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb78f2e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:bb791b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bb794360-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bb796f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bb79978e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:bb79bfd4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bb79e9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb7a11f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bb7a3a22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bb7a625e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bb7a8b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bb7ab362-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bb7adb80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bb7b0434-94cc-11ec-8aec-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bb7b2df6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bb7b58d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bb7b8116-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bb7ba93e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bb7bd210-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bb7bfa24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bb7c224c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bb7c4a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:bb7c72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bb7c9b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bb7cbf22-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bb7ce31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bb7d0bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.018']} DrugCentral uuid:bb7d342a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:bb7d5c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:bb7d848e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bb7dad88-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:bb7dd6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb7e0030-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bb7e2880-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bb7e5134-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bb7e795c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:bb7ea198-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:bb7eca7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.932']} DrugCentral uuid:bb7ef5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bb7f1f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:bb7f4ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bb7f4ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bb7f4ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bb7f8e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bb7fb66e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.658']} DrugCentral uuid:bb7fdebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:918 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenoxylate is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:bb800768-94cc-11ec-8aec-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:918 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenoxylate targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb802f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.076']} DrugCentral uuid:bb8057ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bb807fea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:bb80a97a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:bb80cf40-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bb80f754-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bb811b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:bb814092-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:bb816478-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:bb818868-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bb81ad3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bb81d138-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bb81f9e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bb822214-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb824a50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bb82732c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.802']} DrugCentral uuid:bb829d70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bb82c5c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bb82ee06-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bb8316ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bb833f00-94cc-11ec-8aec-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bb83671e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.158']} DrugCentral uuid:bb839054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:bb83b912-94cc-11ec-8aec-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bb83e540-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb83e540-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bb841c90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb841c90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb8463da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bb84cc1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb84cc1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb84cc1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bb850af6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bb853328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TP1 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Protein prune homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bb855b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bb858418-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bb85ac54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bb85d044-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:bb85f8f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:bb86224c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bb86481c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:bb866c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bb86909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48544 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:bb86b91e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bb86e132-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.604']} DrugCentral uuid:bb8709dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 distigmine is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:bb872dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:bb875766-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:bb877f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Translocator protein) DrugCentral uuid:bb87a36a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:bb87cba6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:bb87f504-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.735']} DrugCentral uuid:bb882042-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.156']} DrugCentral uuid:bb884874-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.658']} DrugCentral uuid:bb8871e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.129']} DrugCentral uuid:bb889b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:bb88c3c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.434']} DrugCentral uuid:bb88ec0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:bb891448-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:bb893d10-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.957']} DrugCentral uuid:bb89654c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:bb898d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:bb89b5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.862']} DrugCentral uuid:bb89df7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05091 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram is inhibitor of Enzyme (Aldehyde dehydrogenase, mitochondrial) DrugCentral uuid:bb8a0380-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.319']} DrugCentral uuid:bb8a2b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.738']} DrugCentral uuid:bb8a53d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:bb8a7c84-94cc-11ec-8aec-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:bb8aa4c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:bb8accf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.794']} DrugCentral uuid:bb8af524-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.669']} DrugCentral uuid:bb8b1e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:bb8b4650-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.333']} DrugCentral uuid:bb8b6e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bb8b96aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bb8bc15c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bb8be98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bb8c11a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bb8c3a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bb8c62b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:bb8c8b96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bb8cb4ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bb8cdd94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bb8d05da-94cc-11ec-8aec-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb8d2e02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bb8d5652-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bb8d7f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bb8da7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bb8dd000-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bb8df846-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bb8e2104-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bb8e49b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bb8e72f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bb8e9b66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bb8ec460-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bb8eeca6-94cc-11ec-8aec-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bb8f14ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bb8f3cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bb8f685c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bb8f9098-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bb8fb8d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z2W7 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bb8fe142-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bb900974-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bb903192-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.976']} DrugCentral uuid:bb9059c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:bb9082d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bb90abf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:bb90d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:bb90fd2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:bb912624-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:bb914e7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:bb9176d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bb919f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bb91c7d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bb91f018-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bb921868-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.256']} DrugCentral uuid:bb92409a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bb9269ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bb929220-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bb92ba70-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:bb92e2a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.401']} DrugCentral uuid:bb930bce-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.301']} DrugCentral uuid:bb933414-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bb935c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bb938496-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bb93ad4a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bb93d568-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.223']} DrugCentral uuid:bb93fd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:bb94266c-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:bb944ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bb947824-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bb94a18c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bb94cbc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bb94f3e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bb9517e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:bb953bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.086']} DrugCentral uuid:bb956496-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:bb958cd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets GPCR (Growth hormone-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb95d4da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bb9655cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb96ab3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:bb973b9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bb9763e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide targets Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:bb9787ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bb97b048-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:bb97d938-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bb980188-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.988']} DrugCentral uuid:bb9829ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bb98520a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bb9878a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bb98a12e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:bb98c97e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bb98f1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:bb991aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:bb9942dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:bb996b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.013']} DrugCentral uuid:bb99934a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:bb99bc3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:bb99e462-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bb9a0d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:bb9a3552-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:bb9a5fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:bb9a889a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:bb9ab0cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:bb9ae100-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:bb9ae100-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:bb9ae100-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:bb9b1972-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bb9b41b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:bb9b69f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bb9b92ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:bb9bbb48-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:bb9be384-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bb9c0b98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bb9c3604-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:bb9c5e40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:bb9c867c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bb9caea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:bb9cd730-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.046']} DrugCentral uuid:bb9d0002-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bb9d2866-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bb9d5174-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bb9d79a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bb9da1c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bb9dc9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:bb9df2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:bb9e1b22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:bb9e4480-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bb9e6cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bb9e9570-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bb9ebdb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bb9ee610-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bb9f0f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bb9f3818-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bb9f6054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:bb9f8886-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bb9fb0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bb9fdb92-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bba003d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bba02c14-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bba05446-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.18']} DrugCentral uuid:bba07ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:bba0a522-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bba0cd72-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bba0f5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bba11f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bba14770-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.375']} DrugCentral uuid:bba16fac-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bba1991e-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bba1c286-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:bba1eac2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bba212ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bba23b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bba263a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bba28bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bba2b40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bba2dd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bba305f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bba32f04-94cc-11ec-8aec-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bba357cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09172 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3']} DrugCentral uuid:bba38f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bba38f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bba38f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bba38f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bba3e73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bba3e73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bba3e73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bba42b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bba42b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bba46df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bba46df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bba46df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bba46df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bba46df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bba4caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bba4caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bba4caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba52548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bba5a5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bba5ce9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bba5f716-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bba61f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopexamine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bba64342-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopexamine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:bba6676e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bba6909a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bba6b8e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bba6e144-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bba70994-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:bba7345a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bba75c82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bba784c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:bba7ad04-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bba7d590-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bba7fdea-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bba8264e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:bba85088-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bba878d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bba8a132-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bba8c98c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bba8f344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bba91ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bba943ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bba96c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bba995e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:bba9be50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bba9e70e-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bbaa0f36-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bbaa3826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bbaa6062-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bbaa88a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bbaab0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bbaadb8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bbab03b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:bbab2c18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bbab545e-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bbab7d1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.066']} DrugCentral uuid:bbaba558-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.337']} DrugCentral uuid:bbabcd80-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.588']} DrugCentral uuid:bbabf68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.378']} DrugCentral uuid:bbac1eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bbac4710-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bbac6f38-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.744']} DrugCentral uuid:bbac98c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:bbacc3ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bbaceea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:bbad1712-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:bbad3f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.275']} DrugCentral uuid:bbad67d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bbad90de-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:bbadb4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:bbadd9ae-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:bbae01fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:bbae2a58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bbae53ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:bbae7e86-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bbaea8f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:bbaed14c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.631']} DrugCentral uuid:bbaef988-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:bbaf225a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bbaf4abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bbaf72fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:bbaf9b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bbafc4c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bbafedb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bbb015fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.381']} DrugCentral uuid:bbb03f3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:bbb06a34-94cc-11ec-8aec-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bbb0927a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bbb0ba84-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bbb0e306-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bbb10b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:bbb13392-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bbb15bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.53']} DrugCentral uuid:bbb185f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:bbb1ae1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:bbb1d630-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bbb1fe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bbb227e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:bbb2502e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 7) DrugCentral uuid:bbb27414-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.629']} DrugCentral uuid:bbb29c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bbb2c4e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.325']} DrugCentral uuid:bbb2ed18-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:bbb3154a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bbb33d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bbb3663a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:bbb38e6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:bbb3b6b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:bbb3def8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:bbb40a90-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bbb43498-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:bbb45edc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bbb48790-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:bbb4afe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:bbb4d812-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5333e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbb5f0f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:bbb61966-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:957 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxercalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:bbb63d6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxifluridine targets Enzyme (Thymidylate synthase) DrugCentral uuid:bbb661d2-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:bbb68a40-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:bbb6b27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.433']} DrugCentral uuid:bbb6daae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:bbb6ff7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bbb72838-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bbb74c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bbb77022-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:bbb79584-94cc-11ec-8aec-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.914']} DrugCentral uuid:bbb7bdf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.496']} DrugCentral uuid:bbb7e642-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.288']} DrugCentral uuid:bbb80e88-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:bbb83728-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bbb85f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bbb88890-94cc-11ec-8aec-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bbb8b0e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bbb8d9da-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bbb90342-94cc-11ec-8aec-0242ac110003 UniProtKB:P61823 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Ribonuclease pancreatic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbb92b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.867']} DrugCentral uuid:bbb953ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.805']} DrugCentral uuid:bbb97e9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bbb9a6da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bbb9cf16-94cc-11ec-8aec-0242ac110003 UniProtKB:P43870 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme HindIII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:bbb9f73e-94cc-11ec-8aec-0242ac110003 UniProtKB:O52691 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme ScaI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbba1ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:bbba47fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bbba702e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bbba986a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:bbbabd18-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bbbae568-94cc-11ec-8aec-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbbb0d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbbb366c-94cc-11ec-8aec-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bbbb60e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bbbb8928-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bbbbb164-94cc-11ec-8aec-0242ac110003 UniProtKB:P09237 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Matrilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bbbbda2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxylamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bbbbfe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drostanolone propionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:bbbc225c-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:bbbc4a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:bbbc7388-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.602']} DrugCentral uuid:bbbc9cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:bbbcc52c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bbbced68-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:bbbd17ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.132']} DrugCentral uuid:bbbd4056-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:bbbd68ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:bbbd9100-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.996']} DrugCentral uuid:bbbdb9be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.027']} DrugCentral uuid:bbbde20e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bbbe0a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bbbe329a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:bbbe5b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:bbbe83e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.076']} DrugCentral uuid:bbbeac3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.175']} DrugCentral uuid:bbbed498-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:bbbf0058-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:bbbf28c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:bbbf510c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bbbf8190-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bbbf8190-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bbbf8190-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bbbfc006-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:bbbfe842-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bbc016be-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:bbc0485a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drotaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:bbc06da8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drotaverine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:bbc091c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc0dbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:bbc14dae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bbc176da-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:bbc19f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bbc1c84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bbc1f178-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bbc21a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:bbc242b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bbc26b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bbc295c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:bbc2bfd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:bbc2e858-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.402']} DrugCentral uuid:bbc310ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bbc339a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bbc361ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.352']} DrugCentral uuid:bbc389f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:bbc3b3a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.09']} DrugCentral uuid:bbc3dd62-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:bbc4068e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bbc42ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bbc457ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bbc483de-94cc-11ec-8aec-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bbc4ac1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:bbc4d44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dyclonine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bbc4fd00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dyclonine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:bbc52118-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dydrogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bbc5497c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dydrogesterone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.561']} DrugCentral uuid:bbc571cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:bbc59620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:bbc5ba2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:bbc5e27e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bbc60aba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.506']} DrugCentral uuid:bbc633a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bbc65bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bbc68436-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:bbc6acd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:bbc6d742-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:bbc6ff60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:bbc727a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:bbc74fec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.905']} DrugCentral uuid:bbc7790e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:bbc7a154-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.472']} DrugCentral uuid:bbc7c990-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.384']} DrugCentral uuid:bbc7f1c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.543']} DrugCentral uuid:bbc81c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bbc84474-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.554']} DrugCentral uuid:bbc86cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:bbc89500-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.937']} DrugCentral uuid:bbc8be7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.615']} DrugCentral uuid:bbc8e6ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:bbc90eea-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.397']} DrugCentral uuid:bbc937a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.106']} DrugCentral uuid:bbc960c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:bbc988fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:bbc9b14c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bbc9dabe-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.126']} DrugCentral uuid:bbca044e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.253']} DrugCentral uuid:bbca2c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:bbca54b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:bbca7dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.191']} DrugCentral uuid:bbcaa62e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.633']} DrugCentral uuid:bbcace56-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:bbcaf6a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:bbcb1f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bbcb478c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bbcb6fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bbcb97fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:979 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebrotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:bbcbbcd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 echothiophate is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:bbcbe0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.131']} DrugCentral uuid:bbcc091a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.543']} DrugCentral uuid:bbcc3232-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:bbcc5bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:bbcc8426-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bbccac80-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.086']} DrugCentral uuid:bbccd4da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bbccfe10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:bbcd2674-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bbcd4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:bbcd76f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:bbcda0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:bbcdc96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:bbcdf1bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:bbce19f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.202']} DrugCentral uuid:bbce42ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:bbce6afc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.572']} DrugCentral uuid:bbce934c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:bbcebb74-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:bbcee4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:bbcf0d36-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:bbcf3572-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.421']} DrugCentral uuid:bbcf5ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.529']} DrugCentral uuid:bbcf8716-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:bbcfaf7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.178']} DrugCentral uuid:bbcfd8ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bbd00178-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.006']} DrugCentral uuid:bbd02ab8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:bbd05312-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.485']} DrugCentral uuid:bbd07b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.359']} DrugCentral uuid:bbd0a466-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.463']} DrugCentral uuid:bbd0ccb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:bbd0f0c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:bbd11914-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbd14380-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.864']} DrugCentral uuid:bbd16c70-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bbd19498-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bbd1bcb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.489']} DrugCentral uuid:bbd1e8da-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:bbd21120-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bbd23970-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bbd261ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.916']} DrugCentral uuid:bbd28a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:bbd2b29c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bbd2db96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bbd30472-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:bbd32d1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bbd3553a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:bbd37d6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:bbd3a71a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.999']} DrugCentral uuid:bbd3cf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.431']} DrugCentral uuid:bbd3f792-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.503']} DrugCentral uuid:bbd41fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P49146 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Neuropeptide Y receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.959']} DrugCentral uuid:bbd44936-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.498']} DrugCentral uuid:bbd4717c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:bbd499a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:bbd4c258-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:bbd4ec74-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:bbd514b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bbd53cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbd5653c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bbd58e40-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:bbd5b69a-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bbd5e016-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bbd60884-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bbd6314c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:bbd659a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:bbd681e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:bbd6a5e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bbd6d19c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bbd6fc26-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bbd7246c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Ceramide glucosyltransferase) DrugCentral uuid:bbd74884-94cc-11ec-8aec-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bbd77174-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XAY4 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Unclassified (Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bbd799c4-94cc-11ec-8aec-0242ac110003 UniProtKB:J3SE37 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:bbd7c1e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bbd7eaa0-94cc-11ec-8aec-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bbd812fa-94cc-11ec-8aec-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bbd83c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edrophonium is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.79']} DrugCentral uuid:bbd8648a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edrophonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbd88e38-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bbd8b674-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bbd8da82-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bbd902e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bbd92be0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bbd9543a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bbd97cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:bbd9a55c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11926 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bbd9ce06-94cc-11ec-8aec-0242ac110003 UniProtKB:P09057 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine targets Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bbd9f66a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9TZZ6 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) DrugCentral uuid:bbda1a64-94cc-11ec-8aec-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bbda428c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.621']} DrugCentral uuid:bbda70d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bbda70d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bbda9e94-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bbdac6da-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bbdaef2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bbdb1838-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bbdb406a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bbdb68ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bbdb9150-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bbdbbaa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bbdbea74-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bbdbea74-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bbdbea74-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdc667a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bbdd3410-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emedastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:bbdd5c56-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bbdd850a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:bbddad5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:bbddd5a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:bbddfdd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bbde27f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75884 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets Enzyme (Putative hydrolase RBBP9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bbde503e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emtricitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:bbde7528-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bbde9df0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bbdec60e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:bbdeee54-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bbdf1686-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bbdf3f44-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:bbdf6780-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5EGZ1 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bbdf8fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09470 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.94']} DrugCentral uuid:bbdfb7d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bbdfdd32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:bbe004ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:bbe028f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:bbe04d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:bbe071c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 endralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:bbe095d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:bbe0b9e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:bbe0ddfe-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:bbe1020c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:bbe126c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:bbe14ae6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:bbe16eea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q53I07 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide targets Viral envelope protein (Envelope glycoprotein) DrugCentral uuid:bbe192ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O40239 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide is inhibitor of Membrane other (Transmembrane glycoprotein gp41) DrugCentral uuid:bbe1b7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76270 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide targets Unclassified (GP41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bbe1dfb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin targets Enzyme (DNA gyrase subunit A) DrugCentral uuid:bbe20396-94cc-11ec-8aec-0242ac110003 UniProtKB:P21281 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin targets Enzyme (V-type proton ATPase subunit B, brain isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bbe23082-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:bbe23082-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:bbe262d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bbe262d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bbe2909a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.345']} DrugCentral uuid:bbe2c524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bbe2c524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bbe2c524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bbe2c524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bbe30f8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bbe337e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:bbe36042-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bbe389b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.03']} DrugCentral uuid:bbe3b1fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:bbe3d5fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bbe3fe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bbe426ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bbe44f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bbe477e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bbe4a16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bbe4ca4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bbe4f27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostacyclin receptor) DrugCentral uuid:bbe5168a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bbe5401a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bbe569d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:bbe59218-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bbe5ba72-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bbe5e29a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bbe60b44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bbe6336c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bbe65cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:bbe6863c-94cc-11ec-8aec-0242ac110003 UniProtKB:P17394 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir targets Polyprotein (Protein P) DrugCentral uuid:bbe6aab8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir is inhibitor of Polyprotein (Protein P) DrugCentral uuid:bbe6cf5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:bbe6f798-94cc-11ec-8aec-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bbe71fca-94cc-11ec-8aec-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bbe74b62-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bbe77394-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bbe79bbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bbe7c484-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bbe7ecd4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:bbe81510-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02928 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat is inhibitor of Enzyme (Cytochrome P450 4A11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bbe83d56-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bbe865ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bbe88e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.859']} DrugCentral uuid:bbe8b66e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bbe8dea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bbe90830-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1024 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ephedrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bbe9306c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bbe95470-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bbe97c8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bbe9a15a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:bbe9c554-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bbe9e962-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bbea11a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Histamine H2 receptor) DrugCentral uuid:bbea35e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bbea5e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bbea866a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bbeaaf82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:bbead91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.401']} DrugCentral uuid:bbeb02f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bbeb2b56-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.26']} DrugCentral uuid:bbeb53ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bbeb7cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:bbeba518-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:bbebcd7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bbebf5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:bbec1f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.449']} DrugCentral uuid:bbec4798-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bbec7006-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bbec9860-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.484']} DrugCentral uuid:bbecc358-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bbeced7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bbed15b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bbed3e00-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bbed670e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bbed8f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bbedb79a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bbede058-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bbee103c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bbee103c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bbee103c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bbee565a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bbee565a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bbee565a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bbee98ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bbeec0d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.878']} DrugCentral uuid:bbeee926-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:bbef114e-94cc-11ec-8aec-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bbef3a34-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bbef6266-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bbef8aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bbefb2f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bbefdc82-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bbf004c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear other (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bbf02d2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bbf0564e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bbf07e94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol targets GPCR (P2Y purinoceptor 12) DrugCentral uuid:bbf0a3b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bbf0cc28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bbf0f522-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bbf11d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf145b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf17290-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf17290-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf1ae18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf1ae18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf1ae18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf1f1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:bbf1f1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:bbf22708-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:bbf252a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bbf27b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:bbf2a37c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.333']} DrugCentral uuid:bbf2cc6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bbf2f4b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.58']} DrugCentral uuid:bbf31d0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bbf34566-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bbf36e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:bbf39692-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.714']} DrugCentral uuid:bbf3bed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf3e700-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.367']} DrugCentral uuid:bbf410cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bbf438fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.889']} DrugCentral uuid:bbf46130-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:bbf48962-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bbf4b27a-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:bbf4dac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:bbf50306-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.722']} DrugCentral uuid:bbf52b60-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:bbf55428-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:bbf57c6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.099']} DrugCentral uuid:bbf5a4b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bbf5ce76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.354']} DrugCentral uuid:bbf5f72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bbf6209c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bbf6490a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bbf67218-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bbf69a5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bbf6be80-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.754']} DrugCentral uuid:bbf6e6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.836']} DrugCentral uuid:bbf70fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bbf73838-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.064']} DrugCentral uuid:bbf7606a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bbf788c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bbf7b22c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bbf7da90-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:bbf802f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.487']} DrugCentral uuid:bbf82b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bbf853e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bbf87c8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bbf8a4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:bbf8cd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bbf8f614-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:bbf91e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:bbf94696-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.041']} DrugCentral uuid:bbf96edc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:bbf9986c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bbf9c09e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bbf9e9b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bbfa11e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bbfa3a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bbfa62ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bbfa8b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:O08786 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Cholecystokinin A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:bbfab3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:O32393 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Unclassified (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bbfadc0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bbfb0454-94cc-11ec-8aec-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bbfb2c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bbfb56a2-94cc-11ec-8aec-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:1044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eritoran targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bbfb7ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bbfba710-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bbfbd000-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bbfbf8d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bbfc224e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bbfc4a80-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bbfc72b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bbfc9b70-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bbfcc3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bbfcebd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bbfd1410-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bbfd3dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bbfd65fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bbfd8e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bbfdb654-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bbfde002-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bbfe0816-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bbfe3052-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bbfe5898-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bbfe8142-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bbfea988-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bbfed1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bbfefc44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bbff26ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bbff4f28-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bbff776e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bbffa004-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bbffc84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bbfff090-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bc0018d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bc004176-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bc0069b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc0091f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bc00bac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bc00e5ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bc010dea-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bc01363a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc015f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bc0187f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bc01b01a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bc01d950-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bc0202ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bc022b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bc02536c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bc027bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bc02a57e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bc02cfea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bc02f81c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bc032062-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bc0348f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bc037152-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bc039984-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bc03c1d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:bc03ea6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bc0412a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bc043af6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc046350-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:bc048de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bc04b620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bc04de66-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bc0506b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bc052f56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bc055792-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bc057fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc05a7f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bc05d23a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bc05fa80-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bc0622d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bc064ca6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bc06750a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bc069d46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:bc06c596-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bc06ee2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc071672-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bc073e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bc0766e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bc078f8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bc07b7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bc07dfee-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bc080974-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc083430-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bc085cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc0884ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bc08ad3e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bc08d5e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bc08fe42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bc092688-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bc094eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bc097764-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bc099f96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:bc09c8ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc09f158-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bc0a1dae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bc0a45ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bc0a6e1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bc0a96e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bc0abf34-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bc0ae77a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bc0b0fde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bc0b387e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bc0b60b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bc0b88ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O94956 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib is inhibitor of Transporter (Solute carrier organic anion transporter family member 2B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bc0bb146-94cc-11ec-8aec-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bc0bdac2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:bc0bfeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:bc0c22b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:bc0c4732-94cc-11ec-8aec-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:bc0c6ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:bc0c8fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:bc0cb3ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bc0cd7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1B) DrugCentral uuid:bc0cfb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:bc0d242c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:bc0d4c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bc0d744a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bc0d9da8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bc0dc71a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bc0df078-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:bc0e18b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:bc0e415e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:bc0e69a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:bc0e91ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.412']} DrugCentral uuid:bc0eba3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.706']} DrugCentral uuid:bc0ee2e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:bc0f0b20-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc0f3384-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bc0f5bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bc0f862c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bc0fb110-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bc0fd942-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:bc100638-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bc100638-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bc103c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc103c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc103c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc107b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc107b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc107b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc10bbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc10bbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc10bbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc10fb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc10fb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc10fb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc1133dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:bc115e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.538']} DrugCentral uuid:bc11867a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.725']} DrugCentral uuid:bc11aede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.926']} DrugCentral uuid:bc11d738-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:bc11ffec-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bc122832-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol is activator of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc12505a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bc127882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bc12a172-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bc12cba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:bc12f3de-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.83']} DrugCentral uuid:bc131d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bc1345b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:bc136dfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bc139640-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.947']} DrugCentral uuid:bc13bee0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:bc13e730-94cc-11ec-8aec-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bc140f76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bc1437c6-94cc-11ec-8aec-0242ac110003 UniProtKB:O08537 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bc1460b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19785 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:bc1488f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc14b4f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:bc14b4f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:bc14e96e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:bc1514fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.767']} DrugCentral uuid:bc154030-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:bc1568b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.637']} DrugCentral uuid:bc15918e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.446']} DrugCentral uuid:bc15b9f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:bc15e260-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bc160aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:bc163396-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:bc165be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.156']} DrugCentral uuid:bc168436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.902']} DrugCentral uuid:bc16ac90-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol cypionate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bc16d224-94cc-11ec-8aec-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol mustard targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bc16fad8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol valerate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bc171ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:bc1742ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bc176b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bc1793e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bc17bc20-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bc17e466-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bc180d56-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:bc18361e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:bc185e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bc1887cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:bc18b170-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bc18daa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:bc19031e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bc192b64-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bc19544a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:bc197cae-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bc19a526-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:bc19d5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc19d5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc19d5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bc1a1510-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:bc1a1510-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:bc1a1510-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:bc1a543a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:bc1a543a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:bc1a543a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:bc1a9544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:bc1a9544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:bc1a9544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:bc1ad48c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:bc1ad48c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:bc1ad48c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:bc1b1438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:bc1b1438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:bc1b1438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:bc1b4bce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid is inhibitor of Transporter (Solute carrier family 12 member 1) DrugCentral uuid:bc1b6fc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bc1b97f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08263 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc1bc1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.939']} DrugCentral uuid:bc1bea20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bc1c125c-94cc-11ec-8aec-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bc1c3a7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bc1c652c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bc1c8d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bc1cb590-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bc1cde08-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNL8 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:bc1d032e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNL6 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase B) DrugCentral uuid:bc1d2728-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNL5 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase C) DrugCentral uuid:bc1d4b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bc1d7386-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNL9 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol is inhibitor of Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:bc1d9852-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bc1dbc2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:bc1de028-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-2) DrugCentral uuid:bc1e0bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:bc1e0bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:bc1e0bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:bc1e4d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bc1e4d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bc1e4d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bc1e84e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:bc1ead32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bc1ed5be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.964']} DrugCentral uuid:bc1efe0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:bc1f265e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bc1f4ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:bc1f7820-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:bc1fa174-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bc1fc9ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.353']} DrugCentral uuid:bc1ff386-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:bc201c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.985']} DrugCentral uuid:bc2044da-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.83']} DrugCentral uuid:bc206d0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bc209598-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:bc20bdc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:bc20e5fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bc210e38-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.246']} DrugCentral uuid:bc213700-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:bc215f3c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bc218764-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bc21afaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bc21d8c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide targets Enzyme (Catalase-peroxidase) DrugCentral uuid:bc21fcda-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) DrugCentral uuid:bc2220de-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bc224a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:bc22730e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.78']} DrugCentral uuid:bc229b68-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:bc22c3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.111']} DrugCentral uuid:bc22ec12-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bc23150c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bc233906-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bc235d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:bc23855a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bc23b0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bc23d97e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:bc2401c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bc242a14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bc2452dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bc247b18-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethosuximide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc24c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bc253d00-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:bc25655a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bc259048-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bc25b8d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:bc25e12e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bc260a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bc263282-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bc265afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bc26835e-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:bc26ac58-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc26d4bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bc26fd34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bc272688-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bc27518a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bc2779e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bc27a23e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bc27caac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bc27f36a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bc281bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bc284432-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc286c96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bc28959a-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bc28bdf4-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:bc28e658-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:bc290f34-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bc29384c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:bc2960a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bc29890a-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:bc29b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc29b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc29e972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bc2a11ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:bc2a3a08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bc2a62f8-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:bc2a8b52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:1091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl biscoumacetate targets Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:bc2aaf56-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:bc2ad7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:bc2b00b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.983']} DrugCentral uuid:bc2b29ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:bc2b524e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:bc2b7652-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:bc2b9f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.889']} DrugCentral uuid:bc2bc742-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bc2bef9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:bc2c17ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bc2c3ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bc2c60c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.368']} DrugCentral uuid:bc2c88f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:bc2cb152-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bc2cdb1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bc2d0242-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:bc2d265a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:bc2d4a5e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bc2d731c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc2d9b44-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bc2dc380-94cc-11ec-8aec-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:1098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc2debe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bc2e14d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilefrine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:bc2e4116-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc2e4116-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc2e4116-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc2e8b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc2e8b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc2e8b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bc2ecb18-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc2ecb18-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc2ecb18-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bc2f0b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc2f0b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc2f0b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bc2f4476-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etodolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bc2f6cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etodolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.577']} DrugCentral uuid:bc2f95e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bc2fbe92-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bc2fe78c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bc300faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:bc3037dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bc3068b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:bc3068b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:bc3068b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:bc30affa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bc30affa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bc30affa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bc30ee16-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bc31129c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bc3136aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bc315edc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:bc318880-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.051']} DrugCentral uuid:bc31b152-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:bc31d98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:bc3201f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.282']} DrugCentral uuid:bc322b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.21']} DrugCentral uuid:bc325508-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bc32790c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bc32a1ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bc32c5c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bc32ea2c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:bc330e94-94cc-11ec-8aec-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:bc333298-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:bc335ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:bc3383c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc33abf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bc33d432-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:bc33fc78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bc34261c-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bc344e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bc34770c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bc349f52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bc34c7fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bc34f024-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bc351856-94cc-11ec-8aec-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bc354074-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bc35696e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:bc358d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bc35b572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bc35dd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bc3608ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1116 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:bc362db8-94cc-11ec-8aec-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:1116 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) DrugCentral uuid:bc36519e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.63']} DrugCentral uuid:bc367994-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:bc36a220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bc36ca2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bc36ee42-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bc371674-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc373f6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exemestane targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:bc376494-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exemestane is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:bc378cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:1123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:bc37b50c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:1123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exenatide targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:bc37dff0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHC9 biolink:molecularly_interacts_with DrugCentral:1125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ezetimibe is antagonist of Membrane other (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bc380836-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6T3U3 biolink:molecularly_interacts_with DrugCentral:1125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ezetimibe targets Unclassified (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bc383090-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bc38594e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc388180-94cc-11ec-8aec-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bc38a9d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:bc38d216-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:bc38f6c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:1128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famciclovir targets Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:bc391ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.93']} DrugCentral uuid:bc39430e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bc396b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bc39950c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bc39bd52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bc39e606-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bc3a0e74-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:bc3a380e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bc3a607c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc3a88d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bc3ab144-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bc3ada34-94cc-11ec-8aec-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:bc3b0284-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bc3b2ad4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bc3b52f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bc3b7d04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bc3ba50e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.304']} DrugCentral uuid:bc3bcd40-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:bc3bf568-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:1130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famprofazone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bc3c1e26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bc3c4676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bc3c6ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bc3c96ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bc3cbfe8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc3ce824-94cc-11ec-8aec-0242ac110003 UniProtKB:P13500 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Cytokine (C-C motif chemokine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bc3d106a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bc3d3aea-94cc-11ec-8aec-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:bc3d65a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62868 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc3d8e00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bc3db682-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bc3ddf90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bc3e07b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bc3e30ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc3e5920-94cc-11ec-8aec-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bc3e82ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:bc3ea6e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:bc3ecf2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bc3ef358-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.049']} DrugCentral uuid:bc3f1d06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bc3f45a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:bc3f6e00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:bc3f9218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:bc3fb694-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.339']} DrugCentral uuid:bc3fdea8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.168']} DrugCentral uuid:bc4006ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc402f48-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is activator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bc405ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bc405ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bc405ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bc409e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bc40c674-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bc40ef82-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bc411390-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bc41378a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bc415fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc418866-94cc-11ec-8aec-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bc41b0a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bc41d8f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35384 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:bc42020a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.004']} DrugCentral uuid:bc422b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:bc42534a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.428']} DrugCentral uuid:bc427b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:bc42a3cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.172']} DrugCentral uuid:bc42ce9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:bc42f85e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bc4320ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bc434908-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:bc4371a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:bc4399f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bc43c23e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:bc43ea84-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:bc441388-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.726']} DrugCentral uuid:bc443bc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.489']} DrugCentral uuid:bc446400-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:bc448d40-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:bc44b5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:bc44de1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.735']} DrugCentral uuid:bc450662-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:bc452f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bc455752-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:bc457f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:bc45a7f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:bc45d0ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.331']} DrugCentral uuid:bc45faa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.032']} DrugCentral uuid:bc4622fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.164']} DrugCentral uuid:bc464b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:bc4674d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.808']} DrugCentral uuid:bc469db0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc46c5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:bc46ee0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bc4716be-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:bc473efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bc476740-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bc478f72-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bc47b876-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bc47e0c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bc48090c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc483170-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc485cae-94cc-11ec-8aec-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc488c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc488c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc488c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc48cc66-94cc-11ec-8aec-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:bc48f556-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bc491d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bc4945c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bc496ea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:bc499ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:bc499ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:bc49cf4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bc49f794-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bc4a2138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bc4a497e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.001']} DrugCentral uuid:bc4a71a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:bc4a99d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bc4ac296-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bc4aeae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bc4b134a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bc4b3b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc4b6462-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bc4b8cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:bc4bb50c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:bc4bde88-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bc4c08b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bc4c3108-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bc4c593a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc4c8d56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:bc4c8d56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:bc4c8d56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:bc4c8d56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:bc4cda86-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bc4cda86-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bc4d0ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bc4d37d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc4d60dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:bc4d8904-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentiazac targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bc4db258-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:bc4ddb20-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bc4e0384-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bc4e2d00-94cc-11ec-8aec-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bc4e55e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bc4e7e36-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc4ea65e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14060 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bc4eceb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P24008 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:bc4ef79e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:bc4f23cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bc4f23cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bc4f5752-94cc-11ec-8aec-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bc4f7f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bc4fa87e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.704']} DrugCentral uuid:bc4fdc40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:bc4fdc40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:bc4fdc40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:bc4fdc40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:bc50210a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:bc50210a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:bc505328-94cc-11ec-8aec-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:bc505328-94cc-11ec-8aec-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:bc508122-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bc50a968-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bc50d262-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:bc50fb7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:bc5123b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.77']} DrugCentral uuid:bc514be8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bc5175b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bc519df0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bc51c6a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fleroxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:bc51eef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:bc521776-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:bc523fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flopropione is inhibitor of Enzyme (Catechol O-methyltransferase) DrugCentral uuid:bc5263a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bc52879c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bc52b06e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bc52d8be-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxuridine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:bc52fce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxuridine targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bc532508-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bc534f56-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bc5378aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bc53a0e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bc53c986-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bc53f24e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bc541aa8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bc5442ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bc546bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bc54944c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bc54bc6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bc54e5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0CS13 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:bc550b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12461 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:bc5531d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02829 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine targets Cytosolic other (ATP-dependent molecular chaperone HSP82) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bc555a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc5582bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc55ab52-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:bc55d398-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bc55fbde-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bc562424-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bc564d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:bc567564-94cc-11ec-8aec-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:bc56995e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bc56c15e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:bc56e6c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:bc570f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:bc5737b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bc575fce-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bc578864-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bc57b06e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bc57d896-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bc5800b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bc58292c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc58514a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bc58795e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bc58a19a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bc58cd96-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bc58f5dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bc591f26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bc594758-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bc597052-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bc599866-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZQ8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bc59c0c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc59e97e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bc5a11c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bc5a39f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bc5a6214-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:bc5a8c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is agonist of GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.863']} DrugCentral uuid:bc5ab700-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bc5adf5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc5b0796-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:bc5b3054-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:bc5b58a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bc5b8112-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc5bb11e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:bc5bb11e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:bc5bb11e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:bc5bf840-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:bc5bf840-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:bc5bf840-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:bc5c3f76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:bc5c3f76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:bc5c3f76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:bc5c8b34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:bc5c8b34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:bc5c8b34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5d03fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5de5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bc5e4ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bc5e4ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bc5e4ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bc5e94d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc5e94d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc5e94d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc5edb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bc5edb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bc5edb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bc5f2146-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bc5f2146-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bc5f2146-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc5f9946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bc606ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumetasone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bc608ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:bc60b77c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bc60dfae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:bc610812-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:bc61306c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:bc615948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bc61818e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.304']} DrugCentral uuid:bc61a9ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:bc61d1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:bc61fd30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:bc622580-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:bc624dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bc627698-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:bc629efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:bc62c756-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:bc62f0aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bc63195e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.151']} DrugCentral uuid:bc63419a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:bc6369f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.103']} DrugCentral uuid:bc63924e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc63bce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:bc63e532-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bc640dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:bc643618-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:bc645f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.357']} DrugCentral uuid:bc64879e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bc64afe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bc64d834-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:bc650156-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:bc6529a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bc6551ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bc657a14-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bc65a3d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bc65cc08-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:bc65fcf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bc65fcf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bc65fcf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bc663c06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bc66642e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bc668c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc66b5b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bc66df12-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bc670780-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bc672fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunisolide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bc6759ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunisolide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:bc678250-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bc67aae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bc67d368-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bc67fc4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bc682c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc682c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc682c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc6872a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc6872a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc6872a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bc68b968-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:bc68b968-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:bc68b968-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:bc68ffa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:bc68ffa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:bc68ffa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:bc694bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:bc694bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:bc694bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:bc6992de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:bc6992de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:bc6992de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6a0b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc6ae2ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bc6ae2ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bc6ae2ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bc6b2c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bc6b2c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bc6b2c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bc6b73c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6b73c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6b73c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6bbb0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bc6bbb0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bc6bbb0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bc6c012c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6c012c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6c012c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bc6c411e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1204 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:bc6c696e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1204 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.475']} DrugCentral uuid:bc6c91dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1205 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.622']} DrugCentral uuid:bc6cba36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1205 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.538']} DrugCentral uuid:bc6ce362-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.042']} DrugCentral uuid:bc6d0ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bc6d33da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:bc6d5c34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:bc6d84e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.801']} DrugCentral uuid:bc6dad4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.067']} DrugCentral uuid:bc6dd6dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:bc6dff04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:bc6e2aba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bc6e5530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bc6e7e66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:bc6ea6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.091']} DrugCentral uuid:bc6ed01e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bc6ef864-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:bc6f20c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc6f4986-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bc6f71e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bc6f9a1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bc6fc26c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:bc6feb66-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bc701410-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:bc703c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.047']} DrugCentral uuid:bc70647e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:bc708e90-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bc70b6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:bc70deea-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:bc710726-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.444']} DrugCentral uuid:bc712fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:bc7157c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bc718070-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bc71a898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bc71d1a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc71f9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bc722214-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bc724a46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:bc7275c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:bc729dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bc72c638-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bc72eef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bc731750-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bc734b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc734b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc734b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc734b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bc739e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc739e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc739e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bc73e478-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bc73e478-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bc73e478-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bc742316-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bc744c56-94cc-11ec-8aec-0242ac110003 UniProtKB:P25122 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:bc74749c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bc749cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxymesterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:bc74c5d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bc74ee36-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc751668-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:bc753e90-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:bc756776-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.058']} DrugCentral uuid:bc758fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bc75b4ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bc75dd1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc7606e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.066']} DrugCentral uuid:bc76302a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:bc76588e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bc7680d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:bc76a988-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:bc76d1e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bc770946-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc770946-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc770946-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc770946-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc770946-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bc775e50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.075']} DrugCentral uuid:bc778678-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.649']} DrugCentral uuid:bc77aed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.269']} DrugCentral uuid:bc77d8bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:bc780116-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.067']} DrugCentral uuid:bc782952-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bc78518e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:bc787a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:bc78a36e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.838']} DrugCentral uuid:bc78cbb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.044']} DrugCentral uuid:bc78f3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:bc791cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:bc7945e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.464']} DrugCentral uuid:bc796e16-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:bc799634-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.191']} DrugCentral uuid:bc79c12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:bc79e95e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:bc7a119a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:bc7a39cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.793']} DrugCentral uuid:bc7a6258-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:bc7a8a80-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bc7ab2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.575']} DrugCentral uuid:bc7adbb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:bc7b0474-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.315']} DrugCentral uuid:bc7b2cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:bc7b54e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.655']} DrugCentral uuid:bc7b7e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:bc7ba6d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:bc7bcefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:bc7bf726-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.788']} DrugCentral uuid:bc7c1f80-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:bc7c47b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.535']} DrugCentral uuid:bc7c7002-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.019']} DrugCentral uuid:bc7c9834-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:bc7cc11a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.005']} DrugCentral uuid:bc7ce956-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:bc7d1192-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:bc7d3ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:bc7d6566-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.397']} DrugCentral uuid:bc7d8de8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bc7db606-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:bc7dde38-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.708']} DrugCentral uuid:bc7e06ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.125']} DrugCentral uuid:bc7e2ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc7e5746-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.67']} DrugCentral uuid:bc7e8130-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bc7eaa34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.061']} DrugCentral uuid:bc7ed28e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:bc7efb9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:bc7f24d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:bc7f4d04-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:bc7f7586-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc7f9dd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bc7fc69e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bc7ff696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bc7ff696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bc7ff696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc804fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bc80c6ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine decanoate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:bc80eaa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bc8114ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:bc813d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:bc81654e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:bc818d80-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:bc81b620-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:bc81de52-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.048']} DrugCentral uuid:bc820684-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bc822eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:bc82577e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bc827fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:bc82a7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:bc82d0be-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:bc82f8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bc832122-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:bc834ada-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.961']} DrugCentral uuid:bc83735c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.145']} DrugCentral uuid:bc839b98-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.841']} DrugCentral uuid:bc83c3d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:bc83ec06-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:bc8414e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:bc843e22-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:bc846640-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:bc848e7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:bc84b87a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:bc84e0a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:bc8508de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:bc853124-94cc-11ec-8aec-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bc8559b0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 3) DrugCentral uuid:bc857db4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bc85a5dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1216 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bc85ca80-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludroxycortide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.695']} DrugCentral uuid:bc85f38e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludroxycortide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:bc861bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.222']} DrugCentral uuid:bc864bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc864bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc864bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bc868ace-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bc86b300-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bc86db32-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bc870350-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:bc872bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bc8753fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bc877c36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bc87a44a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bc87cd30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bc87f63e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:bc881e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:bc8846ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.436']} DrugCentral uuid:bc886fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:bc88980a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bc88c046-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bc88ea26-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bc891262-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bc893abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bc896302-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:bc898bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:bc89b442-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bc89dc74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:bc8a04ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bc8a2f94-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:bc8a5ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:bc8a832c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bc8aab40-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc8ad4b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bc8afcee-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:bc8b2534-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.082']} DrugCentral uuid:bc8b4d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bc8b76ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:bc8b9f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:bc8bc76e-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bc8bf0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.74']} DrugCentral uuid:bc8c19f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bc8c42b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.77']} DrugCentral uuid:bc8c6ad4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate targets Enzyme (Cytosolic phospholipase A2) DrugCentral uuid:bc8c8ee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.12']} DrugCentral uuid:bc8cb778-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bc8cdfa0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:bc8d07be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:bc8d2c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bc8d5480-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bc8d7ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bc8da4e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bc8dce38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bc8df6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bc8e1eec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bc8e4732-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bc8e6faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:bc8e97f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:bc8ec144-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bc8ee9a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bc8f12a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bc8f3ae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 folic acid targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bc8f6338-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 folic acid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bc8f8b56-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucovorin targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.071']} DrugCentral uuid:bc8fb5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucovorin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bc8fe6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:bc8fe6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:bc8fe6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:bc902232-94cc-11ec-8aec-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bc902232-94cc-11ec-8aec-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bc90563a-94cc-11ec-8aec-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fondaparinux is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bc907e6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formestane targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:bc90a68a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bc90ceee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bc90f806-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bc91204c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bc914888-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bc9170ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bc91998c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:bc91c22c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosamprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:bc91e630-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosamprenavir is inhibitor of Enzyme (Pol polyprotein) DrugCentral uuid:bc920a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet is inhibitor of Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:bc9232fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08546 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc925b24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:bc92834c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc92ac3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfluconazole targets Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:bc92d040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q836E5 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1) DrugCentral uuid:bc92f43a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q831A8 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2) DrugCentral uuid:bc931866-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A749 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin is inhibitor of Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bc934098-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HVW7 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bc936b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bc939390-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bc93bce4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosphenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bc93e0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bc940992-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:bc9431f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:bc945ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fructose targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bc9484f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ftivazide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bc94ad34-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:bc94d55c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bc94fd84-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:bc952656-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:bc954e88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bc9576ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bc959eec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bc95c796-94cc-11ec-8aec-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bc95efbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:bc9617fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bc964022-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bc9668f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furaltadone targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bc969144-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bc96b94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bc96ddca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bc970868-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bc9730c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bc9758fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bc97813a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bc97aade-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bc97d31a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bc97fb60-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bc9823ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:bc984cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bc987518-94cc-11ec-8aec-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bc989d36-94cc-11ec-8aec-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bc98c608-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bc98ee80-94cc-11ec-8aec-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bc99169e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bc993eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P96618 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Holo-[acyl-carrieir-protein] synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bc996806-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bc999038-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:bc99b856-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bc99e092-94cc-11ec-8aec-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc9a09fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bc9a334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bc9a5b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bc9a83b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bc9aadd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bc9ad600-94cc-11ec-8aec-0242ac110003 UniProtKB:P48066 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bc9afe46-94cc-11ec-8aec-0242ac110003 UniProtKB:P48065 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bc9b2678-94cc-11ec-8aec-0242ac110003 UniProtKB:P31650 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bc9b4f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P31646 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bc9b7826-94cc-11ec-8aec-0242ac110003 UniProtKB:P31649 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:bc9ba058-94cc-11ec-8aec-0242ac110003 UniProtKB:P23574 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bc9bc89e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid is agonist of GPCR (Gamma-aminobutyric acid type B receptor subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bc9bf18e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSD5 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:bc9c19c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bc9c3d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bc9c618c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Adenosine receptor A1) DrugCentral uuid:bc9c86e4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) DrugCentral uuid:bc9caad4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bc9ccece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:bc9cf796-94cc-11ec-8aec-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bc9d2054-94cc-11ec-8aec-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bc9d487c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bc9d70b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bc9d98fe-94cc-11ec-8aec-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bc9dc202-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.928']} DrugCentral uuid:bc9dea16-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bc9e1270-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bc9e3aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bc9e65ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bc9e8dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bc9eb5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bc9ede44-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bc9f06d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bc9f2eda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bc9f581a-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bc9f80c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bc9fa91e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bc9fd1c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bc9ffb30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bca0252e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bca04d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bca075b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is negative allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:bca0a594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bca0a594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bca0a594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bca0e48c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bca10caa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bca134f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bca15d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bca1861c-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bca1ae3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:bca1d658-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:bca1fc46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Kinase (Thymidine kinase) DrugCentral uuid:bca222fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bca24b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bca273b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10210 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Enzyme (Capsid scaffolding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bca29c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bca2c518-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganirelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:bca2e91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bca31248-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bca33ee4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bca33ee4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bca370b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bca370b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bca3a244-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bca3a244-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bca3d71e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bca3ff6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bca427b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bca45004-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bca478d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bca4a13a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bca4c962-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bca4f1bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bca51a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bca54270-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bca56bf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bca59446-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bca5bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bca5e5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bca60e30-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bca636ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bca65f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bca6875c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bca6af98-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bca6d91e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bca7015a-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bca729a0-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bca751dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bca77b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bca7a3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bca7cbe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:bca7f42a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bca81cd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bca8451a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bca86d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bca89592-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bca8bf04-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bca8e736-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bca91030-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bca93880-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bca9638c-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bca98c54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bca9b4a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bca9dd4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bcaa0594-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bcaa2dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bcaa5620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bcaa7fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bcaaa832-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bcaad140-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bcaaf97c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bcab2262-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bcab4bde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bcab7424-94cc-11ec-8aec-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bcab9c60-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bcabc4ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bcabed1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bcac155a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bcac3d96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bcac667c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bcac8ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bcacb712-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bcacdf58-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcad09ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bcad320a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bcad5a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bcad828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bcadab22-94cc-11ec-8aec-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bcadd386-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcadfbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:bcae24c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bcae4d8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bcae75b6-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bcae9dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bcaec8cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:bcaef3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:bcaf1bf6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bcaf4414-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bcaf6caa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bcaf94dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bcafbd22-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bcafe54a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bcb00e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bcb03676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bcb05ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bcb086d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Enzyme (Thymidylate synthase) DrugCentral uuid:bcb0ac50-94cc-11ec-8aec-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:bcb0d04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:bcb0f458-94cc-11ec-8aec-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:bcb11834-94cc-11ec-8aec-0242ac110003 UniProtKB:P30085 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Kinase (UMP-CMP kinase) DrugCentral uuid:bcb14584-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bcb14584-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bcb14584-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:bcb17cde-94cc-11ec-8aec-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Lipoprotein lipase) DrugCentral uuid:bcb1a0b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:bcb1c8ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bcb1f1dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:bcb21a22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:bcb24268-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:bcb26bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bcb29740-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bcb2c0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:bcb2e4e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:bcb30950-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestodene targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bcb32d36-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestodene targets Enzyme (Cytochrome P450 3A5) DrugCentral uuid:bcb3513a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1292 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestrinone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bcb37994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12882 biolink:molecularly_interacts_with DrugCentral:1293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gimeracil is inhibitor of Enzyme (Dihydropyrimidine dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:bcb3a28e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:bcb3caca-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bcb3f6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bcb3f6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bcb42e70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bcb42e70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bcb4689a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcb4689a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcb4a08a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bcb4a08a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bcb4d80c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:bcb4d80c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:bcb50f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:bcb50f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:bcb546c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:bcb546c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:bcb57ece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:bcb57ece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:bcb5b632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bcb5b632-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bcb5eac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bcb61532-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bcb64034-94cc-11ec-8aec-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:bcb6688e-94cc-11ec-8aec-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bcb690de-94cc-11ec-8aec-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bcb6b988-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bcb6e1d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00367 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 1, mitochondrial) DrugCentral uuid:bcb705dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P49448 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 2, mitochondrial) DrugCentral uuid:bcb729e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bcb75334-94cc-11ec-8aec-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bcb77b84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bcb7a3f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bcb7cc2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bcb7f6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bcb8202a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bcb8483e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bcb87066-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14416 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bcb8999c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:bcb8c200-94cc-11ec-8aec-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:bcb8ea28-94cc-11ec-8aec-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bcb9125a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bcb93b54-94cc-11ec-8aec-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.595']} DrugCentral uuid:bcb96386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.738']} DrugCentral uuid:bcb98bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bcb9b3e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bcb9ddc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bcba05b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bcba2dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:bcba5656-94cc-11ec-8aec-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bcba7e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bcbaa692-94cc-11ec-8aec-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:bcbaceb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bcbaf818-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bcbb2036-94cc-11ec-8aec-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.31']} DrugCentral uuid:bcbb485e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03469 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bcbb7086-94cc-11ec-8aec-0242ac110003 UniProtKB:P70579 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bcbb9a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P47743 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bcbbc252-94cc-11ec-8aec-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bcbbeb7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23385 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bcbc13a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31421 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bcbc3c1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31422 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bcbc6432-94cc-11ec-8aec-0242ac110003 UniProtKB:P56068 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bcbc8c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bcbcb4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:1311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bcbcdd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2Q3 biolink:molecularly_interacts_with DrugCentral:1312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutathione targets Enzyme (Glutathione S-transferase kappa 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bcbd0d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bcbd0d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bcbd0d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bcbd4500-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:bcbd6e5e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bcbd9a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.795']} DrugCentral uuid:bcbdc4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bcbdecf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bcbe1980-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:bcbe1980-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:bcbe4cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bcbe7524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bcbe9e00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96P20 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Unclassified (NACHT, LRR and PYD domains-containing protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bcbec646-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:bcbeee78-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Nuclear other (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bcbf1aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bcbf1aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bcbf5296-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:bcbf5296-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:bcbf85fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bcbfae12-94cc-11ec-8aec-0242ac110003 UniProtKB:P48067 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Transporter (Sodium- and chloride-dependent glycine transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcbfed96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcc057fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bcc081b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bcc0ab28-94cc-11ec-8aec-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bcc0d364-94cc-11ec-8aec-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bcc0fc22-94cc-11ec-8aec-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:bcc126a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:1327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 goserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:bcc14d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 goserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:bcc1724c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bcc19a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bcc1c328-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcc1eb78-94cc-11ec-8aec-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bcc213d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bcc23c36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:bcc26512-94cc-11ec-8aec-0242ac110003 UniProtKB:P00346 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bcc28d44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0PJ46 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Lactate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bcc2b562-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6VVP7 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:bcc2dd76-94cc-11ec-8aec-0242ac110003 UniProtKB:P11708 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bcc30954-94cc-11ec-8aec-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bcc333d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bcc35c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P52732 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Kinesin-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:bcc384f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcc3ad3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bcc3d582-94cc-11ec-8aec-0242ac110003 UniProtKB:P07195 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bcc3fdc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:bcc426ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcc44f08-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bcc47848-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bcc4a444-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:bcc4a444-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:bcc4dd4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bcc4dd4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:bcc51096-94cc-11ec-8aec-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bcc538e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:bcc56172-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bcc58daa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bcc58daa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bcc5bf6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bcc5bf6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bcc5ed4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10875 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Structural (Tubulin beta chain) DrugCentral uuid:bcc611f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bcc63b6a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bcc66b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:bcc66b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:bcc66b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:bcc6a514-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:bcc6ce5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bcc6f6ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanadrel is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bcc71a8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanadrel targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bcc73fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bcc763be-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bcc787ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bcc7ab9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:bcc7d038-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:bcc7f4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:bcc818a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:bcc83da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.065']} DrugCentral uuid:bcc86732-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:bcc88fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:bcc8b82c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.926']} DrugCentral uuid:bcc8e054-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bcc908d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:bcc93130-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bcc95958-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:bcc9819e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.164']} DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bcca3f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bccc1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcccd16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ulobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bcccf568-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halofantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bccd1d86-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bccd464e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:bccd6e94-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bccd96ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bccdbf2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.947']} DrugCentral uuid:bccde8c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:bcce1402-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bcce3c84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bcce64c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bcce8d92-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bcceb5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bccede14-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bccf06e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bccf2f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bccf57ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bccf7fea-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bccfa812-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:bccfd256-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bccffa9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:bcd022d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bcd04b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bcd0751c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bcd09d4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:bcd0c5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bcd0ee3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bcd11684-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:bcd13ea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.569']} DrugCentral uuid:bcd166f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bcd19078-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bcd1b8d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:bcd1e122-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:bcd21246-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcd21246-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcd21246-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcd25134-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.648']} DrugCentral uuid:bcd27970-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bcd2a1c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bcd2ca7e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bcd2f2a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bcd31ace-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:bcd3431e-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:bcd36ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bcd394cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.76']} DrugCentral uuid:bcd3bcea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bcd3e530-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bcd40e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bcd437b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bcd46000-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bcd48850-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bcd4b104-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bcd4d92c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bcd5014a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcd5295e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bcd552a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bcd57ae4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bcd5a302-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bcd5cb48-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bcd5f56e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bcd61d96-94cc-11ec-8aec-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:bcd645c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bcd66f44-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bcd69794-94cc-11ec-8aec-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bcd6bfda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:bcd6e816-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bcd71142-94cc-11ec-8aec-0242ac110003 UniProtKB:P50129 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bcd73a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bcd76278-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bcd78ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P62744 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (AP-2 complex subunit sigma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:bcd7c42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcd7c42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcd7c42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcd7c42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcd7c42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcd82550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd82550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd82550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd82550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd87ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcd87ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcd87ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcd87ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcd8cbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bcd8cbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bcd8cbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bcd90ede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bcd90ede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bcd95150-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcd95150-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcd95150-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcd95150-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcd95150-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bcd9ae20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd9ae20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd9ae20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcd9f3c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bcd9f3c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bcd9f3c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcda4e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bcdacbac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bcdacbac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bcdacbac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bcdb0b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bcdb33a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bcdb5cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bcdb851a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bcdbad74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60493 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (Zinc finger protein 664) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:bcdbd5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:bcdbfe96-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halopredone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bcdc22ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bcdc4af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.339']} DrugCentral uuid:bcdc7358-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.366']} DrugCentral uuid:bcdc9ce8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.561']} DrugCentral uuid:bcdcc5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bcdcee0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:bcdd165a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:bcdd3f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bcdd68a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:bcdd90f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:bcddb948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:bcdde1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bcde0a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.338']} DrugCentral uuid:bcde3256-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:bcde5b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bcde8634-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:bcdeaa2e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:bcdece50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:bcdef25e-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:bcdf173e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:bcdf3f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bcdf3f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bcdfa65e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bce061a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bce089fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:bce0b242-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin targets Unclassified (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:bce0db46-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:bce10378-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bce12ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bce153fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bce17cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bce1a4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bce1cd1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bce1f558-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bce21e48-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce25994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bce2adea-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.212']} DrugCentral uuid:bce2d68a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.191']} DrugCentral uuid:bce2fe9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.043']} DrugCentral uuid:bce326ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.686']} DrugCentral uuid:bce34f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:bce377c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:bce39ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:bce3c84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:bce3f3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:bce41c20-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:bce44556-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.521']} DrugCentral uuid:bce46d92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bce4965a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.882']} DrugCentral uuid:bce4be78-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.126']} DrugCentral uuid:bce4e696-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.911']} DrugCentral uuid:bce50e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P06149 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (D-lactate dehydrogenase) DrugCentral uuid:bce532fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.614']} DrugCentral uuid:bce55b26-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.459']} DrugCentral uuid:bce5834e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.479']} DrugCentral uuid:bce5ab94-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bce5d4ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:bce5fcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.057']} DrugCentral uuid:bce624de-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bce64dce-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.479']} DrugCentral uuid:bce6766e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:bce69e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) DrugCentral uuid:bce6c286-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bce6eb30-94cc-11ec-8aec-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bce71362-94cc-11ec-8aec-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:bce73b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bce76376-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:bce78cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bce7b54c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bce7de6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bce80718-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bce82ffe-94cc-11ec-8aec-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bce8581c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:bce87c34-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bce8a45c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bce8d0c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bce8d0c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bce907d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bce907d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bce93eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bce93eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bce980fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bce980fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bce980fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bce980fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bce9cb98-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bce9f474-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bcea1c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexestrol is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:bcea4c6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bcea4c6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bcea4c6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bcea8b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bcea8b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bcea8b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bceacae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bceacae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bceacae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bceb0b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bceb0b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bceb0b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bceb4bda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bceb4bda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bceb4bda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bceb8a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bcebae04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bcebd6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bcebff1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bcec2744-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bcec4f76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bcec7fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bcec7fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bcec7fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bcecbdbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bcece5d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bced0fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bced3814-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bced6050-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bced8864-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bcedb122-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.508']} DrugCentral uuid:bcedda80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bcee02bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bcee2c42-94cc-11ec-8aec-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bcee54ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bcee7cce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bceea500-94cc-11ec-8aec-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bceecd14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bceef898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bcef237c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:bcef4bae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91ZY3 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bcef7480-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histidine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcef9ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:bcefc4e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:bcefed0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bcf015ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bcf03dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:bcf0661a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hycanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:bcf08e56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bcf0b85e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:bcf0de38-94cc-11ec-8aec-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:bcf10228-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:bcf12618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:bcf14a76-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bcf17294-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.438']} DrugCentral uuid:bcf19abc-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bcf1c302-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bcf1eb84-94cc-11ec-8aec-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bcf21398-94cc-11ec-8aec-0242ac110003 UniProtKB:B0LPN4 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.152']} DrugCentral uuid:bcf23cce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine is blocker of Ion channel (Ryanodine receptor 2) DrugCentral uuid:bcf260d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bcf28ae4-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bcf2b2da-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bcf2db0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:bcf2fef2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:bcf32346-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bcf34b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bcf373aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bcf39cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:bcf3c58a-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:bcf3ee66-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:bcf416ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocodone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bcf43efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortamate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bcf46454-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bcf48c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Cytosolic other (Annexin A1) DrugCentral uuid:bcf4b076-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.95']} DrugCentral uuid:bcf4d89e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bcf50206-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.881']} DrugCentral uuid:bcf52a42-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bcf5527e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bcf57ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone cypionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bcf59f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bcf5c7e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:bcf5f01c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:bcf61858-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bcf650a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bcf650a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bcf650a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bcf650a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bcf69a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.1']} DrugCentral uuid:bcf6c258-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bcf6ead0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.529']} DrugCentral uuid:bcf712da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bcf73b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bcf76398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bcf7877e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bcf7afb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.81']} DrugCentral uuid:bcf7d7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:bcf8010e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bcf8294a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bcf8517c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bcf87990-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bcf8a258-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:bcf8c648-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bcf8ee98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:bcf917ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bcf940e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bcf9690e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxystilbamidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bcf9910e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bcf9b936-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bcf9e348-94cc-11ec-8aec-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:bcfa074c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:bcfa2b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bcfa5378-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bcfa7c72-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bcfaa4ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bcfacccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.409']} DrugCentral uuid:bcfaf4fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bcfb1d6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bcfb45a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:bcfb6dd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bcfb9616-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bcfbbfec-94cc-11ec-8aec-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bcfbe80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:bcfc1032-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bcfc3882-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bcfc6168-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:bcfc8990-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:bcfcb1d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bcfcda3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bcfd02da-94cc-11ec-8aec-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bcfd2af8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bcfd5316-94cc-11ec-8aec-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bcfd7bf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bcfda53c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:bcfdce22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:bcfdf636-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bcfe1ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bcfe4730-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bcfe6f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bcfe9776-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:bcfebfda-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bcfee8fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:bcff0cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:bcff351e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bcff5f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bcff874e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bcffaf80-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bcffd7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bd0000de-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bd002956-94cc-11ec-8aec-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bd005174-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bd007992-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bd00a2c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bd00cece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bd00cece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bd0101f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bd012b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VD48 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bd01539e-94cc-11ec-8aec-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.53']} DrugCentral uuid:bd017bbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bd01a894-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd01a894-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd01dd00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibutilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bd020532-94cc-11ec-8aec-0242ac110003 UniProtKB:O75907 biolink:molecularly_interacts_with DrugCentral:1413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icosapent ethyl is inhibitor of Enzyme (Diacylglycerol O-acyltransferase 1) DrugCentral uuid:bd0228fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bd024cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:bd027134-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bd029510-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:bd02bd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bd02e538-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bd030ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:bd0336e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:1417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idoxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:bd035f22-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:1417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idoxuridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bd03874a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bd03b01c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:bd03d81c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd04004e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bd042858-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bd045198-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bd047aec-94cc-11ec-8aec-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bd04a314-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:bd04cb32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd04f558-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bd051d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bd0545a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd056f88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.99']} DrugCentral uuid:bd059f62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd059f62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd05da54-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd05da54-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd05da54-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd0618f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00960 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate [NMDA] receptor subunit epsilon 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bd064110-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60490 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Unclassified (3-beta-hydroxysteroid-delta(8),delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:bd06694c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bd069188-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bd06bb90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bd06e3ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bd070be0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bd0733d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd075cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:bd0784e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bd07ad2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bd07d552-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd07fdf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bd082638-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bd084e60-94cc-11ec-8aec-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bd08771e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bd08a16c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bd08c98a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd08f1b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bd091a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd09439c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:bd096b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bd0993b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bd09bc82-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bd09e4b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:bd0a0ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:bd0a3662-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:bd0a601a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bd0a8842-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bd0aac32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bd0ad450-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bd0afd54-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bd0b2608-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bd0b4e44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bd0b7680-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bd0b9f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bd0bc7de-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bd0bf038-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bd0c1856-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bd0c42e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bd0c6b12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd0c9358-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bd0cbb8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bd0ce416-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bd0d0c34-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bd0d3560-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bd0d5e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bd0d8678-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bd0daea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bd0dd6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bd0dffea-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:bd0e281c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd0e504e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:bd0e7862-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bd0ea102-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bd0ec916-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bd0ef12a-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bd0f1948-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd0f4206-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd0f6a2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bd0f9256-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bd0fba74-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd0fe4cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bd100cea-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd10365c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bd105e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bd10871a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd10af4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bd10d77e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bd10ffa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:bd11299a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bd1151c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bd117a08-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bd11a3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd11cdf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bd11f5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bd121e18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bd124672-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd126ea4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd1296e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bd12bf1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bd12e80c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bd131048-94cc-11ec-8aec-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:bd133852-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bd136084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bd138a82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bd13b2aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bd13dac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bd1402fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bd142b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:bd145458-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:bd147c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd14a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bd14cd70-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bd14f58e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bd151ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bd1546d8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bd1646be-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd1646be-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd167f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bd167f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bd16b806-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bd16b806-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bd16ee20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05030 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bd171710-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd17410e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd1769fe-94cc-11ec-8aec-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd179334-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bd17bc56-94cc-11ec-8aec-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd17fd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd185d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:bd18860e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:bd18aec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bd18d802-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.854']} DrugCentral uuid:bd190160-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bd19299c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:bd195336-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:bd197bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:bd19a4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:bd19cd02-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bd19f598-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:bd1a1e06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.614']} DrugCentral uuid:bd1a470a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:bd1a6f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:bd1a97fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:bd1ac054-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:bd1ae9bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.081']} DrugCentral uuid:bd1b123e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:bd1b3ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:bd1b637e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd1b8c28-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd1bb464-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bd1bdc82-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bd1c0586-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bd1c2f02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bd1c5720-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bd1c7f98-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bd1ca8ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bd1cd100-94cc-11ec-8aec-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bd1cf950-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd1d216e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:bd1d4b62-94cc-11ec-8aec-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bd1d738a-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bd1d9bbc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1ddbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd1e55a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd1e55a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd1e55a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd1e55a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd1e55a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1edf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bd1fa024-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bd1fa024-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bd1fa024-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bd1feffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bd1feffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bd1feffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bd1feffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bd1feffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bd204e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bd204e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bd204e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bd2094a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd2094a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd2094a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd20da98-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bd20da98-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bd20da98-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bd211972-94cc-11ec-8aec-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bd2141ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bd2169fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd2192c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:bd21bc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:bd21e442-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bd220cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod is agonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:bd22380c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bd226084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8MTZ4 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid targets Unclassified (Vacuolar-type proton translocating pyrophosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bd2288c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:bd22b106-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indalpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd22da78-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd2302c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.54']} DrugCentral uuid:bd232ae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:bd235386-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:bd237c80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bd23a4da-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd23cd20-94cc-11ec-8aec-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) DrugCentral uuid:bd23f2b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bd241d2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:bd244566-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:bd246dca-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bd249796-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bd24bff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.535']} DrugCentral uuid:bd24e82c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bd25107c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:bd253944-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bd255d34-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indenolol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:bd258124-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indenolol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bd25a550-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bd25d084-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:bd25f8fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.733']} DrugCentral uuid:bd26214c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bd264a14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:bd2672be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bd269adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bd26c30e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bd26eb2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bd27144e-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:bd273c94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:bd2764ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bd278d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bd27b2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bd27d6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bd27ff44-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bd282762-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bd284fee-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd287816-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:bd28a034-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:bd28c87a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bd28f156-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bd29197e-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bd2941b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd2969ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bd299494-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.691']} DrugCentral uuid:bd29bcc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bd29e610-94cc-11ec-8aec-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd2a0ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd2a36ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bd2a5f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd2a887c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bd2ab162-94cc-11ec-8aec-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd2ad99e-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd2b01ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd2b2a52-94cc-11ec-8aec-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bd2b539c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bd2b7bc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bd2ba400-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bd2bcc50-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bd2bf8c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bd2bf8c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bd2c3078-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd2c3078-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd2c67aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bd2c67aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bd2c9bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bd2cc402-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bd2cec5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P17516 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bd2d15e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bd2d4080-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:bd2d68da-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bd2d921a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:1442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoprofen targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd2dbaba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:bd2de332-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bd2e0b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bd2e33dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:bd2e5ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bd2e84f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bd2ead62-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bd2ed5b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd2eff42-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bd2f2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd2f2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd2f2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd2f7580-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:bd2f7580-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:bd2f7580-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:bd2fb572-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bd2fddae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bd3005ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bd302ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.278']} DrugCentral uuid:bd305716-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.724']} DrugCentral uuid:bd307f48-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.609']} DrugCentral uuid:bd30a784-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.804']} DrugCentral uuid:bd30d092-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.067']} DrugCentral uuid:bd30f8ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.279']} DrugCentral uuid:bd31220e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.439']} DrugCentral uuid:bd314a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.043']} DrugCentral uuid:bd3172d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.532']} DrugCentral uuid:bd319b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bd31c326-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:bd31eb58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bd321542-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.292']} DrugCentral uuid:bd323e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.181']} DrugCentral uuid:bd326664-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bd328ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bd32b902-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:bd32e198-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.74']} DrugCentral uuid:bd3309ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:bd33326a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipriflavone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:bd335aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipriflavone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:bd3382e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd33ab28-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:bd33d440-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bd33fc72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.185']} DrugCentral uuid:bd3424c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bd344cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd3476f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bd34a262-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bd34cabc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bd34f302-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd351ca6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bd3548ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bd3548ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bd358506-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bd358506-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bd358506-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bd35c46c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd35ecd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bd3610de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:bd363924-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:bd365ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:bd368762-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:bd36ab52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bd36cf4c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:bd36f42c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd371cae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:bd3740bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:bd376902-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bd379288-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:bd37bad8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bd37e328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bd380b78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd383620-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:bd385e48-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irofulven targets Kinase (Serine/threonine-protein kinase Chk2) DrugCentral uuid:bd3882e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isepamicin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bd38ab3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1490 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:bd38d030-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1490 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:bd38f538-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoetarine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bd391d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:bd3945ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:bd396a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:bd398eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:bd39b2ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:bd39d6e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:bd39ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bd39ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3a6684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:bd3b1d04-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bd3b45a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bd3b6dea-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bd3b9630-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:bd3bc074-94cc-11ec-8aec-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd3be89c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q29550 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Liver carboxylesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd3c10ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bd3c38ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Catalase-peroxidase) DrugCentral uuid:bd3c5d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bd3c8568-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bd3cad7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bd3cd5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bd3cfe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bd3d2694-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:bd3d4ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd3d76e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bd3da02e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bd3dc860-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bd3df0a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.752']} DrugCentral uuid:bd3e18d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:bd3e4150-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bd3e6996-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bd3e91b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bd3eba72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd3ee31c-94cc-11ec-8aec-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd3f0b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:bd3f34a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd3f5cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bd3f8808-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bd3fb062-94cc-11ec-8aec-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd3fd984-94cc-11ec-8aec-0242ac110003 UniProtKB:P59534 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd40022e-94cc-11ec-8aec-0242ac110003 UniProtKB:P59535 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 40) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd402a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P59536 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd40529c-94cc-11ec-8aec-0242ac110003 UniProtKB:P59537 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 43) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd407ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:P59538 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 31) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd40a5ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P59539 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 45) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd40ce20-94cc-11ec-8aec-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd40f65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P59541 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 30) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd411e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P59542 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 19) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd41477e-94cc-11ec-8aec-0242ac110003 UniProtKB:P59543 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd417046-94cc-11ec-8aec-0242ac110003 UniProtKB:P59544 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 50) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd419882-94cc-11ec-8aec-0242ac110003 UniProtKB:P59551 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 60) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd41c0be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTR8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 42) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd41e954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYV7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 16) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd4211f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd423a30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYV9 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd426258-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd428b34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW1 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd42b35c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW2 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd42db98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW3 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd430438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd432e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW5 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd435640-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW6 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd437e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd43a6e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bd43cc4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bd43f050-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:bd441fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd441fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd441fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd441fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd446198-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:bd4490fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd4490fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd4490fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd4490fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bd44d344-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:bd44fdb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bd4525f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:bd454e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:bd457650-94cc-11ec-8aec-0242ac110003 UniProtKB:P08319 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (Alcohol dehydrogenase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bd459edc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:bd45c704-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bd45ef36-94cc-11ec-8aec-0242ac110003 UniProtKB:O14756 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (17-beta-hydroxysteroid dehydrogenase type 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:bd461768-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin is inhibitor of Nuclear hormone receptor (Retinoic acid receptor beta) DrugCentral uuid:bd463c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.597']} DrugCentral uuid:bd46643e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.335']} DrugCentral uuid:bd468c70-94cc-11ec-8aec-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bd46b48e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bd46dd88-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1509 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bd4705b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1509 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd472dce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bd4751c8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bd477752-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bd479fa2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bd47c7c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:bd47f092-94cc-11ec-8aec-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bd4818e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bd48410a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd48695a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bd48933a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bd48bd88-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:bd48e628-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.246']} DrugCentral uuid:bd490e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bd49370e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bd495f40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd498786-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd49afb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd49d8a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bd4a00d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bd4a2a42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:bd4a52b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4a9b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:bd4b0e12-94cc-11ec-8aec-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:bd4b3680-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bd4b5ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P29033 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Unclassified (Gap junction beta-2 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bd4b86e4-94cc-11ec-8aec-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:1520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bekanamycin targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bd4bafe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bekanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bd4bd824-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c17a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4c9d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bd4d1342-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:bd4d1342-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:bd4d1342-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:bd4d1342-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:bd4d5546-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd4d7e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bd4da690-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki'} DrugCentral uuid:bd4dd084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bd4df8b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bd4e2228-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bd4e4a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bd4e7282-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd4e9ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bd4ec3cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bd4eec12-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bd4f1458-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bd4f3c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:bd4f653e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd4f8d98-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.747']} DrugCentral uuid:bd4fb5c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bd4fddfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bd50091c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:bd503130-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:bd505980-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bd5082fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bd50ac14-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bd50d450-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.903']} DrugCentral uuid:bd50fc8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:bd51250e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bd514ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bd517702-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bd519f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.33']} DrugCentral uuid:bd51c914-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd51f150-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bd52198c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd5241d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bd527274-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bd527274-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bd527274-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bd52b84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bd52b84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bd52b84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bd52f758-94cc-11ec-8aec-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd531fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd534820-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bd5371b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:bd539c76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.585']} DrugCentral uuid:bd53c5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:bd53f9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd53f9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd53f9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd53f9b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd544f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd544f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd544f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd544f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd549996-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.821']} DrugCentral uuid:bd54c222-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bd54eb44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bd55139e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bd553bda-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bd5565e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bd55910c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bd55bbdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:bd55e440-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.667']} DrugCentral uuid:bd560d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:bd563530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:bd565d4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.729']} DrugCentral uuid:bd568576-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bd56a9b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:bd56d224-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bd56fa60-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:bd5722c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bd574d94-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bd5775da-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bd579e2a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bd57c684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bd57efb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bd5817d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.665']} DrugCentral uuid:bd5840e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'app Ki', 'has_quantitative_value': ['7.197']} DrugCentral uuid:bd5868f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd5891d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bd58bb16-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bd58e46a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bd590dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.266']} DrugCentral uuid:bd593848-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.897']} DrugCentral uuid:bd596098-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.211']} DrugCentral uuid:bd5988e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:bd59b174-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:bd59d9a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:bd5a01d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07973 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.506']} DrugCentral uuid:bd5a2a00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08686 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 21) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bd5a52b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bd5a7afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P14137 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:bd5aa336-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09128 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 24A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bd5acb86-94cc-11ec-8aec-0242ac110003 UniProtKB:P18125 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 7A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bd5af692-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64654 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 51) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd5b1f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:bd5b4764-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:bd5b6fa0-94cc-11ec-8aec-0242ac110003 UniProtKB:O35084 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bd5b9836-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:bd5bc072-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bd5be8ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.896']} DrugCentral uuid:bd5c10cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bd5c3a66-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:bd5c6298-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bd5c8aca-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:bd5cb892-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bd5cb892-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bd5cec04-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bd5d1440-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:bd5d3c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:bd5d653a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.214']} DrugCentral uuid:bd5d8d76-94cc-11ec-8aec-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bd5db5da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bd5dde0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.361']} DrugCentral uuid:bd5e06c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:bd5e2efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bd5e5314-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.839']} DrugCentral uuid:bd5e7d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.047']} DrugCentral uuid:bd5ea7f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bd5ed046-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:bd5ef882-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:bd5f20d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.489']} DrugCentral uuid:bd5f4986-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:bd5f71d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.509']} DrugCentral uuid:bd5f9a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:bd5fc2b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bd5feb8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:bd6013ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:bd603cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:bd6066c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.075']} DrugCentral uuid:bd60916a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:bd60b9b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:bd60e1f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:bd610a96-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd6132e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.234']} DrugCentral uuid:bd615b54-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bd61839a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.117']} DrugCentral uuid:bd61ac4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.478']} DrugCentral uuid:bd61d494-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:bd61fcee-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:bd622548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:bd624ea6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:bd6276ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:bd629f1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:bd62c750-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bd62effa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bd631822-94cc-11ec-8aec-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bd634040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bd6368cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:bd6390fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.245']} DrugCentral uuid:bd63b944-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:bd63e234-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:bd640bce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bd643522-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bd645dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.771']} DrugCentral uuid:bd6487d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:bd64b470-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bd64b470-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bd64e1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:O00214 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:bd650a1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00182 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd653256-94cc-11ec-8aec-0242ac110003 UniProtKB:P17931 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.03']} DrugCentral uuid:bd655b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:bd657f22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine is inhibitor of Polyprotein (Protein P) DrugCentral uuid:bd65a33a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bd65cb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:bd65f682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.839']} DrugCentral uuid:bd662170-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:bd664588-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd666dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd6696aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd66bf04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:bd66e34e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd670b80-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.744']} DrugCentral uuid:bd673484-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:bd675d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:bd678560-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bd67b6fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bd67b6fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bd67b6fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bd67faf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd682308-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1545 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 landiolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:bd684716-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:bd686fca-94cc-11ec-8aec-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd689838-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bd68c07e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bd68e9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bd6911c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:bd693a18-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bd696240-94cc-11ec-8aec-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:bd698be4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bd69b448-94cc-11ec-8aec-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bd69dcac-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.275']} DrugCentral uuid:bd6a04e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.473']} DrugCentral uuid:bd6a2e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bd6a5772-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCT1 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Phosphoethanolamine/phosphocholine phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bd6a7f9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bd6aa7d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bd6ad490-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bd6ad490-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bd6b0262-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:bd6b2aa8-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:bd6b5316-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:bd6b7d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bd6ba12c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bd6bc51c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bd6bee2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd6c16e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:bd6c3f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bd6c6774-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:bd6c8b78-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bd6cb468-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd6cdc7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:bd6d04ae-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bd6d2dd0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd6d5652-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bd6d7e84-94cc-11ec-8aec-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bd6da6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:bd6dcf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bd6df792-94cc-11ec-8aec-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bd6e1fce-94cc-11ec-8aec-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bd6e47e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bd6e70b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bd6e98dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1549 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine hydrochloride targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd6ec12c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:1549 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine hydrochloride is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bd6ee954-94cc-11ec-8aec-0242ac110003 UniProtKB:O75746 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar1) DrugCentral uuid:bd6f0de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P17174 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, cytoplasmic) DrugCentral uuid:bd6f327e-94cc-11ec-8aec-0242ac110003 UniProtKB:P45381 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartoacylase) DrugCentral uuid:bd6f5650-94cc-11ec-8aec-0242ac110003 UniProtKB:P08243 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Asparagine synthetase [glutamine-hydrolyzing]) DrugCentral uuid:bd6f7a40-94cc-11ec-8aec-0242ac110003 UniProtKB:P00966 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Argininosuccinate synthase) DrugCentral uuid:bd6f9e80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03154 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aminoacylase-1) DrugCentral uuid:bd6fc37e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00505 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, mitochondrial) DrugCentral uuid:bd6fe912-94cc-11ec-8aec-0242ac110003 UniProtKB:P14868 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate--tRNA ligase, cytoplasmic) DrugCentral uuid:bd700ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12797 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartyl/asparaginyl beta-hydroxylase) DrugCentral uuid:bd7030de-94cc-11ec-8aec-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bd705a46-94cc-11ec-8aec-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bd708278-94cc-11ec-8aec-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:bd70aa96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UJS0 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar2) DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd70e77c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bd7155e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bd717e62-94cc-11ec-8aec-0242ac110003 UniProtKB:O59010 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Glutamate transporter homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:bd71a6bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.757']} DrugCentral uuid:bd71ceee-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:bd71f748-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bd722060-94cc-11ec-8aec-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bd7248ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:bd727100-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:bd729946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bd72c254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd72ea9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:bd7312e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.684']} DrugCentral uuid:bd733c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bd7364f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bd738d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bd73b54c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bd73dd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bd740696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bd742ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leuprorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:bd74570e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leuprorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bd748012-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:bd74a84e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bd74d09e-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bd750582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bd750582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bd750582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bd750582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bd754f38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N587 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Ion channel (Acetylcholine receptor subunit alpha-type unc-63) DrugCentral uuid:bd757346-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bd759b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:O96760 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole is agonist of Ion channel (Nicotinic acetylcholine receptor alpha subunit) DrugCentral uuid:bd75c062-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.568']} DrugCentral uuid:bd75e93e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09487 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bd761170-94cc-11ec-8aec-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bd76398e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:bd766350-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bd768b78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:bd76b3a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:bd76dccc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd7736ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bd77eeb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:bd78127c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:bd783748-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:bd785b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bd788392-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bd78abba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bd78d022-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.279']} DrugCentral uuid:bd78f872-94cc-11ec-8aec-0242ac110003 UniProtKB:O95665 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bd7921da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63384 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine targets GPCR (Neurotensin receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bd794a2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P70310 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bd797324-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:bd799c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bd79c496-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.541']} DrugCentral uuid:bd79ece6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:bd7a1752-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:bd7a3f66-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:bd7a678e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa is agonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:bd7a8b6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa is agonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:bd7aafc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.04']} DrugCentral uuid:bd7ad7fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bd7b0040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bd7b2c46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bd7b2c46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:bd7b5ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bd7b5ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bd7b8c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bd7bb4c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadyl acetate is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bd7bda24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadyl acetate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bd7c0620-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:bd7c2eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:bd7c56fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bd7c7b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['12.796']} DrugCentral uuid:bd7ca38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.91']} DrugCentral uuid:bd7ccbc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:bd7cf422-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.339']} DrugCentral uuid:bd7d1d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:bd7d459e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bd7d6dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bd7d971a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd7dc0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bd7de922-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:bd7e115e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bd7e3990-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd7e6316-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bd7e8b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:O55242 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7f4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bd7fc9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bd7fc9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bd7fc9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bd7fc9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bd801c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd801c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd801c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bd805ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd8082fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosalbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bd80ab30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:bd80cfb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:bd80f3a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15842 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 8) DrugCentral uuid:bd8117be-94cc-11ec-8aec-0242ac110003 UniProtKB:P63316 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan is opener of Cytosolic other (Troponin C, slow skeletal and cardiac muscles) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.155']} DrugCentral uuid:bd813ff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bd816ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:bd81950e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bd81bdd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bd81e5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:bd820ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bd82460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd82460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd82460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd82460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd82460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bd82a3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bd82a3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bd82a3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bd82e9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bd82e9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bd82e9cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bd832a5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bd83548e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:bd8378ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bd83a100-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bd83c9be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bd83f1d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.296']} DrugCentral uuid:bd841a0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:bd843e1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.559']} DrugCentral uuid:bd846e96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:bd846e96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:bd846e96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:bd84b4a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bd84b4a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bd84b4a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bd84f2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bd851d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bd8545aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bd856dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bd859e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bd859e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bd859e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bd85dccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 limaprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:bd8600c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:1582 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lincomycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:bd8624b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bd864d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bd8676a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75NA5 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bd869ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:bd86cf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bd86cf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bd86cf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bd87156a-94cc-11ec-8aec-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd87156a-94cc-11ec-8aec-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd87156a-94cc-11ec-8aec-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd875598-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd875598-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd875598-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:bd879530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd879530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd879530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bd87dbbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bd87dbbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bd87dbbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bd881a82-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bd8842a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bd886adc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bd8892fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31040 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bd88bdca-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:bd88e6e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:bd890f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bd893764-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:bd895ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bd898912-94cc-11ec-8aec-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bd89b144-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8a1328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8b24ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bd8bf3dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1587 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:bd8c1c04-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1587 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bd8c444a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:bd8c6eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bd8c9706-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bd8cbf4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bd8ce76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.936']} DrugCentral uuid:bd8d100a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bd8d385a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.061']} DrugCentral uuid:bd8d60a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd8d897c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.259']} DrugCentral uuid:bd8db29e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd8ddae4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.625']} DrugCentral uuid:bd8e0320-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bd8e2f58-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bd8e587a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bd8e8188-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:bd8ea9c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bd8ed2a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bd8efaf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.203']} DrugCentral uuid:bd8f2340-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bd8f4cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd8f7610-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.037']} DrugCentral uuid:bd8f9e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:bd8fc67e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:bd8feece-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.338']} DrugCentral uuid:bd9017e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:bd904022-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bd90682c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.33']} DrugCentral uuid:bd90904a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bd90b8ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bd90e16c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.489']} DrugCentral uuid:bd910994-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bd9132b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:bd915ae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:bd91832e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:bd91ab74-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bd91d50e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bd91fd54-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.444']} DrugCentral uuid:bd922590-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:bd924de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:bd927798-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:bd929fca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.468']} DrugCentral uuid:bd92c7fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:bd92f09c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bd931982-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bd9341dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:bd936a18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:bd9399d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bd9399d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bd9399d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bd93e3f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bd93e3f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bd93e3f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bd942250-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:bd944afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bd947714-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bd947714-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:bd94a5fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomerizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bd94ce44-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonazolac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bd94f734-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:bd951f66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bd954798-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:bd956fca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:bd9596da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:bd95c182-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:bd95e9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:bd961376-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.343']} DrugCentral uuid:bd963bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bd9663da-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:bd968c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bd96b4d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:bd96d8d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bd9700ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:bd97291e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:bd975a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:bd975a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:bd975a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:bd979156-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:bd97b992-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.345']} DrugCentral uuid:bd97e1ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) DrugCentral uuid:bd980636-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) DrugCentral uuid:bd982a26-94cc-11ec-8aec-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) DrugCentral uuid:bd984e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bd98765c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:bd989f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:bd98c788-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:bd98efc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bd9917e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:bd9942a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bd996b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bd999adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bd999adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bd999adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bd99da7e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:bd9a027e-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bd9a2bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bd9a53f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:bd9a7cd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:bd9aa102-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:bd9ac95c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bd9af1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bd9b1ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.59']} DrugCentral uuid:bd9b4314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:bd9b72ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bd9b72ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bd9b72ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bd9bb2c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bd9bb2c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bd9bb2c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bd9bf250-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bd9bf250-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bd9bf250-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bd9c3242-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bd9c3242-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bd9c3242-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bd9c69b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9ca47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bd9d0992-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bd9d31c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:bd9d5a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:bd9d82fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bd9dac08-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bd9dd41c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bd9dfc4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bd9e2534-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bd9e4d52-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:bd9e76a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bd9e9ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2J7 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Transporter (Sodium-dependent neutral amino acid transporter B(0)AT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bd9ec89a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bd9ef0ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bd9f20f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:bd9f20f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:bd9f20f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:bd9f5fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bd9f83de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:bd9fa7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:bd9fcbb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:bd9ff058-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:bda0143e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.498']} DrugCentral uuid:bda03c8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bda064ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bda08e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:bda0b6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bda0e026-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bda10876-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bda13152-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bda15998-94cc-11ec-8aec-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:bda181e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bda1aad8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WV26 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bda1d6ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bda1d6ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bda21572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bda21572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bda21572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bda21572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bda26400-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bda26400-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bda29f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:bda29f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:bda29f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:bda2e10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bda2e10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bda314c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCN6 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Unclassified (Platelet glycoprotein VI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bda33cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loteprednol etabonate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bda36242-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:bda38b32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:bda3b378-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:bda3dbc8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bda40404-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.67']} DrugCentral uuid:bda42ec0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bda456e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:bda47f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bda4a76a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bda4d00a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:bda4f814-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:bda52032-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.697']} DrugCentral uuid:bda54882-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bda57190-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bda599b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01237 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:bda5c1e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bda5ea30-94cc-11ec-8aec-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bda615c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95214 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Acyl-CoA:cholesterol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bda6408e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:bda668f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bda691ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:bda6b9e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.244']} DrugCentral uuid:bda6e200-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bda70a64-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bda73340-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bda75b86-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bda783c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:bda7abf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:bda7d660-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bda7fee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:bda82840-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bda8507c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:bda87962-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:bda8a180-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bda8c98a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.376']} DrugCentral uuid:bda8f234-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:bda91b10-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:bda94338-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.829']} DrugCentral uuid:bda96c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:bda994c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bda9c024-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:bda9e874-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bdaa10a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:bdaa3946-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.276']} DrugCentral uuid:bdaa618c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:bdaa89be-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:bdaab1f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bdaadab8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:bdab02cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bdab2af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bdab52fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:bdab7c48-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bdaba48e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bdabccc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bdabfca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bdabfca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bdabfca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bdac3d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:1614 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bdac65a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:1614 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxiglumide is antagonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bdac8e08-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bdacb6c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bdacdeee-94cc-11ec-8aec-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lucanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bdad078e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumefantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bdad2fde-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bdad58e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bdad8150-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bdada98c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:bdadd1f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bdadfae0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.979']} DrugCentral uuid:bdae22fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.856']} DrugCentral uuid:bdae4b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.12']} DrugCentral uuid:bdae73b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bdae9c84-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bdaec4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bdaeed4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bdaf159c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bdaf3fc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bdaf6808-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:bdaf9044-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:bdafb9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bdafe332-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bdb00b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bdb0349a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bdb05d58-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:bdb0863e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bdb0ae98-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bdb0d6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bdb100fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bdb131f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bdb131f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bdb131f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bdb17076-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:bdb19970-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bdb1c1de-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bdb1ea42-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bdb2127e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:bdb23b32-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bdb26378-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:bdb287a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:bdb2afe0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:bdb2d9b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bdb301d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bdb329fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bdb35238-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bdb37b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bdb3a36e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bdb3ccd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bdb3f526-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bdb41dc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bdb44616-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bdb46e48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bdb49788-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bdb4c00a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bdb4e83c-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bdb511a4-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bdb53a94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:bdb5635c-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bdb58bac-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bdb5b410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bdb5dd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bdb60564-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bdb62dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bdb655f0-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bdb68002-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 malathion targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.538']} DrugCentral uuid:bdb6a87a-94cc-11ec-8aec-0242ac110003 UniProtKB:A2PZ98 biolink:molecularly_interacts_with DrugCentral:1626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 malathion is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:bdb6cc88-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bdb6f898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bdb6f898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bdb7270a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.308']} DrugCentral uuid:bdb74f64-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:bdb777c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.165']} DrugCentral uuid:bdb7a00e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.364']} DrugCentral uuid:bdb7c9bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:bdb7f202-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.27']} DrugCentral uuid:bdb81a3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bdb8439c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:bdb86dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:bdb8964e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:bdb8be80-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.854']} DrugCentral uuid:bdb8e75c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.876']} DrugCentral uuid:bdb90fa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:bdb93806-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:bdb96042-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.777']} DrugCentral uuid:bdb9890a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.406']} DrugCentral uuid:bdb9b164-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:bdb9d9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:bdba01f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bdba2c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:bdba56fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.939']} DrugCentral uuid:bdba7f36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:bdbaa754-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.355']} DrugCentral uuid:bdbad04e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bdbaf9b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bdbb21e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:bdbb45d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bdbb6ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bdbb97cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bdbbc0f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bdbbea24-94cc-11ec-8aec-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc is antagonist of GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bdbc12b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bdbc3b78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bdbc63a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P61813 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:bdbc8c90-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bdbcb4cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:bdbcdd12-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bdbd0558-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bdbd2e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bdbd5666-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bdbd7e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bdbda6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bdbdd0b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bdbdf8fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bdbe212c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bdbe4968-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bdbe7276-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bdbe9aa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bdbec2ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bdbeeb16-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bdbf13c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bdbf3bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bdbf6424-94cc-11ec-8aec-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bdbf9034-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bdbf9034-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bdbfc5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdbfedc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:bdc015ea-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:bdc03ed0-94cc-11ec-8aec-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bdc0670c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bdc08f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:1638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maxacalcitol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:bdc0b8a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:1638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maxacalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:bdc0e132-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:bdc10a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bdc1325e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bdc15aae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bdc1856a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bdc1adc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:bdc1d63c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:bdc1fea0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bdc227a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bdc24fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bdc2783a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bdc2a0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BJF5 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Calmodulin-domain protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bdc2d0be-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc2d0be-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc2d0be-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc31efc-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:bdc3818a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:bdc3a9d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (Histamine H4 receptor) DrugCentral uuid:bdc3cdd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:bdc3f6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bdc41ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.161']} DrugCentral uuid:bdc4471e-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bdc4736a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bdc4736a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bdc4aa6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:bdc4aa6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:bdc4e1a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bdc4e1a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bdc51a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bdc51a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bdc55136-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bdc55136-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bdc5911e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdc5911e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdc5911e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdc5911e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdc5dc64-94cc-11ec-8aec-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bdc6057c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bdc62dae-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bdc6561c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bdc67e4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:1648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecillinam is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.035']} DrugCentral uuid:bdc6a66c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:bdc6ce8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bdc6f37e-94cc-11ec-8aec-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is agonist of Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bdc71c14-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bdc744dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bdc76d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bdc795fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bdc7be44-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bdc7e68a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bdc80ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bdc8377a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bdc85fa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:bdc887e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bdc8b042-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bdc8dab8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.503']} DrugCentral uuid:bdc902e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bdc92b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bdc95362-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bdc98030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bdc98030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdc9ec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bdcac83c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bdcac83c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bdcac83c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bdcb0e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bdcb0e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bdcb0e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bdcb5536-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bdcb5536-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bdcb5536-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bdcb9bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bdcb9bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bdcb9bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bdcbdba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxalol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bdcc03dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['6.08']} DrugCentral uuid:bdcc2c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.561']} DrugCentral uuid:bdcc547c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:bdcc7d9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bdcca5bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bdcccdee-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.59']} DrugCentral uuid:bdccf620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bdcd1ede-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bdcd471a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bdcd703c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bdcd9882-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bdcdc140-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:bdcde968-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.032']} DrugCentral uuid:bdce11a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:bdce3fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bdce3fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bdce7356-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1662 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medrysone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bdce975a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bdcebfaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:bdcee872-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bdcf1090-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:bdcf38b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bdcf61da-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bdcf8a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bdcfb2c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bdcfdaf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bdd00324-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bdd02d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bdd055cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bdd07dea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:bdd0a63a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:bdd0ceee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bdd0f70c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bdd11af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:bdd142fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:bdd1678c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bdd18fa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P90584 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Unclassified (Protein kinase Pfmrk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bdd1b7b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:bdd1dbae-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.057']} DrugCentral uuid:bdd20750-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bdd22dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bdd2561a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bdd27eba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:bdd2a6f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meglutol targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:bdd2cf1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bdd2f764-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:bdd320a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bdd34976-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bdd37270-94cc-11ec-8aec-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bdd39a98-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bdd3c432-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bdd3ed90-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:bdd415f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bdd445ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:bdd445ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:bdd445ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:bdd48476-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bdd4ac94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bdd4d502-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bdd4fdf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bdd52642-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bdd54e74-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bdd5769c-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bdd5a004-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:bdd5c836-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bdd5f072-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bdd61476-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:bdd63d20-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:bdd6657a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:bdd68dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bdd6b62e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.063']} DrugCentral uuid:bdd6df14-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:bdd7073c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bdd72f78-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:bdd758a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.469']} DrugCentral uuid:bdd781e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:bdd7a5c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:bdd7cde8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:1678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melphalan targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:bdd7f638-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:bdd81a96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bdd83eae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bdd866cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:bdd88f08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bdd8bbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bdd8bbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bdd8f33a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:bdd8f33a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:bdd926fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bdd95212-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bdd97b98-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bdd9a3e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bdd9cc24-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bdd9f4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P30305 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bdda1de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:bdda4622-94cc-11ec-8aec-0242ac110003 UniProtKB:P30307 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:bdda6ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15374 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Ubiquitin carboxyl-terminal hydrolase isozyme L3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:bdda9744-94cc-11ec-8aec-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bddac02a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64346 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bddae85c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28563 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bddb12e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bddb3dca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bddb6606-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione sodium bisulfite targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bddb8e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1685 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menatetrenone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bddbb6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:bddbdf00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:bddc0746-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:bddc2f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:bddc589a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:bddc80fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:bddca94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:bddcd19e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:bddcfcb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:bddd24dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.504']} DrugCentral uuid:bddd4d04-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bddd7536-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:bddd9e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bdddc644-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bdddee9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:bdde1766-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:bdde3fb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:bdde6874-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:bdde909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:bddeba40-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bddee43e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UDY8 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Enzyme (Mucosa-associated lymphoid tissue lymphoma translocation protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bddf0d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bddf3178-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:bddf5a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:bddf83bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bddfac0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bddfd43e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bddffd24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:bde02114-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:bde04946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bde06d4a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:bde09644-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bde0be76-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bde0e6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bde11a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bde11a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bde11a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bde11a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bde16f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bde16f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bde16f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bde16f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bde1b880-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:bde1e166-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephentermine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde22784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bde2abaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde2abaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde2abaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde2e32c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bde3079e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:bde32b98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:bde34f9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:bde373a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:bde39998-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:bde3bda6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:bde3e1be-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bde405a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.821']} DrugCentral uuid:bde4374a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bde4374a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bde4374a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:bde47674-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bde47674-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bde47674-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:bde4b58a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bde4b58a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bde4b58a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:bde4f504-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde4f504-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde4f504-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:bde52c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meproscillarin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bde55198-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bde57a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:bde5a2c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bde5cad8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bde5f30a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:bde61d76-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:bde6462a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:bde66e48-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:bde69670-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.276']} DrugCentral uuid:bde6befc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.955']} DrugCentral uuid:bde6e71a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bde70f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bde73788-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bde7606e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q389T8 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bde78896-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:bde7b0b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:bde7d49a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:bde7fb78-94cc-11ec-8aec-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) DrugCentral uuid:bde81f86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06203 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine is inhibitor of Enzyme (Amidophosphoribosyltransferase) DrugCentral uuid:bde84380-94cc-11ec-8aec-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:bde868b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bde89164-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:bde8b57c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:bde8d980-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:bde8fd98-94cc-11ec-8aec-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:bde92246-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:bde946ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:bde96bde-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bde99410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bde9be22-94cc-11ec-8aec-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bde9e8a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XEC0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bdea11a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bdea39ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bdea5e5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:bdea82f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:bdeaa72e-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bdeacf60-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bdeaf878-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bdeb20c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WU19 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Hydroxyacid oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bdeb4904-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:bdeb715e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.724']} DrugCentral uuid:bdeb9c24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bdebc5aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:bdebee2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:bdec1668-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:bdec3f12-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bdec673a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:bdec8f76-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.744']} DrugCentral uuid:bdecb7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bdece098-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:bded08a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bded30de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bded5a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:bded86a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.041']} DrugCentral uuid:bdedb220-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.647']} DrugCentral uuid:bdeddc6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:bdee0522-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:bdee2d68-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.282']} DrugCentral uuid:bdee56da-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:bdee7f20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.958']} DrugCentral uuid:bdeea82e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orciprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bdeed074-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orciprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bdeef8ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metaraminol is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bdef1ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:bdef4716-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bdef6f70-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bdef97ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:bdefbff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:bdefe892-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bdf010e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bdf0393c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bdf06178-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bdf08b26-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bdf0b376-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bdf0dbbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bdf1051a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.124']} DrugCentral uuid:bdf12dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.583']} DrugCentral uuid:bdf15614-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:bdf17f40-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:bdf1a7e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bdf1d012-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bdf1f84e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:bdf22094-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:bdf24966-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bdf2718e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bdf299d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.872']} DrugCentral uuid:bdf2c224-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bdf2eb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bdf31396-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bdf33bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:bdf363f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:bdf38ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bdf3b4ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bdf3dd26-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bdf4056c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bdf42fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bdf457f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bdf48bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bdf48bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bdf48bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bdf48bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bdf4e1a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bdf4e1a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bdf4e1a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bdf5215e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:bdf54558-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bdf56df8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.697']} DrugCentral uuid:bdf5960c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.401']} DrugCentral uuid:bdf5be20-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.499']} DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf6a420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:bdf8a91e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:bdf8d1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:bdf8fa68-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bdf91e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bdf946d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:bdf96fc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bdf9984c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bdf9c04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bdf9e87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:1727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metacycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bdfa107e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:bdfa3a22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bdfa6358-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bdfa8b58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:bdfaaf34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:bdfad37e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bdfb070e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bdfb070e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bdfb070e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bdfb070e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:bdfb4ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylmethadol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bdfb78ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylmethadol is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bdfb9cb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.383']} DrugCentral uuid:bdfbc4d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bdfbecfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:bdfc1766-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:bdfc3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bdfc6856-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:bdfc909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bdfcb946-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.611']} DrugCentral uuid:bdfce1f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bdfd0aea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bdfd3326-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bdfd5bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:bdfd83ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bdfdbb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:bdfdbb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:bdfdbb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:bdfdbb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:bdfdbb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:bdfe0b3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bdfe3366-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:bdfe5b70-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bdfe83e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:bdfeac9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:bdfed4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.409']} DrugCentral uuid:bdfefce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:bdff25b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bdff4dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:bdff7726-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:bdff9fb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:bdffca1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:bdfff250-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:be001a96-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:be004af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:be004af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:be004af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:be0091d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:be0091d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:be0091d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:be00d7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be00d7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be00d7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be011e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:be011e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:be011e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:be016400-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:be016400-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:be016400-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:be01ab7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:be01ab7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:be01ab7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:be01f186-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:be01f186-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:be01f186-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:be0233bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:be0233bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:be026e68-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:be026e68-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:be026e68-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:be02b5c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be02b5c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be02b5c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be032cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be03e84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:be04111e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:be043982-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:be0461be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be048a68-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:be04b2b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:be04daf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be0503bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:be052e46-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:be0558ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:be05810c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:be05a95c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:be05d1e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:be05fa1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:be062256-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:be064a92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:be06735a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:be069b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:be06c3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:be06ec0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:be071620-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:be073e70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:be0766b6-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:be078f06-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:be07b8be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:be07e1ea-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:be080a1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:be083276-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:be085b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be08adfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be09562e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:be09562e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:be098a0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:be09b25e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:be09da86-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:be0a02d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methdilazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:be0a2716-94cc-11ec-8aec-0242ac110003 UniProtKB:P07944 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin targets Enzyme (Beta-lactam-inducible penicillin-binding protein) DrugCentral uuid:be0a4b24-94cc-11ec-8aec-0242ac110003 UniProtKB:P18843 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin targets Enzyme (NH(3)-dependent NAD(+) synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:be0a827e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be0a827e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be0a827e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be0a827e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be0a827e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be0ad1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:be0af9ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:be0b21fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:be0b4a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15101 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:be0b72ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1747 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methocarbamol is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be0b9aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:be0bc68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be0bc68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be0bc68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be0c0478-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:be0c0478-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:be0c3204-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:be0c55ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:be0c7ae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:be0c9ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:be0cc2c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be0ceae6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:be0d0ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:be0d3780-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:be0d5b84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be0d83ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:be0dabca-94cc-11ec-8aec-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:be0dd44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:be0dfc60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:be0e247e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:be0e4cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.14']} DrugCentral uuid:be0e78de-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:be0ea2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:be0ecb04-94cc-11ec-8aec-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:be0ef390-94cc-11ec-8aec-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:be0f1bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:be0f43cc-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:be0f6c12-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:be0f9476-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:be0fbda2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:be0fe5d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:be100dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:be1037a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:be105fe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00380 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be108818-94cc-11ec-8aec-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:be10b040-94cc-11ec-8aec-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:be10d8cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:be11018a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:be1129b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomepromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.237']} DrugCentral uuid:be115324-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomepromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:be117bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:be11a41e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:be11cc50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:be11f4a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be12277c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:be12277c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:be12277c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:be1265f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is agonist of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be12c344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:be137974-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:be13a192-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:be13c9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:be13f53e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.01']} DrugCentral uuid:be141d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:be1445ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:be1475ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:be1475ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:be1475ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:be14ad62-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:be14d13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metildigoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:be14f52e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:be151a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:be153e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.282']} DrugCentral uuid:be1566c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:be158ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.672']} DrugCentral uuid:be15b98c-94cc-11ec-8aec-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:be15e448-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:be160c52-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:be163466-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:be165dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:be16860a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15770 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:be16ae3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:be16d678-94cc-11ec-8aec-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:be16fefa-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:be172876-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:be1750a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:be1779fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:be17a404-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.633']} DrugCentral uuid:be17cc86-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:be17f4e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is partial agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:be181dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be18460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.928']} DrugCentral uuid:be186e48-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.678']} DrugCentral uuid:be189666-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:be18bf06-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:be18e724-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:be190f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:be193760-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.033']} DrugCentral uuid:be1960aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:be1988a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:be19b0be-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:be19d8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:be1a01d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be1a29d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:be1a5320-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:be1a7b52-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:be1aa3d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:be1acc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.58']} DrugCentral uuid:be1af56e-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:be1b1daa-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:be1b4898-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:be1b70e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:be1b9924-94cc-11ec-8aec-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:be1bc25a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:be1bea82-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:be1c1dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:be1c1dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:be1c1dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:be1c1dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:be1c6b60-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:be1c6b60-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:be1c9ea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:be1cc6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:be1cef0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:be1d18f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:be1d4198-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:be1d69c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:be1d92ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:be1dbb14-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:be1de328-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:be1e0c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.615']} DrugCentral uuid:be1e34c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:be1e5d12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:be1e853a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:be1ead6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:be1ed6f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:be1efb0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:be1f2328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:be1f4b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:be1f6fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1771 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:be1f9b50-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be1f9b50-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be1f9b50-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:be1fd2a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:be1ffab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:be2024c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:be204d16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:be20753e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:be209e10-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:be20c908-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:be20f14e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.663']} DrugCentral uuid:be21198a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:be214216-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:be216a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:be219266-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.213']} DrugCentral uuid:be21ba7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.334']} DrugCentral uuid:be21e43c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be220c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:be2234b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:be225cfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:be22868a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:be22aed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:be22d720-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:be230006-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:be23289c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:be2350ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:be237900-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:be23a13c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:be23ca2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:be23f240-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:be241a5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:be244b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:be244b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:be244b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:be248ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:be24b784-94cc-11ec-8aec-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be24dfac-94cc-11ec-8aec-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:be250856-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:be25307e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:be2558c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:be2581c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:be25aad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metiazinic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:be25d434-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metipranolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:be25f86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metipranolol is antagonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:be261d5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene is antagonist of GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:be26432e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:be2667e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be269018-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metochalcone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:be26b8a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:be26e0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:be2709e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:be273216-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:be275b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:be27834c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:be27ab92-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:be27d3b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:be27f8f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.509']} DrugCentral uuid:be28216c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:be284994-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:be2871e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be289a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:be28c2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:be28eafc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:be29132e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:be293c28-94cc-11ec-8aec-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:be296450-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:be298c78-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be29b96e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:be29b96e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:be29ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be29ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be29ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be29ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be29ffaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be2a5efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2a5efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2a5efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2a5efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2ab04e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2ab04e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2ab04e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:be2af766-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:be2af766-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:be2af766-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:be2b3df2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:be2b3df2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:be2b3df2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:be2b7fec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be2b7fec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be2bb4e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be2bdd02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone targets Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.45']} DrugCentral uuid:be2c0534-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:be2c2a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:be2c5336-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:be2c7bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:be2ca44e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:be2ccc9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be2cf5a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be2d1dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:be2d4624-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:be2d6ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.83']} DrugCentral uuid:be2d9f66-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be2d9f66-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be2d9f66-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be2ddde6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:be2e0622-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:be2e2ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:C4LW95 biolink:molecularly_interacts_with DrugCentral:1790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metronidazole targets Enzyme (Thioredoxin reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:be2e5794-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:be2e7fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:be2ea88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be2ed0b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:be2ef8e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.84']} DrugCentral uuid:be2f2106-94cc-11ec-8aec-0242ac110003 UniProtKB:P07101 biolink:molecularly_interacts_with DrugCentral:1792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metirosine is inhibitor of Enzyme (Tyrosine 3-monooxygenase) DrugCentral uuid:be2f460e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:be2f714c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:be2f9528-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:be2fba30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:be2fde16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:be30026a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:be302ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:be3053e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:be307ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:be30a4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:be30ccf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:be30f580-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:be311ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:be3149ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.51']} DrugCentral uuid:be317334-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:be319b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:be31c3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62205 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:be31ebd4-94cc-11ec-8aec-0242ac110003 UniProtKB:A2APX8 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:be3213e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be323c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:be3264c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:be328d00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:be32b51e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:be32d8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:be3302ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:be332af8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:be33530c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:be337b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:be33a37a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:be33cbac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:be33f3b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:be341ca6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:be3448e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:be3470f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:be3498fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:be34c228-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:be34eaa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:be3512b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:be353ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:be35634a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:be358c80-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:be35b516-94cc-11ec-8aec-0242ac110003 UniProtKB:P02768 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:be35dd2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be3605de-94cc-11ec-8aec-0242ac110003 UniProtKB:P14778 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Membrane receptor (Interleukin-1 receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:be362dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P41222 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be366d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:be36ce4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be36f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:be371eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:be374750-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:be376f64-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.149']} DrugCentral uuid:be3797a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:be37c0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:be37e9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:be381234-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:be383a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.175']} DrugCentral uuid:be386270-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:be388d86-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:be38b61c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:be38de44-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:be390662-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.245']} DrugCentral uuid:be392f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:be395766-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:be397f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:be39a838-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:be39d056-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:be39f87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.541']} DrugCentral uuid:be3a2100-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:be3a49c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:be3a71f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:be3a9a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:be3ac22c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:be3aebda-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:be3b140c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:be3b3c34-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:be3b6498-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:be3b8d60-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:be3bb678-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:be3bdeaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:be3c06d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:be3c30b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:be3c593e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:be3c8166-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:be3ca97a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:be3cd210-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:be3cfa38-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:be3d2274-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:be3d4a9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:be3d7382-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be3d9bb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:be3dc3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:be3ded1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:be3e1558-94cc-11ec-8aec-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:be3e3d62-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:be3e694a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:be3e694a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:be3ea86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be3ea86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be3ea86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be3ea86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be3ef946-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be3ef946-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be3ef946-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be3f40b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:be3f40b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:be3f40b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:be3f82da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be3f82da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be3fbe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:be3fbe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:be3fbe44-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:be4006b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:be4006b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:be403a04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NG02 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (G-protein coupled receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:be40629a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be408ae0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be40b2e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:be40daf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be4103a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be412bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be4153ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:be417c16-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be41a63c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:be41cf18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be41f736-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:be421f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be4247f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be427170-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be42997a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be42c1c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be42ea9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07652 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent R-type calcium channel subunit alpha-1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:be4312ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:be433b00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:be436314-94cc-11ec-8aec-0242ac110003 UniProtKB:P15390 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be438c22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be43b436-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:be43dc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AIC4 biolink:molecularly_interacts_with DrugCentral:1798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 micafungin targets Unclassified (Beta-1,3-glucan synthase) DrugCentral uuid:be440058-94cc-11ec-8aec-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:1798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 micafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) DrugCentral uuid:be4424ca-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.715']} DrugCentral uuid:be444cde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.137']} DrugCentral uuid:be447510-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.588']} DrugCentral uuid:be449d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:be44c5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:be44ee82-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.505']} DrugCentral uuid:be4516be-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:be454058-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:be456ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:be4594ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:be45b8c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:be45e152-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:be460984-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.535']} DrugCentral uuid:be4631ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.183']} DrugCentral uuid:be465ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:be468350-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.452']} DrugCentral uuid:be46ab82-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.555']} DrugCentral uuid:be46d3b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:be46fbd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:be4725da-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.964']} DrugCentral uuid:be474df8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:be477616-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:be479e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:be47c6f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.175']} DrugCentral uuid:be47ef92-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:be4817b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.386']} DrugCentral uuid:be483fce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.869']} DrugCentral uuid:be486850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be4890b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.136']} DrugCentral uuid:be48b990-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.799']} DrugCentral uuid:be48e1ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.271']} DrugCentral uuid:be490da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:be493668-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:be495e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:be4982f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.923']} DrugCentral uuid:be49ab16-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:be49d334-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.729']} DrugCentral uuid:be49fb48-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:be4a23c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be4a4bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.534']} DrugCentral uuid:be4a74ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:be4a9cec-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:be4ac6b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:be4aeee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:be4b16fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.381']} DrugCentral uuid:be4b3f12-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.562']} DrugCentral uuid:be4b68b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:be4b90d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be4bb8de-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:be4be106-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:be4c09ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:be4c31c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:be4c59f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.029']} DrugCentral uuid:be4c8232-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.922']} DrugCentral uuid:be4cad5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.674']} DrugCentral uuid:be4cd5a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.792']} DrugCentral uuid:be4cfe1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.692']} DrugCentral uuid:be4d2642-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:be4d4ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:be4d7728-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:be4d9fc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:be4dc836-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:be4df054-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be4e18a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:be4e40d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:be4e6b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:be4e93b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:be4ebbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:be4ee400-94cc-11ec-8aec-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:be4f0c6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:be4f348c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6']} DrugCentral uuid:be4f5c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.353']} DrugCentral uuid:be4f84aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be4fad40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:be4fdd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:be4fdd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:be4fdd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:be502310-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be502310-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be502310-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be506a78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:be506a78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:be506a78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be50e25a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be51bb62-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:be51bb62-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:be51bb62-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:be520180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:be520180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:be520180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:be524b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be524b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be524b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be529168-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be529168-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be529168-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:be52d826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be52d826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be52d826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be5317aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midodrine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:be533b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midodrine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:be536426-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.001']} DrugCentral uuid:be538c58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.957']} DrugCentral uuid:be53b458-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:be53dc8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.918']} DrugCentral uuid:be540642-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:be543068-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:be545868-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:be548126-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:be54a958-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:be54d158-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:be54fa48-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:be5522fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:be554b06-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:be557338-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.081']} DrugCentral uuid:be559b56-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.255']} DrugCentral uuid:be55c536-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.256']} DrugCentral uuid:be55ed4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.374']} DrugCentral uuid:be561572-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be563d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:be566612-94cc-11ec-8aec-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:be568e58-94cc-11ec-8aec-0242ac110003 UniProtKB:F1Q298 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be56b680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1U3 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:be56df84-94cc-11ec-8aec-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be57084c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:be572c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:be575464-94cc-11ec-8aec-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:be577c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:be57a5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:be57cdcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:be57f5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be581e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:be584680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q58D55 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:be586e94-94cc-11ec-8aec-0242ac110003 UniProtKB:C0HJB3 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Alpha-mannosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:be5896a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P56526 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:be58bea8-94cc-11ec-8aec-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:be58e7ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:be590fde-94cc-11ec-8aec-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:be5937e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be596114-94cc-11ec-8aec-0242ac110003 UniProtKB:Q69ZF3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:be598a36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:be59b254-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:be59daea-94cc-11ec-8aec-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be5a036c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:be5a2cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P70699 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:be5a54d4-94cc-11ec-8aec-0242ac110003 UniProtKB:B5THE3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be5a7cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9LGC6 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Putative alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:be5aa5c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O70282 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Trehalase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:be5acdd8-94cc-11ec-8aec-0242ac110003 UniProtKB:I3LIR5 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:be5af6d2-94cc-11ec-8aec-0242ac110003 UniProtKB:O88693 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:be5b1ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:be5b47f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:be5b7030-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be5b984e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:be5bc062-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:be5be8ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:be5c10ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:be5c393e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:be5c6166-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:be5c8a38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:be5cb242-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:be5cda56-94cc-11ec-8aec-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:be5d0260-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be5d2d08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:be5d54fe-94cc-11ec-8aec-0242ac110003 UniProtKB:O89085 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:be5d810e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:be5d810e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:be5dc010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:be5dc010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:be5dc010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:be5dc010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:be5e091c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miltefosine targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:be5e3216-94cc-11ec-8aec-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miltefosine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:be5e5ad4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:be5e8004-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:be5ea818-94cc-11ec-8aec-0242ac110003 UniProtKB:P08543 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:be5ed02c-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:be5ef9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:be5f2202-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:be5f4a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:be5f7234-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:be5f9bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:be5fc414-94cc-11ec-8aec-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.638']} DrugCentral uuid:be5fec14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z7H2 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Unclassified (30S ribosomal protein S4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['6']} DrugCentral uuid:be6014a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z8T8 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Unclassified (30S ribosomal protein S9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['5.756']} DrugCentral uuid:be603d90-94cc-11ec-8aec-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:be6069a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:be6069a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:be609736-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:be60c01c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:be60e844-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be611076-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:be613894-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:be616134-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:be618984-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:be61b1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:be61d9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:be6202b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:be622aba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:be6252d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:be627c04-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:be62a0b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:be62c4ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:be62ecf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:be631510-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:be633dba-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be6366c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:be638edc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:be63b70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:be63e7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be63e7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be63e7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:be642662-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:be644e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:be647964-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be64a178-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:be64cd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:be64cd9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:be650140-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitomycin targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:be652aa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:be6552e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:be657b20-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:be65a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.512']} DrugCentral uuid:be65cc4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.186']} DrugCentral uuid:be65f492-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:be661cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:be664726-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) DrugCentral uuid:be666b02-94cc-11ec-8aec-0242ac110003 UniProtKB:P10109 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Unclassified (Adrenodoxin, mitochondrial) DrugCentral uuid:be668ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:be66b314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:be66dba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.841']} DrugCentral uuid:be6703e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.306']} DrugCentral uuid:be672c04-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.729']} DrugCentral uuid:be675440-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.744']} DrugCentral uuid:be677d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:be67a544-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.047']} DrugCentral uuid:be67cd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:be67f170-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC90', 'has_quantitative_value': ['5.959']} DrugCentral uuid:be681b6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.287']} DrugCentral uuid:be684378-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kact', 'has_quantitative_value': ['5.155']} DrugCentral uuid:be686b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:be6893aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:be68bc36-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:be68e44a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:be690c5e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:be693472-94cc-11ec-8aec-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:be695d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:be69856c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:be69ad6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be69d5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:be6a00a0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:be6a29a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:be6a51ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:be6a7a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:be6aa230-94cc-11ec-8aec-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:be6aca4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:be6af366-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:be6b1fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:be6b1fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:be6b1fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:be6b5720-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:be6b7f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:be6ba31a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:be6bcdcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:be6bf5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:be6c1e6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:be6c46c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be6c6f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:be6c9770-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be6cbf98-94cc-11ec-8aec-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:be6ce7ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:be6d1056-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:be6d387e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:be6d5c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.396']} DrugCentral uuid:be6d852c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:be6da944-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:be6dd158-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:be6dfa70-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moexipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:be6e22e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:be6e4b06-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be6e731a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:be6e9b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:be6ec40a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.157']} DrugCentral uuid:be6eec32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:be6f146e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:be6f3c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.421']} DrugCentral uuid:be6f6630-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:be6f8e62-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:be6fb694-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:be6fded0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:be700766-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:be702fa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.254']} DrugCentral uuid:be7057b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:be707fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:be70a9dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:be70d22c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.763']} DrugCentral uuid:be70fa5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:be71227c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:be714d42-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:be717560-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be719d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molsidomine targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:be71c5a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:be71ef5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:be72179a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:be723fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.429']} DrugCentral uuid:be726876-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.992']} DrugCentral uuid:be7290b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.414']} DrugCentral uuid:be72b9ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:be72de32-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.311']} DrugCentral uuid:be730786-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:be73301c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:be735862-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.574']} DrugCentral uuid:be738152-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:be73a9fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:be73d242-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:be73fa74-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.853']} DrugCentral uuid:be7422d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.495']} DrugCentral uuid:be744b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:be7473c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:be749be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:be74c404-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.958']} DrugCentral uuid:be74ee48-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:be751698-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:be753e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.328']} DrugCentral uuid:be7566ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.495']} DrugCentral uuid:be758f9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:be75b7b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.817']} DrugCentral uuid:be75e0be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:be7608e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:be763172-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.895']} DrugCentral uuid:be765990-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:be7682f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:be76ab48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:be76d6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:be76fefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:be772730-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.134']} DrugCentral uuid:be77503e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moracizine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:be777442-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.86']} DrugCentral uuid:be779c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:be77c49c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:be77ed50-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:be781578-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:be783daa-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:be7865d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:be788ea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:be78b6e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:be78df94-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:be7907da-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be7930ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:be7958de-94cc-11ec-8aec-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:be79811a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47748 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:be79b4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be79b4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be79b4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be79b4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be7a0f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:be7a0f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:be7a0f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:be7a0f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:be7a0f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:be7a7110-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be7a7110-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be7a7110-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be7a7110-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:be7aba12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q98UH1 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu opioid receptor-like OR2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:be7ae244-94cc-11ec-8aec-0242ac110003 UniProtKB:B3DH72 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor, delta 1b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:be7b0af8-94cc-11ec-8aec-0242ac110003 UniProtKB:O57585 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor homologue) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:be7b3348-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:be7b5b84-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:be7b8528-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:be7badc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:be7bd604-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.891']} DrugCentral uuid:be7bfe36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:be7c2654-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:be7c4f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.694']} DrugCentral uuid:be7c77c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.725']} DrugCentral uuid:be7ca002-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.683']} DrugCentral uuid:be7cc8fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:be7cf124-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:be7d1a46-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be7d425a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:be7d6afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be7d9700-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:be7d9700-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:be7dca68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:be7df290-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.938']} DrugCentral uuid:be7e1cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.716']} DrugCentral uuid:be7e452e-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.637']} DrugCentral uuid:be7e6d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:be7e915a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:be7eba36-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:be7ee664-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:be7ee664-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:be7f1882-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:be7f1882-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:be7f4c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:be7f7480-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:be7f9cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:be7fc50c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be7feed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:be8016f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:be803f3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine is agonist of Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:be806778-94cc-11ec-8aec-0242ac110003 UniProtKB:P00956 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:be809054-94cc-11ec-8aec-0242ac110003 UniProtKB:P41252 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:be80b87c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41972 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:be80dc80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99YW3 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:be81016a-94cc-11ec-8aec-0242ac110003 UniProtKB:P56690 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:be812b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:be8153c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:be817c08-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:be81a430-94cc-11ec-8aec-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:be81d2e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:be81d2e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:be8206e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5KP44 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Unclassified (Inosine-5'-monophosphate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:be822f04-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:be825808-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:be828044-94cc-11ec-8aec-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:be82a90c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:be82d15c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:be82f5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.34']} DrugCentral uuid:be831df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.732']} DrugCentral uuid:be834646-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:be836e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.001']} DrugCentral uuid:be839830-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:be83c076-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:be83e8c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be841378-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:be843c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:be846486-94cc-11ec-8aec-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:be848c90-94cc-11ec-8aec-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:be84b4a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:be84de20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:be8506d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00736 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Complement C1r subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:be852f10-94cc-11ec-8aec-0242ac110003 UniProtKB:P09871 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Complement C1s subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:be85586e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:be8582c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:be85aaee-94cc-11ec-8aec-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:be85d30c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:be85fbca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:be8623f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:be864c24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:be867460-94cc-11ec-8aec-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:be869d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafarelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.699']} DrugCentral uuid:be86c51e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:be86fc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be86fc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be86fc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be86fc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be86fc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:be87496c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftidrofuryl targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:be877194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:be8799da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:be87c1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (Squalene monooxygenase) DrugCentral uuid:be87e69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:be880a8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:be8832b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O07855 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (Dehydrosqualene desaturase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:be885adc-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be888b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be888b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be888b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:be88d232-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:be88d232-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:be88d232-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:be8912b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:be893b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:be89635a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:be898b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:be89b49a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:be89dcd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be8a04fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:be8a2d12-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:be8a5986-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:be8a5986-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:be8a8758-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.53']} DrugCentral uuid:be8aaf9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:be8ad942-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:be8b0174-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:be8b29b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:be8b51ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be8b7abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:be8ba30e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:be8bcb2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:be8bf480-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:be8c1d2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:be8c4674-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:be8c7a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:be8c7a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:be8c7a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:be8c7a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:be8cd210-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:be8cd210-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:be8cd210-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:be8cd210-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:be8d1b30-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:be8d442a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:be8d6c84-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:be8d94b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:be8dbcfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:be8de5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:be8e0de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:be8e3632-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:be8e5e64-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:be8e8844-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:be8eb3aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:be8edc9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:be8f04cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be8f2da8-94cc-11ec-8aec-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:be8f55bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.98']} DrugCentral uuid:be8f8956-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:be8f8956-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:be8f8956-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:be8f8956-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:be8fd456-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:be8ff846-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:be902082-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be9048d2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:be9072b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.678']} DrugCentral uuid:be909b52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:be90c3ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:be90e8fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:be9111e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:be913ba2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:be9163de-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:be918c88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:be91b4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone phenpropionate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:be91dcd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone phenpropionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:be9205be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:be922f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:be925af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:be928372-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:be92ab86-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:be92d44e-94cc-11ec-8aec-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:be92fc8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:be9324b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:be934cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:be937a48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:be937a48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:be93ad60-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:be93d5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:be93fef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.796']} DrugCentral uuid:be94270e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:be944f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:be947786-94cc-11ec-8aec-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:be94a418-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:be94a418-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:be94db2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:be94db2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:be950ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:be9537c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:be955fde-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:be95889c-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:be95b0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:be95da90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nedocromil targets GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:be960038-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nedocromil is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:be962856-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:be96509c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:be967ae0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.699']} DrugCentral uuid:be96a344-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:be96cb8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:be96f3e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:be971d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.143']} DrugCentral uuid:be9745ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.789']} DrugCentral uuid:be976e14-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.635']} DrugCentral uuid:be9796c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:be97c166-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:be97e9a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:be9811c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:be9839e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:be9862c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:be988ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:be98b31e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:be98dbbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:be9903e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:be992bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:be995422-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:be997d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:be99a148-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:be99c97a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:be99f18e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:be9a1a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:be9a42ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:be9a6b28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:be9a9350-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:be9abbe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:be9ae422-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:be9b0d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:be9b3576-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.057']} DrugCentral uuid:be9b5fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.209']} DrugCentral uuid:be9b8800-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.592']} DrugCentral uuid:be9bb032-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.909']} DrugCentral uuid:be9bd878-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.078']} DrugCentral uuid:be9c0154-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.842']} DrugCentral uuid:be9c2986-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.632']} DrugCentral uuid:be9c51cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.255']} DrugCentral uuid:be9c7b02-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:be9c9f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.101']} DrugCentral uuid:be9cc7b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.098']} DrugCentral uuid:be9cefd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.676']} DrugCentral uuid:be9d1814-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.648']} DrugCentral uuid:be9d428a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.739']} DrugCentral uuid:be9d6ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:be9d92e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.615']} DrugCentral uuid:be9dbb20-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:be9de3e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.236']} DrugCentral uuid:be9e0cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:be9e34ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:be9e5daa-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:be9e8622-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:be9eae54-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:be9ed67c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:be9f0002-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:be9f2bea-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:be9f56f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:be9f7f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:be9fa836-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:be9fd022-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:be9ff408-94cc-11ec-8aec-0242ac110003 UniProtKB:P08312 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase alpha subunit) DrugCentral uuid:bea017da-94cc-11ec-8aec-0242ac110003 UniProtKB:P07395 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase beta subunit) DrugCentral uuid:bea03c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bea0644c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:bea08d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:bea0b514-94cc-11ec-8aec-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:bea0dec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:bea106e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bea12fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:bea157d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:bea180ac-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bea1a8de-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bea1d0fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:bea1f938-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bea2258e-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bea2258e-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bea25dec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bea25dec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bea29140-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepinalone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:bea2bb84-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nesiritide is agonist of Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:bea2df6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:bea3086e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bea33078-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bea35986-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bea3819a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bea3a9b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 2) DrugCentral uuid:bea3ce02-94cc-11ec-8aec-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 3) DrugCentral uuid:bea3f26a-94cc-11ec-8aec-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:bea4165a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:bea43a40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bea4624a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bea48b26-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bea4b330-94cc-11ec-8aec-0242ac110003 UniProtKB:P53686 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase HST2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:bea4db58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NTG7 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase sirtuin 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bea50358-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:bea52c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8I6E4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Unclassified (Putative silent information regulator 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bea55466-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:bea57c70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:bea5a4a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bea5cd38-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bea5f574-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bea6195a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:bea6416e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bea66bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.553']} DrugCentral uuid:bea69402-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:bea6bc3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:bea6e4f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bea70e64-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bea73696-94cc-11ec-8aec-0242ac110003 UniProtKB:O54698 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bea75ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bea78f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bea78f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bea78f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bea7d664-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bea7d664-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bea7d664-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bea81cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:bea81cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:bea81cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:bea85f62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bea85f62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:bea88d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bea8b548-94cc-11ec-8aec-0242ac110003 UniProtKB:P15385 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bea8ddfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bea90656-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:bea92e7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bea95750-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bea97f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bea9a76e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bea9cf82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:bea9f908-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:beaa2202-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:beaa4b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:beaa732e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:beaa9bba-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:beaac3d8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:beaaebd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:beab1400-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:beab3cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:beab64e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:beab8d04-94cc-11ec-8aec-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:beabb4fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:beabde44-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:beac0676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:beac2e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:beac569e-94cc-11ec-8aec-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:beac7f48-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:beaca766-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:beaccf8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:beacf7de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bead21e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:bead4a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P43144 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bead7272-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit beta-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:bead9b58-94cc-11ec-8aec-0242ac110003 UniProtKB:P04757 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:beadc3b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12389 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:beadebf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:beae152e-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:beae3dba-94cc-11ec-8aec-0242ac110003 UniProtKB:P21687 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Enzyme (Lycopene cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:beae65e2-94cc-11ec-8aec-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:beae8e14-94cc-11ec-8aec-0242ac110003 UniProtKB:P25162 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit beta-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:beaeb646-94cc-11ec-8aec-0242ac110003 UniProtKB:P09482 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:beaee148-94cc-11ec-8aec-0242ac110003 UniProtKB:O70174 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:beaf0d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beaf0d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beaf443a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:beaf443a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:beaf7de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:beaf7de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:beafb596-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:beafb596-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:beaff18c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beaff18c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beb02936-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:beb02936-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb08a66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:beb13cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beb13cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:beb178fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:beb178fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:beb1b012-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:beb1b012-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:beb1e7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:beb1e7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:beb21ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:beb21ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:beb26138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:beb26138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:beb26138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:beb26138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:beb26138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:beb2c1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:beb2c1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:beb2c1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:beb2c1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:beb317d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:beb317d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:beb317d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:beb317d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:beb365f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:beb365f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:beb3a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:beb3a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:beb3a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:beb3a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:beb3fe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:beb3fe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:beb3fe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:beb3fe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:beb3fe4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:beb45272-94cc-11ec-8aec-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:beb47a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:beb4a2cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:beb4cae0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:beb4f484-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:beb51dce-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.089']} DrugCentral uuid:beb54a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:beb5736e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:beb59c22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:beb5c440-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:beb5ec72-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.019']} DrugCentral uuid:beb6149a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.348']} DrugCentral uuid:beb63d1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:beb665d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:beb68dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:beb6b5f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:beb6e172-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:beb709a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:beb731d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.672']} DrugCentral uuid:beb75a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:beb78398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:beb7abc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:beb7d3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:beb7fc9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.355']} DrugCentral uuid:beb824ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:beb84cec-94cc-11ec-8aec-0242ac110003 UniProtKB:P16389 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:beb87500-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:beb89ea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.731']} DrugCentral uuid:beb8ccd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:beb8f516-94cc-11ec-8aec-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:beb91d5c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:beb946ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.821']} DrugCentral uuid:beb97504-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:beb9a204-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:beb9ca4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:beb9f2fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:beba1fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:beba4ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:beba7490-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:beba9f92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bebac7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:O35505 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:bebaf7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bebaf7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bebaf7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bebb3fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bebb3fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bebb3fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bebb7e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bebba6b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bebbcf98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bebbf7c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bebc23ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bebc4e32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bebc7880-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bebca0c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bebcca1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:bebcf594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bebd1dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bebd45d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.037']} DrugCentral uuid:bebd6dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.973']} DrugCentral uuid:bebd9698-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bebdbeb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bebde6de-94cc-11ec-8aec-0242ac110003 UniProtKB:P51800 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Ka) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bebe0ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:bebe37ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bebe6000-94cc-11ec-8aec-0242ac110003 UniProtKB:P51801 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Kb) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bebe8832-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bebeb082-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifuroxazide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bebed94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bebf023a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:bebf2a80-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bebf532a-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bebf7b66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bebfa384-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bebfcc4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bebff5dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bec02034-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:bec04852-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:bec07084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.83']} DrugCentral uuid:bec09938-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bec0c32c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bec0eb68-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.33']} DrugCentral uuid:bec11390-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bec13d0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bec16534-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bec18d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:bec1b58e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:bec1e09a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bec208cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bec23176-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bec25994-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:bec2822a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.387']} DrugCentral uuid:bec2aa52-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bec2d284-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bec2fb74-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bec3239c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bec3501a-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bec37838-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:bec3a13c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bec3ca04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bec3f22c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:bec41a40-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:bec442c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:bec46aea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:bec492fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.096']} DrugCentral uuid:bec4bc98-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bec4e560-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:bec511e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bec53b28-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bec56346-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bec58e02-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.141']} DrugCentral uuid:bec5b60c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bec5de3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bec606d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bec6301e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:bec6583c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bec6805a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bec6a95e-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bec6d2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bec6faf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bec72334-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bec74c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bec774b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bec79cec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bec7c51e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:bec7ed82-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bec815c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bec83dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bec865f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bec88eae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bec8b85c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bec8e070-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bec908a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bec932f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:bec95b9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:bec987f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bec9b086-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bec9d89a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:beca00c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:beca28ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:beca51f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:beca7a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:becaa612-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:becaa612-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:becada06-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:becb0530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:becb297a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:becb4d60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:becb7538-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:becb7538-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:becba742-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:becbcf88-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:becbf7b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.927']} DrugCentral uuid:becc201e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:becc4fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:becc7834-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:becca278-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.632']} DrugCentral uuid:becccc76-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:beccf606-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:becd1e38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2A865 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:becd4674-94cc-11ec-8aec-0242ac110003 UniProtKB:L8I2E6 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Dipeptidyl peptidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:becd6f64-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:becd9782-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:becdbfa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:becde7dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:bece107c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bece3868-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:bece5d0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bece8548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:beceac08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:beced016-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:becef834-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:becf211a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:becf4a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:becf7250-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:becf9b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:becfc336-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:becfebae-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bed013d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bed03bf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bed063fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:bed08e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:bed0b66a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:bed0da5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.395']} DrugCentral uuid:bed1035e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bed12bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:bed14fb2-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:bed177e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bed1a840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bed1a840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bed1a840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bed1e68e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bed20eac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99246 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bed23800-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bed260dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q968X7 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate dehydrogenase [NADP(+)]) DrugCentral uuid:bed284d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q24982 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate:ferredoxin oxidoreductase) DrugCentral uuid:bed2a8d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0P8E1 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide targets Enzyme (Pyruvate-flavodoxin oxidoreductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bed2d120-94cc-11ec-8aec-0242ac110003 UniProtKB:P32754 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone is inhibitor of Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bed2f9f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02110 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone targets Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bed322b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P32755 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone targets Unclassified (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bed3528a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bed3528a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bed3528a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed3a410-94cc-11ec-8aec-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bed4043c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bed42e6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:bed456b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bed47ee4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:bed4a2ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.921']} DrugCentral uuid:bed4cb9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bed4f3d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bed51c00-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.056']} DrugCentral uuid:bed54428-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:bed56cb4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bed594dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bed5bd90-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:bed5e6a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bed60eda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bed636ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21556 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:bed666dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bed666dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bed666dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bed6a5fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:bed6d9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed6d9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed6d9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed6d9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed71d52-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurantoin targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:bed74160-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurantoin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:bed76992-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurazone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:bed78d82-94cc-11ec-8aec-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:1950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurazone targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:bed7b58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:bed7e610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed7e610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed7e610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed7e610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:bed8271a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bed84f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bed87850-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bed8a082-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bed8c940-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bed8f1ae-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bed919ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nizatidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bed9421c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nizatidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.251']} DrugCentral uuid:bed96a44-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bed993b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:bed9bdf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bed9e618-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:beda0e68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:beda371c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.947']} DrugCentral uuid:beda5f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.963']} DrugCentral uuid:beda876c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bedaaf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:bedad974-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:bedb0188-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bedb2d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:bedb2d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:bedb609c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norelgestromin is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bedb8784-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bedbafca-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bedbd810-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bedc00e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bedc2950-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:bedc52cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bedc7b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bedca394-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.367']} DrugCentral uuid:bedccbee-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bedcf420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:bedd1c66-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bedd4628-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bedd6e64-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:bedd972c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:beddbf7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bedde84e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bede1080-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bede3880-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bede6134-94cc-11ec-8aec-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:bede89d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bedeb1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bedee2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:bedee2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:bedee2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:bedf2b6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bedf2b6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bedf2b6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedf7c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bedfe3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bedfe3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bedfe3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bee02262-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01337 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bee04b20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bee07370-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:bee09ba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:bee0c3ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.636']} DrugCentral uuid:bee0eeae-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bee1174e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:bee13f94-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:bee16870-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bee191b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.914']} DrugCentral uuid:bee1bf5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bee1bf5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:bee1f2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bee21bbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.533']} DrugCentral uuid:bee243f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bee26c16-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bee29448-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:bee2bdb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:bee2e5e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:bee30e00-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:bee3363c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:bee35edc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethynodrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bee382d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethynodrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:bee3ab26-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee3d362-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee3fc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee4245c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee44c8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bee474c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bee49ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bee4c722-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bee4ef40-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee5175e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bee53fd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bee568ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee5ca3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bee69d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.01']} DrugCentral uuid:bee6c5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bee6e9a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bee71252-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bee73a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bee762b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bee78ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:bee7b3c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bee7dd90-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.36']} DrugCentral uuid:bee805ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:bee82dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:bee85950-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:bee88402-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bee8ac34-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:bee8d4c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bee8fcf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bee92524-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:bee94d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.033']} DrugCentral uuid:bee975e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.639']} DrugCentral uuid:bee99e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bee9c614-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:bee9ee32-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:beea16f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:beea3efa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:beea6718-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:beea8f22-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:beeab7ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.921']} DrugCentral uuid:beeadfb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6.225']} DrugCentral uuid:beeb08f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:beeb3152-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:beeb5a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:beeb824c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:beebaa7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:beebd3aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:beebfec0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:beec272e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:beec4f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P78508 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:beec7774-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.087']} DrugCentral uuid:beec9fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:beecc800-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:beecf0d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:beed19ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:beed41c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:beed69e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A4L9 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:beed926c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7X1P7 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (ParE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:beedbb98-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SLN2 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:beede7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:beede7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:beee1eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:beee1eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:beee4cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C559 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:beee752e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0K8 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:beee9d6a-94cc-11ec-8aec-0242ac110003 UniProtKB:A0QNE0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:beeec5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SLN3 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:beeef65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:beeef65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:beeef65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:beef3482-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:beef5cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.699']} DrugCentral uuid:beef864e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:beefaef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:beefd716-94cc-11ec-8aec-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:beefff2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bef027de-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bef0501a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.98']} DrugCentral uuid:bef0786a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:bef0a1c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bef0caa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bef0f2e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O08858 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:bef11b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:bef14330-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bef16d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bef1954c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bef1bd56-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:bef1e132-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:bef209be-94cc-11ec-8aec-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef26ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bef33c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:bef3641c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bef38c12-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bef3b44e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bef3dcee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bef4053e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:bef42d70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.492']} DrugCentral uuid:bef45598-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bef47e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bef4a688-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bef4ceba-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:bef4f836-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bef52360-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bef54b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:bef573a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:bef59c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:bef5c536-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:bef5ee80-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:bef6169e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:bef63f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:bef667ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:bef68ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.506']} DrugCentral uuid:bef6b810-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:bef6e222-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.136']} DrugCentral uuid:bef70a90-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.682']} DrugCentral uuid:bef732c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:bef75acc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bef78326-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.233']} DrugCentral uuid:bef7ab62-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:bef7d394-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:bef7fbc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:bef824a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:bef84cca-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:bef874e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:bef89d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.916']} DrugCentral uuid:bef8c786-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:bef8efb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bef917e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.558']} DrugCentral uuid:bef94008-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bef9689e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:bef990bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:bef9b8d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bef9e1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:befa0b00-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:befa3332-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:befa5b64-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:befa8472-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:befaaeac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:befad6de-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:befb0032-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:befb28c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:befb50dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:befb790e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:befba140-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:befbd1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:befbd1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:befbd1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:befc1882-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:befc1882-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:befc1882-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:befc5784-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:befc81a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:befcaa4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmesartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:befcd2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmesartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:befcfb6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olopatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.284']} DrugCentral uuid:befd23b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olopatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:befd4fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:befd4fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:befd7ea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:befda346-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:befdcb28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:befdcb28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:befdf90e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:befe212c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:befe4b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:befe7320-94cc-11ec-8aec-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:befe9b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:befec316-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:befeeb66-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.31']} DrugCentral uuid:beff1370-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.051']} DrugCentral uuid:beff3b70-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:beff6384-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:beff8c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:beffb456-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:beffe1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:beffe1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf001b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf001b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf004e84-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bf00768e-94cc-11ec-8aec-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:bf009f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bf00cb98-94cc-11ec-8aec-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:bf00cb98-94cc-11ec-8aec-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:bf00fec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:bf0127dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:bf0150f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.678']} DrugCentral uuid:bf017908-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bf01a13a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bf01c944-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:bf01f2c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:bf021af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf024306-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bf026b42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bf029504-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bf02bd22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf02e54a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bf030d72-94cc-11ec-8aec-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bf033658-94cc-11ec-8aec-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bf035e80-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf038680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bf03b02e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bf03d838-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bf040434-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bf040434-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bf043b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bf043b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:bf04770c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf04770c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf04770c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf04ba14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bf04ba14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bf04ee1c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf05164e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bf053e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:bf0567e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:bf0591fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf05ba4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:bf05e27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bf060aae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4D2 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bf063326-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bf065b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NCG7 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf068376-94cc-11ec-8aec-0242ac110003 UniProtKB:O95870 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Abhydrolase domain-containing protein 16A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bf06ab9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N2K0 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bf06d43e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13093 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Platelet-activating factor acetylhydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bf06fc52-94cc-11ec-8aec-0242ac110003 UniProtKB:P00591 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bf072452-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BV23 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bf074c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6WQJ1 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf0776dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:bf079f90-94cc-11ec-8aec-0242ac110003 UniProtKB:P11150 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Hepatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bf07c7cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5X9 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Endothelial lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bf07f058-94cc-11ec-8aec-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.9']} DrugCentral uuid:bf0818bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07098 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat is inhibitor of Enzyme (Gastric triacylglycerol lipase) DrugCentral uuid:bf083cac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:bf0864ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:bf088e46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:bf08b65a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.614']} DrugCentral uuid:bf08dea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:bf0906c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:bf093062-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:bf0958da-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:bf0980ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:bf09a92a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:bf09d206-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bf09fa42-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.165']} DrugCentral uuid:bf0a226a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf0a4a9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.873']} DrugCentral uuid:bf0a7332-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bf0a9b64-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:bf0ac396-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bf0aebe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.889']} DrugCentral uuid:bf0b15c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:bf0b3f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.764']} DrugCentral uuid:bf0b6846-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bf0b908c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:bf0bb922-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf0be140-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c2182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf0c8dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06818 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.83']} DrugCentral uuid:bf0cb5de-94cc-11ec-8aec-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bf0cdfe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bf0d082c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bf0d3054-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:bf0d5872-94cc-11ec-8aec-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bf0d8108-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:bf0da91c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:bf0dd14e-94cc-11ec-8aec-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bf0df962-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:bf0e2248-94cc-11ec-8aec-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bf0e4a5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:bf0e725c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:bf0e9a52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bf0ec392-94cc-11ec-8aec-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:bf0eebc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf0f13ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.96']} DrugCentral uuid:bf0f3c14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf0f64aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P11172 biolink:molecularly_interacts_with DrugCentral:2002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oteracil is inhibitor of Enzyme (Uridine 5'-monophosphate synthase) DrugCentral uuid:bf0f88b8-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.169']} DrugCentral uuid:bf0fb0d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.009']} DrugCentral uuid:bf0fd8f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bf0ffe60-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:bf10266a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf104e88-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bf1076a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bf109e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf10d6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bf10d6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bf10d6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bf10d6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bf10d6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:bf1121b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bf1149f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bf11760a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bf11760a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bf11a940-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:bf11cda8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bf11f5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:bf121dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:bf1241fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf126ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bf1294cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bf12bd30-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:bf12e53a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:bf130e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.148']} DrugCentral uuid:bf13365c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:bf135e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:bf1386ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf13b014-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:bf13e016-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bf13e016-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bf13e016-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bf141e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxcarbazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bf1444c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bf1468c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bf148cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bf14b522-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bf14de26-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:bf150630-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bf152e76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.991']} DrugCentral uuid:bf1556a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.589']} DrugCentral uuid:bf157f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:bf15a914-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:bf15d15a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:bf15fa22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bf1624c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:bf164cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.168']} DrugCentral uuid:bf167524-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:bf169dec-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:bf16c628-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:bf16ee64-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:bf1716b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:bf173fae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bf1768ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:bf179116-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bf17b9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bf17e2ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bf180ad8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:bf18330a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bf185b28-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bf1883dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bf18ac18-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bf18d422-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bf18fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bf19258a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bf194dc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:bf197602-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.493']} DrugCentral uuid:bf199e34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bf19c922-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bf19f14a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bf1a197c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.111']} DrugCentral uuid:bf1a4230-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:bf1a6a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:bf1a9294-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bf1abb5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf1ae44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bf1b0c88-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bf1b349c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bf1b5e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bf1b87ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:bf1bb160-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:bf1bd9a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.162']} DrugCentral uuid:bf1c01ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.041']} DrugCentral uuid:bf1c2a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:bf1c5282-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bf1c7aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:bf1ca2be-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:bf1ccba4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bf1cf3fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bf1d1c26-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:bf1d4c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bf1d4c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bf1d4c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:bf1d92b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bf1d92b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bf1d92b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bf1dd0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bf1dfa10-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bf1e2238-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bf1e463c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:bf1e6a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:bf1e92f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:bf1ebb3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bf1ee38a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bf1f0cac-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:bf1f36a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf1f5ee6-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:bf1f8704-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bf1faf40-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bf1fd7ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:bf200026-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bf2033d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:bf2033d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:bf2033d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:bf2033d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:bf208186-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bf208186-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bf20b62e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:bf20da1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:bf2102dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:bf2102dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:bf21309a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:bf2158cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bf217ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bf21a156-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:bf21c99c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2041 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:bf21ede6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2041 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:bf2211d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:bf223a94-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bf2262bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bf228aee-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bf22b316-94cc-11ec-8aec-0242ac110003 UniProtKB:P01178 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets Secreted (Oxytocin-neurophysin 1) DrugCentral uuid:bf22d990-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bf2303b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf232c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bf23544c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bf237cec-94cc-11ec-8aec-0242ac110003 UniProtKB:P49430 biolink:molecularly_interacts_with DrugCentral:2043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf23a514-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bf23cd46-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf23f550-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:bf241e22-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Bile salt export pump) DrugCentral uuid:bf2441f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:bf2465ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf248e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.621']} DrugCentral uuid:bf24b80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.954']} DrugCentral uuid:bf24e032-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.643']} DrugCentral uuid:bf250878-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:bf2530a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.794']} DrugCentral uuid:bf25599a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bf2581d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:bf25aa08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13509 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Structural (Tubulin beta-3 chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bf25d24e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf2619ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:bf269e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf26c640-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf26ee7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf27171c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol is agonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bf273f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:bf276b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:bf276b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:bf279eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamabrom targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:bf27c748-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bf27efac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:bf2817e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07010 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bf284024-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:bf28698c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bf2891be-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:bf28b9f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf28e218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q81VW8 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bf290ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf2932ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WNC6 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) DrugCentral uuid:bf2956d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.92']} DrugCentral uuid:bf29836c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:bf29836c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:bf29b8dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:bf29b8dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:bf29b8dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:bf29ff68-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bf29ff68-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:bf2a3fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bf2a3fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bf2a3fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bf2a3fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bf2a8a64-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bf2aaed6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bf2ad776-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf2affa8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bf2b27c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bf2b4fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:bf2b7c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bf2b7c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bf2baa2a-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bf2bd63a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf2bd63a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf2c0d9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bf2c35bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bf2c5dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:bf2c81ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:bf2caa42-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bf2cd256-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:bf2cfa7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.118']} DrugCentral uuid:bf2d24f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:bf2d4dda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf2d760c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bf2d9e02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bf2dc6de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:bf2df0c8-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:bf2e1972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:bf2e417c-94cc-11ec-8aec-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf2e69f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYJ6 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:bf2e99a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bf2e99a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bf2e99a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:bf2edb8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bf2edb8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bf2f16ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bf2f16ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bf2f16ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bf2f54d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bf2f7d76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf2fadfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf2fadfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf2fadfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf2fe680-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.854']} DrugCentral uuid:bf300eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:bf3036ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bf3060c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bf3088e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:bf30b10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bf30d9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bf3101c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paricalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bf3129c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf3151f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:bf317b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.068']} DrugCentral uuid:bf31a42a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:bf31cc48-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bf31f470-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.52']} DrugCentral uuid:bf321d38-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf32456a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:bf326da6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:bf3295d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf32be64-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:bf32e6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:bf330ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:bf33370e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf336094-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bf3388a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:bf33b0a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf33d8b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bf340170-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:bf3429ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:bf3452a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:bf347aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.36']} DrugCentral uuid:bf34a33c-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf34cb6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:bf34f38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bf351d26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bf354d82-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bf354d82-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bf354d82-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bf3594f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bf3594f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bf3594f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bf35d43c-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bf35fc78-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bf362496-94cc-11ec-8aec-0242ac110003 UniProtKB:P21146 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bf364ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:bf367590-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:bf369da4-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.097']} DrugCentral uuid:bf36c5ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:bf36ede0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.468']} DrugCentral uuid:bf371734-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:bf373f52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:bf376392-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bf378c32-94cc-11ec-8aec-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Serine hydroxymethyltransferase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bf37b45a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf37dc82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:bf3805ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:bf382ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf3856da-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bf387eee-94cc-11ec-8aec-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bf38a72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bf38d0d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bf38f914-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bf392132-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bf394a40-94cc-11ec-8aec-0242ac110003 UniProtKB:E2QDN0 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bf397308-94cc-11ec-8aec-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.86']} DrugCentral uuid:bf399b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bf39c330-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64737 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:bf39ec20-94cc-11ec-8aec-0242ac110003 UniProtKB:P22102 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:bf3a14b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:bf3a3ce8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bf3a6538-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bf3a8d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:bf3ab664-94cc-11ec-8aec-0242ac110003 UniProtKB:P02763 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets Secreted (Alpha-1-acid glycoprotein 1) DrugCentral uuid:bf3ada5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bf3b03da-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:bf3b2860-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bf3b5146-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bf3b7964-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:bf3ba1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bf3bc9f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bf3bf2a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:bf3c1bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bf3c4402-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bf3c6c34-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:bf3c9632-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3cbe78-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bf3ce6be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:bf3d0fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bf3d3812-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3d6044-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3d8876-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:bf3db10c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:bf3dd948-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:bf3e018e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3e29c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bf3e5300-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3e7b46-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf3ea382-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bf3edae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf3edae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf3edae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf3edae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf3edae6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:bf3f2fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:2081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penicillamine targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bf3f57f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bf3f7c44-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bf3fa48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf3fe468-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf404796-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bf406fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf40aa92-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf410938-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:bf41316a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bf415a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:bf418232-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bf41aa64-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.287']} DrugCentral uuid:bf41d282-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bf41fc58-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:bf42246c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:bf424ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:bf4274c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:bf429dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.295']} DrugCentral uuid:bf42c610-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:bf42ef46-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.683']} DrugCentral uuid:bf43176e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf43402c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:bf436840-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.101']} DrugCentral uuid:bf439054-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bf43b868-94cc-11ec-8aec-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bf43e2ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bf440afc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:bf44331a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04271 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Cytosolic other (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:bf445b6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bf44841e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bf44ac46-94cc-11ec-8aec-0242ac110003 UniProtKB:P19801 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bf44d5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:bf44fe58-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bf45268a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bf454ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bf4576d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bf45a04c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf45e0ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf46508c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bf46508c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:bf468462-94cc-11ec-8aec-0242ac110003 UniProtKB:P21673 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Spermidine/spermine N(1)-acetyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf46ac94-94cc-11ec-8aec-0242ac110003 UniProtKB:O75365 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein-tyrosine phosphatase 4A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bf46d534-94cc-11ec-8aec-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bf46fd66-94cc-11ec-8aec-0242ac110003 UniProtKB:P04631 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Unclassified (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.36']} DrugCentral uuid:bf472598-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bf474dca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bf477764-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12974 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bf479fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q93096 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bf47c7dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:bf47efe6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.553']} DrugCentral uuid:bf482060-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:bf482060-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:bf482060-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf4898ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf497442-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bf497442-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bf497442-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bf49b27c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:bf49da5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:bf49da5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:bf4a08b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:2098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentostatin is inhibitor of Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.8']} DrugCentral uuid:bf4a30d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56658 biolink:molecularly_interacts_with DrugCentral:2098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentostatin targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:bf4a5920-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bf4a81ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:bf4aa5ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bf4acde2-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) DrugCentral uuid:bf4af1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bf4b1ae0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf4b42e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:bf4b6af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bf4b92e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:bf4bbb44-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bf4be358-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:bf4c0c48-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bf4c3466-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bf4c5cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:bf4c84fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:bf4cad24-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bf4cd524-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:bf4cfec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bf4d26fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bf4d4ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bf4d77a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:bf4da06c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bf4dc8b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.838']} DrugCentral uuid:bf4df210-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:bf4e1a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:bf4e42ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:bf4e6ace-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf4e92e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bf4ebb1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bf4ee3f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bf4f0bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bf4f3bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf4f3bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf4f3bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf4f7ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bf4f7ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:bf4fc0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf4fc0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf4fc0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf4fc0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf4fc0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf501ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf501ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf504dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf50760c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bf509fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:bf50c918-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:bf50f140-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.486']} DrugCentral uuid:bf511954-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:bf5141ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bf516a08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bf51923a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:bf51ba4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.027']} DrugCentral uuid:bf51e316-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:bf5206e8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:bf522f10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) DrugCentral uuid:bf5252f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:bf5278c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23786 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:bf52a3dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.828']} DrugCentral uuid:bf52cc22-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:bf52f58a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bf5325b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf5325b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf5325b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf5364fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bf538d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32198 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:bf53b5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bf53de14-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bf54065a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bf542e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bf545952-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2108 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perindopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:bf548166-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:bf54a966-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.704']} DrugCentral uuid:bf54d18e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:bf54fa24-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bf55224c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bf554a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:bf557292-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:bf559b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bf55c350-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:bf55eb82-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:bf561530-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:bf563d76-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:bf5665a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:bf568dda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:bf56b652-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:bf56de70-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:bf570792-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:bf572fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bf5758aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:bf5780be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bf57a918-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:bf57d1f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.521']} DrugCentral uuid:bf57fb8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.088']} DrugCentral uuid:bf5823ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:bf584bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.481']} DrugCentral uuid:bf587438-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:bf589d28-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:bf58c69a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bf58eec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bf591712-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf593fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacemide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:bf59638e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacetin targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bf598774-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bf59af92-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bf59d9fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf5a021c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bf5a2a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5a74e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bf5af118-94cc-11ec-8aec-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bf5b1ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bf5b4316-94cc-11ec-8aec-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:bf5b6b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bf5b949c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bf5bbcce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf5be500-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bf5c0d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5c4d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5ccf60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:bf5d3fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bf5d3fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bf5d78de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bf5d78de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bf5dbb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf5dbb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf5dbb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf5dbb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf5dbb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:bf5e1028-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bf5e340e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf5e5c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:bf5e8026-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bf5ea8e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.076']} DrugCentral uuid:bf5ed116-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf5ef92a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:bf5f215c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:bf5f4a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:bf5f72d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:bf5f9b0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:bf5fc332-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16853 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf5febd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bf6013dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bf603bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bf606404-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bf608de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bf60b5da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:2126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:bf60da2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bf61024c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:bf6127ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione targets Enzyme (Prothrombin) DrugCentral uuid:bf614bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf617416-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2131 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:bf61993c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2131 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:bf61be12-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bf61e20c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:bf62122c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bf62122c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bf62122c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bf625106-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.298']} DrugCentral uuid:bf627938-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.883']} DrugCentral uuid:bf62a156-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:bf62c546-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:bf62eae4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:bf63169a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bf63169a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bf63169a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bf6355a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf6355a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf6355a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf639458-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bf63bc8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bf63e4c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:bf640dde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q834R3 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf6436e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:bf645f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:bf64873c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:bf64af78-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf64e966-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf64e966-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf64e966-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf64e966-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf64e966-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf654528-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bf654528-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bf654528-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:bf658bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bf658bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bf658bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:bf65cb06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bf65f3ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf661c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf664464-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.745']} DrugCentral uuid:bf667448-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf667448-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf667448-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:bf66aec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentermine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bf66d2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.801']} DrugCentral uuid:bf66fcb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:bf67250a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:bf674d8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:bf6775d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.667']} DrugCentral uuid:bf679e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:bf67c88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.616']} DrugCentral uuid:bf67f4da-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.684']} DrugCentral uuid:bf681d34-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bf68458e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:bf686e7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:bf6896c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:bf68bf00-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bf68e732-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:bf690fe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:bf69382c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:bf69604a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:bf698868-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bf69b130-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:bf69d94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:bf6a018a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:bf6a29a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf6a54d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:bf6a8006-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bf6aafd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bf6aafd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bf6aafd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bf6af784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bf6af784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bf6af784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bf6b371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:bf6b5f26-94cc-11ec-8aec-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:bf6b880c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:bf6bb034-94cc-11ec-8aec-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bf6bd85c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:bf6c0084-94cc-11ec-8aec-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bf6c2b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P98170 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Unclassified (E3 ubiquitin-protein ligase XIAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bf6c532c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:bf6c7b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bf6ca368-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:bf6cc7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bf6cefd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf6d1ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf6d1ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf6d4f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:bf6d77b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf6d9fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bf6dc824-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bf6df1d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bf6e19fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bf6e4218-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bf6e7314-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bf6e7314-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bf6e7314-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:bf6eb982-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bf6eb982-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bf6eb982-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bf6eff5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bf6eff5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bf6eff5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bf6f3eac-94cc-11ec-8aec-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bf6f66ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:bf6f8f06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:bf6fb396-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:bf6fdbb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:bf7003f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bf70290c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:bf7051b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:bf7079d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:bf70a1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.166']} DrugCentral uuid:bf70ca38-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bf70f314-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bf711b46-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:bf71436e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:bf716ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:bf7194a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:bf71bdda-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:bf71e616-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:bf720e66-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bf723332-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:bf72572c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bf727ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:bf729fac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf72c842-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:bf72ec50-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:bf7314a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:bf7338ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:bf735d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:bf73909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bf73909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bf73909c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bf73d232-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phloroglucinol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bf73ff64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf73ff64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bf743a56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf743a56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf743a56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf7478a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:bf74a11c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.37']} DrugCentral uuid:bf74c944-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bf74f176-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:bf75199e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:bf754496-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:bf756dd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:bf7595ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:bf75be62-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bf75e752-94cc-11ec-8aec-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:bf760f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bf76377a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bf766060-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:bf76895a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36196 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf76b18c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bf76d9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf770286-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bf772e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf779232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bf7861bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:bf7889c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bf78b1da-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bf78db06-94cc-11ec-8aec-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bf79036a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bf792764-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bf794b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:bf797372-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bf799c26-94cc-11ec-8aec-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bf79c444-94cc-11ec-8aec-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bf79fdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bf79fdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bf79fdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bf79fdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bf79fdba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:bf7a52ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:bf7a7b82-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:bf7aa3a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:bf7accb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bf7af4cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bf7b1ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilsicainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:bf7b45f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilsicainide is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.377']} DrugCentral uuid:bf7b6e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interleukin-5) DrugCentral uuid:bf7b922e-94cc-11ec-8aec-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interferon gamma) DrugCentral uuid:bf7bb628-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:bf7bde5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interleukin-2) DrugCentral uuid:bf7c02f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) DrugCentral uuid:bf7c26ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62658 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:bf7c4f02-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:bf7c7748-94cc-11ec-8aec-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:bf7ca164-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:bf7cc98c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bf7cf588-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bf7cf588-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:bf7d292c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:bf7d5154-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.862']} DrugCentral uuid:bf7d797c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.798']} DrugCentral uuid:bf7da1b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:bf7dca58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:bf7df26c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:bf7e1a80-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.63']} DrugCentral uuid:bf7e42bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.559']} DrugCentral uuid:bf7e6b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:bf7e93a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:bf7ebbca-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.301']} DrugCentral uuid:bf7ee3de-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:bf7f0cce-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:bf7f36c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:bf7f5ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:bf7f8726-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf7fb002-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.709']} DrugCentral uuid:bf7fd82a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:bf800066-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.424']} DrugCentral uuid:bf8028a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:bf8051a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf8079c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf80a1ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bf80ca0a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bf80f9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bf80f9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bf80f9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:bf8137e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bf81600a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bf8188dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:bf81b0fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bf81d922-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bf820154-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:bf822a1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:bf825230-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bf827a62-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:bf82b20c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf82b20c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf82b20c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf82b20c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf82b20c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf83075c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94782 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Enzyme (Ubiquitin carboxyl-terminal hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf832f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EQ60 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bf835838-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bf83804c-94cc-11ec-8aec-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bf83a86a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60706 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil targets Ion channel (ATP-binding cassette sub-family C member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:bf83d06a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:bf83fb08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bf83fb08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bf842e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is partial agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bf8456b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is partial agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:bf848078-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bf84a8be-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:bf84d0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf84f92c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bf8521fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.78']} DrugCentral uuid:bf854a30-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bf857262-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.209']} DrugCentral uuid:bf859b48-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bf85c532-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bf85f96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bf85f96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bf85f96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bf85f96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bf864d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:bf864d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:bf864d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:bf868b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.943']} DrugCentral uuid:bf86b37a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bf86db8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bf870442-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.455']} DrugCentral uuid:bf872c56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bf87546a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:bf877c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.879']} DrugCentral uuid:bf87a564-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bf87cd78-94cc-11ec-8aec-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:bf87f56e-94cc-11ec-8aec-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bf881de6-94cc-11ec-8aec-0242ac110003 UniProtKB:O88275 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:bf88460e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:bf886e18-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bf88962c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:bf88befe-94cc-11ec-8aec-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bf88e726-94cc-11ec-8aec-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:bf890f12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:bf893708-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bf895fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.87']} DrugCentral uuid:bf8987ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:bf89b0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:bf89d906-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.461']} DrugCentral uuid:bf8a02b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:bf8a2abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.992']} DrugCentral uuid:bf8a52e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.256']} DrugCentral uuid:bf8a7b18-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:bf8aa3fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bf8acc26-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:bf8af444-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.105']} DrugCentral uuid:bf8b1c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.799']} DrugCentral uuid:bf8b4656-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.939']} DrugCentral uuid:bf8b6ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:bf8b96ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.189']} DrugCentral uuid:bf8bbf28-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bf8be78c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:bf8c0fa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:bf8c37be-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:bf8c5fdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.429']} DrugCentral uuid:bf8c8890-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:bf8cb090-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:bf8cd8a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf8d01a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf8d2c6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:bf8d546e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:bf8d7c78-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf8da5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf8dcde0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.324']} DrugCentral uuid:bf8df5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:bf8e1de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:bf8e4694-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:bf8e6ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bf8e96da-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bf8ebeda-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bf8ee824-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:bf8f1056-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf8f386a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bf8f652e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:bf8f652e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:bf8f9ada-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:bf8f9ada-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:bf8f9ada-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:bf8fd748-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:bf8fd748-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:bf900894-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:bf900894-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:bf9036de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:bf905ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:bf9082e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf90c446-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:bf9122ba-94cc-11ec-8aec-0242ac110003 UniProtKB:O18276 biolink:molecularly_interacts_with DrugCentral:2188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperazine targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) DrugCentral uuid:bf914736-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipotiazine palmitate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:bf916f68-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipotiazine palmitate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:bf91979a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2199 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirbuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bf91bb9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:bf91e47a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:bf920cac-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:bf9234de-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:bf925cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:bf92866e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:bf92afcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:bf92d86c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:bf9300d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:bf932966-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:bf935198-94cc-11ec-8aec-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:bf9379ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:bf93a1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bf93d9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf93d9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf93d9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf93d9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf93d9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bf943eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bf943eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bf943eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bf943eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bf943eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:bf949b5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:bf94c686-94cc-11ec-8aec-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:2201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:bf94ef12-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bf95174e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:bf953f94-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bf9567b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:bf959174-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:bf95b99c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bf95e232-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bf960a64-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bf96334a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bf965b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bf9683a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bf96abea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bf96d48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28347 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:bf96fcbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:bf9724da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15562 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:bf974cda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99594 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:bf9775a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:bf979d98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirmenol targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:bf97c188-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bf97e9ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:bf981354-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:bf984054-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bf984054-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:bf987768-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bf987768-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bf98aad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bf98cea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bf98f2a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.168']} DrugCentral uuid:bf991b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:bf99440e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:bf996d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bf999544-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bf99bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:bf99e652-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bf9a0e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:bf9a36c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:bf9a5ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:bf9a8792-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polythiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['9.09']} DrugCentral uuid:bf9aafba-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralidoxime is activator of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.59']} DrugCentral uuid:bf9ad7ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O08725 biolink:molecularly_interacts_with DrugCentral:2232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:bf9b0014-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:2232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) DrugCentral uuid:bf9b2486-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:bf9b4cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bf9b74c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.121']} DrugCentral uuid:bf9b9ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:bf9bc6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:bf9bee98-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:bf9c17f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bf9c401e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.668']} DrugCentral uuid:bf9c686e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:bf9c906e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:bf9cb88c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:bf9ce168-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.282']} DrugCentral uuid:bf9d09ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:bf9d31d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:bf9d59fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:bf9d8320-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:bf9daf44-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bf9daf44-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:bf9de63a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:bf9de63a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:bf9e1dc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bf9e1dc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bf9e50e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf9e78f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bf9ea0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bf9ec9ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:bf9ef2f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bf9f1ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Nuclear other (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:bf9f43c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:bf9f6e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bf9f9642-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bf9fbf6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bf9fe782-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bfa01018-94cc-11ec-8aec-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bfa03ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfa03ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfa03ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfa07742-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:bfa09ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08515 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel targets Enzyme (Glutathione S-transferase class-mu 26 kDa isozyme) DrugCentral uuid:bfa0c3dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95US7 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB1) DrugCentral uuid:bfa0e7ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q962H3 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB2) DrugCentral uuid:bfa10bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednicarbate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bfa130ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:bfa158ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:bfa17ca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:bfa1a4be-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bfa1cdc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bfa1f5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:bfa21dd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bfa245e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bfa26e44-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bfa2964e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bfa2be62-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bfa2e662-94cc-11ec-8aec-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:bfa3111e-94cc-11ec-8aec-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:bfa33928-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bfa3615a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:bfa386b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.28']} DrugCentral uuid:bfa3afe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:bfa3d806-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bfa4001a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bfa42964-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:bfa4524a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:bfa47b94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bfa4a3b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:bfa4ccc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:bfa4f560-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:bfa51d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:bfa545d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:bfa56e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:bfa59646-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:bfa5be78-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:bfa5e66e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone targets Cytosolic other (Annexin A1) DrugCentral uuid:bfa60aae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.801']} DrugCentral uuid:bfa632d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:bfa65af4-94cc-11ec-8aec-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:bfa68326-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:bfa6ad06-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bfa6d81c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bfa7004e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:bfa72844-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenalterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bfa751a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenalterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:bfa78186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bfa78186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bfa78186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bfa7c754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bfa7c754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bfa7c754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:bfa805fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bfa82e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:bfa85638-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bfa87ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.194']} DrugCentral uuid:bfa8a84a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:bfa8d05e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.799']} DrugCentral uuid:bfa90038-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bfa90038-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bfa90038-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:bfa93f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.668']} DrugCentral uuid:bfa9678a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.075']} DrugCentral uuid:bfa98fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:bfa9b53c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:bfa9dd46-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bfaa0564-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.739']} DrugCentral uuid:bfaa2d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:bfaa5744-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:bfaa7b20-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:bfaaa41a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bfaacc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P35869 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transcription factor (Aryl hydrocarbon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:bfaaf49c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:bfab1cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:bfab44d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bfab7476-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfab7476-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfab7476-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:bfabac7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:bfabd48e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bfabfca2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bfac25ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bfac4e78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:bfac7696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 8) DrugCentral uuid:bfac9a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 11) DrugCentral uuid:bfacbf16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bface720-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bfad0f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:bfad3752-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.02']} DrugCentral uuid:bfad6006-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:bfad87fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.686']} DrugCentral uuid:bfadaff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfadd810-94cc-11ec-8aec-0242ac110003 UniProtKB:O95477 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol is inhibitor of Transporter (ATP-binding cassette sub-family A member 1) DrugCentral uuid:bfadfd7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:bfae268a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:bfae4e94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.86']} DrugCentral uuid:bfae778e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.812']} DrugCentral uuid:bfaea04c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bfaec87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:bfaeec5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:bfaf1040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:bfaf348a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaf7ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:bfaffe6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.569']} DrugCentral uuid:bfb0269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.529']} DrugCentral uuid:bfb04ece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:bfb0735e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.222']} DrugCentral uuid:bfb0a2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:bfb0a2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:bfb0a2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:bfb0e136-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:bfb109c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bfb131e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:bfb159fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:bfb18226-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.764']} DrugCentral uuid:bfb1ac74-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:bfb1d4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:bfb1fcce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:bfb224f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.207']} DrugCentral uuid:bfb24d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.402']} DrugCentral uuid:bfb27596-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:bfb29dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:bfb2c5e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:bfb2ee72-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:bfb316ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:bfb33ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.622']} DrugCentral uuid:bfb367bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.324']} DrugCentral uuid:bfb391ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.611']} DrugCentral uuid:bfb3b9c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.723']} DrugCentral uuid:bfb3e1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.613']} DrugCentral uuid:bfb40bf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:bfb4348a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.493']} DrugCentral uuid:bfb45ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:bfb484ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:bfb4aea6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bfb4d6e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:bfb4ff00-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bfb5271e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:bfb5504a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:bfb57886-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bfb5a1d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.245']} DrugCentral uuid:bfb5c9ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bfb5f25c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:bfb61a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:bfb642d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.381']} DrugCentral uuid:bfb66b06-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:bfb6941e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:bfb6bc50-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb6e478-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.337']} DrugCentral uuid:bfb70c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:bfb7370c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.907']} DrugCentral uuid:bfb75f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:bfb78766-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:bfb7af66-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb7eecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfb86186-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:bfb86186-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:bfb86186-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb8d882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfb9eeca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfbabf12-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.174']} DrugCentral uuid:bfbaeaaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:bfbb13ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:bfbb3bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:bfbb643a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:bfbb8c26-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bfbbaff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:bfbbd8b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['9.876']} DrugCentral uuid:bfbc0282-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:bfbc2aa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.94']} DrugCentral uuid:bfbc52b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35610 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Sterol O-acyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:bfbc7abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bfbca444-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:bfbccec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:bfbcf6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:bfbd1f00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:bfbd478c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:bfbd6fa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:bfbd97be-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bfbdc0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:bfbdedea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bfbdedea-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bfbe24f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:bfbe24f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:bfbe583e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bfbe8192-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bfbea9a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bfbed1a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:bfbef988-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bfbf21f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bfbf4a14-94cc-11ec-8aec-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proglumide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.6']} DrugCentral uuid:bfbf7246-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proglumide is antagonist of GPCR (Gastrin/cholecystokinin type B receptor) DrugCentral uuid:bfbf9622-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0IJY2 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:bfbfba80-94cc-11ec-8aec-0242ac110003 UniProtKB:O02604 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:bfbfde7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:bfc0024c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bfc02a38-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:bfc053e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:bfc07c0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bfc0a436-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:bfc0cc68-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:bfc0f4ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:bfc11d12-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.529']} DrugCentral uuid:bfc145c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:bfc16efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.656']} DrugCentral uuid:bfc198f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:bfc1c12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:bfc1e94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.226']} DrugCentral uuid:bfc2115e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bfc23cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:bfc26514-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:bfc28d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.551']} DrugCentral uuid:bfc2b69a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:bfc2deae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:bfc306d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.056']} DrugCentral uuid:bfc32ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:bfc35866-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:bfc38084-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.796']} DrugCentral uuid:bfc3a88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:bfc3d0c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bfc3fa00-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:bfc42232-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bfc44a50-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:bfc47250-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:bfc49af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.344']} DrugCentral uuid:bfc4c322-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.806']} DrugCentral uuid:bfc4eb36-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:bfc51340-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bfc53c12-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bfc56520-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bfc5911c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bfc5911c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bfc5d58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bfc5d58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bfc5d58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bfc5d58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bfc5d58c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:bfc632d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bfc632d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bfc632d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:bfc6721c-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:bfc69a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promegestone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:bfc6c2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promegestone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:bfc6ebe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:bfc714c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:bfc73cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:bfc7656e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:bfc78d82-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bfc7b6f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:bfc7df08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:bfc80726-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:bfc82f44-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:bfc857d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.188']} DrugCentral uuid:bfc87fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.948']} DrugCentral uuid:bfc8a8b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bfc8cc7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:bfc8f53c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:bfc91d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:bfc94582-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.941']} DrugCentral uuid:bfc96ea4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.823']} DrugCentral uuid:bfc9996a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.479']} DrugCentral uuid:bfc9c188-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bfc9e9ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.382']} DrugCentral uuid:bfca1232-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.975']} DrugCentral uuid:bfca3a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:bfca6232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:bfca8a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.452']} DrugCentral uuid:bfcab2f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:bfcadb0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:bfcb0322-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bfcb2b22-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:bfcb5462-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:bfcb7c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:bfcba494-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bfcbcc80-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bfcbf502-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:bfcc24d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bfcc24d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bfcc24d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bfcc63f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:bfcc8dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bfccb5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:bfccdde6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:bfcd067c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pronetalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:bfcd3142-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:bfcd59ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:bfcd820a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bfcdaa14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:bfcdce54-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:bfcdf230-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:bfce1602-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:bfce39de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bfce6288-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:bfce8a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:bfceb292-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:bfceda7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.029']} DrugCentral uuid:bfcf0544-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.728']} DrugCentral uuid:bfcf3082-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:bfcf58b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:bfcf80d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:bfcfa95e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:bfcfd136-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.498']} DrugCentral uuid:bfcff954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:bfd02168-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.337']} DrugCentral uuid:bfd04a62-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:bfd07370-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.483']} DrugCentral uuid:bfd09b84-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:bfd0c47e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:bfd0ec88-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:bfd1147e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bfd13c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:bfd16546-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:bfd18d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:bfd1b55a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bfd1de0e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.602']} DrugCentral uuid:bfd20afa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bfd20afa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bfd23e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:bfd26752-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:bfd2902e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:bfd2b95a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:bfd2e20e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bfd30a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:bfd33308-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:bfd35efa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bfd35efa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bfd35efa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:bfd39d34-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propentofylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:bfd3c52a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:bfd3e9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(2) dopamine receptor) DrugCentral uuid:bfd40ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:bfd432b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:bfd456b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:bfd47bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:bfd49fae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:bfd4c376-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:bfd4e73e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:bfd50b88-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:bfd52f3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(4) dopamine receptor) DrugCentral uuid:bfd5530e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:bfd576f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiram is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:bfd59ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:bfd5c37a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.417']} DrugCentral uuid:bfd5eb8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.031']} DrugCentral uuid:bfd613a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:bfd63bc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.218']} DrugCentral uuid:bfd6653c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.005']} DrugCentral uuid:bfd68d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:bfd6b528-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:bfd6dd96-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.119']} DrugCentral uuid:bfd70596-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:bfd72daa-94cc-11ec-8aec-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bfd75d98-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bfd75d98-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bfd75d98-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bfd7a5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bfd7a5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bfd7a5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd81fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:bfd8f518-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bfd8f518-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bfd8f518-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bfd93384-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:bfd95c10-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:bfd984b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:bfd9acc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.913']} DrugCentral uuid:bfd9d5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:bfda0002-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:bfda283e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:bfda507a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:bfda78a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.699']} DrugCentral uuid:bfdaa142-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:bfdac960-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:bfdaf17e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:bfdb19b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:bfdb4246-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.319']} DrugCentral uuid:bfdb6a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:bfdb92b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:bfdbbd34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.297']} DrugCentral uuid:bfdbe570-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:bfdc0dac-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:bfdc35d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bfdc5e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:bfdc86ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.01']} DrugCentral uuid:bfdcaf28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:bfdcd75a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:bfdcfffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:bfdd2822-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:bfdd5810-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bfdd5810-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bfdd5810-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bfdd9938-94cc-11ec-8aec-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:bfddc19c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bfdde9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:bfde1228-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:bfde3adc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:bfde6318-94cc-11ec-8aec-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:bfde8b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:bfdeb368-94cc-11ec-8aec-0242ac110003 UniProtKB:P49895 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil is inhibitor of Enzyme (Type I iodothyronine deiodinase) DrugCentral uuid:bfded7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bfdeffda-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:2309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propyphenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.481']} DrugCentral uuid:bfdf27b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:bfdf4b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:bfdf755a-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bfdf755a-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:bfdfa886-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proscillaridin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:bfdfd09a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proscillaridin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bfdff480-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bfe01d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bfe04570-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bfe06d98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R297 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bfe095c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bfe0be42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERT1 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:bfe0e64c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protokylol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bfe10a32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.928']} DrugCentral uuid:bfe1343a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:bfe15d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:bfe18674-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:bfe1ae92-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bfe1d7fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:bfe20022-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:bfe2284a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:bfe2505e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:bfe278f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:bfe2a0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:bfe2c93a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:bfe2f162-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:bfe31b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:bfe344aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:bfe36886-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:bfe38c94-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:bfe3b1ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:bfe3d5aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:bfe3fdd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:bfe425e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPB6 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cyclopropane mycolic acid synthase 1) DrugCentral uuid:bfe44a30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50575 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA) DrugCentral uuid:bfe46e16-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:bfe49652-94cc-11ec-8aec-0242ac110003 UniProtKB:P95029 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide is inhibitor of Enzyme (3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase)) DrugCentral uuid:bfe4ba56-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:bfe4e314-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:bfe50e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:bfe5399a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:bfe56208-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:bfe58b98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:bfe5b438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:bfe5dc60-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:bfe60488-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bfe62d64-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.751']} DrugCentral uuid:bfe65596-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:bfe67ddc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:bfe6a60e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:bfe6d0b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bfe6fbf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:bfe72412-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:bfe74c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:bfe774bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:bfe79cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:bfe7c4ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.288']} DrugCentral uuid:bfe7ed0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.409']} DrugCentral uuid:bfe81660-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:bfe83ea6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bfe866d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:bfe8902c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bfe8b926-94cc-11ec-8aec-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:bfe8e158-94cc-11ec-8aec-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:bfe90976-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:bfe93284-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bfe95a98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.009']} DrugCentral uuid:bfe983ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:bfe9ac00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:bfe9d55e-94cc-11ec-8aec-0242ac110003 UniProtKB:O08966 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bfe9fd86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K0H1 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Unclassified (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:bfea25b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bfea4db8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06865 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:bfea77e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07686 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bfeaa222-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3V050 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Unclassified (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bfeaca36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:bfeaf268-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8I1R6 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:bfeb1b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:F1KRD8 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Unclassified (Fumarate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:bfeb4448-94cc-11ec-8aec-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bfeb6c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43426 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Synaptojanin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:bfeb9484-94cc-11ec-8aec-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bfebc576-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:bfebc576-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:bfebc576-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:bfec0b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:bfec0b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:bfec0b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:bfec52a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:bfec52a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:bfec52a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:bfec923a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bfecbb66-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:bfece492-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:bfed0cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.483']} DrugCentral uuid:bfed3500-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:bfed5d32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:bfed867c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:bfedaea4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:bfedd6e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:bfedff1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:bfee2a32-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:bfee52aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:bfee7abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:bfeea2c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.512']} DrugCentral uuid:bfeecbe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.027']} DrugCentral uuid:bfeef3f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.127']} DrugCentral uuid:bfef1c44-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bfef4570-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:bfef6dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:bfef95de-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:bfefbe10-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:bfefe71e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.795']} DrugCentral uuid:bff00f46-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.266']} DrugCentral uuid:bff0376e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:bff06018-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:bff08ca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:bff0b5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:bff0ddf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.241']} DrugCentral uuid:bff10630-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bff13114-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:bff15950-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:bff1815a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.506']} DrugCentral uuid:bff1a98c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:bff1d33a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:bff1fb76-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.866']} DrugCentral uuid:bff223a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:bff24cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.06']} DrugCentral uuid:bff276fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bff29f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:bff2c74a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:bff2f058-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:bff3188a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:bff3408a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:bff368b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:bff39238-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:bff3bc90-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.542']} DrugCentral uuid:bff3e4c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:bff40d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.079']} DrugCentral uuid:bff4362a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:bff45e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.459']} DrugCentral uuid:bff486b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:bff4afce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:bff4d85a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.575']} DrugCentral uuid:bff5008c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.558']} DrugCentral uuid:bff528c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:bff550e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:bff57a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:bff5a28a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:bff5cabc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.574']} DrugCentral uuid:bff5f2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:bff61b98-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:bff643c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:bff66be8-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bff69406-94cc-11ec-8aec-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:bff6c070-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bff6c070-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:bff6fb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bff6fb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bff6fb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:bff74716-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bff74716-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bff74716-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bff74716-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:bff79040-94cc-11ec-8aec-0242ac110003 UniProtKB:P00592 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bff7b9ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P04055 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8140c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:bff8d5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bff8d5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bff8d5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:bff918c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bff918c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:bff95362-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bff95362-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bff95362-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:bff991ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:bff9ba6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.397']} DrugCentral uuid:bff9e2aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:bffa06ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinethazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:bffa2a9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quingestanol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:bffa5000-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:bffa781e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:bffa9c68-94cc-11ec-8aec-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:bffac058-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:bffae588-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:bffb0a40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:bffb327c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:bffb5aae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:bffb8362-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:bffbab6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:bffbd4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:bffbfd1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.106']} DrugCentral uuid:bffc25ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:bffc4de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:bffc75f6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:bffc9e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:bffccede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bffccede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bffccede-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:bffd0ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:bffd350e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:bffd5de0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:bffd85fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:bffdae30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is inhibitor of Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:bffdd66c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:bffdfff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.102']} DrugCentral uuid:bffe2824-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:bffe504c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:bffe7450-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:bffe9df4-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:bffeca04-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bffeca04-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:bffef862-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bfff208a-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bfff4df8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:bfff7616-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:bfff9e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:bfffc7e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:bfffeff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:c0001828-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:c0004050-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.408']} DrugCentral uuid:c0006a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:c0009244-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.205']} DrugCentral uuid:c000ba76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c000e29e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c0010b84-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:c00133ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:c0015d14-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:c001853c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c001addc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c001d5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c001ff12-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:c0022730-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:c00251ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:c00279c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:c002a1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:c002ca0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:c002f2dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:c0031af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:c0034322-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.193']} DrugCentral uuid:c0036bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c00393cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c003bbf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:c003e412-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c0040d5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c004355c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c0045d48-94cc-11ec-8aec-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c00485b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:c004ae6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:c004d67e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.876']} DrugCentral uuid:c004fe88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13393 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Phospholipase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c0052692-94cc-11ec-8aec-0242ac110003 UniProtKB:O14939 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Phospholipase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c0054ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:c0057700-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:c0059f28-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.625']} DrugCentral uuid:c005c73c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c005f0ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:c0061912-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:c0064144-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c0066980-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c0069608-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:c0069608-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:c006c948-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c006f166-94cc-11ec-8aec-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c00719f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c007433c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:c0076b96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c00793be-94cc-11ec-8aec-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c007bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c007e580-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c0080d94-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:c00835b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c0085e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c0088684-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c008ae84-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.244']} DrugCentral uuid:c008d6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c008ff42-94cc-11ec-8aec-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c0092756-94cc-11ec-8aec-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c0094f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c0097760-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c009a122-94cc-11ec-8aec-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c009ca58-94cc-11ec-8aec-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c009f280-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c00a1abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is inverse agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c00a433e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c00a6b66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XKD3 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c00a93fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c00abc92-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:2355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.9']} DrugCentral uuid:c00ae4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:2355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.39']} DrugCentral uuid:c00b0cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:c00b3532-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramipril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c00b5e86-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c00b86cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:c00baefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c00bd71c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c00bff9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c00c27d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c00c5034-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c00c785c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:c00ca0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c00cc4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5YLN7 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Unclassified (Voltage-gated sodium channel Nav1.5 cardiac isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c00ced1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rebamipide is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c00d16a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c00d402a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c00d6866-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c00d908e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c00db9c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c00de2b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:c00e0ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c00e32fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:c00e5b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:c00e8764-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:c00e8764-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:c00ebe64-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:c00ebe64-94cc-11ec-8aec-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:c00ef28a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:c00f1c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.398']} DrugCentral uuid:c00f44b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c00f6cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c00f94f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c00fbeea-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:c00fe2ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c0100b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c010335c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0105c60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c0108492-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c010ac9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:c010d564-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c0110020-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0112866-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c011507a-94cc-11ec-8aec-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0117924-94cc-11ec-8aec-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c011b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c011b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c011b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c011b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c011b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c01205b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09428 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Ion channel (ATP-binding cassette sub-family C member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c0122edc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:c01252e0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c0128026-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c0128026-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c012b906-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:c012b906-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:c012ec8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reproterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:c013111c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rescinnamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:c013352a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:c0135e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.415']} DrugCentral uuid:c01386a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.232']} DrugCentral uuid:c013aeec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c013d714-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:c013ffc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:c0142804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c0145040-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c0147890-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c014a252-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c014ca52-94cc-11ec-8aec-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:c014fa40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c014fa40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c014fa40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0153adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:c015630e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.836']} DrugCentral uuid:c0158b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol acetate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c015b372-94cc-11ec-8aec-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol acetate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c015dcda-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c01604f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Kinase (Adenosine kinase) DrugCentral uuid:c01628de-94cc-11ec-8aec-0242ac110003 UniProtKB:P22413 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 1) DrugCentral uuid:c0164cce-94cc-11ec-8aec-0242ac110003 UniProtKB:P49902 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (Cytosolic purine 5'-nucleotidase) DrugCentral uuid:c0167348-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c0169bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c016c410-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c016ec42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (NS5B protein) DrugCentral uuid:c01710be-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c01738f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WGY9 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin targets Enzyme (DNA-directed RNA polymerase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c0176c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0176c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0176c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0176c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c017af88-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c017d7c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c017ffd8-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:c01828c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c018510e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0187954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c018a19a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:c018c710-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c018ef4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c01917a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0193fce-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c01968b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c0199c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0199c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0199c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c0199c62-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c019dd76-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c01a11b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c01a11b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c01a11b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c01a11b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:c01a52c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c01a7b00-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c01aa3aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:c01acc04-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c01af440-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c01b1c7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:c01b4562-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:c01b69a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c01b91e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:c01bba1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c01be44a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:c01c0948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c01c3170-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c01c5a92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c01c83b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c01cabd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c01cd51c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21430 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Ion channel (Matrix protein 2) DrugCentral uuid:c01cf934-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c01d221a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c01d4a56-94cc-11ec-8aec-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine is inhibitor of Ion channel (Matrix protein 2) DrugCentral uuid:c01d6e82-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c01d96dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c01dbfe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c01de83a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c01e10a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimexolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01e6ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c01f4054-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c01f689a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c01f91a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q197X6 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:c01fb9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WS26 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c01fe220-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c0200ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c02033b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0205bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c020843c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c020ac78-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c020d568-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c020fd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c0212702-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c0214fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:c0217afe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c021a34e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c021cb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.788']} DrugCentral uuid:c021f40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c0221c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.443']} DrugCentral uuid:c02244e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.364']} DrugCentral uuid:c0226d10-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c02295ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c022bef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c022e718-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c0230f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:c0233880-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c02360bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:c02388da-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.023']} DrugCentral uuid:c023b0f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:c023d98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:c02401d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c02429fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:c0245224-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c0247aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:c024a328-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c024cb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c024f382-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:c0251f56-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.278']} DrugCentral uuid:c025477e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c0256fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0259878-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c025c0a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c025e896-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.687']} DrugCentral uuid:c02610c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c02639ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c02661f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.967']} DrugCentral uuid:c0268a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c026b352-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c026dd64-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c02705d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c0272f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c027578a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c027802a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c027a85c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c027d098-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c027f8c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c028221e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:c0284a50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c0287264-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c0289aa0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c028c3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c028ebea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c02914f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c0293d16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c029710a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c029710a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c029710a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c029710a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c029c20e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c029c20e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c029c20e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c02a08ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c02a08ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c02a08ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c02a4850-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c02a70a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritodrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c02a9b3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritodrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c02ac35c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:c02aeb7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c02b13b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c02b3bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:c02b63d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:c02b87ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:c02bb0a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c02bd8b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.303']} DrugCentral uuid:c02c00dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:c02c2904-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.119']} DrugCentral uuid:c02c53ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c02c7c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:c02ca460-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c02cccc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:c02cf564-94cc-11ec-8aec-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c02d1d96-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c02d45b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c02d6df0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c02d97a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.47']} DrugCentral uuid:c02dbfee-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c02de834-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c02e1138-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c02e3b86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c02e639a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c02e8bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c02eb3fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c02edc8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c02f04a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c02f2cda-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c02f555c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c02f7ece-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c02fa700-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c02fcf32-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c02ff89a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c03023f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:c0304c3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0307478-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0309d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c030c536-94cc-11ec-8aec-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c030f150-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c030f150-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c0312c4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0312c4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0312c4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c031771a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c031771a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c031771a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c031771a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c031c2b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c031ed9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c03215a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.466']} DrugCentral uuid:c0323dd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c032663e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c0328e52-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:c032b666-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c032de70-94cc-11ec-8aec-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c0330724-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:c0332f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c0335774-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c0337f88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c033a8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c033d30c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c033faee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c0342316-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c0344bac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c03473d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c0349c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c034c424-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c034ecd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c03514e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c0353d14-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c0356622-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c035911a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:c035b9b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c035e1d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c0360a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c03632aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c0365ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c03682e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:c036aaf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:c036cf80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:c036f366-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:c0371756-94cc-11ec-8aec-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:c0373b50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:c03760a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:c03785e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:c037a9e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c037d1f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c037fa9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c03822ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:c0384ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c03872ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c0389bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:c038c402-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c038ec20-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c0391452-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c0393fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c039695c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:c039918e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c039b9f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c039e210-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c03a0a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c03a3288-94cc-11ec-8aec-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c03a5bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c03a83e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c03aac2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c03ad468-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c03afdf8-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c03b26b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c03b4f06-94cc-11ec-8aec-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c03b7738-94cc-11ec-8aec-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c03b9fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c03bc80a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c03bf028-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c03c185a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:c03c414a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:c03c6986-94cc-11ec-8aec-0242ac110003 UniProtKB:O43924 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin targets Enzyme (Phosphodiesterase 6D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c03c91b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c03cbae4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c03ce622-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c03d107a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c03d39a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c03d6354-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c03d8c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c03db480-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxatidine acetate is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c03ddc94-94cc-11ec-8aec-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:c03e0156-94cc-11ec-8aec-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c03e2988-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.261']} DrugCentral uuid:c03e51d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rupatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c03e7a00-94cc-11ec-8aec-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rupatadine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c03ea336-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c03ecbd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c03ef3f4-94cc-11ec-8aec-0242ac110003 UniProtKB:C3SIU2 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Unclassified (Met repressor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c03f1c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P11086 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Phenylethanolamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c03f44bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22061 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Protein-beta-aspartate methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c03f6cee-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c03f9534-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c03fbd70-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.95']} DrugCentral uuid:c03fe66a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6RYA0 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Salicylic acid-binding protein 2) DrugCentral uuid:c0400a50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c0403282-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c0405abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c04083fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c040ac26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c040d444-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c040fcee-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c0412570-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c0414e92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.36']} DrugCentral uuid:c041769c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c0419ece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c041c78c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c041eff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:c042185e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c0424090-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c0426b92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.004']} DrugCentral uuid:c04293b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c042bbce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c042e464-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c0430cb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c043361c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:c0435e44-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:c04386f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:c043af20-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:c043d75c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.282']} DrugCentral uuid:c043ff8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.699']} DrugCentral uuid:c0442978-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.555']} DrugCentral uuid:c0445204-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.556']} DrugCentral uuid:c0447a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:c0449e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.003']} DrugCentral uuid:c044c6e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.153']} DrugCentral uuid:c044ef34-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.187']} DrugCentral uuid:c045177a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.661']} DrugCentral uuid:c0453f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:c045698c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c04591a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c045b9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c045e1be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c0460bee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c04633ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c0465c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c0468416-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c046aca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c046d4d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0470530-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c0470530-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c0470530-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c047443c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c0476c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:c0479482-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c047bc96-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:c047e752-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c0480f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c0483798-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:c048601a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c04888ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c048b10a-94cc-11ec-8aec-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c048e850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c048e850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c048e850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c048e850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c048e850-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c0493f94-94cc-11ec-8aec-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:2427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secnidazole targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c049679e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.578']} DrugCentral uuid:c049984a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c049984a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c049984a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c049cfd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.171']} DrugCentral uuid:c049f812-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.764']} DrugCentral uuid:c04a2076-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c04a4920-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c04a7166-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c04a9998-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c04ac1ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c04aea74-94cc-11ec-8aec-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c04b16a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c04b16a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c04b49c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 seratrodast targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c04b7390-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:2433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sermorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:c04b97a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c04bbb8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertaconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c04be3ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c04c0cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c04c3532-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c04c5d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.194']} DrugCentral uuid:c04c8690-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c04caf4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c04cd898-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c04d00ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c04d28fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:c04d535e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:c04d7cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:c04da516-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:c04dcd3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:c04df5ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c04e1f32-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c04e476e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c04e6f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:c04e985e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c04ec0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c04ee8e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c04f1108-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c04f3d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:c04f659a-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c04f8de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c04fb694-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c04fdee4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:c050073e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:c0502f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:c050603a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c050603a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c050603a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c050a770-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:c050a770-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:c050a770-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:c050e5be-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c0510fb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c05137ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c0516016-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.965']} DrugCentral uuid:c05188b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c051b0e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:c051d94c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.54']} DrugCentral uuid:c052017e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c0522a82-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:c05252be-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:c0527afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.246']} DrugCentral uuid:c052a336-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:c052cd02-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.082']} DrugCentral uuid:c052f714-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:c0531f28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:c0534750-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:c0536fdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:c0539804-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:c053c18a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:c053e9d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c05413a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c0543bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.475']} DrugCentral uuid:c0546414-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:c0548c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:c054b7d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c054e164-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c0550996-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0553272-94cc-11ec-8aec-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c0555ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:c0557ed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:c055a2d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:c055c6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:c055eb40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:c0560f30-94cc-11ec-8aec-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:c0563334-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05690fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c05746e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:c0576f2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:c057974c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:c057bfe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:c057e51c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.026']} DrugCentral uuid:c0580d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c058354e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c0586078-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.538']} DrugCentral uuid:c058888c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c058b0be-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c058d8e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c0590190-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0592a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Transporter (Multidrug resistance-associated protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0595262-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c0597ac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) DrugCentral uuid:c0599eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c059c6ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c059eee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c05a17ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c05a4212-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c05a6a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c05a9226-94cc-11ec-8aec-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c05abac6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c05ae3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.094']} DrugCentral uuid:c05b0c06-94cc-11ec-8aec-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c05b341a-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c05b5d32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c05b8532-94cc-11ec-8aec-0242ac110003 UniProtKB:P16586 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c05bad28-94cc-11ec-8aec-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c05bd528-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c05bff26-94cc-11ec-8aec-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c05c2adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c05c2adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c05c692a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c05c692a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c05c692a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c05c692a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c05cbdee-94cc-11ec-8aec-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c05cbdee-94cc-11ec-8aec-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c05cbdee-94cc-11ec-8aec-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c05cbdee-94cc-11ec-8aec-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c05d0e52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c05d0e52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c05d0e52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c05d5236-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c05d5236-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05d9804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c05e017c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c05e017c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c05e017c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c05e3f84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c05e67fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14099 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:c05e9006-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c05eb81a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c05ee0a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c05f09a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c05f31b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:c05f5a54-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c05f8290-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.73']} DrugCentral uuid:c05fac3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c05fd4de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c05ffcfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c0602510-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c0604d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c0607592-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:c0609dba-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c060c5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c060ee64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0611682-94cc-11ec-8aec-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c0613f90-94cc-11ec-8aec-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c061693e-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c06192ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P14142 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c061bad8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:c061debe-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c062088a-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c06230d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c06258e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c062810c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q10283 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:c062a97a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.431']} DrugCentral uuid:c062d1ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c062f998-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c06321ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c0634c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c06375b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c0639da8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c063c5b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:c063eefc-94cc-11ec-8aec-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c0641706-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c0643f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q53EL6 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Nuclear other (Programmed cell death protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c0646788-94cc-11ec-8aec-0242ac110003 UniProtKB:P06730 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Nuclear other (Eukaryotic translation initiation factor 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c0649000-94cc-11ec-8aec-0242ac110003 UniProtKB:P26883 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c064b80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2447 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sisomicin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:c064dbdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c06503f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c0653046-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.774']} DrugCentral uuid:c0655850-94cc-11ec-8aec-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c065803c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c065a846-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c065d0b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c065f8a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHL4 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c06620c8-94cc-11ec-8aec-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c0664940-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:2449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitafloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:c0666d12-94cc-11ec-8aec-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:2449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitafloxacin targets Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:c06690f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c066b8f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c066e116-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c0670d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c0673594-94cc-11ec-8aec-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c0675d80-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:c0678602-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c067ae02-94cc-11ec-8aec-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (DNA polymerase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c067d602-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:c067ff42-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c06827c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c0684fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c06877ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0689fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24158 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Myeloblastin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c068ca3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3UP87 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:c068f28a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c0691a9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c06943b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:c0696c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0699460-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c069bc74-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c069e474-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c06a0d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c06a3514-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c06a5da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:c06a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:c06ab1c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c06ad9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c06b0228-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c06b2ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c06b5368-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c06b7b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c06ba39a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c06bcc58-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c06bf476-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:c06c1c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c06c4494-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c06c6e56-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c06c9656-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c06cbe60-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c06ce67e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c06d0f14-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c06d3818-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c06d6054-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c06d88cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c06db16c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:c06ddab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c06e02de-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c06e2afc-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c06e548c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c06e7caa-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c06ea4c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c06eccdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c06ef55e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c06f1d72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c06f4586-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c06f6da4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c06f9676-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c06fbe94-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c06fe694-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c0700fb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c07039d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c07061e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c07089fa-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c070b268-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c070da68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c071025e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c0712b62-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0715416-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0717c20-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c071a434-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c071cc48-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c071f54c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c0721d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c072456a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c0726d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P53778 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c07295f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c072be00-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c072e5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c0730e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c07336dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c0735ee6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c0738704-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c073af40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c073daa6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c07402b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c0742ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c0745364-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c0747b78-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c074a38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c074cba0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c074f4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c0751de4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c0754616-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c0756e20-94cc-11ec-8aec-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c07597b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c075bff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c075e800-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0761014-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c0763896-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c07660a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c07688c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c076b12c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15264 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c076d9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c077021c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c0772a30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c0775230-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c0777c38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c077a442-94cc-11ec-8aec-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c077cc42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c077f44c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0781cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c07844d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c0786cce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:c07894ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c078bd6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c078e56e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c0790e54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c0793762-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c0795f80-94cc-11ec-8aec-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c0798780-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c079af94-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c079d9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c07a01e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00526 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c07a29ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c07a520a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c07a7ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c07aa368-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c07acb7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c07af390-94cc-11ec-8aec-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c07b1d5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c07b4570-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVW4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c07b6d70-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c07b9570-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c07bbdde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c07be5e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c07c0dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c07c3606-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c07c5e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c07c86ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c07caeba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c07cd6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c07d034c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c07d2c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c07d543c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c07d7cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c07da55e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5GIT4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c07dcd72-94cc-11ec-8aec-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c07df55e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c07e1e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c07e461c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05622 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c07e6e26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c07e963a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c07ebfe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c07ee806-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c07f1010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c07f3838-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c07f60b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c07f889c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c07fb0a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XZT6 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Deoxynucleoside kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c07fd9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:O00142 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c08002ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c0802af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c0805330-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:c0807b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c080a5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c080cdc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.413']} DrugCentral uuid:c080faba-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c080faba-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c0812ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c0812ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c0815a6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spectinomycin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:c0817e54-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2469 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiclomazine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c081a640-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c081cf1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c081f744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c0821f44-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0824762-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:c08270a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c08298ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c082c0de-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c082e988-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c083121e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c0833a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:c0836246-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c0838a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.322']} DrugCentral uuid:c083b30e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c083db22-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c0840322-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c0842b36-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c0845610-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c0847e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c084a656-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:c084cee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c084f804-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c0852022-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c085484a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c0857126-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:c0859a5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c085c28e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c085eab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c08613a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c0863be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c086640a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:c0868c1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c086b496-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c086ebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c086ebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c086ebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c086ebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c086ebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c0874c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0874c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0874c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0874c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c087a4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c087a4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c087a4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c087a4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c087a4aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c088021a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c088021a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c088021a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c08847d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c08847d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c08847d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c08895d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c08895d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c08895d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c08895d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c08895d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c088e9e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:c08913a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c0893bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c0896416-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spirapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c0898c34-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spirapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c089b664-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.227']} DrugCentral uuid:c089df86-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:c08a0376-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.884']} DrugCentral uuid:c08a2ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c08a5434-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.029']} DrugCentral uuid:c08a7c52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c08aa466-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c08acc84-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c08af54c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.663']} DrugCentral uuid:c08b1e64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:c08b4664-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:c08b6e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.327']} DrugCentral uuid:c08b9736-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:c08bbf7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c08be376-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.948']} DrugCentral uuid:c08c0b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:c08c33ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c08c5c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.316']} DrugCentral uuid:c08c8452-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:c08ca86a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c08cd100-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c08cf8f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:c08d1cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c08d44c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:c08d69da-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:c08d8dac-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WH62 biolink:molecularly_interacts_with DrugCentral:2481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 streptomycin targets Ribosomal protein (30S ribosomal protein S12) DrugCentral uuid:c08db1e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c08dd9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c08e0278-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c08e2a8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c08e528c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c08e822a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c08e822a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c08e822a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c08ec17c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07727 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c08eea6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c08f128a-94cc-11ec-8aec-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is agonist of GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.367']} DrugCentral uuid:c08f3c1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:2487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinic acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c08f6582-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA5 biolink:molecularly_interacts_with DrugCentral:2487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinic acid is agonist of GPCR (Succinate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c08f8d96-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c08fc5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c08fc5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c08fc5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c08fc5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c08fc5cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c09010c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c09038c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c09060cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:c09089a8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c090b1bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c090d9f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0910ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c0910ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c0910ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c0910ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c09157ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c0917ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c091a860-94cc-11ec-8aec-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c091d07e-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c091f87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c0922150-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0924b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c0927308-94cc-11ec-8aec-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c0929b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c092c33a-94cc-11ec-8aec-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c092ed92-94cc-11ec-8aec-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c09317cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c0933fea-94cc-11ec-8aec-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c0936826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c09390bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7X575 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c093b8da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0VTR6 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c093e0f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0VTR8 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c0940902-94cc-11ec-8aec-0242ac110003 UniProtKB:D5HSX5 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c09431c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P83111 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Serine beta-lactamase-like protein LACTB, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c09459b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c09482ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0VTS0 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (ADC-18 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:c094abb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00809 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c094d3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c094fbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c095247c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:c0954d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c0957544-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:c0959d62-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:c095c58a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c095ee5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.716']} DrugCentral uuid:c0961698-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:c0963ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.786']} DrugCentral uuid:c09667ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:c096942e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:c096bc60-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:c096e4c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.258']} DrugCentral uuid:c0970cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:c09735a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.144']} DrugCentral uuid:c0975ddc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:c09785fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:c097ae18-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:c097d6c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c097fa9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c098229e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c0984a94-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:c09894e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c098e51c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c0993684-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.431']} DrugCentral uuid:c0998666-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.738']} DrugCentral uuid:c099d792-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c09a274c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c09a578a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:c09a841c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c09ab090-94cc-11ec-8aec-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c09add68-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c09b09d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c09b366e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09b5e50-94cc-11ec-8aec-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c09b8e16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacytine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:c09bb60c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c09be276-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c09c0fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:c09c37bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09c5f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c09c8c08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZV3 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c09cb8e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimethoxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:c09ce590-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimidine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09d0d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimidine targets Enzyme (Lactoylglutathione lyase) DrugCentral uuid:c09d35fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2503 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadoxine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:c09d5e12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IAU3 biolink:molecularly_interacts_with DrugCentral:2503 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadoxine targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c09d8ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:2504 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaethidole targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c09db736-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c09deefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c09deefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c09deefe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c09e3968-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2510 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamerazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09e6140-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfameter is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09e8990-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethizole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09eb15e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08192 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Bifunctional protein FolC) DrugCentral uuid:c09ed94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c09f05be-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c09f330e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c09f5f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c09f8c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfalene is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c09fb5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c09fe5c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c0a01364-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c0a03ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c0a06d14-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c0a099a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c0a0c19c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c0a0eeb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c0a11b38-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c0a147b6-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c0a1743e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0a1a6c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c0a1d38e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c0a20016-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c0a22d02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c0a2598a-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c0a2861c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c0a2b2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c0a2e012-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c0a30c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:c0a3392c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c0a36744-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c0a393ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c0a3c07c-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c0a3ed54-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c0a41a04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c0a446aa-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c0a47346-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c0a4a1ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c0a4ce54-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c0a4fadc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c0a52872-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0a55536-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c0a581a0-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0a5ae3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaphenazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c0a5db32-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaphenazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c0a60332-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfapyridine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c0a62b14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q49184 biolink:molecularly_interacts_with DrugCentral:2524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfapyridine targets Enzyme (Dihydropteroate synthase type-1) DrugCentral uuid:c0a65314-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c0a6803c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c0a6acc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P24752 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Acetyl-CoA acetyltransferase, mitochondrial) DrugCentral uuid:c0a6d4a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:c0a6fd82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c0a729e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c0a756ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.707']} DrugCentral uuid:c0a78338-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.628']} DrugCentral uuid:c0a7b060-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:c0a7dce8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c0a80a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.768']} DrugCentral uuid:c0a837ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.198']} DrugCentral uuid:c0a8688e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:c0a8688e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:c0a89b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c0a8c810-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c0a8f7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c0a92530-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.161']} DrugCentral uuid:c0a951ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:c0a97ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25084 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets Unclassified (Transcriptional activator protein LasR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c0a9ab22-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:c0a9d2fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c0a9ff8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c0aa2ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c0aa596e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c0aa85ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:c0aaaf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c0aad9a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c0ab063e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c0ab3316-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c0ab6016-94cc-11ec-8aec-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfobromophthalein targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c0ab8c80-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulforidazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:c0abb944-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulforidazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c0abe69e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:2533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesulfone is inhibitor of Enzyme (Dihydropteroate synthase 1) DrugCentral uuid:c0ac0e6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesulfone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:c0ac3658-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c0ac62e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0ac909e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c0acbcf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c0ace972-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:c0ad1622-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (72 kDa type IV collagenase) DrugCentral uuid:c0ad3dfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c0ad6a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.362']} DrugCentral uuid:c0ad96d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c0adc5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c0adf308-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c0ae1f72-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:c0ae4dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c0ae7dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c0aeac94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.307']} DrugCentral uuid:c0aed93a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:c0af063a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.857']} DrugCentral uuid:c0af32cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.508']} DrugCentral uuid:c0af5f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:c0af8cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.146']} DrugCentral uuid:c0afb9a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:c0afe636-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.053']} DrugCentral uuid:c0b012be-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:c0b0414e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:c0b06dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.196']} DrugCentral uuid:c0b09a86-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:c0b0c7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.426']} DrugCentral uuid:c0b0f436-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c0b120fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c0b14d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:c0b17afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c0b1a782-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.141']} DrugCentral uuid:c0b1d400-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.645']} DrugCentral uuid:c0b20204-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c0b22fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c0b25c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:c0b288fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c0b2b5b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0b2e23c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:c0b30e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0b33bc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c0b36842-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c0b394e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:c0b3c170-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c0b3f136-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c0b41db4-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c0b44a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c0b477b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c0b4a446-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c0b4d22c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GJU1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0b4fea0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c0b52c04-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:c0b558a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0b58546-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:c0b5b3f4-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c0b5e414-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c0b61100-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c0b63e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c0b66ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c0b69742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c0b6c4ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c0b702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0b702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0b702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0b702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0b702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c0b7608c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c0b78df0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0b7ba78-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c0b7e6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c0b813ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:c0b84024-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:c0b86ca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0b8992a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c0b8c63e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c0b8f2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.38']} DrugCentral uuid:c0b91f08-94cc-11ec-8aec-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c0b94cbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c0b97cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c0b9abd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:c0b9d83a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c0ba0530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c0ba31a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c0ba5e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c0ba8b54-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c0bab7d2-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:c0bae5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c0bb13c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0bb413e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c0bb6dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c0bb9a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c0bbc76c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c0bbf3d6-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c0bc2036-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2541 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.571']} DrugCentral uuid:c0bc4cb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2541 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c0bc7a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c0bca6aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c0bcd350-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c0bd00a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c0bd2d28-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c0bd59c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:c0bd8688-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c0bdb388-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c0bde01a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c0be0c84-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c0be39b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c0be6634-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c0be92c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0bebf4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c0beef6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c0bf1c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c0bf498c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c0bf76a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c0bfa328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c0bfcf92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N2B7 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:c0bffc1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8MI13 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Unclassified (5-hydroxytryptamine 1D receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c0c02956-94cc-11ec-8aec-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c0c055d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0c08248-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c0c0aff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0c0dc84-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.12']} DrugCentral uuid:c0c10916-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c0c135bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:c0c1633e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c0c18fbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0c1bd7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c0c1eac0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c0c21748-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0c243f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c0c2709e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c0c29e5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0c2cb02-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c0c2f79e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c0c3249e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c0c35112-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c0c37d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c0c3abb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c0c3d858-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c0c404cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0c43154-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c0c45f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c0c48bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c0c4b840-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c0c4e554-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c0c511d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c0c53e32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c0c56aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c0c597d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c0c5c442-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c0c5f0c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c0c61e60-94cc-11ec-8aec-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c0c64e9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c0c67b30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c0c6a7d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c0c6d4c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c0c70140-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c0c72daa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0c75adc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c0c78764-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c0c7b3e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0c7e060-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c0c81166-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c0c83f56-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0c86c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:c0c89992-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c0c8c610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c0c8f298-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0c91f0c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c0c94c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0c97876-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c0c9a4fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c0c9d500-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c0ca019c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c0ca2e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c0ca5a98-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0ca8784-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0cab40c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c0cae094-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c0cb0d94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c0cb3a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c0cb66ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c0cb9322-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c0cbc23e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c0cbeebc-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c0cc1b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c0cc484e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0cc75bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:c0cca24e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c0cccecc-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0ccfbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c0cd2836-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c0cd54b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0cd8362-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c0cdaffe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c0cddc68-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c0ce08e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c0ce35d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c0ce6264-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c0ce8eec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c0cebc28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c0ceea04-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0cf1682-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c0cf43c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c0cf7366-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c0cf9fee-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0cfcc94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c0cff9f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c0d02662-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c0d052ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c0d08026-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c0d0aca4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c0d0d9fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c0d10672-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c0d13516-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c0d1619e-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0d18e08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c0d1bb12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0d1e790-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0d2142c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c0d240a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0d26ddc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c0d29a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c0d2c6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c0d2f46e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c0d320ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c0d34d6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c0d379fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0d3a706-94cc-11ec-8aec-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c0d3d37a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0d3ffda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c0d42d20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0d459b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c0d4864e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c0d4b2cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c0d4e026-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c0d50ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c0d53a44-94cc-11ec-8aec-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c0d5671c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c0d59502-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0d5c18a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c0d5ee1c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c0d61b62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c0d647f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c0d67486-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c0d6a2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0d6cf62-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c0d6fbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c0d72908-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c0d7561c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c0d782a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c0d7af36-94cc-11ec-8aec-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0d7dc4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c0d808d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0d8356e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c0d861f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c0d89248-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0d8bf34-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c0d8ebb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0d918b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c0d94530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c0d971ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c0d99f30-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c0d9cc8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c0d9f8fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0da2572-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c0da53e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c0da8058-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c0daaccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c0dad936-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c0db0654-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c0db32b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c0db5f1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c0db8c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c0dbb8ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0dbe542-94cc-11ec-8aec-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c0dc11de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c0dc40a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c0dc6d14-94cc-11ec-8aec-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c0dc9992-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c0dcc66a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c0dcf2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c0dd1f84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0dd4c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0dd792a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c0dda5b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0ddd230-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c0de00ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c0de2d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c0de59bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c0de8716-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c0deb3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c0dee03a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c0df0cae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c0df39f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c0df6672-94cc-11ec-8aec-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c0df92d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c0dfc054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c0dff074-94cc-11ec-8aec-0242ac110003 UniProtKB:P11799 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c0e01d06-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c0e04970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0e0763e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c0e0a2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c0e0cf26-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0e0fc62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCP0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c0e128c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c0e1552c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c0e1818c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c0e1b076-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c0e1dce0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c0e2094a-94cc-11ec-8aec-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c0e23640-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0e263c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c0e29054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c0e2bcdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c0e2eb44-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c0e317c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c0e3442c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c0e371c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c0e39e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0e3cad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c0e3f750-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c0e4246e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c0e450e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c0e47d74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c0e4aa9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c0e4d71a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c0e50398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c0e5302a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c0e56068-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0e5902e-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c0e5bc8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P80370 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Unclassified (Protein delta homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c0e5ea1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0e616ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c0e64348-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c0e66fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c0e69d0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c0e6ca5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c0e6f6d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c0e7256a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c0e751d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c0e77e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c0e7aa94-94cc-11ec-8aec-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c0e7d776-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c0e803ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0e83054-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c0e85d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c0e889e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c0e8b66e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c0e8e2ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0e9123a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c0e93eae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c0e96b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c0e99958-94cc-11ec-8aec-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c0e9c5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c0e9f268-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c0ea1fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c0ea4c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c0ea78be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c0eaa532-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c0ead30e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c0eb00a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c0eb2d36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c0eb5a22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c0eb86a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c0ebb30a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0ebdf92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c0ec0cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0ec3942-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c0ec65b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0ec931a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c0ecbf84-94cc-11ec-8aec-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c0ecebf8-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0ed1858-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c0ed453a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c0ed719a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c0ed9e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c0edcc08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c0edf890-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c0ee24f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c0ee5178-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c0ee7fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0eeac22-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c0eed8b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c0ef05b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H8M2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Unclassified (Bromodomain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c0ef323c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c0ef5faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.509']} DrugCentral uuid:c0ef8c46-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c0efb9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:c0efe61e-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.959']} DrugCentral uuid:c0f012a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c0f041ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c0f06e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:c0f09ac8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47872 biolink:molecularly_interacts_with DrugCentral:2548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secretin human is agonist of GPCR (Secretin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c0f0c750-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c0f0f43c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c0f120a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:c0f14cfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:c0f17a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c0f1a742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04844 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Acetylcholine receptor subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c0f1d3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c0f20034-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0f23004-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c0f26024-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c0f28c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c0f2b98e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c0f2e602-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c0f31280-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c0f33f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0f36c6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c0f3998a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c0f3c6f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c0f3f59c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c0f4222e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c0f44f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01984 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c0f47b84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c0f4a866-94cc-11ec-8aec-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c0f4d4e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.61']} DrugCentral uuid:c0f5059a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:c0f5059a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:c0f543a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c0f543a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c0f58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0f58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0f58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0f58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0f58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c0f5f00e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:c0f61c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:c0f64a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c0f6774a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c0f6a396-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c0f6d000-94cc-11ec-8aec-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c0f6fd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c0f72992-94cc-11ec-8aec-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interleukin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:c0f755f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:c0f7836a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:c0f7b2a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c0f7df22-94cc-11ec-8aec-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c0f80ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c0f838a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15393 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Nuclear other (Splicing factor 3B subunit 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c0f8651e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96AY3 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:c0f8917e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c0f8bdfc-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c0f8eb2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c0f91798-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c0f9440c-94cc-11ec-8aec-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c0f971a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c0f99e02-94cc-11ec-8aec-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0f9df48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0fa5ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c0facaa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fb371c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c0fc0be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c0fc386a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c0fc64fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c0fc8dce-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c0fcba56-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c0fce71a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c0fd14b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:c0fd4160-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.915']} DrugCentral uuid:c0fd6dca-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c0fd9a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c0fdc752-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:c0fdf4fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c0fe2170-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:c0fe4e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c0fe7b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c0fea7da-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c0fed480-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c0ff0de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c0ff0de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c0ff0de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c0ff53b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 taltirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c0ff80c4-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.807']} DrugCentral uuid:c0ffad60-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.001']} DrugCentral uuid:c0ffd9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c100067a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:c10033ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:c100605c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:c1008e38-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.335']} DrugCentral uuid:c100bc32-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c100e8f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.139']} DrugCentral uuid:c1011574-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c10141e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c1016ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c1019b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c101c80c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:c101f552-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:c10222e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:c1024f84-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:c1027c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:c102abdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.618']} DrugCentral uuid:c102d88c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c10305b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.794']} DrugCentral uuid:c10332b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:c1035f46-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:c1038bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:c103b87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.557']} DrugCentral uuid:c103e5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:c104126a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:c1043efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.731']} DrugCentral uuid:c1046d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:c1049cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.238']} DrugCentral uuid:c104c958-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.835']} DrugCentral uuid:c104f5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.858']} DrugCentral uuid:c10522cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:c1054f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:c1057be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:c105a922-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.611']} DrugCentral uuid:c105d5be-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.204']} DrugCentral uuid:c1060282-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c1062f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c1065caa-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.328']} DrugCentral uuid:c1068a36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:c106b6a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c106e364-94cc-11ec-8aec-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c107100a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:c1073dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:c1076b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.095']} DrugCentral uuid:c10797b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.923']} DrugCentral uuid:c107c43c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c107f0ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.038']} DrugCentral uuid:c1081fae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c1084c40-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.913']} DrugCentral uuid:c10878dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.821']} DrugCentral uuid:c108a5f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.919']} DrugCentral uuid:c108d296-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:c108ff3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.604']} DrugCentral uuid:c1092bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.761']} DrugCentral uuid:c1095914-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.419']} DrugCentral uuid:c1098646-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.515']} DrugCentral uuid:c109b2ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.587']} DrugCentral uuid:c109e096-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c10a0d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c10a3a00-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c10a669c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:c10a939c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c10ac47a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c10ac47a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c10afed6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c10b2c26-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c10b58d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:c10b859a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c10bb38a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c10be058-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:c10c0cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c10c399a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c10c66b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:c10c935e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:c10cbffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:c10ced54-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c10d19fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c10d4682-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c10d731e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c10db018-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c10db018-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c10db018-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c10db018-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c10e03b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c10e30c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c10e5d74-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c10e8a42-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c10eb6f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c10ee56e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c10f11ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c10f3e56-94cc-11ec-8aec-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:c10f6cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:c10f996e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c10fc5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c10ff256-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c1101f56-94cc-11ec-8aec-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:c1104bc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q46991 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (IMI-1; IMI-1 carbapenemase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c1107852-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c110a584-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6W9J1 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c110d220-94cc-11ec-8aec-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c110fe80-94cc-11ec-8aec-0242ac110003 UniProtKB:P94958 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c1112aea-94cc-11ec-8aec-0242ac110003 UniProtKB:P05193 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c11159ac-94cc-11ec-8aec-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c111860c-94cc-11ec-8aec-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c111b294-94cc-11ec-8aec-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c111df9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c1120c08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c11238a4-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c11264fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c112920e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c112be8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c112eaec-94cc-11ec-8aec-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c11319ae-94cc-11ec-8aec-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c113499c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c1137764-94cc-11ec-8aec-0242ac110003 UniProtKB:B8R6A5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c113a450-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c113d0d8-94cc-11ec-8aec-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c113fd4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1142b14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c114586e-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c11484d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1A) DrugCentral uuid:c114acc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c114da50-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:c115026e-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c1152f1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod is partial agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c1155bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:2580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teicoplanin aglycone is inhibitor of Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:c11588f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c115b592-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c115e21a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c1160fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.31']} DrugCentral uuid:c1163c42-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c11668ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:c1169534-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c116c266-94cc-11ec-8aec-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c116eeee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c1171b58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:c1174c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c1174c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c1174c36-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c11789f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.444']} DrugCentral uuid:c117b770-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:c117df2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c11807e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:c1182fc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:c1185798-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:c1187f66-94cc-11ec-8aec-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:c118a860-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c118d4e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:2592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c1190120-94cc-11ec-8aec-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir disoproxil targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:c119298e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir disoproxil is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:c1195148-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:c1197916-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.943']} DrugCentral uuid:c119a59e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:c119d2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.628']} DrugCentral uuid:c119ff44-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.388']} DrugCentral uuid:c11a2cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c11a5ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c11a89a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:c11ab18c-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.662']} DrugCentral uuid:c11ade3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P52020 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:c11b0b46-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2598 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbutaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c11b37e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2598 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbutaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c11b647e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.373']} DrugCentral uuid:c11b91d8-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:c11bbe60-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.895']} DrugCentral uuid:c11beaf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.433']} DrugCentral uuid:c11c178e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:c11c4754-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.216']} DrugCentral uuid:c11c73dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.599']} DrugCentral uuid:c11ca064-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.632']} DrugCentral uuid:c11ccd96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.438']} DrugCentral uuid:c11cfa5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:c11d2700-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:c11d5392-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.862']} DrugCentral uuid:c11d80ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:c11dad56-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:c11dd9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:c11e07ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:c11e3780-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:c11e63f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:c11e9072-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c11ebd72-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c11ee568-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.666']} DrugCentral uuid:c11f11e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.963']} DrugCentral uuid:c11f3f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c11f6bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c11f983c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.612']} DrugCentral uuid:c11fc4c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.102']} DrugCentral uuid:c11ff372-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.389']} DrugCentral uuid:c1201ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c1204c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:c120798c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c120a736-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.874']} DrugCentral uuid:c120d508-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.687']} DrugCentral uuid:c12101ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:c1212ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:c1215b86-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:c1218822-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:c121b5fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:c121e29a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c1220f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:c1223bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:c122690e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c1229654-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c122c2d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:c122f00e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:c1231caa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.448']} DrugCentral uuid:c1234932-94cc-11ec-8aec-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c12375d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:c123a652-94cc-11ec-8aec-0242ac110003 UniProtKB:P51589 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Enzyme (Cytochrome P450 2J2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c123d2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c123ff80-94cc-11ec-8aec-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c1242c76-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.734']} DrugCentral uuid:c1245944-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:c12485cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c124bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c124bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c124bd58-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c1250452-94cc-11ec-8aec-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c12530d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c1255ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c1258b7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c125b816-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c125e494-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:c1261324-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c1263fb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c1266c34-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c1269948-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c126c5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c126f258-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:c127202a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c1274dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c1277a7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c127a720-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c127d466-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c12800f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c1282d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c1285a30-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c1288758-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c128b408-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c128e09a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c1290eb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terodiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1293c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.087']} DrugCentral uuid:c12968d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c129958a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c129c2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c129ef62-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c12a1c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testolactone is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c12a4994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c12a763a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:c12aa2e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c12acf68-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c12b001e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c12b2cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c12b597e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c12b867e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c12bb310-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.599']} DrugCentral uuid:c12bdfac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c12c117a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c12c117a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c12c4a8c-94cc-11ec-8aec-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c12c7700-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone undecanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c12c9ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:c12ccc1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:c12cf8b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:c12d2560-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c12d5256-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c12d7fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c12dadaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c12de3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c12de3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c12de3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c12e2988-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c12e561a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:c12e83ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:c12eb06a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:c12edd2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c12f09de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel protein type 8 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c12f36f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c12f638e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.499']} DrugCentral uuid:c12f8fee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00194 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c12fc5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c12fc5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c12fc5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c1301428-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c1301428-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c1301428-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c1305b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:c1308340-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:c130ab0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:2612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sapropterin targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c130d7a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00439 biolink:molecularly_interacts_with DrugCentral:2612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sapropterin is activator of Enzyme (Phenylalanine-4-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c1310590-94cc-11ec-8aec-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c1313218-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c1315ea0-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c1318bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c131b85a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:c131e4ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.432']} DrugCentral uuid:c1321138-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c132402c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c1326cb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1329932-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c132c68c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.393']} DrugCentral uuid:c132f328-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c1331fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:c1334c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c1337b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c133a804-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c133d4c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c13402ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c1342f54-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c1345bdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c1348896-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c134b5a0-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c134e23c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c1350ece-94cc-11ec-8aec-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c1353c3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c1356e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c1356e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c135a758-94cc-11ec-8aec-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c135e330-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c135e330-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c135e330-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c135e330-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1363fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c1363fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c1363fba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c1368592-94cc-11ec-8aec-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c136b22e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c136ded4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS9 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Unclassified (Transmembrane domain-containing protein TMIGD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:c1370cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c1373942-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:c13765c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09508 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) DrugCentral uuid:c1378d98-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c137bcdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c137eca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AE18 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c1381952-94cc-11ec-8aec-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c1384ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c1384ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c1384ed6-94cc-11ec-8aec-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c138a606-94cc-11ec-8aec-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:c1391208-94cc-11ec-8aec-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:c13939d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c139664a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c139d508-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c13a9ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:c13acd0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c13af9ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c13b262e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:c13b5432-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c13b80d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c13bad60-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c13bd9fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c13c0864-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c13c3500-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:c13c6188-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:c13c89e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:c13cb1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:c13cd974-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:c13d02dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:c13d2c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c13d5b10-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c13d877a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.221']} DrugCentral uuid:c13db3f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.912']} DrugCentral uuid:c13de15c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:c13e0934-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:c13e312a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) DrugCentral uuid:c13e5970-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:c13e860c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) DrugCentral uuid:c13eade4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:c13ed652-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:c13f03b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.792']} DrugCentral uuid:c13f3066-94cc-11ec-8aec-0242ac110003 UniProtKB:P26281 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c13f659a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c13f659a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c13f659a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c13fe31c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c140cce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63734 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is gating inhibitor of Ion channel (Potassium voltage-gated channel subfamily C member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c140fca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioproperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:c1412a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioproperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:c1415670-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:c1417e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c141ac60-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c141d910-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.872']} DrugCentral uuid:c1420674-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:c14232f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c1425f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c1428bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.813']} DrugCentral uuid:c142b920-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c142e59e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c1431212-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:c143402a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c1436cb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c143993a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c143c5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c143f2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.466']} DrugCentral uuid:c1441f90-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c1444c04-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c14479cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c144a8fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.866']} DrugCentral uuid:c144d598-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c1450220-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:c1452f0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:c1455b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.595']} DrugCentral uuid:c14587fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:c145b508-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c145e17c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:c1460dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:c1463a46-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:c146693a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.126']} DrugCentral uuid:c14695b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.774']} DrugCentral uuid:c146c222-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.751']} DrugCentral uuid:c146ef0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:c1471ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:c147481e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c14774b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:c147a390-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:c147d022-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c147fc96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:c1482c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:c14858d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.195']} DrugCentral uuid:c1488562-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.297']} DrugCentral uuid:c148b1e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c148deb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:c1490b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:c14937fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:c149652c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c14991a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c149be3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:c149eac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c14a1b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c14a47da-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c14a8542-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c14a8542-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c14a8542-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c14a8542-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c14a8542-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c14af04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c14af04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c14af04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c14af04a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c14b4c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c14b4c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c14b4c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c14ba224-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c14ba224-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c14ba224-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c14ba224-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c14ba224-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c14c0e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c14c0e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c14c0e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c14c5c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c14c5c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c14c5c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c14ca23c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c14cd004-94cc-11ec-8aec-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiotepa is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c14cfca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:c14d29fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:c14d5696-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:c14d8328-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:c14db1d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:c14dde86-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c14e0b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:c14e3804-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.681']} DrugCentral uuid:c14e648c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.817']} DrugCentral uuid:c14e9218-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:c14ebeaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c14eebe6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:c14f1878-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:c14f44f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c14f7296-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:c14f9f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:c14fcc00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:c14ff87e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:c1502600-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:c150526a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:c1507ede-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:c150ac24-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.181']} DrugCentral uuid:c150d8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:c151052a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:c15131b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c1516114-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:c1518dba-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:c151ba60-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) DrugCentral uuid:c151e2e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c1520f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c1523bca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c1526834-94cc-11ec-8aec-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c152955c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Unclassified (THAP domain-containing protein 1) DrugCentral uuid:c152bd3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c152eab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P40926 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:c153175c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine is inhibitor of Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c1534646-94cc-11ec-8aec-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c15372ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c1539f88-94cc-11ec-8aec-0242ac110003 UniProtKB:P31651 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c153d4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c153d4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c153d4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c1542296-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c1542296-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c1542296-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c15468d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tianeptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:c1549546-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.077']} DrugCentral uuid:c154c1c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.108']} DrugCentral uuid:c154ef28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.756']} DrugCentral uuid:c1551c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:c15548b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c1557524-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c155a21a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.317']} DrugCentral uuid:c155ceb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:c155fb34-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c1562302-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:c1564b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c15677d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Enzyme (Steryl-sulfatase) DrugCentral uuid:c1569f94-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.123']} DrugCentral uuid:c156cd70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.542']} DrugCentral uuid:c156fcfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c1573e72-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c157a7c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:c157d422-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c1580168-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:c1582e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.747']} DrugCentral uuid:c1585aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:c158873c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.767']} DrugCentral uuid:c158b84c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:c158e560-94cc-11ec-8aec-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c1591210-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c1593f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:c1596710-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.175']} DrugCentral uuid:c159938e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c159c034-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:c159ed8e-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:c15a1a16-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tienilic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.494']} DrugCentral uuid:c15a468a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tilidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c15a747a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiliquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c15aa13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:c15ac920-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13488 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (V-type proton ATPase 116 kDa subunit a isoform 3) DrugCentral uuid:c15af12a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c15b1f38-94cc-11ec-8aec-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c15b4bf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c15b7884-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tinoridine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.987']} DrugCentral uuid:c15ba5ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O69638 biolink:molecularly_interacts_with DrugCentral:2673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiocarlide targets Enzyme (Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c15bd284-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2675 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c15bfa70-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:2675 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c15c272a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiopronin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c15c5506-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:c15c81ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:c15cae52-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11.1']} DrugCentral uuid:c15cdad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:c15d07c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:c15d344e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c15d60d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c15d8e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c15dbad6-94cc-11ec-8aec-0242ac110003 UniProtKB:F1PT23 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c15de7f4-94cc-11ec-8aec-0242ac110003 UniProtKB:F1PWR7 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.94']} DrugCentral uuid:c15e1530-94cc-11ec-8aec-0242ac110003 UniProtKB:F1PGZ2 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:c15e444c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiracizine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c15e7598-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:c15e7598-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:c15eaebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c15edbb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:c15f0530-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:c15f31b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c15f602a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c15f8cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c15fb94e-94cc-11ec-8aec-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:2684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tobramycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.824']} DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c1600eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c160992c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c160c5be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c160f23c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.292']} DrugCentral uuid:c161239c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:c161239c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:c16156aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c1618350-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c161aff6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c161df08-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c1620bae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c162409c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c162409c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c162409c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c1628f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c1628f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c1628f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c162d5ac-94cc-11ec-8aec-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c16302de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c16333bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:c16333bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:c1636cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:c1639a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c163c7dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c163f43c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1642132-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:c1644e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.569']} DrugCentral uuid:c1647ace-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c164a738-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c164d474-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c16500e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:c1652d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c16559f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:c1658770-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c165b3ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c165e04e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:c1660d58-94cc-11ec-8aec-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c16639a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.667']} DrugCentral uuid:c1666604-94cc-11ec-8aec-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:2701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolonium targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c1669278-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:2701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolonium targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:c166bfaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c166ed36-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c16719d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c16747e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c167749a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c167a122-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:c167cda0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:c167faaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P70634 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Unclassified (SMR1-alpha3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:c1682728-94cc-11ec-8aec-0242ac110003 UniProtKB:P70635 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Unclassified (BetaB2-crystallin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.474']} DrugCentral uuid:c1685392-94cc-11ec-8aec-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c16880b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c168ad2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c168d98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c169060c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c16934b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c169611a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c1698d8e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c169ba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.509']} DrugCentral uuid:c169e6f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c16a138a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c16a403a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c16a6ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:c16a9b7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:c16ac8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c16af6c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c16b237e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c16b510a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c16b7db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c16baaa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:c16bd756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:c16bff38-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:c16c27c4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:c16c4fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c16c7c56-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c16ca906-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c16cd66a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c16d02de-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c16d2f70-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c16d5c84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c16d890c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c16db58a-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:c16de1fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c16e0f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:c16e3bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c16e6854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:c16e9608-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:c16ec254-94cc-11ec-8aec-0242ac110003 UniProtKB:P27139 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c16eeec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c16f1b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.63']} DrugCentral uuid:c16f4814-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c16f7488-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c16fa106-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c16fcf50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c16ffbe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c1702892-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c17054f2-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c1708418-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c170b08c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c170de54-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c1710b68-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c171382c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c17164d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c17199e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c17199e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c17199e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:c171dc96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c171dc96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c172269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:c172269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:c172269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:c172269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:c172269c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:c1728d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:c1728d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:c1728d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:c1728d08-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:c172d5ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c173026a-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:c1732efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.818']} DrugCentral uuid:c1735b52-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c17384c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:c173ac92-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:c173d438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:c173fbf2-94cc-11ec-8aec-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:c1742622-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan is inhibitor of Enzyme (DNA topoisomerase I, mitochondrial) DrugCentral uuid:c1744fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.58']} DrugCentral uuid:c1747c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c174a8b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c174d57c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c17501e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1752e28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04750 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (DNA topoisomerase I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1755b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:c175879c-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c175b410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 torsemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c175e084-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c176113a-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene is modulator of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c1763bec-94cc-11ec-8aec-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets Nuclear hormone receptor (Estrogen-related receptor gamma) DrugCentral uuid:c17663ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05320 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets Unclassified (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c17690e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c176be28-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c176eab0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c177174c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c17744ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c177712e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c1779da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c177cb60-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trandolapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c177f7e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranexamic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c1782588-94cc-11ec-8aec-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranilast targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:c17851f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:c1787ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:c178ab5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:c178d7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:c1790552-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c17931da-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c1795eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c1798c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c179bc72-94cc-11ec-8aec-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:c179ebfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:c17a188e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c17a4566-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c17a71a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c17a9e44-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c17acb76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NB78 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c17af7ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c17b2472-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 travoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:c17b510e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 travoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:c17b800c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:c17bad16-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:c17bd980-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c17c0680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.033']} DrugCentral uuid:c17c32d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c17c5f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c17c8cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c17cbada-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:c17ce7c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c17d143a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c17d4234-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c17d6ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:c17d9b30-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.551']} DrugCentral uuid:c17dc79a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c17df4cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:c17e2140-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c17e4dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.483']} DrugCentral uuid:c17e7a8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:c17ea714-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c17ed388-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c17effde-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:c17f2ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:c17f5b50-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:c17f87ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.081']} DrugCentral uuid:c17fb4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.083']} DrugCentral uuid:c17fe174-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:c1800dd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c1803a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c1806748-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c18093c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c180c03a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c180ef9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c1811f62-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c1814bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c181784a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c181a536-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c181d1be-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.642']} DrugCentral uuid:c181fe46-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:c1822b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c18257ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c182846a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c182b0de-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c182e05e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c1830cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c1833ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c183684e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c18394e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c183c186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92753 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is antagonist of Nuclear hormone receptor (Nuclear receptor ROR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c183eeb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c1841b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c18447e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c184746e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c184a3a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c184d3be-94cc-11ec-8aec-0242ac110003 UniProtKB:P62965 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c1850352-94cc-11ec-8aec-0242ac110003 UniProtKB:P22935 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c185311a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c1855da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c1858a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c185b6a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c185e40c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c1861080-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c1863ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c1866abc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13526 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Unclassified (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c186974e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c186c37c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:c186effa-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:c1871cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c1874950-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:c187759c-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.76']} DrugCentral uuid:c187ab34-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c187ab34-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c187ab34-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c188014c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c188014c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c188014c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c188014c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c188014c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c1887a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c188f066-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c188f066-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c188f066-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c18935da-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:c1896258-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone targets Cytosolic other (Annexin A1) DrugCentral uuid:c1898ada-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:c189b2da-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c189df3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide targets Cytosolic other (Annexin A1) DrugCentral uuid:c18a07bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:c18a3494-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c18a5c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Transporter (Solute carrier family 12 member 1) DrugCentral uuid:c18a84b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c18ab1a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:c18addf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c18b0a40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c18b3fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c18b3fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c18b3fa6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c18b851a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c18bb17a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.879']} DrugCentral uuid:c18bdede-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c18c13d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c18c13d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c18c13d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c18c6336-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:c18c6336-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:c18c6336-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:c18cb192-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:c18cb192-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:c18cb192-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:c18cff76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:c18cff76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:c18cff76-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:c18d4e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:c18d4e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:c18d4e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:c18d9d96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:c18d9d96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:c18d9d96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18e22d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c18f3dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c1901418-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:c1901418-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:c1901418-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:c19063c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:c19063c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:c19063c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:c190b36e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c190b36e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c190b36e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c1910206-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:c1910206-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:c1910206-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:c191503a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c191503a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c191503a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c191963a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c191c2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7']} DrugCentral uuid:c191ef5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c1921c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c192494a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c19275f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c192a3ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c192d04a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c192fcfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c19329a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:c1935966-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c19386f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c193b3b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclabendazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c1941f72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:c194ed76-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:c1951666-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:c1953e48-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:c1956abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:c1959730-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c195c3fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c195f072-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1961cfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c1964a04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.31']} DrugCentral uuid:c1967696-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c196a300-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c196d078-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:c196ffda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c1972c4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c19758cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:c19785cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.841']} DrugCentral uuid:c197b272-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:c197df0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c1980b8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:c19838e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c1986596-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c19891f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:c198bf5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c198ebce-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c199182e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:c19944b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:c19971c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c1999e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.786']} DrugCentral uuid:c199cb5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.251']} DrugCentral uuid:c199f8c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c19a253e-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c19a51bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:c19a7e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:c19ab40e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c19ab40e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c19ab40e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c19afbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c19b28bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.27']} DrugCentral uuid:c19b5562-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c19b81ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c19bae54-94cc-11ec-8aec-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c19bdb7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06760 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Beta-glucuronidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c19c0804-94cc-11ec-8aec-0242ac110003 UniProtKB:P00697 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Lysozyme C-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c19c3478-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c19c622c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c19c8eb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c19cc3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c19cc3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c19cc3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c19d123a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c19d123a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c19d123a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c19d6014-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:c19d6014-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:c19d6014-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:c19da63c-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c19dd2b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:c19dff2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c19e2c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c19e5938-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:c19e85a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:c19eb324-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c19edff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c19f0c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:c19f393e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c19f667a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:c19f9302-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c19fbf94-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c19fec1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c1a01b56-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2743 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1a04810-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2743 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.01']} DrugCentral uuid:c1a0752e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:c1a0a38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c1a0d01e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.73']} DrugCentral uuid:c1a0fcb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:c1a1294c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c1a15688-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:c1a182fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.611']} DrugCentral uuid:c1a1af8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P26439 biolink:molecularly_interacts_with DrugCentral:2746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilostane is inhibitor of Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2) DrugCentral uuid:c1a1d8ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alimemazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:c1a203ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alimemazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c1a2329c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2750 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetazidine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c1a25f10-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethadione is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:c1a28742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:c1a2af06-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) DrugCentral uuid:c1a2d6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c1a3035c-94cc-11ec-8aec-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c1a335e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:c1a335e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:c1a368a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c1a3954c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c1a3c364-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c1a3eff6-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c1a41c92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27713 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c1a4497e-94cc-11ec-8aec-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:c1a475fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1a4a266-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c1a4cef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c1a4fc20-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:c1a528bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c1a55530-94cc-11ec-8aec-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:c1a582a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c1a5af12-94cc-11ec-8aec-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c1a5db7c-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c1a6087c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c1a63572-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c1a661fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c1a68e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04174 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c1a6bbc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59487 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c1a6e97c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c1a71640-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27552 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c1a74296-94cc-11ec-8aec-0242ac110003 UniProtKB:P00382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1a770cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:c1a79d54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q54801 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c1a7c9e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UUP5 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c1a7f6e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c1a82378-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:c1a84b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:c1a877d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c1a8a528-94cc-11ec-8aec-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c1a8d1c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c1a8fe42-94cc-11ec-8aec-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c1a92bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c1a95860-94cc-11ec-8aec-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c1a984fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c1a9b18e-94cc-11ec-8aec-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c1a9de5c-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c1aa0ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:c1aa3762-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:c1aa649e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:c1aa9130-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:c1aabdb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.423']} DrugCentral uuid:c1aaea2c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:c1ab1948-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:c1ab45e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:c1ab7294-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c1ab9f8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c1abcd34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c1abf9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c1ac270c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tripelennamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c1ac5452-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triprolidine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c1ac80bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triprolidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c1acad26-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.208']} DrugCentral uuid:c1acdb16-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.078']} DrugCentral uuid:c1ad0afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:c1ad3796-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:c1ad654a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c1ad925e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:c1adbedc-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c1adeb5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c1ae188c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Aldose reductase) DrugCentral uuid:c1ae406e-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c1ae6ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c1ae994c-94cc-11ec-8aec-0242ac110003 UniProtKB:P54840 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Glycogen [starch] synthase, liver) DrugCentral uuid:c1aec408-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:c1aef2de-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:c1af1f52-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.907']} DrugCentral uuid:c1af4c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c1af789e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c1afa526-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c1afd190-94cc-11ec-8aec-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1affeea-94cc-11ec-8aec-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c1b02b4a-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c1b058e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1b086c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2769 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troleandomycin is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c1b0b5ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:c1b0e24c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:c1b10efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:c1b13bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:c1b16870-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:c1b194f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c1b1c220-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c1b1ee9e-94cc-11ec-8aec-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c1b21b26-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:c1b247a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c1b2751c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:c1b2a226-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c1b2ce90-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c1b2fb86-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c1b327fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c1b35478-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c1b380e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c1b3ae3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c1b3dbbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c1b4085a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c1b4365e-94cc-11ec-8aec-0242ac110003 UniProtKB:O70212 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c1b46714-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c1b46714-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c1b4a562-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c1b4a562-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c1b4eb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c1b4eb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c1b4eb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c1b4eb94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c1b54198-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c1b54198-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c1b57b68-94cc-11ec-8aec-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c1b5a7be-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c1b5d450-94cc-11ec-8aec-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c1b60236-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:c1b62c16-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:c1b6540c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:c1b67bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:c1b6a47a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.306']} DrugCentral uuid:c1b6d0ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.395']} DrugCentral uuid:c1b701e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c1b701e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c1b739da-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c1b739da-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c1b76ca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan is allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c1b79916-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:c1b7c594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:c1b7f2da-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:c1b81f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:c1b84bb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c1b879b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c1b8a61c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c1b8d29a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2S1 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1b8ff2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c1b92c90-94cc-11ec-8aec-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c1b959ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q401N2 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Zinc-activated ligand-gated ion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c1b9874e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c1b9b4d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c1b9e13a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c1ba0dc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c1ba3a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c1ba6754-94cc-11ec-8aec-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c1ba9846-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c1ba9846-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c1bad9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c1bad9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c1bad9d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c1bb2446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c1bb2446-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c1bb615e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:c1bb615e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:c1bba27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1bba27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1bbdf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:c1bbdf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:c1bc2710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1bc2710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1bc2710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1bc2710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1bc7cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c1bc7cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c1bcb676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1bd21e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1be1778-94cc-11ec-8aec-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c1be4400-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tulobuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c1be70a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tulobuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:c1be9932-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:c1bec5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.7']} DrugCentral uuid:c1bef224-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c1bf1e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c1bf4bde-94cc-11ec-8aec-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1bfaeb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c1c07da6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c1c0aa42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyrosine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c1c0d6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c1c10442-94cc-11ec-8aec-0242ac110003 UniProtKB:P15144 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c1c131e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28838 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c1c15f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1c18b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P15145 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c1c1b8b0-94cc-11ec-8aec-0242ac110003 UniProtKB:O96935 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (M1 family aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c1c1e538-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VCT3 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c1c211ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P97629 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Leucyl-cystinyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c1c24028-94cc-11ec-8aec-0242ac110003 UniProtKB:O09175 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c1c26cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P00727 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c1c2996a-94cc-11ec-8aec-0242ac110003 UniProtKB:P97449 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c1c2c5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c1c2f4dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c1c3216e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15684 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c1c34e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P55786 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Puromycin-sensitive aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c1c37b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c1c3a7ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ08 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Endoplasmic reticulum aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1c3d42e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:c1c400d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c1c42e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c1c45af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c1c4877a-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Enzyme (Aldo-keto reductase family 1 member C2) DrugCentral uuid:c1c4b164-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol is agonist of Nuclear hormone receptor (Bile acid receptor) DrugCentral uuid:c1c4db76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c1c507e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c1c53486-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c1c561ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valaciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:c1c589c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c1c5b762-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c1c5e4c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.537']} DrugCentral uuid:c1c6114e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:c1c63dea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:c1c66a90-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c1c698bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c1c6c558-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c1c6f1ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c1c71ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c1c74b86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c1c77822-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c1c7a554-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c1c7d2cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c1c7ff68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c1c82bf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c1c85a94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c1c887da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c1c8b4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c1c8e28e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c1c90f8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c1c93c48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c1c96952-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c1c9968e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:c1c9c348-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c1c9f020-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c1ca1e88-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c1ca4b74-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c1ca7810-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c1caa4ac-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c1cad1ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c1cafe52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c1cb2b02-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c1cb5852-94cc-11ec-8aec-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:c1cb84c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c1cbb162-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c1cbddfe-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c1cc0af4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c1cc3330-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:c1cc5b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c1cc83b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:c1ccac5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c1ccd48e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c1ccfcca-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c1cd24de-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:c1cd4a04-94cc-11ec-8aec-0242ac110003 UniProtKB:P51649 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid is inhibitor of Enzyme (Succinate-semialdehyde dehydrogenase, mitochondrial) DrugCentral uuid:c1cd6dea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c1cd95f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c1cdbdfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1cde892-94cc-11ec-8aec-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c1ce109c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c1ce3888-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c1ce616e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1ce89d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35504 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (UDP-glucuronosyltransferase 1-5) DrugCentral uuid:c1cead9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5RJP0 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase-related protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c1ced5a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valrubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:c1cef9b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c1cf23d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c1cf4c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c1cf77fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c1cf77fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c1cfac2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c1cfd468-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06241 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets Enzyme (D-alanyl-D-alanine dipeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c1cffc90-94cc-11ec-8aec-0242ac110003 UniProtKB:P17443 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets Enzyme (UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c1d024ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c1d04d30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c1d07940-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c1d07940-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c1d0b036-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c1d0b036-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c1d0e7f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c1d0e7f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c1d11ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c1d11ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c1d15630-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c1d15630-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c1d1905a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c1d1905a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c1d1caac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:c1d1caac-94cc-11ec-8aec-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:c1d201a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c1d201a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c1d240d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c1d240d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c1d240d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c1d240d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c1d28dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c1d28dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c1d2cd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c1d2cd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c1d2cd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c1d2cd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c1d316a0-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c1d33ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.465']} DrugCentral uuid:c1d368c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c1d390da-94cc-11ec-8aec-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.041']} DrugCentral uuid:c1d3b970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c1d3e1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c1d40a2e-94cc-11ec-8aec-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c1d43634-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c1d43634-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c1d475f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c1d475f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c1d475f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c1d475f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c1d4c3b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c1d4c3b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c1d4f70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:c1d5204e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:c1d548a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c1d570da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:c1d59902-94cc-11ec-8aec-0242ac110003 UniProtKB:P32307 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c1d5c18e-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:c1d5e9a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:c1d611ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P48044 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c1d639de-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c1d662c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:c1d68eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c1d68eca-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c1d6c232-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c1d6ea32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c1d714e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c1d740a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:c1d740a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:c1d77600-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c1d77600-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c1d77600-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c1d7b98a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:c1d7b98a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:c1d7eb26-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:c1d7eb26-94cc-11ec-8aec-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:c1d8242e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1d8242e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1d8242e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1d8242e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c1d86f9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.051']} DrugCentral uuid:c1d897ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:c1d8bfec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.652']} DrugCentral uuid:c1d8e922-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:c1d91140-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.554']} DrugCentral uuid:c1d93986-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c1d96208-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c1d98a30-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c1d9b258-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c1d9daee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:c1da03c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c1da2bca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:c1da4fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:c1da77e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c1daa168-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c1dac9e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c1daf226-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:c1db1a58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.763']} DrugCentral uuid:c1db43ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:c1db6c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:c1db946a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c1dbbc92-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:c1dbe550-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.594']} DrugCentral uuid:c1dc0d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:c1dc356e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:c1dc5daa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c1dc887a-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:c1dcb098-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:c1dcd88e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:c1dcfc56-94cc-11ec-8aec-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (G protein-activated inward rectifier potassium channel 2) DrugCentral uuid:c1dd20be-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.485']} DrugCentral uuid:c1dd48fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) DrugCentral uuid:c1dd6cf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1dd9526-94cc-11ec-8aec-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c1ddbf1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96PR1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c1dde72e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c1de0f56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.348']} DrugCentral uuid:c1de3774-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c1de606e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:c1de88aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c1deb0dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c1ded90e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c1df01b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c1df2ada-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c1df5302-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c1df7bde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c1dfa410-94cc-11ec-8aec-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c1dfcc2e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.071']} DrugCentral uuid:c1dffc9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c1dffc9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c1dffc9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c1e0435c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:c1e0435c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:c1e0435c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:c1e081aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:c1e0a9c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c1e0d24a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c1e0fa5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULQ1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c1e12286-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NHX9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c1e14aae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c1e1738a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c1e19bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:c1e1c7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c1e1c7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c1e1fbca-94cc-11ec-8aec-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Transitional endoplasmic reticulum ATPase) DrugCentral uuid:c1e21fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:c1e2438c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:c1e26790-94cc-11ec-8aec-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:c1e28d42-94cc-11ec-8aec-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:c1e2b132-94cc-11ec-8aec-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:c1e2d518-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16854 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Deoxyguanosine kinase, mitochondrial) DrugCentral uuid:c1e2f908-94cc-11ec-8aec-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:c1e31e10-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c1e346ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04400 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Adenylate cyclase type V) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c1e36ee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P50247 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c1e39728-94cc-11ec-8aec-0242ac110003 UniProtKB:P80404 biolink:molecularly_interacts_with DrugCentral:2819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vigabatrin is inhibitor of Enzyme (4-aminobutyrate aminotransferase, mitochondrial) DrugCentral uuid:c1e3bb22-94cc-11ec-8aec-0242ac110003 UniProtKB:P50554 biolink:molecularly_interacts_with DrugCentral:2819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vigabatrin targets Enzyme (Gamma-amino-N-butyrate transaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c1e3e5fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.76']} DrugCentral uuid:c1e40e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c1e43642-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:c1e45f14-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c1e48746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c1e4af96-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine is antagonist of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c1e4d7c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c1e5005e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:c1e52444-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:c1e5482a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:c1e56c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.728']} DrugCentral uuid:c1e594ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.298']} DrugCentral uuid:c1e5bf9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e606de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c1e688e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c1e6b11a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c1e6d9e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c1e7020a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c1e72a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c1e74dfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:c1e7735c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:c1e79738-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:c1e7c2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c1e7c2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c1e7c2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e8219e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e89278-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vindesine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.607']} DrugCentral uuid:c1e8bb40-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c1e8e368-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e92a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c1e99d76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c1e9c58a-94cc-11ec-8aec-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c1e9ee02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine is inhibitor of Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c1ea19f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:c1ea19f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:c1ea4d2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (11-cis retinol dehydrogenase) DrugCentral uuid:c1ea7124-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NR8 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 12) DrugCentral uuid:c1ea95a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NBN7 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 13) DrugCentral uuid:c1eab990-94cc-11ec-8aec-0242ac110003 UniProtKB:P10745 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Surface antigen (Retinol-binding protein 3) DrugCentral uuid:c1eadd76-94cc-11ec-8aec-0242ac110003 UniProtKB:P82980 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 5) DrugCentral uuid:c1eb015c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96R05 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinoid-binding protein 7) DrugCentral uuid:c1eb261e-94cc-11ec-8aec-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c1eb4e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50120 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 2) DrugCentral uuid:c1eb7218-94cc-11ec-8aec-0242ac110003 UniProtKB:O94788 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 2) DrugCentral uuid:c1eb95e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00352 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 1) DrugCentral uuid:c1ebba20-94cc-11ec-8aec-0242ac110003 UniProtKB:P12271 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Transporter (Retinaldehyde-binding protein 1) DrugCentral uuid:c1ebdf28-94cc-11ec-8aec-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c1ec073c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09455 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 1) DrugCentral uuid:c1ec2b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c1ec5408-94cc-11ec-8aec-0242ac110003 UniProtKB:O60779 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Transporter (Thiamine transporter 1) DrugCentral uuid:c1ec788e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29401 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Transketolase) DrugCentral uuid:c1ec9c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3S4 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Kinase (Thiamin pyrophosphokinase 1) DrugCentral uuid:c1ecc050-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BU02 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Thiamine-triphosphatase) DrugCentral uuid:c1ece530-94cc-11ec-8aec-0242ac110003 UniProtKB:P51854 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Transketolase-like protein 1) DrugCentral uuid:c1ed0a56-94cc-11ec-8aec-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c1ed3292-94cc-11ec-8aec-0242ac110003 UniProtKB:A2RI47 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Transporter (Thiamine transporter ThiT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.91']} DrugCentral uuid:c1ed5a9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30043 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Enzyme (Flavin reductase (NADPH)) DrugCentral uuid:c1ed7eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969G6 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Kinase (Riboflavin kinase) DrugCentral uuid:c1eda308-94cc-11ec-8aec-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c1edcb44-94cc-11ec-8aec-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c1edf33a-94cc-11ec-8aec-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:c1ee1716-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:c1ee3bba-94cc-11ec-8aec-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinamide phosphoribosyltransferase) DrugCentral uuid:c1ee5fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80Z39 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c1ee87dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EP66 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c1eeaffa-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:c1eeda20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c1ef022a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:c1ef2606-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NVS9 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Pyridoxine-5'-phosphate oxidase) DrugCentral uuid:c1ef49ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD0 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Pyridoxal phosphate phosphatase) DrugCentral uuid:c1ef6e36-94cc-11ec-8aec-0242ac110003 UniProtKB:O00764 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Kinase (Pyridoxal kinase) DrugCentral uuid:c1ef9208-94cc-11ec-8aec-0242ac110003 UniProtKB:P35520 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Cystathionine beta-synthase) DrugCentral uuid:c1efb5da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y617 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Phosphoserine aminotransferase) DrugCentral uuid:c1efd9c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:c1effe5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:c1f0224a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:c1f04626-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c1f06e08-94cc-11ec-8aec-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:c1f0931a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:c1f0bb88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:c1f0df6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02318 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (Sterol 26-hydroxylase, mitochondrial) DrugCentral uuid:c1f1034a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydrotachysterol targets Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:c1f1274e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c1f151d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c1f17a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c1f1a250-94cc-11ec-8aec-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:c1f1cb5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c1f1f3a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c1f21be0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['8.73']} DrugCentral uuid:c1f24426-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c1f26da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c1f2962e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['5.844']} DrugCentral uuid:c1f2be74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c1f2e71e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c1f30faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c1f337d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c1f3600e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6A2 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cholesterol 24-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c1f3882c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.98']} DrugCentral uuid:c1f3b0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.867']} DrugCentral uuid:c1f3d93a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c1f401a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c1f429bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N0U8 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Vitamin K epoxide reductase complex subunit 1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.284']} DrugCentral uuid:c1f4536a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c1f47bb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c1f4a400-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1f4cc32-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c1f4f4b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c1f51cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c1f545cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c1f56dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08709 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor VII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c1f596f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c1f5bf16-94cc-11ec-8aec-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:c1f5e72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P03951 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor XI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c1f60fde-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c1f6387e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:c1f660b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.873']} DrugCentral uuid:c1f688ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.114']} DrugCentral uuid:c1f6b1b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:c1f6da04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:c1f70240-94cc-11ec-8aec-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytosolic phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c1f72a72-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c1f7548e-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:c1f77cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.419']} DrugCentral uuid:c1f7a4f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.359']} DrugCentral uuid:c1f7ccf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c1f7f60a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.452']} DrugCentral uuid:c1f81e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:c1f8465a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c1f86ee6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.269']} DrugCentral uuid:c1f8977c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c1f8bfa4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c1f8e7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c1f90fc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c1f9398e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c1f961ca-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c1f989f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c1f9b1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zalcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:c1f9d6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zalcitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c1fa06de-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:c1fa06de-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:c1fa06de-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:c1fa4cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c1fa4cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c1fa4cb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c1fa8bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c1fab3cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c1fadc12-94cc-11ec-8aec-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:c1fb04a8-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c1fb2cbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:c1fb54e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c1fb7d02-94cc-11ec-8aec-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c1fba6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c1fbcf0a-94cc-11ec-8aec-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c1fbf746-94cc-11ec-8aec-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c1fc1f64-94cc-11ec-8aec-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c1fc4840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c1fc704a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ49 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c1fc984a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c1fcc270-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c1fceb10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3S340 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c1fd13b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWR8 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c1fd3bd8-94cc-11ec-8aec-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c1fd64f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:c1fd8ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c1fdb70c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:c1fddf16-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c1fe07de-94cc-11ec-8aec-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c1fe2ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23919 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c1fe582e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c1fe806a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c1fea8d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c1fed0ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c1fef900-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c1ff2132-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c1ff4ab8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9PPP5 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c1ff72ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c1ff9b30-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c1ffc3b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c1ffec7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:c200148e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:c2003cac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c20064ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c2008d56-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c200b57e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c200de5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c2010682-94cc-11ec-8aec-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c20130da-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:c20158ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:c20180f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:c201a9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c201d1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c201fa2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:c202224c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2024b00-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c2027314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c2029b14-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c202c440-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:c202ee70-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c20316ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c2033ede-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.565']} DrugCentral uuid:c2036706-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c2038fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c203b800-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c203e028-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c2040850-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:c204315e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c2045986-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:c20481ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c204a9b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:c204d3f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c204fc38-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c205246a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c2054c88-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:c20575aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:c2059dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c205c5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c205ee72-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:c2061708-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:c2063af8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c206632a-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2068c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:c206b500-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:c206dd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c2070546-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c2072ddc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c2075604-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2077e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:c207a640-94cc-11ec-8aec-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c207ceb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c207fe88-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c207fe88-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c207fe88-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2083ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c20866ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c20890aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c208b9d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c208e1fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c2090aa8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c20932d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c2095b16-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c2098370-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c209ac06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c209d44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c209fd0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c20a253c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c20a4f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c20a7780-94cc-11ec-8aec-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c20a9f94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c20ac7bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c20af052-94cc-11ec-8aec-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c20b188e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00481 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Unclassified (Butyrophilin subfamily 3 member A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c20b408e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c20b68e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c20b919c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:c20bb9ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:c20be228-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c20c0b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c20c33c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c20c637e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c20c637e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c20c637e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c20ca334-94cc-11ec-8aec-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c20ccbca-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c20cf406-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c20d1c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.703']} DrugCentral uuid:c20d44ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c20d6d1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c20d9564-94cc-11ec-8aec-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c20dbdaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c20defbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:c20defbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:c20defbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:c20e3776-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:c20e3776-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:c20e3776-94cc-11ec-8aec-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:c20e7df8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:c20e7df8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:c20e7df8-94cc-11ec-8aec-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:c20ec40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:c20ec40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:c20ec40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c20f3ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c21017a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c21017a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c21017a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c2105de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c2105de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c2105de4-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c210a434-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c210a434-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c210a434-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c210ea48-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c210ea48-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c210ea48-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c21132aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:c21132aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:c21132aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:c2117102-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c2119b28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:c211c350-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:c211ef74-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c211ef74-94cc-11ec-8aec-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c2122322-94cc-11ec-8aec-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:c2124730-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:c2126f62-94cc-11ec-8aec-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:c2129352-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:c212bb98-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c212e442-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c2130c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c21334a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c2135de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c213883e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c213b070-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:c213d8a2-94cc-11ec-8aec-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c21401ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c21429f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c214521e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c2147a50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c214a2fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c214cc58-94cc-11ec-8aec-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c214f494-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c2151cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c2154624-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:c2156e42-94cc-11ec-8aec-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c215967e-94cc-11ec-8aec-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c215bea6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c215e78c-94cc-11ec-8aec-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c216100e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2163840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c21660a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c2168da4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:c2168da4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:c216c22e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c216ea56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6NSN2 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c21713d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c2173bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c217642c-94cc-11ec-8aec-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c217c854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c218a03a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:c218a03a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:c218a03a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:c218e838-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c218e838-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c218e838-94cc-11ec-8aec-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c2192e42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c2192e42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c2192e42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c219747e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:c219747e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:c219747e-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:c219bb00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:c219bb00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:c219bb00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:c21a02ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21a02ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21a02ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21a49b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c21a49b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c21a49b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:c21a8fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21a8fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21a8fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c21acfa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.394']} DrugCentral uuid:c21af7e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:c21b2026-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c21b483a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c21b70c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:c21b98ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:c21bc12a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c21be9c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c21c1210-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:c21c3a42-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c21c6288-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c21c8c68-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c21cb468-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:c21cdc72-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.273']} DrugCentral uuid:c21d0490-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:c21d2cd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.606']} DrugCentral uuid:c21d5602-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:c21d7e02-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:c21da620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.704']} DrugCentral uuid:c21dce98-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:c21df74c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:c21e1f74-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:c21e4792-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c21e708c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:c21e98b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c21ec0fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c21ee922-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:c21f11fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:c21f3a08-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c21f6352-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:c21f8b98-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c21fb438-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c21fdc7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c22004ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c2202d8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:c22058d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:c2207de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c220a618-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:c220cb0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:c220ef06-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:c221130a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) DrugCentral uuid:c22136f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c2216012-94cc-11ec-8aec-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c22188a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotarolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c221b0bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotarolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c221d8ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eledoisin is agonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c22201c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:2955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eledoisin targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c2222c18-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c2225440-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c2227c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P16235 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:c222acec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:c222acec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:c222acec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:c222e464-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifamurtide is activator of Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) DrugCentral uuid:c2230854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c223305e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['4']} DrugCentral uuid:c22359a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c22381da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c223a9da-94cc-11ec-8aec-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c223d1e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c223faca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c22422e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c2244af2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c2247374-94cc-11ec-8aec-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c2249bf6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c224c3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.749']} DrugCentral uuid:c224ec32-94cc-11ec-8aec-0242ac110003 UniProtKB:O15648 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (ATP-dependent 6-phosphofructokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2253c28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c225d930-94cc-11ec-8aec-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:c2260180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c22629bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80Z26 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Nucleoside triphosphate diphosphohydrolase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c2265234-94cc-11ec-8aec-0242ac110003 UniProtKB:O35795 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Ectonucleoside triphosphate diphosphohydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c2267a66-94cc-11ec-8aec-0242ac110003 UniProtKB:P49654 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c226a284-94cc-11ec-8aec-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c226caac-94cc-11ec-8aec-0242ac110003 UniProtKB:P47824 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c226f5ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c2271de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42224 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 1-alpha/beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c2274626-94cc-11ec-8aec-0242ac110003 UniProtKB:P42229 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c2276e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P51692 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c2279806-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.025']} DrugCentral uuid:c227bffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c227e806-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:c2280c00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:c22839fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:c22839fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:c22839fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:c2287154-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histrelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:c2289544-94cc-11ec-8aec-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c228be3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WLT4 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin is inhibitor of Enzyme (1,3-beta-glucan synthase catalytic subunit FksP) DrugCentral uuid:c228e242-94cc-11ec-8aec-0242ac110003 UniProtKB:O13383 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin targets Unclassified (1,3-beta-D-glucan synthase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:c2290e34-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:c2290e34-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:c229453e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:c229453e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:c2297e14-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:c2297e14-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:c229b2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.086']} DrugCentral uuid:c229dab2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['12.7']} DrugCentral uuid:c22a033e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c22a2b70-94cc-11ec-8aec-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c22a5384-94cc-11ec-8aec-0242ac110003 UniProtKB:P30082 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22a97a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c22b0d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:F8V479 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:c22b3740-94cc-11ec-8aec-0242ac110003 UniProtKB:O35659 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.36']} DrugCentral uuid:c22b5f86-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lepirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['13']} DrugCentral uuid:c22b87b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c22bafe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c22bd84e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c22c004e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c22c288a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c22c5fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c22c5fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c22c5fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c22c5fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c22c5fda-94cc-11ec-8aec-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c22cc3da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c22cc3da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c22cc3da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c22cc3da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c22cc3da-94cc-11ec-8aec-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c22d1952-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.46']} DrugCentral uuid:c22d41a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:c22d69f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c22d9238-94cc-11ec-8aec-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:c22dbaf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:c22de454-94cc-11ec-8aec-0242ac110003 UniProtKB:O96529 biolink:molecularly_interacts_with DrugCentral:2999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrantel targets Enzyme (Acetylcholinesterase) DrugCentral uuid:c22e083a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c22e3076-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c22e5a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c22e82b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c22eab14-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban is antagonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c22ed42c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:c22f01e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c22f01e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c22f01e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c22f402e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.934']} DrugCentral uuid:c22f687e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:c22f9132-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:c22fb946-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:c22fe16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:c23009be-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:c230327c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.532']} DrugCentral uuid:c2305b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.004']} DrugCentral uuid:c2308358-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c230acc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.092']} DrugCentral uuid:c230d538-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:c230fd6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:c2312574-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:c2314e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:c231761e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.649']} DrugCentral uuid:c2319e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.115']} DrugCentral uuid:c231c664-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.681']} DrugCentral uuid:c231ef18-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.192']} DrugCentral uuid:c2321830-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:c2324076-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969F8 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (KiSS-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c232686c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:c23292ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c232baf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c232e31e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c2330b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c23333c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c2335c18-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.299']} DrugCentral uuid:c2338558-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.651']} DrugCentral uuid:c233ad94-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:c233d670-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:c233fe8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:c23426c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.501']} DrugCentral uuid:c2344ede-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:c2347832-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:c234a064-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:c234c882-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.844']} DrugCentral uuid:c234f118-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:c2351954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.761']} DrugCentral uuid:c2354172-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c23569ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c23592ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c235bb02-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.212']} DrugCentral uuid:c235e316-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.647']} DrugCentral uuid:c2360c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:c23634f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.735']} DrugCentral uuid:c2365d1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.498']} DrugCentral uuid:c236853c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c236ad5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:c236d5fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.415']} DrugCentral uuid:c236fe04-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c2372622-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c2374e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c23776f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c2379f08-94cc-11ec-8aec-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c237c71c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:c237ef26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2381820-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c238402a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c2386866-94cc-11ec-8aec-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:3042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c238908e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:3042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxuridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c238b96a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c238e19c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.91']} DrugCentral uuid:c23909ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c23931c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c2396220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c2396220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c2396220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c239a97e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c239a97e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c239a97e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:c239eb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c23a140e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c23a3c40-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c23a6472-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c23a8d08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c23ab508-94cc-11ec-8aec-0242ac110003 UniProtKB:P54577 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Tyrosine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c23add44-94cc-11ec-8aec-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c23b056c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03887 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Unclassified (NADH-ubiquinone oxidoreductase chain 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c23b2eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c23b56ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q704Y3 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is activator of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c23b7eca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c23ba814-94cc-11ec-8aec-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c23bd38e-94cc-11ec-8aec-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c23bfbca-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c23c23e8-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c23c4c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c23c7456-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NJH6 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Unclassified (Ace-orthologous acetylcholinesterase; Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c23c9c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7YWJ9 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c23cc488-94cc-11ec-8aec-0242ac110003 UniProtKB:K4JQ36 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c23ced3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:3067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbon tetrachloride targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:c23d1578-94cc-11ec-8aec-0242ac110003 UniProtKB:P31327 biolink:molecularly_interacts_with DrugCentral:3068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carglumic acid is positive allosteric modulator of Enzyme (Carbamoyl-phosphate synthase [ammonia], mitochondrial) DrugCentral uuid:c23d412e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c23d412e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c23d412e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c23d81ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:3082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrimonium targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c23da9f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetylpyridinium targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c23dd238-94cc-11ec-8aec-0242ac110003 UniProtKB:P42575 biolink:molecularly_interacts_with DrugCentral:3083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetylpyridinium targets Enzyme (Caspase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c23dfa56-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxylenol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:c23e22d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxylenol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.738']} DrugCentral uuid:c23e4af6-94cc-11ec-8aec-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:3095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorquinaldol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c23e7314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c23e9b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:3096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c23ec3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c23eed30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c23f192c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c23f192c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c23f5176-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:c23f5176-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:c23f89c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c23f89c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c23fc0f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:c23fc0f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:c23ff86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c23ff86a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c2402b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c24053be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.9']} DrugCentral uuid:c2407ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:3102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinromide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c240a602-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c240ce2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c240f63e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:c2411e52-94cc-11ec-8aec-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c24151ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c24151ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c24151ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2418ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cynarine targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c241b81c-94cc-11ec-8aec-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demoxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:c241ec10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c241ec10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c241ec10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c241ec10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2423512-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c24258f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c24281fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c242aa38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c242d256-94cc-11ec-8aec-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c242fb82-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 difluprednate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c2432742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c2432742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c2432742-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c2436568-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:c2438ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:c243b824-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxadrol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c243e06a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c2440888-94cc-11ec-8aec-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c244315a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:3165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:c2445982-94cc-11ec-8aec-0242ac110003 UniProtKB:P30987 biolink:molecularly_interacts_with DrugCentral:3165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c24481aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c244a9be-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c244d2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c244fafe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c2452330-94cc-11ec-8aec-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:3173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edoxudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c2454b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c24573b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2459bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c245c3ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c245ec2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c24614fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2463d10-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c2466542-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c2468dec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c246b880-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c246e3b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enilconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c2470df8-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c247360c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:c2475e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c247877e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c247af92-94cc-11ec-8aec-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.91']} DrugCentral uuid:c247d79c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:c248003c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c2482850-94cc-11ec-8aec-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:c248505a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c2487968-94cc-11ec-8aec-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c248a186-94cc-11ec-8aec-0242ac110003 UniProtKB:P16232 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c248c99a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50233 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c248f19a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c2491a08-94cc-11ec-8aec-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c2494230-94cc-11ec-8aec-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:c2496ba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c24993ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9CPU0 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c249bcb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c249e4c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c24a0d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c24a3546-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c24a5f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.748']} DrugCentral uuid:c24a8776-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:c24aafbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c24ad7ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c24b008e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:c24b28b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.064']} DrugCentral uuid:c24b50e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:c24b7a32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c24ba2e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c24bcb86-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.062']} DrugCentral uuid:c24bf3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c24c1c08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:c24c46ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c24c6ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c24c9714-94cc-11ec-8aec-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c24cbf8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:c24ce7aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c24d0fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:c24d380e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:c24d60b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:c24d88ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacridine targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c24db0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:3194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacridine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c24dd91c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c24e020c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c24e2a48-94cc-11ec-8aec-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c24e5252-94cc-11ec-8aec-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:c24e7a84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c24ea306-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c24ecb4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c24ef374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c24f1b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c24f445a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c24f6e9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:c24f96c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:c24fbf02-94cc-11ec-8aec-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c24fe7e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c250101a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c250384c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c2506074-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01812 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:c2508900-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c250b132-94cc-11ec-8aec-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c250e4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c250e4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c250e4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c250e4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c2513ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c2513ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c2513ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c2513ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c2513ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:c2519aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c2519aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c2519aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c251f11e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c2525cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2528520-94cc-11ec-8aec-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c252ad3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c252d62e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13822 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c25300f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c2532912-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.217']} DrugCentral uuid:c2535130-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c2537ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.859']} DrugCentral uuid:c253a2e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:c253cb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:c253f450-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:c2541d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.641']} DrugCentral uuid:c2544586-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.377']} DrugCentral uuid:c2546d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:c25495c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:c254be30-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:c254e644-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.328']} DrugCentral uuid:c2550e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:c2553680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.688']} DrugCentral uuid:c2556042-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c2558874-94cc-11ec-8aec-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c255b09c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:3224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendosal is inhibitor of Secreted (Plasminogen activator inhibitor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:c255d98c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoxazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c256025e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04303 biolink:molecularly_interacts_with DrugCentral:3227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenticlor targets Enzyme (Uracil-DNA glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c2562a72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:3229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fumaric acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:c2565286-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c2567aa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:c256a344-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c256cf54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c256cf54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c2572c74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:c257cae4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fumagillin targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c257f2f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c2581b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c2584366-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c2586d28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c25895e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c258be0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:c258e730-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c2591250-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c2593a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:c25962be-94cc-11ec-8aec-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c2598ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c259b39a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c259dbb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c25a03fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c25a2c76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c25a54b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c25a7ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c25aa53e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c25acec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c25af76e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c25b1fdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c25b480e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c25b7108-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c25b9944-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c25bc158-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c25be96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c25c11ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c25c3a34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c25c6248-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c25c8a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c25cb388-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c25cdbd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c25d050e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c25d2d40-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c25d55fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c25d7e30-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c25da676-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c25dcea8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c25df7d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:c25e2006-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c25e481a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c25e72c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c25e9b80-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.89']} DrugCentral uuid:c25ec3bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c25eebee-94cc-11ec-8aec-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c25f1498-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c25f3cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c25f64de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c25f8d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:3293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibufenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c25fb5a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:c25fddf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.969']} DrugCentral uuid:c260063c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c2602e6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c2605862-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c26080bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.181']} DrugCentral uuid:c260a902-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.859']} DrugCentral uuid:c260d134-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.227']} DrugCentral uuid:c260fb00-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:c2612332-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c2614b64-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c261738c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c2619f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c261c74c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.496']} DrugCentral uuid:c261ef88-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:c2621832-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c262405a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c262686e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c262908c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c262b954-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c262e17c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:c26309a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c26331ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c2635a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c263823a-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c263aa4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c263d280-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c263fc74-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c26424a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c2644e04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c264762c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c2649f08-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c264cef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c264cef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c264cef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c2650f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:3309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c26537a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c2655fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c2658814-94cc-11ec-8aec-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c265b050-94cc-11ec-8aec-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c265db16-94cc-11ec-8aec-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2660352-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:c266276a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2664fb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 khellin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c266788c-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c266a0be-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c266c8fa-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c266f168-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:c26719d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c2674208-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:c2676a26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2679258-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c267bd46-94cc-11ec-8aec-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c267e56e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c2680db4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c2683686-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2685ea4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14721 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is activator of Ion channel (Potassium voltage-gated channel subfamily B member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c268879e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:c268afd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c268d852-94cc-11ec-8aec-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:c269008e-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:c26928c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c26950fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lodoxamide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.793']} DrugCentral uuid:c2697a3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:3328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubeluzole targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c269a264-94cc-11ec-8aec-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:3328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubeluzole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c269ca96-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestanolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c269efd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.81']} DrugCentral uuid:c26a18ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesterolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.6']} DrugCentral uuid:c26a4192-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesterolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c26a69b0-94cc-11ec-8aec-0242ac110003 UniProtKB:O34667 biolink:molecularly_interacts_with DrugCentral:3347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methionine targets Unclassified (S-ribosylhomocysteine lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c26a9200-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.077']} DrugCentral uuid:c26ababe-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:c26ae2d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:c26b0b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c26b3336-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:c26b5c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:3362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoguazone targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c26b84b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36633 biolink:molecularly_interacts_with DrugCentral:3362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoguazone targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c26bb0c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c26bb0c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c26be4b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c26c0d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c26c3588-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c26c5eb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c26c8754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c26cb72e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26cb72e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26cb72e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26cfd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c26cfd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c26cfd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26d4f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c26dae4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:3377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neridronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c26dd712-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifenalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c26dff30-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c26e2744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c26e4fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c26e77d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c26e9fee-94cc-11ec-8aec-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c26ec94c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01705 biolink:molecularly_interacts_with DrugCentral:3399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleandrin targets Unclassified (Neurogenic locus notch homolog protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c26ef2aa-94cc-11ec-8aec-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c26f1b68-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c26f4386-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c26f6cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c26f958e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c26fbdac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c26fe5ac-94cc-11ec-8aec-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c2700de8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01469 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, epidermal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c27036ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c2705f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2708728-94cc-11ec-8aec-0242ac110003 UniProtKB:P07148 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c270af64-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c270d94e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c2710176-94cc-11ec-8aec-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c271298a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c2715194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:3401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ornithine is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c2718204-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c2718204-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c2718204-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c271c052-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:c271e884-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.815']} DrugCentral uuid:c2721138-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:c2723960-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.372']} DrugCentral uuid:c272617e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.723']} DrugCentral uuid:c272899c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:c272b3f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:c272dc3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.533']} DrugCentral uuid:c273055c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:c2732d8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.169']} DrugCentral uuid:c273566a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.943']} DrugCentral uuid:c2737eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:c273a6e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.449']} DrugCentral uuid:c273cf96-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:c273f7c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.676']} DrugCentral uuid:c2741ff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c274480e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:c274716c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c274967e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:c274bea6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.333']} DrugCentral uuid:c274e6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c275111c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:c2753930-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.209']} DrugCentral uuid:c27561a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c27589da-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.969']} DrugCentral uuid:c275b248-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c275daca-94cc-11ec-8aec-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:3412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybenzone targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c27602f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:3413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycinchophen targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c2762b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c2765496-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:c2767cc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine is modulator of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:c276a4be-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.658']} DrugCentral uuid:c276cce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.307']} DrugCentral uuid:c276f69e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c2771ec6-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c2774702-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c2776f20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:c277a314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c277a314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c277a314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c277a314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c277f3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c277f3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c277f3c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c27832f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3467 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picloxydine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c2785b42-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:3467 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picloxydine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c2788374-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:3474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adipic acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c278aba6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:c278d464-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c278fc78-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:c2792504-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c2794d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04015 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c27975cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c2799df4-94cc-11ec-8aec-0242ac110003 UniProtKB:P03118 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c279fc5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c27ac972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c27ac972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c27ac972-94cc-11ec-8aec-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c27b0b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c27b0b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c27b3f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P03120 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Human papillomavirus regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:c27b6756-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polyestradiol phosphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c27b8b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:c27baf4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c27bd984-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c27c01a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c27c2a42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c27c5260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c27c7b28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c27ca346-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c27ccc4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.69']} DrugCentral uuid:c27cf4d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c27d1cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:c27d4530-94cc-11ec-8aec-0242ac110003 UniProtKB:P18762 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:c27d6d44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:c27d96c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:c27dc6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c27dc6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c27dc6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c27e0678-94cc-11ec-8aec-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c27e2f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c27e5f60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c27e5f60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c27e5f60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c27e9d54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:3500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protoporphyrin targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c27ec568-94cc-11ec-8aec-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:3500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protoporphyrin targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c27eedcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:c27f1612-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c27f3e3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:c27f6766-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c27f8f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:3505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homonicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c27fb75c-94cc-11ec-8aec-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:3506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxal phosphate targets Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c27fdf7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c280086a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c280309c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c28059c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c28081fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c280ab12-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c280d344-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c280fb80-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c28123bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c2814d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c28175ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c2819df6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c281c61e-94cc-11ec-8aec-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c281eefa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c282172c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c2823f36-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c2826754-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c2829008-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c282b830-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c282e04e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c283084e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c28332f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c2835b0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c283845e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c283ad62-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c283d59e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c283fdbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c2842666-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c2845780-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c2845780-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c2845780-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c28495ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c284bde2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c284e718-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c2850f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c2853790-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c2855fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c2858876-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c285b080-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:c285d894-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c28600da-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c286295c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c2865210-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c2867a24-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c286a224-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c286cccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c286f53a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c2871d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c287458a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c2876e70-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:c287967a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c287be70-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c287e67a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c2880ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c28837f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c288600a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c288880a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c288b136-94cc-11ec-8aec-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c288d94a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c2890154-94cc-11ec-8aec-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c2892a30-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c28953ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c2897bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c289a3de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c289cc56-94cc-11ec-8aec-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c289f47e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c28a1ca6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c28a44ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c28a6dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c28a95fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c28abe22-94cc-11ec-8aec-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c28ae636-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c28b0f26-94cc-11ec-8aec-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:c28b3726-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c28b5f30-94cc-11ec-8aec-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c28b8744-94cc-11ec-8aec-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c28bafc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c28bd7d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c28bffee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c28c2910-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c28c53d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c28c7be0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c28ca3e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c28ccbea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c28cf516-94cc-11ec-8aec-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c28d1d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P39900 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Macrophage metalloelastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:c28d4516-94cc-11ec-8aec-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c28d6d66-94cc-11ec-8aec-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c28d9570-94cc-11ec-8aec-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c28dbd70-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c28de570-94cc-11ec-8aec-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c28e0e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c28e36ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c28e5ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06737 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Glycogen phosphorylase, liver form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c28e8700-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c28eaf96-94cc-11ec-8aec-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c28ed796-94cc-11ec-8aec-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c28effbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c28f27b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c28f5162-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c28f798a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c28fa19e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c28fc9da-94cc-11ec-8aec-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c28ff3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:c2901c32-94cc-11ec-8aec-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c2904568-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2906d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c2909658-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c290be6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c290e680-94cc-11ec-8aec-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c2910e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c2913716-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c2915f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c2918748-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c291af52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c291dacc-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c29204fc-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c2922d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c29255ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:c2927e82-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c292a696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c292ce96-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c292f704-94cc-11ec-8aec-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c2931f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:c2934722-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:c2936f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2939998-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c293c1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10584 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c293ea06-94cc-11ec-8aec-0242ac110003 UniProtKB:P21588 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (5'-nucleotidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c2941224-94cc-11ec-8aec-0242ac110003 UniProtKB:Q965D6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (3-oxoacyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c2943bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q965D7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c29463e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P27986 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Phosphatidylinositol 3-kinase regulatory subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c2948bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPH5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (NADPH oxidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c294b40e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c294dca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c29504a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c2952cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q1CTD3 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (D-alanine--D-alanine ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c2955620-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c29581ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c295ae68-94cc-11ec-8aec-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c295ae68-94cc-11ec-8aec-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c295e586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c295e586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:c29624c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c29624c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c29624c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c29624c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c29671cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c29671cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c296a93a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c296a93a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c296dc8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c29704ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:c2972cca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:c2975678-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c2977f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03114 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cell division protein kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c297a772-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:c297cff4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07862 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (D-alanylalanine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c297f826-94cc-11ec-8aec-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c2982030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01062 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c298483a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c29870da-94cc-11ec-8aec-0242ac110003 UniProtKB:P41921 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:c298997a-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c298c198-94cc-11ec-8aec-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c298e98e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11168 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c29912ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14576 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (ELAV-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c2993b0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15717 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (ELAV-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2996328-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c2998b32-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c299b3aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P19357 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c299dbdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c29a03f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c29a2c04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c29a54d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c29a8c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c29a8c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c29a8c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c29a8c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c29a8c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:c29ad852-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c29b041c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c29b2d70-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c29b5584-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c29b7e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:c29ba67e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c29bce9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c29bf6ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:c29c1fb4-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c29c47f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c29c700e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c29c9854-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c29cc27a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c29ceae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:c29d131a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c29d3f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c29d3f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c29d6d38-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:3529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rioprostil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) DrugCentral uuid:c29d9196-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c29db9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.46']} DrugCentral uuid:c29de1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:c29e15f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c29e15f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c29e15f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c29e15f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c29e5f40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WQX9 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (Phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c29e881c-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c29eb058-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c29ed966-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c29f018e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c29f2a06-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c29f5242-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c29f7a6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c29fa288-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c29fcce0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c29ff512-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2a01d44-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c2a04576-94cc-11ec-8aec-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:c2a06fce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2a09b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c2a0c35c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c2a0eb7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c2a113e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c2a13c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c2a16410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c2a18c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c2a1b50a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c2a1dd5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c2a20564-94cc-11ec-8aec-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c2a22e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c2a25654-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c2a27e90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c2a2a794-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c2a2d02a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2a2f852-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c2a32070-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c2a3488e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c2a3714c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c2a39960-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c2a3c1ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c2a3e9f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c2a413c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c2a43e92-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c2a466c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c2a48ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2a4b7e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2a4e018-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2a50836-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2a5307c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c2a55962-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2a58176-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2a5aaca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c2a5d2e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2a5fc0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c2a6243c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c2a64c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c2a674e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c2a69de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c2a6c5fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c2a6ee1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c2a71702-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c2a73f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c2a7673e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2a78f48-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c2a7b8d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c2a7e0ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c2a8091e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c2a83132-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c2a859c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c2a88204-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c2a8aa2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c2a8d240-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c2a8fb08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c2a92312-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c2a94b26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c2a97330-94cc-11ec-8aec-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2a99d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2a9c54c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c2a9ed6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2aa1574-94cc-11ec-8aec-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2aa3e82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c2aa66a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c2aa8f9a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c2aab7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c2aae062-94cc-11ec-8aec-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c2ab0880-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c2ab30a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c2ab59c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c2ab830a-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2abab1e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2abd346-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c2abfbc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c2ac23e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c2ac4bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c2ac7418-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c2ac9ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2acc51c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2aced3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c2ad1562-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c2ad3e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c2ad6698-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c2ad8ede-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c2adb6f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c2addf74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c2ae079c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c2ae2fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c2ae58be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c2ae819a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c2aea9ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c2aed1cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c2aef9e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c2af253c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2af4d82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c2af75aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c2af9e40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c2afc668-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c2afee86-94cc-11ec-8aec-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c2b016ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P41743 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C iota type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2b03fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2b067d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c2b08fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2b0b88e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c2b0e232-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2b10aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b14d62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c2b1d138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2b1d138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2b1d138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2b1d138-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c2b21b02-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2654e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c2b2e51e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c2b30d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c2b33564-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.454']} DrugCentral uuid:c2b35e0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c2b38640-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c2b3ae72-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c2b3d690-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c2b3ff4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c2b42762-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:c2b44f8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c2b47794-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c2b4a16a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:c2b4caaa-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:c2b4f2d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c2b51b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:c2b54476-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:c2b56ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c2b594da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c2b5bdde-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c2b5e62e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c2b60e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c2b645c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c2b645c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c2b645c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c2b645c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c2b645c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c2b6a0b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:c2b6cbb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c2b6f64a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c2b71e7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin is antagonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c2b74a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c2b74a78-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c2b77e62-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:c2b7a770-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c2b7cfac-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:c2b7f7ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c2b81ffc-94cc-11ec-8aec-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2b84dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c2b84dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c2b88136-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbentine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c2b8a97c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:3557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbentine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c2b8d208-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c2b8fe04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c2b8fe04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c2b93144-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxedrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c2b95980-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxedrine targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c2b98266-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:c2b9a660-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c2b9ce88-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:c2b9f6b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c2ba21da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c2ba4a34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c2ba725c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c2ba9c32-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:c2bac482-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:c2baecf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:c2bb154a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c2bb3e44-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c2bb668a-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:c2bb8a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:c2bbb2c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c2bbdbc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:c2bc0400-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c2bc2d22-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c2bc555e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c2bc7e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:c2bcae00-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c2bcae00-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c2bcae00-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c2bcf3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2bcf3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2bcf3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bd4626-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2bdba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:c2be0e4e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c2be366c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c2be5ef8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c2be8720-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c2beaf52-94cc-11ec-8aec-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c2bed784-94cc-11ec-8aec-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c2bf02d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c2bf2b30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c2bf5376-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2bf7cac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c2bfa506-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:c2bfcd2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.72']} DrugCentral uuid:c2bff560-94cc-11ec-8aec-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c2c01dec-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c2c0460a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c2c06e3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c2c09646-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c2c0baea-94cc-11ec-8aec-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c2c0e330-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c2c10b62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c2c1338a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c2c15d56-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Pepsin A-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2c18862-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c2c1b094-94cc-11ec-8aec-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:c2c1d8a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c2c2012a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c2c2293e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c2c25170-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c2c27a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c2c2a314-94cc-11ec-8aec-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:3613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Vitamin E targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c2c2cb3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49638 biolink:molecularly_interacts_with DrugCentral:3613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Vitamin E targets Transporter (Alpha-tocopherol transfer protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c2c2f44a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:c2c31c4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c2c34670-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c2c36e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.75']} DrugCentral uuid:c2c396ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:c2c3bef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c2c3e756-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c2c40f56-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c2c43774-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:c2c4605a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c2c4902a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c2c4902a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c2c4902a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c2c4d756-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2c4d756-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2c4d756-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2c51892-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c2c5409c-94cc-11ec-8aec-0242ac110003 UniProtKB:P95276 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase; Epoxide hydrolase EphB) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c2c568c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07099 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c2c590d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D379 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c2c5b964-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2c5e1a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P16152 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Carbonyl reductase [NADPH] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c2c609f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6GI75 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c2c632d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c2c65b12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:c2c68416-94cc-11ec-8aec-0242ac110003 UniProtKB:P54616 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c2c6ac48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6UCJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c2c6d5ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BJJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-ACP reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2c6ffc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9RMI3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c2c727ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2c74ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:M9TGV3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NULLDH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2c7789e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c2c7a09e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c2c7c8bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c2c7f0bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c2c819d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c2c841c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:c2c869d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c2c891fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c2c8bcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c2c8e6f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c2c90f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c2c93738-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BI31 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c2c95ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c2c9883c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2c9b05a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c2c9d878-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c2ca0140-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2ca295e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2ca7030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c2cae51a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:c2cb0d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c2cb35ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c2cb5e00-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c2cb863c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c2cbaefa-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c2cbd740-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c2cbff7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c2cc27ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2cc50b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c2cc78ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c2cca116-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c2ccc92a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c2ccf1b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c2cd19de-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c2cd421a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c2cd6a38-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c2cd936e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c2cdbba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c2cde4c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c2ce0ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c2ce3774-94cc-11ec-8aec-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c2ce718a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c2ce718a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c2ce718a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c2ce718a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c2ce718a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:c2cec644-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c2ceee76-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c2cf17d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c2cf4024-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c2cf6914-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c2cf98f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c2cf98f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c2cf98f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c2cfdeee-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c2cfdeee-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c2cfdeee-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d0334e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c2d093fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c2d0bc1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.163']} DrugCentral uuid:c2d0e44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:c2d10c92-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c2d13564-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c2d15dc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:c2d18604-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c2d1ae22-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2d1d762-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c2d1ff80-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:c2d22794-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c2d24fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c2d27848-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c2d2a084-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:c2d2c884-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c2d2f084-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c2d31956-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c2d34174-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c2d3699c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c2d391a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c2d3bba4-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c2d3e3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:c2d40be0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:c2d43548-94cc-11ec-8aec-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c2d45de8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c2d486f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c2d4af0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c2d4d7be-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c2d4fff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c2d5289a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c2d550b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c2d57a52-94cc-11ec-8aec-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:c2d5a4a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:c2d5ccbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c2d5fc8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d5fc8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d5fc8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d64a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2d64a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2d64a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2d64a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2d64a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2d6a65c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c2d6a65c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c2d6a65c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c2d6ed06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d6ed06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d6ed06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c2d72af0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:c2d753fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c2d77cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c2d7a502-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c2d7cd02-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c2d7fd36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2d7fd36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2d7fd36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2d83b52-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:c2d86370-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:c2d88c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c2d8b460-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c2d8ddd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bropirimine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c2d905fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:3707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorthenoxazine targets Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c2d9303e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciramadol is modulator of GPCR (Mu-type opioid receptor) DrugCentral uuid:c2d95442-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:3715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobenztropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c2d98408-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2d98408-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2d98408-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2d9ca4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c2d9ca4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c2d9ca4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c2da0874-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 myrtecaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:c2da383a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c2da383a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c2da383a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c2da7be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c2da7be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c2daaf0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c2dad790-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c2db004e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c2db284e-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c2db5044-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c2db784e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:c2dba0a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c2dbc89e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c2dbf0a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:c2dc18a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c2dc413e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c2dc6934-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c2dc915c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c2dcb970-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c2dce40e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c2dd0c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c2dd342c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c2dd5c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c2dd84ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c2ddaca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c2ddd4b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:c2ddfe7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2de27ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c2de4fec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c2de7800-94cc-11ec-8aec-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c2dea10e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c2dec8fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c2def104-94cc-11ec-8aec-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c2df1922-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c2df415e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22736 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Nuclear receptor subfamily 4 group A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c2df6986-94cc-11ec-8aec-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c2df9186-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2dfb986-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 artemisinin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c2dfe2c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c2e00abc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:c2e032b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c2e05abc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c2e084c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:c2e0ae4a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.843']} DrugCentral uuid:c2e0da46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c2e0da46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c2e11948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c2e11948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c2e11948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c2e11948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c2e16240-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c2e18a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:c2e1b3d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c2e1dbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c2e203e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c2e227c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:c2e2513c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c2e27946-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.665']} DrugCentral uuid:c2e2a146-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.372']} DrugCentral uuid:c2e2c95a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:c2e2f1d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c2e319dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:c2e341f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c2e369f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:c2e393ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c2e3bc02-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c2e3e40c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:c2e40c02-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:c2e43664-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c2e45e78-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:c2e495be-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2e495be-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2e495be-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2e495be-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2e495be-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2e4f1d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:c2e4f1d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:c2e4f1d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:c2e538d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c2e538d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c2e538d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c2e57ace-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c2e5a2f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c2e5cb14-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c2e5f4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2e61d44-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c2e6454e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.79']} DrugCentral uuid:c2e66d80-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c2e695da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c2e6bdda-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c2e6e5c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c2e70d9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c2e73652-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c2e75e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c2e7865c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c2e7ae52-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c2e7d846-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:c2e80064-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.57']} DrugCentral uuid:c2e82878-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:c2e850f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c2e87a94-94cc-11ec-8aec-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c2e8a2a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c2e8cbac-94cc-11ec-8aec-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c2e8f3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c2e91c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolasetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.226']} DrugCentral uuid:c2e944a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.698']} DrugCentral uuid:c2e96cce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:3944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide phosphate is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:c2e990c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c2e9bbac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:c2e9e3e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:c2ea0c10-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:c2ea34c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:c2ea5cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:c2ea853c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.793']} DrugCentral uuid:c2eaad8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:c2ead65e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:c2eafe72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c2eb267c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c2eb4f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c2eb78ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.122']} DrugCentral uuid:c2eba30e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c2ebcaf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c2ebfa98-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c2ebfa98-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c2ebfa98-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c2ec3940-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c2ec60e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c2ec60e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c2ec8f6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:c2ecb834-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c2ece048-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c2ed0848-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:c2ed3048-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:c2ed5a00-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.924']} DrugCentral uuid:c2ed8214-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.891']} DrugCentral uuid:c2edaa28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:c2edd23c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:c2edfab4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.451']} DrugCentral uuid:c2ee23fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.539']} DrugCentral uuid:c2ee4c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is allosteric modulator of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c2ee7458-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c2eea888-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2eea888-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2eea888-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2eea888-94cc-11ec-8aec-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c2eef2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P91730 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:c2ef17aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:c2ef3bae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11507 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c2ef63cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06685 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c2ef8bcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64578 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c2efb48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is allosteric modulator of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c2efdcb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:3976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kinetin targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c2f0049e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c2f02d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:c2f05692-94cc-11ec-8aec-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c2f07e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00371 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c2f0a6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:c2f0ceba-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:c2f0f82c-94cc-11ec-8aec-0242ac110003 UniProtKB:B2ZB02 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c2f1211c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:c2f149bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00024 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c2f171da-94cc-11ec-8aec-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meldonium targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c2f19afc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c2f1c338-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:c2f1eb6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niperotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:c2f20f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c2f2384a-94cc-11ec-8aec-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c2f2605e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c2f28868-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c2f2b072-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c2f2dde0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c2f2dde0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c2f31120-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c2f3392a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:c2f36274-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c2f38bdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c2f3b3e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:c2f3dbdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:c2f404cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:4050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spaglumic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c2f42dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:c2f455d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c2f47dc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f4dffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c2f5aeee-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c2f5d824-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c2f60088-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c2f628e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:c2f65114-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c2f67a40-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c2f6a376-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.78']} DrugCentral uuid:c2f6cbc6-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c2f6f402-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:c2f71c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:c2f74542-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.929']} DrugCentral uuid:c2f76d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.425']} DrugCentral uuid:c2f795b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.857']} DrugCentral uuid:c2f7be8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c2f7e6be-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:c2f8101c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.802']} DrugCentral uuid:c2f83858-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.952']} DrugCentral uuid:c2f86328-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:c2f88b32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c2f8b346-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c2f8dbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13674 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Prolyl 4-hydroxylase subunit alpha-1) DrugCentral uuid:c2f902ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02809 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) DrugCentral uuid:c2f926d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGH3 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 2) DrugCentral uuid:c2f94ab8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHI7 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 1) DrugCentral uuid:c2f96ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00689 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c2f9975c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c2f9bf7a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c2f9e798-94cc-11ec-8aec-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c2fa0fac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c2fa3cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:c2fa3cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:c2fa6a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:4106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sucralfate is inhibitor of Enzyme (Pepsin A-5) DrugCentral uuid:c2fa8e96-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c2fab84e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:c2fae058-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c2fb086c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c2fb3080-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c2fb5902-94cc-11ec-8aec-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c2fb810c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c2fba920-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c2fbd116-94cc-11ec-8aec-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c2fbfa24-94cc-11ec-8aec-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c2fc2242-94cc-11ec-8aec-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c2fc4a7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2fc767a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c2fc767a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c2fcae06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c2fcae06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c2fce178-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c2fd098c-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c2fd32cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:c2fd5af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c2fd83a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c2fdb0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c2fdb0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:c2fde528-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c2fde528-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:c2fe12f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:c2fe3b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c2fe6502-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c2fe8d34-94cc-11ec-8aec-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c2feb55c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c2fedd70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:c2ff061a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) DrugCentral uuid:c2ff2a28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:c2ff4e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) DrugCentral uuid:c2ff7258-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) DrugCentral uuid:c2ff97a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasugrel is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:c2ffbc22-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:c2ffe008-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c300040c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c3002cde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c3005524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c3007d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c300a542-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c300cdce-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c300f600-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:c3011e28-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.187']} DrugCentral uuid:c301466e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:c3017026-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.61']} DrugCentral uuid:c301988a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c301c0a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.93']} DrugCentral uuid:c301e8d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c30211d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:c30239fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c3026300-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.73']} DrugCentral uuid:c3028b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c302b3d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.644']} DrugCentral uuid:c302dbfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c30303fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:c3032d26-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.107']} DrugCentral uuid:c3035846-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.039']} DrugCentral uuid:c3038366-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.491']} DrugCentral uuid:c303ac06-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.565']} DrugCentral uuid:c303d44c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c303fd28-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c304255a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c3044d82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:c304760e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:c3049e22-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:c304c6cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:c304eef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c305188e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c3054304-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c3056b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c3059386-94cc-11ec-8aec-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:c305bc76-94cc-11ec-8aec-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c305e49e-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c3060cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c30634ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c3065e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c30686ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c306aed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c306d728-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c307019e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c30729c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c30751e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3077a02-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c307a2d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c307cade-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c307f2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c3081b88-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c30843c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c3086c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c3089446-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c308bd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c308e608-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3090e4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c30937ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c3096074-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3098892-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c309b0ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c309d8ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c30a0182-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c30a29a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c30a52cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c30a7aea-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c30aa556-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c30acd7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c30af5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c30b1de2-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c30b46b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c30b6edc-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c30b96fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c30bbf18-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c30be7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c30c0fea-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c30c3812-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c30c6030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c30c8c2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c30cb774-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c30cdfba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c30d0878-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c30d30aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c30d58dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c30d80f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c30da990-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c30dd1d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c30dfa08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c30e2226-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c30e4d78-94cc-11ec-8aec-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c30e779e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c30e9fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c30ec7ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c30ef0de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) DrugCentral uuid:c30f14ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c30f3e36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c30f6668-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c30f8f12-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c30fb744-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c30fdf76-94cc-11ec-8aec-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c310079e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c31030ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c31058ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c31080e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c310a9d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c310d200-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c310fa1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c3112282-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3114b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c31173fe-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3119c30-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c311c476-94cc-11ec-8aec-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c311ed3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c312157a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c3123e88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c31266ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c3128f82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c312b7aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c312dfbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c31307fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c31330e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c313591c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c313814e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c313a980-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c313d4d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c313ff5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c3142784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3144fac-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c31478c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c314a0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c314c914-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c314f27c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c3151aa4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c315440c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c3156c3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3159524-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c315bd56-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c315e5a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3160edc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c31637fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c3166030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c3168876-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c316b094-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c316d9ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.328']} DrugCentral uuid:c31701de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c3172a10-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.604']} DrugCentral uuid:c317524c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:c3177d9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c317a7ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c317d014-94cc-11ec-8aec-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:c317f864-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c31820fa-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c3184d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c3184d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c3188496-94cc-11ec-8aec-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c3188496-94cc-11ec-8aec-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:c318b88a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z2V5 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3190664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3199ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c319c6b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c319ef16-94cc-11ec-8aec-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c31a1810-94cc-11ec-8aec-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c31a4038-94cc-11ec-8aec-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c31a6842-94cc-11ec-8aec-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c31a911e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c31ab950-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c31ae178-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c31b0aa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:c31b32fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c31b5b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.405']} DrugCentral uuid:c31b8326-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:c31ba770-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:c31bcb4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.922']} DrugCentral uuid:c31bf388-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c31c1b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P51788 biolink:molecularly_interacts_with DrugCentral:4123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubiprostone is opener of Ion channel (Chloride channel protein 2) DrugCentral uuid:c31c3ffa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c31c68b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c31c90fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c31cb93a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c31ce40a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c31d0ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c31d36e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:c31d5f02-94cc-11ec-8aec-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c31d8798-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c31dafd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c31dd7de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c31e0006-94cc-11ec-8aec-0242ac110003 UniProtKB:Q94F81 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c31e28ba-94cc-11ec-8aec-0242ac110003 UniProtKB:O09106 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:c31e50c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ZTP8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c31e78ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c31ea15a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q70I53 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase-like amidohydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c31ecbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c31ef68c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7K6A1 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c31f1e96-94cc-11ec-8aec-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c31f46b4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c31f7328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c31f7328-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c31faa50-94cc-11ec-8aec-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c31faa50-94cc-11ec-8aec-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c32005a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c320ab6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c320ab6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c320ab6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c320ab6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c320faf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c320faf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:c321af58-94cc-11ec-8aec-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c321d848-94cc-11ec-8aec-0242ac110003 UniProtKB:P24527 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c3220070-94cc-11ec-8aec-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:4125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c32228ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:4125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proline targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:c32250c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asparagine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c3227c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c322a48a-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c322cdb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07314 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c322f5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P63116 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Unclassified (Asc-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c3231e60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c32346a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:4128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:c3236ece-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:4134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxal targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c32397aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:c323bcd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:c323e0de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:c32404ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c3242d1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:c324562c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:c3247ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.925']} DrugCentral uuid:c324a6fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c324cf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c324f7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:c3251fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.209']} DrugCentral uuid:c3254816-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:c32570fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:c3259924-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:c325c16a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:c325e9b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.635']} DrugCentral uuid:c32612c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:c3263afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c326632c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.251']} DrugCentral uuid:c3268b68-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.916']} DrugCentral uuid:c326b3fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:c326dd16-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:c327053e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:c3272d70-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:c327567e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.265']} DrugCentral uuid:c3277eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c327a6ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.556']} DrugCentral uuid:c327cef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:c327f872-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c328209a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c32848e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c3287108-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c32899b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:c328c1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.975']} DrugCentral uuid:c328ea16-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:c32912fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:c3293b42-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c3296356-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.124']} DrugCentral uuid:c3298caa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:c329b5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c329de30-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.945']} DrugCentral uuid:c32a0658-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:c32a2e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:c32a56f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:c32a7f0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:c32aa75c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.416']} DrugCentral uuid:c32ad088-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:c32af95a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c32b2178-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.084']} DrugCentral uuid:c32b49a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:c32b725e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.012']} DrugCentral uuid:c32b9c70-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c32bc4c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.233']} DrugCentral uuid:c32becfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.325']} DrugCentral uuid:c32c14fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:c32c3d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:c32c65ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c32c8e00-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:c32cb628-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 udenafil targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c32cdb58-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 udenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.084']} DrugCentral uuid:c32d0380-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine silver is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c32d2784-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine silver targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c32d4f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c32d789c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.658']} DrugCentral uuid:c32da0ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.85']} DrugCentral uuid:c32dc91e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.21']} DrugCentral uuid:c32df128-94cc-11ec-8aec-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.96']} DrugCentral uuid:c32e19dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c32e41f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:c32e6a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c32e931c-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c32ebb4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:c32ee484-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c32f0c98-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32f4eba-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c32faec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c32fd74a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c32fff68-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c33027ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3304fe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:c33078bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c330a170-94cc-11ec-8aec-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c330c9c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c330f1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant is antagonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:c3311bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c33143dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c33167ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:c3319026-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c331b8f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c331e13e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c3320984-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2VKV7 biolink:molecularly_interacts_with DrugCentral:4152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 permethrin is blocker of Ion channel (Sodium channel protein) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c3324d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c332bee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:4156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edaravone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:c332ed18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:c332ed18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:c3331a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c3333e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) DrugCentral uuid:c3336270-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c3338b56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) DrugCentral uuid:c333b446-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c333b446-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c333e218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c3340a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c334c9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c336a958-94cc-11ec-8aec-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c336d18a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c336f9d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liraglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.2']} DrugCentral uuid:c3372270-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcaftadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:c3374692-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ulipristal is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c3376f46-94cc-11ec-8aec-0242ac110003 UniProtKB:O95470 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod targets Enzyme (Sphingosine-1-phosphate lyase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c3379782-94cc-11ec-8aec-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c337c04a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c337e872-94cc-11ec-8aec-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c33810a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c33838cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923J1 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c3386284-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c3388af2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:c338b32e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.305']} DrugCentral uuid:c338db38-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.967']} DrugCentral uuid:c33903b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c3392c00-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c3395428-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:c3397c78-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.003']} DrugCentral uuid:c339a64e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c339e550-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c33a4392-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:4170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tesamorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33a8618-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c33b0822-94cc-11ec-8aec-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c33b3036-94cc-11ec-8aec-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c33b5840-94cc-11ec-8aec-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c33b8158-94cc-11ec-8aec-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c33ba976-94cc-11ec-8aec-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c33bd194-94cc-11ec-8aec-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c33bf994-94cc-11ec-8aec-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c33c2536-94cc-11ec-8aec-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c33c4d22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBX1 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c33c7a04-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c33c7a04-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c33cadbc-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c33cd60c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c33cfe2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c33d2652-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNI1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Chymotrypsin-like elastase family member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c33d4efc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c33d7710-94cc-11ec-8aec-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c33d9f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c33dc738-94cc-11ec-8aec-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c33df262-94cc-11ec-8aec-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c33e1ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c33e4366-94cc-11ec-8aec-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c33e6fda-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:c33e6fda-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:c33e9dac-94cc-11ec-8aec-0242ac110003 UniProtKB:C1KIQ2 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c33ec5b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c33eee2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q91RS4 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c33f16e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c33f3f00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:c33f630e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c33f8b36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c33fb584-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c33fddac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c34005c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c3402dde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c3405728-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c3407f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c340a782-94cc-11ec-8aec-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c340cfb4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c340f890-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c34120cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c34148e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c34170f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c3419aa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c341c2f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:4177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) DrugCentral uuid:c341e6f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:4177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) DrugCentral uuid:c3420adc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c3423354-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c3425b72-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c3428390-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:c342abcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c342d4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c342fc9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c34324bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c3434cda-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c343789a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c343a0e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c343c980-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c343f202-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c3441a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c344434c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c3446b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3449432-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c344bc50-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c344e464-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c3450c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c345355e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3455d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c34586d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c345aef8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c345d784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c345ffb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c34627fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c3465092-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c346795a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c346a178-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c346c9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c346f1aa-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c3471bee-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c347440c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3476c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c347945c-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c347bcf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c347e510-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3480d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c34836e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3485ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c348870e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c348af22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c348d812-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3490044-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c3492862-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c349509e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3497916-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c349a134-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.34']} DrugCentral uuid:c349c93e-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c349f152-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c34a1a6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c34a430a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c34a6b00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c34a9314-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c34abd80-94cc-11ec-8aec-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c34ae594-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c34b0d94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c34b35b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c34b5f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c34b877e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c34bafb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c34bd7c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c34c00be-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c34c29cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c34c51d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c34c7ada-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c34ca30c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c34ccb52-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c34cf35c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c34d1bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c34d441a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c34d6c38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c34d9456-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c34dbd14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c34de532-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c34e0d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c34e355a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c34e5eae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c34e86d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c34eaf08-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c34ed71c-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c34eff9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c34f27bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c34f4fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c34f77f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c34fa0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c34fc8ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c34ff0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c35019ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c35044b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c3506cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c3509502-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c350bd66-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c350e624-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c3510e42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3513660-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c3516054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c351889a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c351b0c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c351d8ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3520220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c3522a48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c3525270-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c3527a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c352a31a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c352cb2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c352f324-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c3531b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c3534414-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c35377c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:c35377c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:c35377c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:c35377c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:c353b8d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c353e3ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c3540bf6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c354341e-94cc-11ec-8aec-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c3545c32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z351 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c35484aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c354acd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c354d4f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c354fcf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c35525d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c3554de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c35575e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c3559dfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c355c8c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor is negative allosteric modulator of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c355f0ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c35618f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EPX4 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor targets GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c3564178-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c35669b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c3569182-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c356b9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c356e358-94cc-11ec-8aec-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c3570bee-94cc-11ec-8aec-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:c3573416-94cc-11ec-8aec-0242ac110003 UniProtKB:P22830 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Enzyme (Ferrochelatase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c3575c52-94cc-11ec-8aec-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c3578650-94cc-11ec-8aec-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:c357b080-94cc-11ec-8aec-0242ac110003 UniProtKB:P25023 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.11']} DrugCentral uuid:c357d97a-94cc-11ec-8aec-0242ac110003 UniProtKB:O70526 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.96']} DrugCentral uuid:c3580184-94cc-11ec-8aec-0242ac110003 UniProtKB:P46663 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c35829fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P32299 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:c358521a-94cc-11ec-8aec-0242ac110003 UniProtKB:P97583 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c3587a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c358a27e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c358cb50-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c358f378-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c3591b96-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c35943be-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c3596dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c35995da-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c359bde4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c359e65c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c35a0e66-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c35a3684-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c35a5e8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c35a87e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c35aafe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c35ad7f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c35b000a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c35b294a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c35b514a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c35b794a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c35ba172-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c35bcaee-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c35bf30c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c35c1b20-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c35c4352-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c35c6c06-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c35c9424-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c35cbc56-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c35ce5a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c35d107a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c35d3abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c35d62c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c35d8b72-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c35db3ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c35ddc08-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c35e0412-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c35e2cc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c35e552a-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c35e7d34-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c35ea552-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c35ece9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c35ef6b0-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c35f1ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.13']} DrugCentral uuid:c35f4714-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c35f6f8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c35f97a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c35fc09a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c35fe8b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3601176-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c3603980-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3606194-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c36089a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c360b31a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c360db2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3610338-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c3612b60-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c36153ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c3617c00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c361a400-94cc-11ec-8aec-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c361cc28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c361f4dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c3621ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c36244e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c3626cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c36295cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c362bf0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c362e73e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c3630fd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c36337fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c363601a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c363882e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c363b1e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c363da04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c364020e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c3642a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c364542a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c3647c48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c364a4a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c364ccca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c364f538-94cc-11ec-8aec-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c3651d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c365456a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c3656d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c3659650-94cc-11ec-8aec-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c365be6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c365e682-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c3660e82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c36639c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c36661de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c36689fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c366b21a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c366da9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c36702a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c3672aa6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c3675314-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c3677b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c367a42c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c367cc36-94cc-11ec-8aec-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c367f59e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c3681fba-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c36847ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c3686ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c368986e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c368c17c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c368e99a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c36911b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c3693a76-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c369628a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c3698ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c369b2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c369dce2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c36a04ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c36a2d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:c36a5514-94cc-11ec-8aec-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c36a7d8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c36aa596-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c36acda0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c36af622-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c36b1ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c36b4726-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c36b6f30-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c36b98d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c36bc336-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c36beb4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c36c1372-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c36c3c08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c36c6426-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c36c8c30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c36cb430-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c36cdcda-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c36d04f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c36d2ce4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c36d54f8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c36d7de8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c36da5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c36dcdf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c36df610-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c36e1e7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c36e469c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c36e6e9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c36e97dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c36ec0d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c36ee908-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62190 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c36f1108-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02858 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c36f391c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c36f6478-94cc-11ec-8aec-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c36f8c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c36fb478-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c36fdc8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c370095a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c370095a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c3703cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15357 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Enzyme (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c37064cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c3708d44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NB16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mixed lineage kinase domain-like protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c370b544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c370dd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:4188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferiprone targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c37105e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:c3713082-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.261']} DrugCentral uuid:c37158c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.573']} DrugCentral uuid:c37180d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c371a8fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c371d1ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.501']} DrugCentral uuid:c371f9b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:c37221ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:c3724a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.664']} DrugCentral uuid:c3727262-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c3729a76-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c372c28a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c372ea6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3731730-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c373412e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c3736938-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3739200-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c373ba1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c373e23c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c3740a50-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c37432dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c3745c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c3748458-94cc-11ec-8aec-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c374ac6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c374d610-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c374fe42-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.44']} DrugCentral uuid:c375264c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c3754e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c3757778-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c3759f8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c375c80e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c375f004-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c3761886-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c37640a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c37668c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c37690cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c376bc3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c376e540-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c3770dd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c3773694-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c3775ec6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c37786d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c377aeda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c377d752-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c377ff5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c378275c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c3784f70-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c3787874-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c378a07e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c378c89c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c378f0d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c379193c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c3794178-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3796996-94cc-11ec-8aec-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c37991aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c379bad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c379e2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c37a0af4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c37a3312-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c37a5db0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c37a85e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c37aae1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c37ad736-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c37affb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c37b27d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c37b4ff4-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c37b78da-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c37ba116-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c37bc952-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c37bf170-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c37c1af6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c37c458a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c37c6db2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c37c95c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c37cbec0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c37ce6e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c37d0f10-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c37d3724-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c37d5fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c37d87e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c37db082-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c37dd8a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c37e0316-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:c37e2b2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c37e5334-94cc-11ec-8aec-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c37e7b48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c37ea3b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c37ecd1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c37ef53c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c37f1d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c37f4604-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c37f6e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c37f9672-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c37fbf94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c37fea78-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3801296-94cc-11ec-8aec-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c3803bf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c3806462-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c3808c8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c380b4a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c380dcc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c381057a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c3812d8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c38155ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c3817dc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c381aa02-94cc-11ec-8aec-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c381d20c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c381fa20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c382223e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3824ac0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c38272d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3829be2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c382c414-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c382ecd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c383150e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3833d36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c383654a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3838f66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c383b784-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c383df98-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c384082e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c38430c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c38458ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c3848100-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c384a9be-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c384d1d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c384f9e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c38521f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3854aea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c38572fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c3859b12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c385c330-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c385eb94-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c3861790-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c3861790-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c3864fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c3864fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c386890a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c386890a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c386c3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c386c3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c386c3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c387060a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c387060a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c3873b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c387632a-94cc-11ec-8aec-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c3878b66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c387b3f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c387dc06-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.393']} DrugCentral uuid:c3880438-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:c3882c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:c388551e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:c3887d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:c388a5c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:c388cde6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:c388f6e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.627']} DrugCentral uuid:c3891f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is binding agent of Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.812']} DrugCentral uuid:c389473a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99707 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase) DrugCentral uuid:c3896b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBK8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase reductase) DrugCentral uuid:c3898f42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXJ7 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Unclassified (Protein amnionless) DrugCentral uuid:c389b33c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96EY8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial) DrugCentral uuid:c389d70e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH4 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methylmalonic aciduria type A protein, mitochondrial) DrugCentral uuid:c389fc70-94cc-11ec-8aec-0242ac110003 UniProtKB:P20062 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-2) DrugCentral uuid:c38a2114-94cc-11ec-8aec-0242ac110003 UniProtKB:P20061 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-1) DrugCentral uuid:c38a44fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:4197 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vitamin A palmitate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c38a6d18-94cc-11ec-8aec-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:4197 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vitamin A palmitate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c38a954a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4199 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium chloride targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c38abe9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:c38ae81a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:c38b142a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:c38b142a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:c38b431e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:c38b6772-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c38b8fae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c38bb7cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:c38be026-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.582']} DrugCentral uuid:c38c092a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c38c3148-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c38c5966-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:c38c818e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c38cacd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c38cd4ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c38cfd44-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c38d2562-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:c38d4e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c38d7652-94cc-11ec-8aec-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.157']} DrugCentral uuid:c38d9e84-94cc-11ec-8aec-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.394']} DrugCentral uuid:c38dc742-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c38df03c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:c38e1878-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c38e40b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c38e6a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c38e9244-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c38eba4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c38ee280-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c38f0b0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:c38f333e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:c38f5b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c38f8410-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c38facf6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c38fd528-94cc-11ec-8aec-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:c38ffd28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3902546-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c39059f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c39059f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c39059f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c390a016-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:c390a016-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:c390a016-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:c390e7d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c390e7d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c390e7d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3912dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c3912dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c3912dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c39175b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c39175b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c39175b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c391b3fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c391dc10-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c392041a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3922f12-94cc-11ec-8aec-0242ac110003 UniProtKB:O15552 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid is agonist of GPCR (Free fatty acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c392573a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14843 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c3927f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c392a33e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c392d39a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c392d39a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c392d39a-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c3930ad6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium phosphate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c39332fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:4220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telbivudine targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c3935bbc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:4220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telbivudine is inhibitor of Polyprotein (Protein P) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:c39383da-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4221 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequinol is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:c393a7ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c393cfb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c393fa04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c3942236-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c3944a5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c394727c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c3949af4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c394c326-94cc-11ec-8aec-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c394ec48-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c3951448-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c3953d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c39565ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3958dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c395b6a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c395e062-94cc-11ec-8aec-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c39608c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c39630e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c3965984-94cc-11ec-8aec-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c39681ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c396a9ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c396d5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c396d5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c3971144-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c3971144-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c3971144-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c3975708-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3975708-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3975708-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c39796be-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c397bf22-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c397e736-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c3980f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c39837f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.31']} DrugCentral uuid:c39860ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c398892a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c398b148-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c398da7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c3990288-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c3992aba-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c39952e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:c3997c22-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c399a422-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c399cc36-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.29']} DrugCentral uuid:c399f436-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c39a1ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c39a44cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c39a6cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c39a94cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c39abd94-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c39ae5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c39b0db2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c39b3832-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c39b60aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c39b88be-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c39bb0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c39bd990-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c39c01c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c39c2a62-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c39c5366-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c39c7c10-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c39ca438-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c39ccc4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c39cf47e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c39d1d50-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c39d456e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c39d6d96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c39d95a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c39dbe22-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c39de636-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c39e0e68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c39e369a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c39e5fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c39e87ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c39eb002-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c39ed80c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c39f02f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c39f2b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c39f5336-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c39f7bae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c39fa3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c39fcbae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c39ff3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3a01ca8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3a045a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c3a06db6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c3a095de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c3a0be7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3a0e6a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c3a10eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3a1382c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c3a160c2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c3a188e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3a1b0fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c3a1d926-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c3a201ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c3a22a02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c3a25216-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3a27a3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c3a2a482-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3a2cca0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c3a2f52c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3a31d40-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3a345cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c3a36dea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3a395f4-94cc-11ec-8aec-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c3a3bdfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c3a3e6bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c3a40eda-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c3a437f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c3a4611e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3a4896e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3a4b18c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c3a4d996-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c3a5020e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3a52a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3a5522c-94cc-11ec-8aec-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3a57a36-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3a5a2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c3a5caea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3a5f2fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c3a61b12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c3a644f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c3a66d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c3a69524-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3a6bd42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c3a6e5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c3a70dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c3a73704-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c3a75f22-94cc-11ec-8aec-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.79']} DrugCentral uuid:c3a787fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:c3a7b026-94cc-11ec-8aec-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.197']} DrugCentral uuid:c3a7d830-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c3a80030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:c3a82d08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.328']} DrugCentral uuid:c3a85724-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c3a87f38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15465 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c3a8a80a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib is inhibitor of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:c3a8d03c-94cc-11ec-8aec-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c3a8f8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivacaftor is positive modulator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c3a9212c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafluprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:c3a945ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginesatide is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.43']} DrugCentral uuid:c3a96e0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:c3a991fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c3a9ba10-94cc-11ec-8aec-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c3a9e3a0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:c3aa0e70-94cc-11ec-8aec-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:c3aa3698-94cc-11ec-8aec-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:c3aa5ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c3aa8774-94cc-11ec-8aec-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3aaaf88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c3aad7a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c3aaffe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3ab28c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c3ab50e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c3ab7922-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c3aba168-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3abcc74-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:c3abf712-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3ac2052-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3ac488e-94cc-11ec-8aec-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3ac7124-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c3ac9d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:c3ac9d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:c3accb24-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c3acf4fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c3ad1d22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4QYD9 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Unclassified (Heat sensitive channel TRPV3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c3ad452c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c3ad6d36-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c3ad96f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:4264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamide targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c3adbf0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c3ade6f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c3ae0f0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c3ae3766-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c3ae6010-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c3ae882e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c3aeb038-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c3aed90a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c3af0132-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3af2950-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:c3af5164-94cc-11ec-8aec-0242ac110003 UniProtKB:P00720 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Endolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c3af7ce8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:c3afa7cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:c3afcffe-94cc-11ec-8aec-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c3aff89e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:c3b021b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:c3b049ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:c3b071d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c3b09a74-94cc-11ec-8aec-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c3b0c274-94cc-11ec-8aec-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c3b0eaec-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b1944c-94cc-11ec-8aec-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:c3b301c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:c3b32be0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:c3b35408-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c3b37c1c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c3b3a476-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Florbetapir F-18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:c3b3cc94-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c3b3f480-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c3b41c9e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c3b44516-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c3b46d16-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c3b49534-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3b4bd2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6RI86 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c3b4e64c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c3b50f82-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium iodide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c3b537dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3b55ff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c3b58886-94cc-11ec-8aec-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:c3b5bc5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:c3b5bc5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:c3b5bc5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:c3b5bc5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:c3b60716-94cc-11ec-8aec-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c3b62ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c3b6581a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c3b68024-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:c3b6a82e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Flutemetamol (18F) targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c3b6d16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.69']} DrugCentral uuid:c3b6f9dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:c3b72236-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c3b74b08-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c3b77358-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b7bdae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:c3b83914-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c3b86132-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:c3b88a90-94cc-11ec-8aec-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c3b8b4a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c3b8dd88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.87']} DrugCentral uuid:c3b905a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:c3b92e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.201']} DrugCentral uuid:c3b95632-94cc-11ec-8aec-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c3b98210-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:c3b98210-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:c3b9b6d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c3b9df80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c3ba0848-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c3ba303e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c3ba5988-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3ba830e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c3baab22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:c3bad340-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c3bafbae-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c3bb23b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c3bb4bcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c3bb73fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c3bb9d20-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c3bbc548-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c3bbed66-94cc-11ec-8aec-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c3bc155c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3bc3faa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c3bc67c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c3bc8fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16555 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Dihydropyrimidinase-related protein 2) DrugCentral uuid:c3bcb4b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c3bcdd5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c3bd0548-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3bd2d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c3bd550c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c3bd7da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c3bda598-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c3bddcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c3bddcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c3bddcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c3bddcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c3bddcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c3be3558-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c3be5d4e-94cc-11ec-8aec-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c3be854e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c3beada8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c3bed5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:c3beff24-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c3bf2760-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3bf503c-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c3bf7878-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c3bfa08c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c3bfc8b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3bff438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c3c01ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c3c045fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3c06ee0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3c096fe-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c3c0befe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3c0e71c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c3c10fee-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3c1380c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3c16020-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c3c18820-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c3c1b138-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3c1d956-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c3c20174-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3c22988-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c3c251f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c3c27a0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3c2a232-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3c2ca50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c3c2f322-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3c31b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c3c343b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3c36bcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c3c3966a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3c3c0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3c3e908-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3c41112-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c3c43a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c3c46298-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c3c48ab6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3c4b2de-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azilsartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c3c4dbb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:4322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azilsartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c3c504fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c3c52d04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c3c5563a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3c57ebc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c3c5a6ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:c3c5cf2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c3c5f798-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c3c61ff2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant is antagonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.52']} DrugCentral uuid:c3c64824-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c3c67042-94cc-11ec-8aec-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c3c698ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c3c6c128-94cc-11ec-8aec-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c3c6e946-94cc-11ec-8aec-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c3c71218-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c3c73b08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c7f69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:c3c99cc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambrisentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:c3c9c512-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambrisentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:c3c9ed94-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c3ca15ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zucapsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:c3ca3e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:c3ca66de-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:c3ca8f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3cab71a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.726']} DrugCentral uuid:c3cae12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.363']} DrugCentral uuid:c3cb09e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.958']} DrugCentral uuid:c3cb31f4-94cc-11ec-8aec-0242ac110003 UniProtKB:O43194 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets GPCR (G-protein coupled receptor 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c3cb59f4-94cc-11ec-8aec-0242ac110003 UniProtKB:A6QR73 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets GPCR (G protein-coupled receptor 39-1b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c3cb8276-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPD8 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Unclassified (Ubiquitin-conjugating enzyme E2 T) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c3cbaa9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cbe9aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:c3cc4990-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:c3cc71ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:c3cc9a26-94cc-11ec-8aec-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c3ccc424-94cc-11ec-8aec-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c3ccec60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c3cd1488-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bilastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:c3cd3cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:4357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anidulafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c3cd6550-94cc-11ec-8aec-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:4358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine glutamate targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c3cd8da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3cdb5dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c3cddf3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c3ce078a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.54']} DrugCentral uuid:c3ce2fd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c3ce57ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c3ce819c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c3ceacbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.23']} DrugCentral uuid:c3ced520-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c3cefd48-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c3cf25de-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c3cf4df2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c3cf761a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c3cf9e2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c3cfc700-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c3cfef1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c3d01750-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3d03faa-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3d06a98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c3d0946e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c3d0bd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3d0e5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c3d10e62-94cc-11ec-8aec-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3d13694-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c3d15ec6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c3d1878e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3d1afe8-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3d1d824-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3d20182-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c3d22b12-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c3d25394-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c3d27bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c3d2a40c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c3d2ccc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3d2f4f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3d31d4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c3d345a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c3d36e82-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3d396e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3d3bf2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c3d3e772-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c3d41260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c3d43ae2-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c3d463a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3d48bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3d4b666-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c3d4de8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c3d506ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c3d52f7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3d557c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c3d57fec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c3d5a828-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c3d5d172-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c3d5fbf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c3d62424-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c3d64c42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3d674ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c3d69ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c3d6c500-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c3d6ed5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c3d716c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c3d73eea-94cc-11ec-8aec-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c3d76726-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c3d78f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c3d7b9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c3d7e35e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c3d80b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c3d833cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c3d85c76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3d884a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c3d8ade8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c3d8d61a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.33']} DrugCentral uuid:c3d8ff00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3d9273c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c3d94f64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c3d978b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c3d9a306-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c3d9cb38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3d9f36a-94cc-11ec-8aec-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c3da1c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c3da443c-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c3da6c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c3da94b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3dabd86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c3dae5b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3db0de0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c3db368a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3db5fde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c3db8806-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:c3dbb038-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3dbd856-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c3dc00ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3dc2914-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c3dc513c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c3dc7964-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3dca33a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c3dccb76-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c3dcf3b2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3dd1bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c3dd46f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c3dd6f18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c3dd9754-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c3ddc026-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3dde984-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c3de11ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c3de3a1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3de638c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c3de8bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c3deb40e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c3dedc40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3df0666-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c3df30c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c3df58fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c3df8136-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c3dfa9ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c3dfd21c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c3dffa44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c3e0228a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c3e04b84-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c3e073a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c3e09cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c3e0c50a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c3e0ee2c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c3e1167c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c3e13e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c3e1676c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3e18fda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c3e1b802-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c3e1e03e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c3e20992-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.29']} DrugCentral uuid:c3e231ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c3e259e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c3e282a0-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:c3e2ac6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c3e2d782-94cc-11ec-8aec-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3e301c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c3e329f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3e35298-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3e37aca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c3e3a2f2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3e3cb24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c3e3f54a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3e41d7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3e445c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3e46e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c3e49842-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c3e4c06a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3e4e89c-94cc-11ec-8aec-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c3e51164-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c3e5398c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c3e561b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c3e589fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c3e5b2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:c3e5db12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.49']} DrugCentral uuid:c3e6034e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c3e62b76-94cc-11ec-8aec-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c3e65466-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c3e67c98-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c3e6a4d4-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c3e6cd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c3e6f5b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c3e71dce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3e7461e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3e76e28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c3e79704-94cc-11ec-8aec-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c3e7bf22-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c3e7e75e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:c3e80f90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c3e839e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:c3e86210-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c3e88b32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c3e8b35a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c3e8dc9a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c3e904cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c3e92cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3e955ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c3e97e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c3e9a652-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c3e9ce84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c3e9f940-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c3ea2190-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c3ea49cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c3ea721c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c3ea9ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c3eac2e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.11']} DrugCentral uuid:c3eaeb0c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c3eb1348-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c3eb3c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c3eb6456-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c3eb8c88-94cc-11ec-8aec-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c3ebb4ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c3ebde86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c3ec06c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c3ec2ecc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c3ec5712-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:c3ec80b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c3eca8de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c3ecd106-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c3ecf960-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c3ed261a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c3ed261a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c3ed5d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c3ed5d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c3ed9438-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c3ed9438-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c3edcc1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:4360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrimide targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c3edf446-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:c3ee1c96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c3ee452c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c3ee6d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:4362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chiniofon targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c3ee957c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:c3eebd90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c3eee680-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZV8 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c3ef0ec6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.875']} DrugCentral uuid:c3ef3770-94cc-11ec-8aec-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c3ef5fa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c3ef8982-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c3efb2fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:c3efdb58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c3f00394-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c3f02d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:c3f05574-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:c3f07de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c3f0a632-94cc-11ec-8aec-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c3f0cef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c3f0f718-94cc-11ec-8aec-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c3f11f68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c3f148b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c3f17300-94cc-11ec-8aec-0242ac110003 UniProtKB:P29973 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c3f19b14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16280 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Cyclic nucleotide-gated olfactory channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c3f1c35a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:4379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 degarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c3f1ebfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.325']} DrugCentral uuid:c3f21440-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:c3f23ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c3f264fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.95']} DrugCentral uuid:c3f28e02-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirabegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.65']} DrugCentral uuid:c3f2b648-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c3f2dea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c3f306fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c3f33096-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c3f358c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c3f3810e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c3f3a936-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c3f3d1e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c3f3faf8-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c3f4232a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c3f44b66-94cc-11ec-8aec-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c3f47474-94cc-11ec-8aec-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c3f4a0a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c3f4a0a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c3f4d856-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:c3f4d856-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:c3f51398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c3f51398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c3f51398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c3f51398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c3f55e20-94cc-11ec-8aec-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c3f5930e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c3f5930e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c3f5930e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c3f5930e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c3f5e084-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c3f5e084-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c3f61ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c3f61ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c3f61ba8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c3f65a46-94cc-11ec-8aec-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c3f68296-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:c3f6aadc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:c3f6d61a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c3f7007c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:c3f72494-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c3f74cda-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:c3f7716a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:c3f79564-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.582']} DrugCentral uuid:c3f7bdaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.639']} DrugCentral uuid:c3f7e5d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.321']} DrugCentral uuid:c3f80e68-94cc-11ec-8aec-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.024']} DrugCentral uuid:c3f836ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.029']} DrugCentral uuid:c3f85eea-94cc-11ec-8aec-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.154']} DrugCentral uuid:c3f8874e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.335']} DrugCentral uuid:c3f8b21e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:c3f8dd3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofenotane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c3f9084a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c3f93086-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltrombopag targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c3f9596c-94cc-11ec-8aec-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c3f9818a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casopitant targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c3f9a9f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casopitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c3f9d2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7DHH4 biolink:molecularly_interacts_with DrugCentral:4402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftobiprole medocaril targets Enzyme (MecA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c3f9fae8-94cc-11ec-8aec-0242ac110003 UniProtKB:P61073 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is partial agonist of GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c3fa2450-94cc-11ec-8aec-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c3fa4c96-94cc-11ec-8aec-0242ac110003 UniProtKB:P48061 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets Cytokine (Stromal cell-derived factor 1) DrugCentral uuid:c3fa71f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is antagonist of GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c3fa9c6e-94cc-11ec-8aec-0242ac110003 UniProtKB:O08565 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c3fac496-94cc-11ec-8aec-0242ac110003 UniProtKB:P25106 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is agonist of GPCR (Atypical chemokine receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c3faee4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.118']} DrugCentral uuid:c3fb173e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.157']} DrugCentral uuid:c3fb3f70-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c3fb67b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.308']} DrugCentral uuid:c3fb9006-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:c3fbb8d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.915']} DrugCentral uuid:c3fbe11e-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:c3fc0982-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c3fc31dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.085']} DrugCentral uuid:c3fc5c48-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.478']} DrugCentral uuid:c3fc847a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:c3fcacca-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.262']} DrugCentral uuid:c3fcd4fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:c3fcfe6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:c3fd26a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:c3fd4ec8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.781']} DrugCentral uuid:c3fd76fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:c3fd9f7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.931']} DrugCentral uuid:c3fdc7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c3fdefd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c3fe192a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c3fe4210-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibutylphthalate is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c3fe6a2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c3fe9242-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c3febbfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c3fee440-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:c3ff0c68-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.018']} DrugCentral uuid:c3ff3490-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.652']} DrugCentral uuid:c3ff5d1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:c3ff8562-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.604']} DrugCentral uuid:c3ffada8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.775']} DrugCentral uuid:c3ffd5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c40000aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c40029ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c400523a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c4007a94-94cc-11ec-8aec-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:c400a352-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c400cb66-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c400f398-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c4011bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c40144b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c4016cec-94cc-11ec-8aec-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c4019532-94cc-11ec-8aec-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c401c246-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c401c246-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c401f9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:c401f9a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:c402330c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c402330c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c402330c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c402330c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c4027dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:c402b17e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c402b17e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c402b17e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c402b17e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c402ff62-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c402ff62-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:c4033a86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c4033a86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c4033a86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c40378e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c403a21e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:c403ce42-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c403ce42-94cc-11ec-8aec-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c4040592-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:c4040592-94cc-11ec-8aec-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:c4043d32-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:c4043d32-94cc-11ec-8aec-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:c4047086-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone sodium phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c40495f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.179']} DrugCentral uuid:c404be2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Cytosolic other (Annexin A1) DrugCentral uuid:c404e2be-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c4050afa-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:c4053354-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c4055b86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.818']} DrugCentral uuid:c40586c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c405aee2-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c405d7be-94cc-11ec-8aec-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c406000e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone cypionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c406248a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c4064898-94cc-11ec-8aec-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:4456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone succinate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c40670f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:c406950a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c406be0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c406e64a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c4070e72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:4466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eosin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c407369a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:4466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eosin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c40778b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:c407e3ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosaprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c4080c00-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c408345a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c4085c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c4088586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c408adcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:4480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium phosphate, monobasic targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c408d612-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c40906f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c40906f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c40906f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c4095268-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4095268-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4095268-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4099da4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c4099da4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c4099da4-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:c409d58a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c409fdda-94cc-11ec-8aec-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c40a2602-94cc-11ec-8aec-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c40a4ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:c40a7724-94cc-11ec-8aec-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:c40a9f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c40ac76a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:c40af0e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c40b1af8-94cc-11ec-8aec-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c40b432a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c40b6bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:c40b947e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c40bbcba-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c40be50a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c40c0d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c40c35f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c40c5e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4485 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflorasone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.536']} DrugCentral uuid:c40c8744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4485 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflorasone diacetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c40caf80-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c40cd65e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:c40cfed6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:c40d2712-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c40d4f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c40d7816-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol acetate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c40d9c10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c40dc438-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:c40de846-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:c40e0cea-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:c40e3512-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c40e5d58-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:c40e8576-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:c40eac36-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:c40ed1fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:c40ef5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c40f1e46-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4504 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c40f42fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:c40f6b4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c40f9380-94cc-11ec-8aec-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c40fbbb2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c40fe4a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.135']} DrugCentral uuid:c4100cde-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:c410351a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.917']} DrugCentral uuid:c4105d60-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c410875e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:c410afb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c410dc7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:c410dc7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:c4110ada-94cc-11ec-8aec-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:c4112ef2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c4115742-94cc-11ec-8aec-0242ac110003 UniProtKB:P49190 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c4117f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P70555 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c411a81e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25961 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c411d03c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracosactide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c411f864-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracosactide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:c412208c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:c4124616-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c4126e66-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:c412929c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92953 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine is blocker of Ion channel (Potassium voltage-gated channel subfamily B member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c412bad8-94cc-11ec-8aec-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c412eb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c412eb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c412eb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c41329aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:c41351d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbendazole targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.496']} DrugCentral uuid:c4137ab8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:4536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbendazole targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:c413a2ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.12']} DrugCentral uuid:c413cb30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:c413f376-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c4141d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c41446b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c4146ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c4149718-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c414bfc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c414e7fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4151058-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c4154438-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4154438-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4154438-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4154438-94cc-11ec-8aec-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4159640-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c4159640-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c4159640-94cc-11ec-8aec-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c415d894-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:c415d894-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:c4160846-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6RY99 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate targets Unclassified (Gamma-hydroxybutyrate receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c4163078-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochloric acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c41658f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone probutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c4167d76-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c416a616-94cc-11ec-8aec-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c416ce3e-94cc-11ec-8aec-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c416f670-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c4172ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4172ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4172ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4172ad2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c417750a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c4179d46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c417c74e-94cc-11ec-8aec-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c417ef94-94cc-11ec-8aec-0242ac110003 UniProtKB:O88944 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c41817c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c4184002-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c4186870-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c4189084-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c418b8ac-94cc-11ec-8aec-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:c418e0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c4190b90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c41933e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tonzonium targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c4195d34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:4605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tonzonium targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c419857a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clocortolone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c419aaaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:4608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c419d2dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:4608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c419fb40-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone enantate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:c41a1f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c41a47c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c41a6fe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c41a9820-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c41ac052-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c41ae956-94cc-11ec-8aec-0242ac110003 UniProtKB:P27471 biolink:molecularly_interacts_with DrugCentral:4615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 N-Acetylglucosamine targets Unclassified (Killer cell lectin-like receptor subfamily B member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c41b128c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c41b3ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c41b6458-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c41b8cee-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c41bb52a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c41bddf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c41c069c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c41c2ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:c41c5700-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c41c7f28-94cc-11ec-8aec-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.56']} DrugCentral uuid:c41ca804-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c41cd02c-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c41cf840-94cc-11ec-8aec-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c41d2054-94cc-11ec-8aec-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:c41d49c6-94cc-11ec-8aec-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:c41d7202-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c41d9a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:c41dc252-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c41deab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:4621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomefolic acid targets Enzyme (Thymidylate synthase) DrugCentral uuid:c41e0ea6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23897 biolink:molecularly_interacts_with DrugCentral:4622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:c41e36e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:4622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.907']} DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41e72ec-94cc-11ec-8aec-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:c41ec918-94cc-11ec-8aec-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:4624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylacetic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:c41ef17c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c41f1b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c41f43e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c41f6c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c41f9492-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c41fbd1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c41fe942-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c41fe942-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c4201cdc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4628 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enzalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c42045e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4628 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enzalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:c4206e12-94cc-11ec-8aec-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium pyrophosphate targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c4209658-94cc-11ec-8aec-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:c420c614-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:c420c614-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:c420c614-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:c420c614-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:c4210a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trabectedin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c42132c0-94cc-11ec-8aec-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:4633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trabectedin is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c4215b9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c4218450-94cc-11ec-8aec-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c421ac82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c421d4be-94cc-11ec-8aec-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c421fcfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c42225ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:4635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Choline C-11 targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4224f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c422773e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c4229f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c422c914-94cc-11ec-8aec-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c422f146-94cc-11ec-8aec-0242ac110003 UniProtKB:O06446 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c4231996-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2FUW6 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c42341be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c4236a68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:c4239286-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c423bacc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c423e2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c4240d06-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c4243556-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c4245db0-94cc-11ec-8aec-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c4248600-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid is agonist of GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c424af0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:c424d75e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c424ffae-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c4252862-94cc-11ec-8aec-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c42550a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c42578e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c425a120-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:c425ca10-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c425f26a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c4261c22-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c4264472-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4266dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c4269616-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c426be48-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c426e698-94cc-11ec-8aec-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c4270f38-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4273774-94cc-11ec-8aec-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4275fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c42787e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c427b154-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c427d99a-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c42801cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c42829e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c428544c-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c4287c7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c428a4ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:4655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedisamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:c428cd1e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metamizole is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.041']} DrugCentral uuid:c428f5aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c4291dd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c4294604-94cc-11ec-8aec-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:c4296ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c4299744-94cc-11ec-8aec-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:4663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoin targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c429bf8a-94cc-11ec-8aec-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:4663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoin targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:c429e9b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:c42a139a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c42a3d34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c42a658e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:c42a8dde-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.776']} DrugCentral uuid:c42ab674-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:c42adec4-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:c42b070a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:c42b2f96-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.428']} DrugCentral uuid:c42b587c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c42b8144-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c42ba96c-94cc-11ec-8aec-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:c42bd1b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c42bfd04-94cc-11ec-8aec-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c42c2838-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c42c509c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:c42c7964-94cc-11ec-8aec-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:c42ca4de-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c42ccd10-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c42cf52e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:c42d1dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c42d4600-94cc-11ec-8aec-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c42d6e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:c42d965a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:c42dc030-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c42de934-94cc-11ec-8aec-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:c42e1166-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c42e3984-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c42e6260-94cc-11ec-8aec-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c42e8a9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c42eb30a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obidoxime targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.67']} DrugCentral uuid:c42edb3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c42f03dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c42f2bfa-94cc-11ec-8aec-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c42f544a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c42f7cb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c42fa6b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c42fd028-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c42ff8a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c430223a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:c4304ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c4307334-94cc-11ec-8aec-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:c4309bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c430c4b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c430edaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:c43115f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c4313e18-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c43167e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c431900c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c431b83e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c431e12e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c43209ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4323232-94cc-11ec-8aec-0242ac110003 UniProtKB:O35678 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4325a6e-94cc-11ec-8aec-0242ac110003 UniProtKB:O08914 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c4328e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c4328e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c4328e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c4328e76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c432d89a-94cc-11ec-8aec-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c43300a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c43328cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7T664 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c4335464-94cc-11ec-8aec-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:4696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remikiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c4337dae-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c433a5ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c433ceb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:c433f6d0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:c4341f20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:c434477a-94cc-11ec-8aec-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c43470ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 semustine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:c434990a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.074']} DrugCentral uuid:c434c150-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:c434e55e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.624']} DrugCentral uuid:c4350f16-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:c435375c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c43560ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:4710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatorelin is agonist of GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c4358a18-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:c435b2ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c435dafe-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c4360344-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c4362b94-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c43654f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4367d24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c436a5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:c436ce46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c436f754-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c4371fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c43747ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c437701c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c43798d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c437c12a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c437e966-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c4381260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c4383ab0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c43862f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4388b1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c438b472-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c438dcae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c43904f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c4392d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c43955e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:c4397f24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c439a756-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c439cf7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c439f850-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c43a20a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c43a48dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c43a7118-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62137 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c43a9b20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c43ac37a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c43aeba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c43b17ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c43b17ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c43b548e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c43b548e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c43b548e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c43b96f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c43b96f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c43bcaf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63272 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c43bf718-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:c43bf718-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:c43c2ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:c43c2ef4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:c43c63e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.907']} DrugCentral uuid:c43c8dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:c43cb630-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c43cdf48-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c43d07d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c43d2fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:c43d5824-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c43d804c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c43da928-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c43dd164-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:c43df996-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.947']} DrugCentral uuid:c43e21c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:c43e4c2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.456']} DrugCentral uuid:c43e74de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.845']} DrugCentral uuid:c43e9d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.886']} DrugCentral uuid:c43ec54c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c43eede2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:c43f1614-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.903']} DrugCentral uuid:c43f3e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Breakpoint cluster region protein) DrugCentral uuid:c43f6268-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c43f8ae0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c43fb31c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c43fdb58-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:c4400470-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c4402ca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c44054ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.268']} DrugCentral uuid:c4407d06-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:c440a7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:c440d008-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c440f858-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c441209e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:c4414948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c44171b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c4419a10-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c441c256-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c441f10e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c441f10e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c44225c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c4424ea6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95838 biolink:molecularly_interacts_with DrugCentral:4718 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teduglutide is agonist of GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c44277aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z0W0 biolink:molecularly_interacts_with DrugCentral:4718 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teduglutide targets GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:c4429fc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:c442c3b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:c442e7b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:c4430bb6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:c443300a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:c4435418-94cc-11ec-8aec-0242ac110003 UniProtKB:P55157 biolink:molecularly_interacts_with DrugCentral:4721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomitapide is inhibitor of Cytosolic other (Microsomal triglyceride transfer protein large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:c4437c90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinimide targets Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:c443a4e0-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinimide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c443ce5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:4727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c443f684-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.573']} DrugCentral uuid:c4441eac-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c44447ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:c4447050-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c44499a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c444c1cc-94cc-11ec-8aec-0242ac110003 UniProtKB:O97554 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c444ea8a-94cc-11ec-8aec-0242ac110003 UniProtKB:O02768 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c445169a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c445169a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c44549c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P48050 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap is activator of Ion channel (Inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c445ac0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c4468368-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c4468368-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c4468368-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c446caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:c446caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:c446caf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:c4471116-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:c4471116-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:c4471116-94cc-11ec-8aec-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:c4474f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c4477e26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c4477e26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c447b170-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c447d998-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c4480274-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:c4482ac4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:c4485300-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c4487bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:c448a47c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c448ccb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.135']} DrugCentral uuid:c448f4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c4491d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:c44947a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c4496fec-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c4499828-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c449c05a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c449ea80-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c44a13de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c44a3c24-94cc-11ec-8aec-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c44a64ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c44a8d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c44ab5aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:c44adde6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c44b078a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:c44b32aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44b759e-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:c44bddae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5TIX5 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c44c05f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00845 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c44c2e44-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crofelemer is inhibitor of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:c44c56da-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5XXA6 biolink:molecularly_interacts_with DrugCentral:4744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crofelemer is inhibitor of Ion channel (Anoctamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:c44c7f16-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c44ca748-94cc-11ec-8aec-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c44ccfa2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.577']} DrugCentral uuid:c44cf8e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ospemifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.082']} DrugCentral uuid:c44d210a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobetaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c44d4946-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobetaxolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c44d7218-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:4757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyl fumarate targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c44d9b62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14145 biolink:molecularly_interacts_with DrugCentral:4757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyl fumarate is inhibitor of Cytosolic other (Kelch-like ECH-associated protein 1) DrugCentral uuid:c44dbf70-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:c44de810-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c44e10c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c44e38ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c44e6128-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:c44e8946-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c44eb236-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c44eda5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c44f03d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c44f2c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c44f560a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c44f7eaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4778 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ridaforolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:c44fa6c8-94cc-11ec-8aec-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.289']} DrugCentral uuid:c44fcf04-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:c44ff7e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.961']} DrugCentral uuid:c4502026-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.477']} DrugCentral uuid:c4504876-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:c45070bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:c4509b50-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:c450c38c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:c450ebc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium propionate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c4511404-94cc-11ec-8aec-0242ac110003 UniProtKB:B2GV46 biolink:molecularly_interacts_with DrugCentral:4796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium propionate targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c4513c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.2']} DrugCentral uuid:c45164ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.08']} DrugCentral uuid:c4518e20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.9']} DrugCentral uuid:c451b72e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c451df60-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c4520788-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c4522fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c4525968-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c4528488-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c452acec-94cc-11ec-8aec-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c452d532-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c452fe40-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c4532672-94cc-11ec-8aec-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c4534f12-94cc-11ec-8aec-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c4537730-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4539fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c453c820-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c453f052-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c4541884-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c45443ea-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c4546d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:c45495c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.036']} DrugCentral uuid:c454bdf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:c454e804-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4804 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palifermin is agonist of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:c4550c08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c455344e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c4555dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c455864c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c455ae74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c455d6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.131']} DrugCentral uuid:c4560054-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c45628fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c456514e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c456798a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c456a266-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c456caa2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c456f2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c4571ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c4574392-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c4576bc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c45793f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c457bc1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c457e6bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:c45811f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:c4583a2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c4586272-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:c4588b58-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:c458b45c-94cc-11ec-8aec-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:c458dcc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:c4590556-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:4807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riociguat targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:c4592d9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riociguat is positive allosteric modulator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'MEC', 'has_quantitative_value': ['7.523']} DrugCentral uuid:c45956aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c4597ee6-94cc-11ec-8aec-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c459a826-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c459d288-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.658']} DrugCentral uuid:c459fa9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.569']} DrugCentral uuid:c45a22ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macitentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:c45a4be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macitentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.408']} DrugCentral uuid:c45a740e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c45a9ccc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c45ac4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:c45aeea2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c45b172e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c45b3f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c45b67d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c45b91c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c45bba3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c45be280-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRX8 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Unclassified (Redox-regulatory protein FAM213A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c45c0abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:c45c33b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:c45c5bfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:c45c8442-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:c45cac88-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:c45cd564-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c45cfd96-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:c45d267c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c45d50a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:c45d78ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:c45da106-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c45dc956-94cc-11ec-8aec-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:c45df2be-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c45e1b0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c45e435e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.143']} DrugCentral uuid:c45e6bae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofosbuvir is inhibitor of Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c45e9458-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofosbuvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC90', 'has_quantitative_value': ['6.959']} DrugCentral uuid:c45ebc76-94cc-11ec-8aec-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c45ee930-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c45ee930-94cc-11ec-8aec-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c45f1c84-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c45f47c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6GYR8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Polyprotein (Polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:c45f7026-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:c45f986c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:4813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luliconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c45fbd06-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c45fe54c-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c4600d88-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c46035f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lixisenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.845']} DrugCentral uuid:c4605e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c46086be-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c460b044-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:c460d876-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.824']} DrugCentral uuid:c4610224-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:c4612b50-94cc-11ec-8aec-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c4615382-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c4617bc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c461a526-94cc-11ec-8aec-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c461cd4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:c461f152-94cc-11ec-8aec-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 florbetaben F18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:c46219a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:4820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:c462426a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:4820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c4626aba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 seractide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.009']} DrugCentral uuid:c46292f6-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c462bb32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:4822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c462e5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c4630dda-94cc-11ec-8aec-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:c4633602-94cc-11ec-8aec-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c4635e34-94cc-11ec-8aec-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c463871a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:c463af74-94cc-11ec-8aec-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c463d79c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c463ffe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:c4642896-94cc-11ec-8aec-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c46450e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9IGQ6 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c464794a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilefrine pivalate is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:c4649d76-94cc-11ec-8aec-0242ac110003 UniProtKB:P48357 biolink:molecularly_interacts_with DrugCentral:4826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metreleptin is agonist of Membrane receptor (Leptin receptor) DrugCentral uuid:c464c3dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c464ec18-94cc-11ec-8aec-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c4651454-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:c4653e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:c4656670-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M3M2 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:c4658e7a-94cc-11ec-8aec-0242ac110003 UniProtKB:A0PJK1 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:c465b6a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.081']} DrugCentral uuid:c465df24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c46607e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.244']} DrugCentral uuid:c4663028-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxegol is antagonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:c4665422-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemigliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.328']} DrugCentral uuid:c4667e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c466a6fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:4834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eliglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.827']} DrugCentral uuid:c466cf10-94cc-11ec-8aec-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c466f788-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c4672050-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c4674878-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:c46770be-94cc-11ec-8aec-0242ac110003 UniProtKB:P33033 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c46798d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P41149 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c467c1c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P56450 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:c467e9fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01727 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:c4681226-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c4683a4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprotinin is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c4686406-94cc-11ec-8aec-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprotinin is inhibitor of Enzyme (Plasma kallikrein) DrugCentral uuid:c4688814-94cc-11ec-8aec-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ecallantide is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.602']} DrugCentral uuid:c468b082-94cc-11ec-8aec-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:4848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatropin is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:c468d472-94cc-11ec-8aec-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:4853 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cridanimod targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c468fce0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3TBT3 biolink:molecularly_interacts_with DrugCentral:4853 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cridanimod targets Unclassified (Stimulator of interferon genes protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c4692526-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c4694a1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:c4696e0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:c4699722-94cc-11ec-8aec-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c469bfd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:c469e3e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:c46a07e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q60748 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c46a3182-94cc-11ec-8aec-0242ac110003 UniProtKB:P47866 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c46a59d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13324 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c46a820e-94cc-11ec-8aec-0242ac110003 UniProtKB:P34998 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.481']} DrugCentral uuid:c46aae32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:c46aae32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:c46adc4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c46b0486-94cc-11ec-8aec-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46b440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c46bb098-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.951']} DrugCentral uuid:c46bd8f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.035']} DrugCentral uuid:c46c0200-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:c46c260e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:c46c49f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c46c721c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c46c9ba2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c46cc3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c46cebfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c46d1410-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c46d3d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c46d6532-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c46d8d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c46db578-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c46de00c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c46e0884-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c46e30a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c46e58d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c46e816a-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c46ea988-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:c46ed192-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c46ef9b0-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c46f22a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c46f4abe-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:c46f72d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c46f9b90-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c46fc412-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:c46fec26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:c470144e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c4703cda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c470650c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c4708dfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c470b624-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c470ded8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c4710714-94cc-11ec-8aec-0242ac110003 UniProtKB:P41212 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transcription factor (Transcription factor ETV6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c4712f50-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c471580e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:c4718374-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:c471aeee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:c471d752-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:c471ff98-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c472284c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c472509c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c47278f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c472a150-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c472cab8-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c472f2fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c4731b12-94cc-11ec-8aec-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:c473434e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c4736c70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c473988a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c473988a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:c473c648-94cc-11ec-8aec-0242ac110003 UniProtKB:P25116 biolink:molecularly_interacts_with DrugCentral:4870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorapaxar is antagonist of GPCR (Proteinase-activated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.092']} DrugCentral uuid:c473eef2-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c4741706-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c4743f2e-94cc-11ec-8aec-0242ac110003 UniProtKB:F2SHH3 biolink:molecularly_interacts_with DrugCentral:4874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efinaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:c4746422-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:c4748cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:c474b544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:c474dd8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:c47505a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.301']} DrugCentral uuid:c4753000-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c4755846-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c47580a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c475a8f0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c475d1fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c475fac6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c476233e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c4764b98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c4767456-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c4769cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:c476c4ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c476ed14-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c47716ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.569']} DrugCentral uuid:c4773ff8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c4776852-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c4779160-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c477b992-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c477e1d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P26637 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Leucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c4780a1e-94cc-11ec-8aec-0242ac110003 UniProtKB:F2SF18 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole is inhibitor of Enzyme (Leucine-tRNA ligase) DrugCentral uuid:c4782eae-94cc-11ec-8aec-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c47857e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NEB9 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 3-kinase catalytic subunit type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c4788020-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.086']} DrugCentral uuid:c478a85c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.248']} DrugCentral uuid:c478d1ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.051']} DrugCentral uuid:c478fa1e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:c479225a-94cc-11ec-8aec-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:4879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxaparin sodium is activator of Secreted (Antithrombin-III) DrugCentral uuid:c4794672-94cc-11ec-8aec-0242ac110003 UniProtKB:P58308 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant targets GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:c4796f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P58307 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c47997da-94cc-11ec-8aec-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c479c020-94cc-11ec-8aec-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:c479e8ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c47a1390-94cc-11ec-8aec-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c47a3bf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c47a641c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c47a8cee-94cc-11ec-8aec-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c47ab700-94cc-11ec-8aec-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c47adf3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c47b0778-94cc-11ec-8aec-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c47b2fd2-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dulaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) DrugCentral uuid:c47b54a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:4886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetilistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.225']} DrugCentral uuid:c47b7cf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:4888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiroxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c47ba534-94cc-11ec-8aec-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:4888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiroxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.276']} DrugCentral uuid:c47bcd70-94cc-11ec-8aec-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:4889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asunaprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c47bf5e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asunaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:c47c1e42-94cc-11ec-8aec-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c47c4778-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8C3K6 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:c47c7130-94cc-11ec-8aec-0242ac110003 UniProtKB:P53790 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:c47c9994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q923I7 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:c47cc1bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.727']} DrugCentral uuid:c47ce9ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.132']} DrugCentral uuid:c47d13b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luseogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.399']} DrugCentral uuid:c47d3be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luseogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.646']} DrugCentral uuid:c47d640a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4892 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.073']} DrugCentral uuid:c47d8c32-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4892 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:c47db496-94cc-11ec-8aec-0242ac110003 UniProtKB:P07650 biolink:molecularly_interacts_with DrugCentral:4893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipiracil targets Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c47ddce6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19971 biolink:molecularly_interacts_with DrugCentral:4893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipiracil is inhibitor of Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:c47e050e-94cc-11ec-8aec-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:4894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iguratimod targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c47e2d36-94cc-11ec-8aec-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.54']} DrugCentral uuid:c47e563a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:c47e7e62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:c47ea69e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:c47eceda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:c47ef766-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:c47f1f8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:c47f47ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c47f7074-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edoxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.252']} DrugCentral uuid:c47f996e-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4898 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:c47fc1be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:c47fe9fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:c4801222-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:c4803bf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.509']} DrugCentral uuid:c4806420-94cc-11ec-8aec-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:4900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c4808c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:4900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:c480b510-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin glargine is agonist of Kinase (Insulin receptor) DrugCentral uuid:c480d914-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidafenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['8.384']} DrugCentral uuid:c4810150-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidafenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['9.499']} DrugCentral uuid:c481298c-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:c4815290-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:c4817ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c481a2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c481cb12-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c481f452-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:c4821c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c48244ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:c4826cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c482954c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c482bd6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c482e6b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.38']} DrugCentral uuid:c4830ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.02']} DrugCentral uuid:c48337b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c4835ffe-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c4838844-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c483b058-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c483d95c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c484018e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c4842aec-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c4845300-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4847bd2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c484a404-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c484cc54-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c484f486-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c4851dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c485460c-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:c4856e34-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c485976a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c485bf9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c485e7ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c486100a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c486388c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c48660a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c486892c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c486b140-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c486d9fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c487021c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c4872a3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c4875276-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c4877b66-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c487a398-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c487cba2-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c487f3b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c4881d32-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c4884550-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c4886d64-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c4889582-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c488be5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c488e7ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c4891016-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c489385c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c48963e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c4898c12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c489b458-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c489dce4-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c48a0502-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c48a2d20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c48a5552-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c48a7e4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c48aa67e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c48ace88-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:c48af6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c48b1fbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c48b47f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c48b7018-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c48b9840-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c48bc0e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c48be976-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c48c1298-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c48c3ad4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c48c63c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.29']} DrugCentral uuid:c48c8bce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c48cb400-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c48cdc28-94cc-11ec-8aec-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c48d072a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c48d2f98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c48d57c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c48d7fd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c48da856-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c48dd06a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c48df89c-94cc-11ec-8aec-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c48e216e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c48e49aa-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c48e71be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c48e99dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c48ec484-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c48eed10-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c48f154c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c48f3d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c48f660a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c48f8e28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c48fb664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c48fde8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c4900826-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c4903044-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c4905876-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c49080a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c490ab64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c490d3a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c490fbbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c4912404-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c4914ca4-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c49174d6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c4919cfe-94cc-11ec-8aec-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c491c51c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c491ee70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c49216a2-94cc-11ec-8aec-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c4923ec0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c49267f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c49290fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c492b922-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c492e140-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c4930a12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:c493324e-94cc-11ec-8aec-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c4935a8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c493829e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c493ab5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c493d38e-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c493fca6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c49424ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c4944dfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c4947622-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:c4949e54-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c494c7c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c494f066-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c4951898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c49540ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c49568f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c49591ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c495b9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c495e228-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c4960a5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c49635fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c4966108-94cc-11ec-8aec-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c4968994-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c496b22a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c496da52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c497025c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c4972a84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c4975356-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c4977b92-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c497a3c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c497ccdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c497f73e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c4981f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:c498478e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c4986fc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c49898ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c498c0e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c498e900-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.07']} DrugCentral uuid:c4991128-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c4993a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c49962cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c4998b08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:c499b326-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c499de5a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c49a0696-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c49a2ebe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c49a574a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c49a7f86-94cc-11ec-8aec-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c49aa8c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c49ad0f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c49af9d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c49b221a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c49b4a42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c49b727e-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c49b9bdc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c49bc4fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c49bed3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c49c156c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c49c3e02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c49c663e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c49c8e70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c49cb698-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c49cdf74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c49d0788-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c49d2fd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c49d57f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c49d8370-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c49dacec-94cc-11ec-8aec-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c49dd4f6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c49dfd14-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c49e258c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c49e4dbe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c49e75f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c49e9f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c49ec744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c49eef8a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c49f17b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c49f40fc-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c49f691a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c49f9142-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:c49fba50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c49fe386-94cc-11ec-8aec-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c4a00ba4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c4a033d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c4a05c1c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:c4a084ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c4a0ae74-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c4a0d69c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c4a0fec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c4a1296c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c4a1519e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c4a17a2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c4a1a25c-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c4a1cae8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c4a1f324-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c4a21b56-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:c4a2440a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c4a26c5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c4a29478-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c4a2bca0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c4a2e5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c4a31056-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4a33892-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c4a360b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c4a38a18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c4a3b27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c4a3dacc-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.983']} DrugCentral uuid:c4a40330-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c4a42c16-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c4a4545c-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:c4a47c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c4a4a498-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adalimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:c4a4c9be-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4905 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegaptanib is antagonist of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:c4a4edd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fimasartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.377']} DrugCentral uuid:c4a5161c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c4a53e8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c4a567c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c4a59010-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c4a5b86a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c4a5e0a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2NL67 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Unclassified (Poly [ADP-ribose] polymerase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c4a609b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5Y8 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Unclassified (Mono [ADP-ribose] polymerase PARP16) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c4a631dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:c4a65a0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c4a6836c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c4a6ad60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c4a6d5ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acotiamide is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:c4a6fe14-94cc-11ec-8aec-0242ac110003 UniProtKB:P31358 biolink:molecularly_interacts_with DrugCentral:4909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alemtuzumab is antibody binding of Surface antigen (CAMPATH-1 antigen) DrugCentral uuid:c4a72218-94cc-11ec-8aec-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4910 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felypressin is agonist of GPCR (Vasopressin V1a receptor) DrugCentral uuid:c4a746a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.85']} DrugCentral uuid:c4a76f16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.92']} DrugCentral uuid:c4a79874-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.301']} DrugCentral uuid:c4a7c0c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:c4a7e996-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasabuvir targets Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c4a811c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasabuvir targets Unclassified (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c4a83a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c4a86be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c4a86be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c4a86be6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c4a8ab42-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:c4a8d3a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49763 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Placenta growth factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.409']} DrugCentral uuid:c4a8fc78-94cc-11ec-8aec-0242ac110003 UniProtKB:P49765 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.717']} DrugCentral uuid:c4a924d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4917 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramucirumab is antibody binding of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c4a94d0e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c4a97536-94cc-11ec-8aec-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c4a99e26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:c4a9c72a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c4a9f70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c4a9f70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c4a9f70e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c4aa36c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:c4aa620c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nivolumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.14']} DrugCentral uuid:c4aa8d72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pembrolizumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:c4aabbc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:c4aabbc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:c4aae9f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:4927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c4ab135a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:c4ab3ba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:4928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 follitropin is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:c4ab5fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:4929 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lutropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.9']} DrugCentral uuid:c4ab88da-94cc-11ec-8aec-0242ac110003 UniProtKB:P16473 biolink:molecularly_interacts_with DrugCentral:4930 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyrotropin alfa is agonist of GPCR (Thyrotropin receptor) DrugCentral uuid:c4abace8-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c4abd542-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c4abfec8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c4ac2a24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:c4ac50a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q64326 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c4ac7eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:c4ac7eb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:c4acad00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:4934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secukinumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:c4acd12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P03420 biolink:molecularly_interacts_with DrugCentral:4935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palivizumab is antibody binding of Surface antigen (Fusion glycoprotein F0) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:c4acf968-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4936 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parathyroid hormone is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) DrugCentral uuid:c4ad1d76-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c4ad4648-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c4ad6e98-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c4ad96de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c4adbf38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:c4ade922-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.319']} DrugCentral uuid:c4ae1366-94cc-11ec-8aec-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4ae3bac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:c4ae6424-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:c4ae8cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:c4aeb532-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c4aedd78-94cc-11ec-8aec-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c4af06b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.301']} DrugCentral uuid:c4af2fc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:c4af5820-94cc-11ec-8aec-0242ac110003 UniProtKB:P01589 biolink:molecularly_interacts_with DrugCentral:4940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 basiliximab is antibody binding of Membrane receptor (Interleukin-2 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:c4af803e-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c4afa87a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c4afd174-94cc-11ec-8aec-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c4affd84-94cc-11ec-8aec-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4affd84-94cc-11ec-8aec-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c4b0347a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c4b0347a-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c4b06da0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c4b06da0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c4b0a0f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:c4b0c908-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:c4b0f252-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c4b11a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:c4b142c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:c4b16c28-94cc-11ec-8aec-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:c4b19554-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:c4b1bd9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:c4b1e5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4b20e62-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c4b23720-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.658']} DrugCentral uuid:c4b25f5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:c4b287b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:c4b2b0e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:c4b2d9dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:c4b30218-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:c4b32a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:c4b35308-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.947']} DrugCentral uuid:c4b37d7e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.538']} DrugCentral uuid:c4b3a5ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c4b3ce0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin is agonist of GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c4b3f600-94cc-11ec-8aec-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c4b41e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c4b446b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c4b46ef0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:c4b497f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c4b4c030-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c4b4e86c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.155']} DrugCentral uuid:c4b510b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c4b53c86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c4b56530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y275 biolink:molecularly_interacts_with DrugCentral:4949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belimumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 13B) DrugCentral uuid:c4b58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:c4b58d30-94cc-11ec-8aec-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:c4b5bb2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofatumumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.92']} DrugCentral uuid:c4b5e3c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:4952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canakinumab is antibody binding of Cytokine (Interleukin-1 beta) DrugCentral uuid:c4b60f80-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c4b60f80-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c4b60f80-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c4b64dd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetuximab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:c4b677c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panitumumab is agonist of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c4b6a012-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bevacizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:c4b6c3f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4957 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pertuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:c4b6e806-94cc-11ec-8aec-0242ac110003 UniProtKB:P16410 biolink:molecularly_interacts_with DrugCentral:4958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipilimumab is antibody binding of Surface antigen (Cytotoxic T-lymphocyte protein 4) DrugCentral uuid:c4b70ea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:4959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efalizumab is antibody binding of Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.4']} DrugCentral uuid:c4b736f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin degludec is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4b75b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:4961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raxibacumab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.556']} DrugCentral uuid:c4b783f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P28908 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is binding agent of Membrane receptor (Tumor necrosis factor receptor superfamily member 8) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b7c744-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4b83878-94cc-11ec-8aec-0242ac110003 UniProtKB:O14788 biolink:molecularly_interacts_with DrugCentral:4965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denosumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 11) DrugCentral uuid:c4b8612c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:c4b8612c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:c4b892c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:c4b892c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:c4b8c09a-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 golimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:c4b8e750-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 certolizumab pegol is antibody binding of Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.046']} DrugCentral uuid:c4b90f8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:4969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eculizumab is antibody binding of Secreted (Complement C5) DrugCentral uuid:c4b93782-94cc-11ec-8aec-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:c4b93782-94cc-11ec-8aec-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:c4b96928-94cc-11ec-8aec-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:c4b96928-94cc-11ec-8aec-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:c4b997d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranibizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:c4b9bbda-94cc-11ec-8aec-0242ac110003 UniProtKB:P01854 biolink:molecularly_interacts_with DrugCentral:4972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omalizumab is antibody binding of Antibody (Ig epsilon chain C region) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c4b9e510-94cc-11ec-8aec-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4ba0d2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide targets Cytokine (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4ba35e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.135']} DrugCentral uuid:c4ba5e1e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.365']} DrugCentral uuid:c4ba8664-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:c4bab026-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.022']} DrugCentral uuid:c4bad8d0-94cc-11ec-8aec-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:c4bb010c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.108']} DrugCentral uuid:c4bb295c-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infliximab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:c4bb4de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rituximab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:c4bb77f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone hexacetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:c4bb9c16-94cc-11ec-8aec-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:4977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siltuximab is antibody binding of Cytokine (Interleukin-6) DrugCentral uuid:c4bbc042-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4978 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etanercept is inhibitor of Cytokine (Tumor necrosis factor) DrugCentral uuid:c4bbe45a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4979 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:c4bc0980-94cc-11ec-8aec-0242ac110003 UniProtKB:P20138 biolink:molecularly_interacts_with DrugCentral:4980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemtuzumab ozogamicin is antibody binding of Surface antigen (Myeloid cell surface antigen CD33) DrugCentral uuid:c4bc2dac-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin aspart is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4bc55c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c4bc55c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c4bc8a40-94cc-11ec-8aec-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obinutuzumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) DrugCentral uuid:c4bcae6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4984 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibritumomab tiuxetan is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.854']} DrugCentral uuid:c4bcd6b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin detemir is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4bcfae8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:c4bd1f5a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:c4bd435e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:c4bd6bae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:c4bd93cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:c4bdbc80-94cc-11ec-8aec-0242ac110003 UniProtKB:P07445 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid targets Unclassified (Steroid Delta-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c4bde5de-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be2882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c4be9fe2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4991 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lipegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:c4bec80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c4bec80a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c4befbfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.15']} DrugCentral uuid:c4bf241c-94cc-11ec-8aec-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romiplostim is agonist of Membrane receptor (Thrombopoietin receptor) DrugCentral uuid:c4bf4816-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5000 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evolocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.72']} DrugCentral uuid:c4bf7020-94cc-11ec-8aec-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:c4bf98e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:c4bfc1ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c4bfeb36-94cc-11ec-8aec-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c4c01390-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c4c03d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:c4c06584-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin lispro is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4c0897e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:c4c0b192-94cc-11ec-8aec-0242ac110003 UniProtKB:P15127 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.71']} DrugCentral uuid:c4c0da1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4c0fe36-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirodenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.469']} DrugCentral uuid:c4c12654-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c4c14f62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c4c1783e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.627']} DrugCentral uuid:c4c1a066-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin theta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:c4c1c456-94cc-11ec-8aec-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:5008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sonidegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:c4c1ec9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sonidegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:c4c21708-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecasermin targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:c4c23f9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecasermin is agonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c4c267ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:c4c297d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4c297d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4c297d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4c2cf9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:5012 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacubitril is inhibitor of Enzyme (Neprilysin) DrugCentral uuid:c4c2f39e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trelagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:c4c31c52-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c4c3452e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c4c36de2-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:c4c396a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c4c3bef0-94cc-11ec-8aec-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:c4c3ebfa-94cc-11ec-8aec-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:c4c41472-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:c4c43c9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c4c464cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:c4c48d4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.857']} DrugCentral uuid:c4c4b56c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:c4c4dd62-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:c4c5058a-94cc-11ec-8aec-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:c4c52f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:c4c557a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c4c580f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c4c5a92c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c4c5d410-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:c4c5fc2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:c4c62460-94cc-11ec-8aec-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:c4c64d0a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.025']} DrugCentral uuid:c4c6751e-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:c4c69d5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:c4c6c582-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:c4c6ee72-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:c4c716e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:c4c73f3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.921']} DrugCentral uuid:c4c76776-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:c4c79174-94cc-11ec-8aec-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegvisomant is antagonist of GPCR (Growth hormone receptor) DrugCentral uuid:c4c7b596-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alirocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:c4c7e1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c4c7e1b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c4c81518-94cc-11ec-8aec-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:c4c83dcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.516']} DrugCentral uuid:c4c86612-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:c4c88e62-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:c4c8b6a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.049']} DrugCentral uuid:c4c8dff2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:c4c90982-94cc-11ec-8aec-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.093']} DrugCentral uuid:c4c931e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c4c95bd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c4c9881c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c4c9881c-94cc-11ec-8aec-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c4c9bf76-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:c4c9bf76-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:c4c9ed52-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolapitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:c4ca1606-94cc-11ec-8aec-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:5031 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mogamulizumab is antibody binding of GPCR (C-C chemokine receptor type 4) DrugCentral uuid:c4ca3a14-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4ca626e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:c4ca8ab4-94cc-11ec-8aec-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c4cab3ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c4cadbfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c4cb0552-94cc-11ec-8aec-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c4cb2ed8-94cc-11ec-8aec-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c4cb571e-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c4cb7f64-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:c4cba7b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.07']} DrugCentral uuid:c4cbd068-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:c4cbf8a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c4cc20fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:c4cc494e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:c4cc725c-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:c4cc9a84-94cc-11ec-8aec-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c4ccc2ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c4ccebe2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c4cd166c-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c4cd4128-94cc-11ec-8aec-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c4cd6964-94cc-11ec-8aec-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c4cd9178-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c4cdba04-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c4cde222-94cc-11ec-8aec-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c4ce0a72-94cc-11ec-8aec-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c4ce32a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c4ce5b8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c4ce8394-94cc-11ec-8aec-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c4ceabf8-94cc-11ec-8aec-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c4ced524-94cc-11ec-8aec-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c4cf0030-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c4cf286c-94cc-11ec-8aec-0242ac110003 UniProtKB:A6XA80 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Unclassified (Leukotriene C4 synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c4cf509e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatrem is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:c4cf751a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:c4cf9914-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:c4cfc13c-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib is allosteric modulator of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c4cfe98c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:c4d01308-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.187']} DrugCentral uuid:c4d03b3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:c4d06362-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c4d08b9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:c4d0b556-94cc-11ec-8aec-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c4d0de6e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c4d107a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c4d12fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c4d15876-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c4d180bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c4d1a8e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c4d1d102-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c4d1f9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:c4d22224-94cc-11ec-8aec-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c4d24a6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c4d272ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c4d29d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c4d2c5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c4d2ee16-94cc-11ec-8aec-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c4d31652-94cc-11ec-8aec-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c4d33ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c4d3671a-94cc-11ec-8aec-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:c4d38f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:c4d3b864-94cc-11ec-8aec-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:c4d3e0be-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:c4d40922-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.469']} DrugCentral uuid:c4d43186-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c4d45bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.469']} DrugCentral uuid:c4d4846a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:c4d4ac92-94cc-11ec-8aec-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:c4d4d5e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:c4d4fe86-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin glulisine is agonist of Kinase (Insulin receptor) DrugCentral uuid:c4d5229e-94cc-11ec-8aec-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lusutrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.076']} DrugCentral uuid:c4d54abc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5060 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c4d572d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:5060 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c4d59bca-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepolizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:c4d5c406-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:c4d5ec06-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c4d6142e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c4d63e9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:c4d666a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P53634 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Enzyme (Dipeptidyl peptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:c4d68ec2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c4d6b834-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c4d6e0d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daratumumab is antibody binding of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c4d7094c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 climbazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c4d7316a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trenbolone hexahydrobenzylcarbonate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:c4d75988-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trenbolone hexahydrobenzylcarbonate targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:c4d78278-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenecteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:c4d7a67c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.509']} DrugCentral uuid:c4d7ce9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:c4d7f6e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:c4d820f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:5068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivaracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c4d84938-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:5068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivaracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c4d8719c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 necitumumab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.49']} DrugCentral uuid:c4d89aa0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQ25 biolink:molecularly_interacts_with DrugCentral:5072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elotuzumab is antibody binding of Membrane receptor (SLAM family member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c4d8c3cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:5075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.432']} DrugCentral uuid:c4d8ec8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.137']} DrugCentral uuid:c4d914bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c4d93da2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c4d965f2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c4d98e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4d9b674-94cc-11ec-8aec-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:c4d9dfaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c4da07fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:c4da302c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:c4da5872-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:c4da80ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c4daa8fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:c4dad144-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.523']} DrugCentral uuid:c4daf98a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:c4db227a-94cc-11ec-8aec-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:c4db4a8e-94cc-11ec-8aec-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c4db72d4-94cc-11ec-8aec-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:c4db9b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c4dbc5f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.301']} DrugCentral uuid:c4dbee26-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.398']} DrugCentral uuid:c4dc1658-94cc-11ec-8aec-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:c4dc3e76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:5083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixekizumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:c4dc6a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4dc6a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4dc6a7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:c4dca42e-94cc-11ec-8aec-0242ac110003 UniProtKB:P06729 biolink:molecularly_interacts_with DrugCentral:5088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alefacept is inhibitor of Surface antigen (T-cell surface antigen CD2) DrugCentral uuid:c4dcc83c-94cc-11ec-8aec-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c4dcf140-94cc-11ec-8aec-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c4dd1986-94cc-11ec-8aec-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) DrugCentral uuid:c4dd3d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) DrugCentral uuid:c4dd622e-94cc-11ec-8aec-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5093 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reslizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.092']} DrugCentral uuid:c4dd8b82-94cc-11ec-8aec-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:5094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obiltoxaximab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.481']} DrugCentral uuid:c4ddb3d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P01583 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.854']} DrugCentral uuid:c4dddc04-94cc-11ec-8aec-0242ac110003 UniProtKB:P18510 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Unclassified (Interleukin-1 receptor antagonist protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.215']} DrugCentral uuid:c4de0440-94cc-11ec-8aec-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:c4de2ce0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urokinase is activator of Enzyme (Plasminogen) DrugCentral uuid:c4de50c6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c4de78ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c4dea10c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c4dec9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c4def22e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c4df1a4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:c4df4274-94cc-11ec-8aec-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:c4df6db2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59750 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c4df98f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02401 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:c4dfc0f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UUZ4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Alpha-galactosidase C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:c4dfe936-94cc-11ec-8aec-0242ac110003 UniProtKB:Q42656 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Alpha-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c4e01140-94cc-11ec-8aec-0242ac110003 UniProtKB:D3ZUM4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:c4e03954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8VNN2 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:c4e06172-94cc-11ec-8aec-0242ac110003 UniProtKB:P06280 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat is pharmacological chaperone of Enzyme (Alpha-galactosidase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c4e08b02-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chromic chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c4e0b2f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chromic chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c4e0db2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:c4e10366-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:c4e12cd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:c4e158f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e158f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e18aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e18aac-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e1bc48-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e1bc48-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e1eba0-94cc-11ec-8aec-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:c4e20fb8-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c4e23812-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c4e2612a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4e28966-94cc-11ec-8aec-0242ac110003 UniProtKB:O88587 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c4e2b1a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:c4e2d9ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:5144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gluconolactone targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:c4e30396-94cc-11ec-8aec-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:5149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choriogonadotropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:c4e32970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atezolizumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c4e351b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:c4e37a60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:c4e3a300-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.796']} DrugCentral uuid:c4e3cb1e-94cc-11ec-8aec-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:c4e3f350-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.979']} DrugCentral uuid:c4e41b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:c4e44530-94cc-11ec-8aec-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:c4e46d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9DHD6 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:c4e495c6-94cc-11ec-8aec-0242ac110003 UniProtKB:O91936 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.426']} DrugCentral uuid:c4e4be02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5I2N3 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.097']} DrugCentral uuid:c4e4e922-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:5155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obeticholic acid targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c4e5135c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:5155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obeticholic acid is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.004']} DrugCentral uuid:c4e53b8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darbepoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:c4e56366-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e56366-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e591a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:c4e5b99c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e5b99c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c4e5e782-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxy polyethylene glycol-epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:c4e60c3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:5167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenograstim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:c4e6303e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:5169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eldecalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:c4e65438-94cc-11ec-8aec-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:5169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eldecalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c4e67c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin zeta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:c4e6a12c-94cc-11ec-8aec-0242ac110003 UniProtKB:P05362 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast targets Unclassified (Intercellular adhesion molecule 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:c4e6cf30-94cc-11ec-8aec-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:c4e6cf30-94cc-11ec-8aec-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:c4e70a72-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:c4e70a72-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:c4e70a72-94cc-11ec-8aec-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:c4e7478a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c4e7478a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:c4e77b1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etelcalcetide is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:c4e7a342-94cc-11ec-8aec-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eteplirsen is binding agent of RNA (exon 51 of dystrophin pre-mRNA) DrugCentral uuid:c4e7c840-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaratumab is antibody binding of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:c4e7f13a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallium (68Ga) edotreotide is antagonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c4e81a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P18177 biolink:molecularly_interacts_with DrugCentral:5186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezlotoxumab is antibody binding of Enzyme (Toxin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c4e84248-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 radotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.514']} DrugCentral uuid:c4e86a66-94cc-11ec-8aec-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c4e895c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c4e8c970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c4e8c970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c4e8c970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c4e8c970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c4e91308-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c4e93b44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c4e96376-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c4e98bc6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.87']} DrugCentral uuid:c4e9b4ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.276']} DrugCentral uuid:c4e9dcfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:c4ea0538-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:c4ea2d60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c4ea565a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:c4ea7e82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c4eaa696-94cc-11ec-8aec-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c4eaceaa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c4eaf722-94cc-11ec-8aec-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c4eb1f4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:c4eb4754-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c4eb7076-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:c4eb9948-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c4ebc15c-94cc-11ec-8aec-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c4ebe97a-94cc-11ec-8aec-0242ac110003 UniProtKB:P19438 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide targets Unclassified (Tumor necrosis factor receptor superfamily member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:c4ec11d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.721']} DrugCentral uuid:c4ec3c0e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:c4ec6440-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c4ec8dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmutinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.036']} DrugCentral uuid:c4ecb5e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c4ecdeac-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.368']} DrugCentral uuid:c4ed06fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.276']} DrugCentral uuid:c4ed2f42-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:c4ed5850-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c4ed8168-94cc-11ec-8aec-0242ac110003 UniProtKB:P17752 biolink:molecularly_interacts_with DrugCentral:5214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telotristat ethyl is inhibitor of Enzyme (Tryptophan 5-hydroxylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c4eda9a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclabuvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:c4edd212-94cc-11ec-8aec-0242ac110003 UniProtKB:O39930 biolink:molecularly_interacts_with DrugCentral:5215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclabuvir targets Unclassified (RNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c4edfbc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c4ee2528-94cc-11ec-8aec-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c4ee4d64-94cc-11ec-8aec-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:c4ee758c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:c4ee9e2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c4eec65e-94cc-11ec-8aec-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:c4eeef6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:c4ef17d0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:c4ef421e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c4ef6a64-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naldemedine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:c4ef92be-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naldemedine is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:c4efbb18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5221 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avelumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:c4efdff8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c4f00816-94cc-11ec-8aec-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c4f03066-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c4f058a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c4f08160-94cc-11ec-8aec-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c4f0a9a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c4f0d200-94cc-11ec-8aec-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:c4f0fa46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c4f12336-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:c4f14b7c-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:c4f173c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:5223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ocrelizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c4f19d52-94cc-11ec-8aec-0242ac110003 UniProtKB:P24394 biolink:molecularly_interacts_with DrugCentral:5224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dupilumab is antibody binding of Membrane receptor (Interleukin-4 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.06']} DrugCentral uuid:c4f1c836-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deutetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:c4f1ec12-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:5227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:c4f21462-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:c4f23d16-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:c4f2667e-94cc-11ec-8aec-0242ac110003 UniProtKB:P55859 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.64']} DrugCentral uuid:c4f28ef6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine is inhibitor of Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.143']} DrugCentral uuid:c4f2b714-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c4f2dff0-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c4f30818-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c4f33158-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c4f35976-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:c4f3839c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4f3ac32-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c4f3d46e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c4f3fc96-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c4f42522-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c4f44d54-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c4f47590-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c4f49d9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4f4c694-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c4f4eea8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c4f516c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c4f53eee-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c4f569be-94cc-11ec-8aec-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c4f591e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c4f5ba0e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c4f5e286-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c4f60afe-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c4f63326-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c4f65b44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c4f68498-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c4f6acd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4f6d506-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c4f6fd2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4f72722-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c4f74f54-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c4f7777c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c4f79fc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c4f7c95c-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c4f7f198-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c4f819b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c4f841de-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c4f86c36-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:c4f8947c-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c4f8bcb8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c4f8e4f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c4f90ff6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c4f93850-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c4f96078-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c4f988aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c4f9b172-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c4f9d9ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c4fa01cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c4fa2ab2-94cc-11ec-8aec-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c4fa52ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c4fa7b02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c4faa320-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c4facc9c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c4faf636-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c4fb1e68-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c4fb469a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c4fb6f44-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c4fb976c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c4fbbf94-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c4fbe7c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c4fc1098-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c4fc3898-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c4fc60ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c4fc8906-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c4fcb3e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c4fcdc12-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c4fd0458-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c4fd2c62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c4fd54ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c4fd7d02-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c4fda52a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c4fdcd66-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c4fdf64c-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c4fe1e60-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c4fe47e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c4fe7176-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c4fe99bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c4fec1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c4feeb24-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c4ff141e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c4ff3c46-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c4ff646e-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c4ff8c96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c4ffb554-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c4ffdd90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c50005b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c5002dea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c500572a-94cc-11ec-8aec-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:c5007f7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c500a798-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c500cfe8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c500f888-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c50120f6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c501491e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c5017146-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c5019a22-94cc-11ec-8aec-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c501c25e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c501ea7c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c50212b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c5023bb2-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c50263e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c5028c0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:c502b59c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c502ddc4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c50305ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c5032e00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:c50356fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c5037f0e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c503a740-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c503cf7c-94cc-11ec-8aec-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c503f92a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c50421ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c5044b32-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c5047378-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c5049c18-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c504c44a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c504ec68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c5051508-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c5053dda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c5056602-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c5058e3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c505b670-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c505e1d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c5060d3c-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c5063578-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c5065dfa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c5068730-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c506af62-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c506d78a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c5070066-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c5072898-94cc-11ec-8aec-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c50750c0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c5077906-94cc-11ec-8aec-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c507a2aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c507cc6c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c507f49e-94cc-11ec-8aec-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c5081cd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c5084548-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c5086d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c5089584-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c508bdac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:c508e660-94cc-11ec-8aec-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c5090e88-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c50936a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c5095eb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c50988e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c509b0ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c509d912-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c50a013a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c50a2afc-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c50a532e-94cc-11ec-8aec-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c50a7c64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c50aa55e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c50acd90-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c50af5ae-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c50b1dd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c50b4734-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c50b6f70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c50b981a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c50bc02e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c50be892-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c50c10a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c50c38b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c50c60ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c50c89b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:c50cb1dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c50cda04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c50d020e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c50d2c66-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c50d548e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c50d7cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c50da4de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:c50dcd42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c50df56a-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c50e1da6-94cc-11ec-8aec-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c50e45ba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c50e6ffe-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c50e983a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c50ec04e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c50ee902-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c50f1260-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c50f3a88-94cc-11ec-8aec-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c50f62b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c50f8b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c50fb36e-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c50fdb96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c51003c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c5102dd0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c51055ee-94cc-11ec-8aec-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c5107e2a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c510a65c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c510d000-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c510f832-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c5112046-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c5114882-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c5117104-94cc-11ec-8aec-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c5119936-94cc-11ec-8aec-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c511c14a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c511e954-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c5121258-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:c5123b70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c5126398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5128c38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:c512b73a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c512df76-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c51307bc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c5133052-94cc-11ec-8aec-0242ac110003 UniProtKB:P51817 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit PRKX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c513587a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c51380a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c513a8de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:5232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abaloparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c513d1ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:c513f9e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:c5142200-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.137']} DrugCentral uuid:c5144a28-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:c51473cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:c5149dde-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:c514c5fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 durvalumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:c514e9ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5235 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenegermin is agonist of Kinase (High affinity nerve growth factor receptor) DrugCentral uuid:c5150e4a-94cc-11ec-8aec-0242ac110003 UniProtKB:P08138 biolink:molecularly_interacts_with DrugCentral:5235 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenegermin is agonist of Membrane receptor (Tumor necrosis factor receptor superfamily member 16) DrugCentral uuid:c515362c-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:c515362c-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:c51569a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evogliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:c51591c6-94cc-11ec-8aec-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:c515ba8e-94cc-11ec-8aec-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c515e3d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5160cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.081']} DrugCentral uuid:c516352c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:c51660d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c5168932-94cc-11ec-8aec-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:c516b164-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:c516da36-94cc-11ec-8aec-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.42']} DrugCentral uuid:c51702a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:c5172af4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pibrentasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.19']} DrugCentral uuid:c5175344-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:5244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pibrentasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c5177c16-94cc-11ec-8aec-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:5245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corifollitropin alfa is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:c517a470-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:c517a470-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:c517d292-94cc-11ec-8aec-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inotuzumab ozogamicin is antibody binding of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c517fad8-94cc-11ec-8aec-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:c51824f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.801']} DrugCentral uuid:c5184d76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c5187576-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:c5189dbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:c518c684-94cc-11ec-8aec-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:c518eec0-94cc-11ec-8aec-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c5191710-94cc-11ec-8aec-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c5193f4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P48735 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP], mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c5196814-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c519903c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:c519b864-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c519e17c-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c51a0a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c51a329e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c51a5ad0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c51a838e-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c51aabc0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c51ad3e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c51afbfc-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c51b24d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c51b4d14-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c51b7546-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c51b9d6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c51bc776-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c51befbc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c51c17ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c51c405c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c51c68f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c51c912e-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c51cb960-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c51ce1a6-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c51d0a82-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c51d32c8-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c51d5ae6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c51d8304-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c51dae56-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c51dd778-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c51dff96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c51e27be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:c51e5054-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c51e78a4-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c51ea0cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:c51ec9c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c51ef1ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c51f1a20-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c51f423e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c51f6b60-94cc-11ec-8aec-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c51f93c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c51fbbec-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:c51fe400-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c5200c8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c52034be-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c5205cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c520850e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c520ae08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c520d61c-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c520fe3a-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c5212658-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c52150d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c521790a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c521a254-94cc-11ec-8aec-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c521cb8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c521f420-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c5221c5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:c52244a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c5226cca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c52295c4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c522bdec-94cc-11ec-8aec-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c522e63c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c5230f86-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c5233aec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c523665c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c5238ed4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c523b774-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c523dfb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c52407ec-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c524301e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c52458f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c52481b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c524a9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c524d212-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:c524fbf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c525241a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c5254c42-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c525746a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c5259cf6-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c525c82a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c525f070-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:c52618b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c5264188-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c52669d8-94cc-11ec-8aec-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c5269200-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c526bb4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c526e6ec-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5270f14-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:c5273750-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c5275ff0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c5278836-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:c527b19e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c527d9f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c52802d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:c5282be2-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c5285414-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c5287c50-94cc-11ec-8aec-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c528a702-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c528cf48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c528f77a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c5291fac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY57 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 32B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c5294874-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c52970ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.036']} DrugCentral uuid:c52998d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:c529c20e-94cc-11ec-8aec-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c529ead6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.432']} DrugCentral uuid:c52a1308-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:c52a3b44-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:c52a64ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:c52a8dc4-94cc-11ec-8aec-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:5257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butylphthalide is blocker of Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:c52ab5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:c52ade0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:c52b0696-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.764']} DrugCentral uuid:c52b2ea0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.788']} DrugCentral uuid:c52b56d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.375']} DrugCentral uuid:c52b7ee6-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.866']} DrugCentral uuid:c52ba7b8-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:c52bcfd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:c52bf81c-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.796']} DrugCentral uuid:c52c204e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:c52c4934-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:c52c7170-94cc-11ec-8aec-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c52c9984-94cc-11ec-8aec-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c52cc184-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c52cea10-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c52d1242-94cc-11ec-8aec-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c52d3a92-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c52d62ce-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:c52d8d12-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c52db652-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c52dde7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c52e06a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c52e2fce-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:c52e57f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:c52e8032-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.434']} DrugCentral uuid:c52ea8e6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.292']} DrugCentral uuid:c52ed118-94cc-11ec-8aec-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:5261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprostene bunod targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c52ef95e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:5261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprostene bunod is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c52f2988-94cc-11ec-8aec-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:c52f2988-94cc-11ec-8aec-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:c52f2988-94cc-11ec-8aec-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:c52f68a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01344 biolink:molecularly_interacts_with DrugCentral:5263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benralizumab is antibody binding of Membrane receptor (Interleukin-5 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.959']} DrugCentral uuid:c52f90da-94cc-11ec-8aec-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:5267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 semaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.42']} DrugCentral uuid:c52fb984-94cc-11ec-8aec-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.73']} DrugCentral uuid:c52fe2f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P00740 biolink:molecularly_interacts_with DrugCentral:5268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor IX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c5300b28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c5303382-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:c5305baa-94cc-11ec-8aec-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.94']} DrugCentral uuid:c5308440-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c530ac72-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.708']} DrugCentral uuid:c530d4a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.057']} DrugCentral uuid:c530fcd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:5271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macimorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:c5312684-94cc-11ec-8aec-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II is agonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.2']} DrugCentral uuid:c5314eac-94cc-11ec-8aec-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:c53176e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:c5319f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c531c88c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II is agonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c531f096-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c53218aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c53240dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.125']} DrugCentral uuid:c5326972-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lutetium (177Lu) oxodotreotide is agonist of GPCR (Somatostatin receptor type 2) DrugCentral uuid:c5328d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tezacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c532b5a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12908 biolink:molecularly_interacts_with DrugCentral:5277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elobixibat is inhibitor of Transporter (Ileal sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.276']} DrugCentral uuid:c532ddda-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apalutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c53306e8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apalutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:c5332f06-94cc-11ec-8aec-0242ac110003 UniProtKB:P01730 biolink:molecularly_interacts_with DrugCentral:5279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibalizumab is antibody binding of Membrane receptor (T-cell surface glycoprotein CD4) DrugCentral uuid:c533544a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c5337c86-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:c533a814-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c533d320-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.092']} DrugCentral uuid:c533fb7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.387']} DrugCentral uuid:c534280c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:c534280c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:c5345b60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZV9 biolink:molecularly_interacts_with DrugCentral:5282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 burosumab is antibody binding of Secreted (Fibroblast growth factor 23) DrugCentral uuid:c5347f82-94cc-11ec-8aec-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosnetupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:c534ac28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:c534ac28-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:c534e15c-94cc-11ec-8aec-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avatrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:c53509a2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:5286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxidectin is inhibitor of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:c5352db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c53555f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5357fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is agonist of GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:c535a7cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:c535d012-94cc-11ec-8aec-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c535f89e-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c53620e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c5364902-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5S1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:c5367116-94cc-11ec-8aec-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:c53699ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is inhibitor of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:c536bdb0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is antagonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c536e5e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c5370e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:c53737fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.328']} DrugCentral uuid:c5376058-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c5378894-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:c537b0e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P33815 biolink:molecularly_interacts_with DrugCentral:5291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tecovirimat is inhibitor of Viral envelope protein (Envelope protein F13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.382']} DrugCentral uuid:c537d9a2-94cc-11ec-8aec-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5292 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivosidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.149']} DrugCentral uuid:c53801d4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c5382a06-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8SPZ1 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c5385256-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:c5387b64-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c538a38c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c538ccc2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:c538f616-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c53920b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c5394c06-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.638']} DrugCentral uuid:c539746a-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:c5399cba-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:c539c5b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c539edc8-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c53a1604-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:c53a3e90-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c53a66e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.133']} DrugCentral uuid:c53a8f1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c53ab74e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:c53ae0de-94cc-11ec-8aec-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baloxavir marboxil is inhibitor of Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.854']} DrugCentral uuid:c53b0956-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c53b3192-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.959']} DrugCentral uuid:c53b59e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:c53b82aa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c53baaf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:c53bd322-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:c53bfb54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c53c2408-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:c53c4c1c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:c53c7444-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:c53c9d3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.569']} DrugCentral uuid:c53cc7b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:c53cf2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:c53d1b4c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c53d4388-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:c53d6c82-94cc-11ec-8aec-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c53d9572-94cc-11ec-8aec-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c53dbdae-94cc-11ec-8aec-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:5304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glasdegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c53de5d6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glasdegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c53e0e58-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.187']} DrugCentral uuid:c53e36b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.092']} DrugCentral uuid:c53e5eee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.975']} DrugCentral uuid:c53e891e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c53eb150-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c53ed9fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c53f036c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c53f2ca2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c53f54de-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c53f7d92-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c53fa5c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:c53fce6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5307 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evocalcet is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:c53ff682-94cc-11ec-8aec-0242ac110003 UniProtKB:P04275 biolink:molecularly_interacts_with DrugCentral:5308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caplacizumab is antibody binding of Unclassified (von Willebrand factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.509']} DrugCentral uuid:c5401ed2-94cc-11ec-8aec-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanadelumab is antibody binding of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:c54046fa-94cc-11ec-8aec-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:c5407184-94cc-11ec-8aec-0242ac110003 UniProtKB:O02662 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c54099ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q28524 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c540c1f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:c540ea9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omidenepag isopropyl is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:c5411418-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 patisiran is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:c5413830-94cc-11ec-8aec-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxetumomab pasudotox is binding agent of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c5416080-94cc-11ec-8aec-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5315 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fremanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:c54188da-94cc-11ec-8aec-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galcanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c541b18e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cemiplimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.102']} DrugCentral uuid:c541d9c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inotersen is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:c541fdd8-94cc-11ec-8aec-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:5320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emapalumab is antibody binding of Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:c5422628-94cc-11ec-8aec-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:5322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ravulizumab is antibody binding of Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.357']} DrugCentral uuid:c5425486-94cc-11ec-8aec-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:c5425486-94cc-11ec-8aec-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:c542824e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:c542b232-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:c542b232-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:c542b232-94cc-11ec-8aec-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:c542f8e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:c542f8e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:c542f8e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:c5433edc-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c5433edc-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c5433edc-94cc-11ec-8aec-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:c5437d7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.088']} DrugCentral uuid:c543a6ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:c543ceec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.848']} DrugCentral uuid:c543f732-94cc-11ec-8aec-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:c544239c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3']} DrugCentral uuid:c5444f02-94cc-11ec-8aec-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:c5447874-94cc-11ec-8aec-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.409']} DrugCentral uuid:c544a16e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.009']} DrugCentral uuid:c544c964-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c544f16e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:c54519a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.434']} DrugCentral uuid:c5454254-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:c5456aae-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.921']} DrugCentral uuid:c54592e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:c545bbe4-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:c545e5ce-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c5460e32-94cc-11ec-8aec-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c5463646-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c5465e82-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Z1L0 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c5468754-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:c546af90-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:c546d7fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:c5470044-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.02']} DrugCentral uuid:c54728c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:c5474d1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:c5477650-94cc-11ec-8aec-0242ac110003 UniProtKB:O14980 biolink:molecularly_interacts_with DrugCentral:5330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selinexor is inhibitor of Nuclear other (Exportin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:c5479e8c-94cc-11ec-8aec-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prabotulinumtoxinA is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c547e5e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c54857b4-94cc-11ec-8aec-0242ac110003 UniProtKB:P40259 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is antibody binding of Tumour-associated antigen (B-cell antigen receptor complex-associated protein beta chain) DrugCentral uuid:c5487bc2-94cc-11ec-8aec-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c548a412-94cc-11ec-8aec-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is antagonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:c548c848-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.187']} DrugCentral uuid:c548f0ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P02656 biolink:molecularly_interacts_with DrugCentral:5335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 volanesorsen is antisense inhibitor of RNA (apolipoprotein C-III (apoC-III) mRNA) DrugCentral uuid:c5491640-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risankizumab is inhibitor of Cytokine (Interleukin-23 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:c5494296-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c5494296-94cc-11ec-8aec-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:c5497072-94cc-11ec-8aec-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:c5499a52-94cc-11ec-8aec-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.444']} DrugCentral uuid:c549c2fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c549eb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c54a1338-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c54a3c0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c54a6446-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c54a8c6e-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c54ab482-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:c54addfe-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:c54b061c-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c54b2e44-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c54b5748-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c54b7fb6-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c54ba7de-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c54bd01a-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c54bf900-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:c54c211e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c54c4946-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c54c7182-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c54c99fa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c54cc22c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c54cea54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:c54d1272-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:c54d3c98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c54d64e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c54d8cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c54db506-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c54ddda6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:c54e05ce-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c54e2dec-94cc-11ec-8aec-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c54e5628-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c54e7efa-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c54ea736-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c54ed148-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c54ef984-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c54f242c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c54f4c68-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c54f74a4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c54f9d58-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.796']} DrugCentral uuid:c54fc58a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8RL90 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c54fedc6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2PUH3 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:c55015e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9X5A7 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c5503f60-94cc-11ec-8aec-0242ac110003 UniProtKB:Q93LQ9 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c55067a6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q93DC4 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:c5508fc4-94cc-11ec-8aec-0242ac110003 UniProtKB:B1PL86 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c550b7e2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c550e1a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c5510a12-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:c5513244-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:c5515a8a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c551830c-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.56']} DrugCentral uuid:c551ab3e-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c551d370-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.88']} DrugCentral uuid:c551fb84-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c5522456-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c5524c6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c552747e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:c5529c9c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c552c906-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c552f192-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:c55319ba-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:c553420a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c5536b22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c5539354-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c553bb72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c553e462-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c5540c80-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:c55434b2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5545cda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:c5548674-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c554aee2-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c554d872-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:c55500a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c55529c6-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c55551e4-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c5557a0c-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c555a252-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:c555cb1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c555f342-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:c5561b6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c55643a6-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c5566ca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:c55694e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c556bdf4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:c556e630-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c5570ed0-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c5573702-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c5575f34-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c557877a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c557b06a-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c557d892-94cc-11ec-8aec-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c55800b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c55829aa-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c55851c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c55879d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c558a1e6-94cc-11ec-8aec-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:c558cae0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c558f308-94cc-11ec-8aec-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c5591b1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c5594330-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c5596bda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c5599402-94cc-11ec-8aec-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c559bc2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c559e452-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c55a0dce-94cc-11ec-8aec-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c55a35ec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:c55a5e00-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c55a8628-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c55ab09e-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c55ad8c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c55b00f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c55b2916-94cc-11ec-8aec-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:c55b556c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c55b7d8a-94cc-11ec-8aec-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:c55ba5c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:c55bce70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c55bf95e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c55c2186-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c55c49a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c55c7244-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c55c9a6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c55cc28a-94cc-11ec-8aec-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:c55ceab2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c55d1384-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c55d3bac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c55d6406-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:c55d8c2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:c55db546-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c55ddd6e-94cc-11ec-8aec-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:c55e0582-94cc-11ec-8aec-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c55e2da0-94cc-11ec-8aec-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c55e5636-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c55e7e68-94cc-11ec-8aec-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:c55ea76c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c55ecf80-94cc-11ec-8aec-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:c55ef866-94cc-11ec-8aec-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c55f2098-94cc-11ec-8aec-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c55f48ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c55f70fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:c55f9c44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c55fc458-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c55fec76-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c560149e-94cc-11ec-8aec-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:c5603d16-94cc-11ec-8aec-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c560652a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c5608d5c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c560b78c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:c560dfc8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c56107e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:c561300e-94cc-11ec-8aec-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c56159b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5618220-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c561aa20-94cc-11ec-8aec-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:c561d25c-94cc-11ec-8aec-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c561fade-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c5622324-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:c5624b38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c5627356-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:c5629cf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:c562c5ae-94cc-11ec-8aec-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c562edea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c5631612-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c5634128-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:c5636b6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:c56393a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:c563bbd0-94cc-11ec-8aec-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c563e452-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c5640c7a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c56434ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c5645d92-94cc-11ec-8aec-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c56485b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c564adce-94cc-11ec-8aec-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:c564d5f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c564ff5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c565293e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c5655170-94cc-11ec-8aec-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c5657970-94cc-11ec-8aec-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c565a206-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:c565ca06-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c565f242-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c5661a60-94cc-11ec-8aec-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c5664328-94cc-11ec-8aec-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:c5666b3c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c5669544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c566bd6c-94cc-11ec-8aec-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c566e74c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c5670f60-94cc-11ec-8aec-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c567379c-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c5675fba-94cc-11ec-8aec-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c5678864-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c567b082-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c567d8be-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:c56800f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c56829ea-94cc-11ec-8aec-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c5685226-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:c5687a62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:c568a398-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c568cc06-94cc-11ec-8aec-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c568f438-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c5691c88-94cc-11ec-8aec-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c569453c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:c5696de6-94cc-11ec-8aec-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c569960e-94cc-11ec-8aec-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c569be54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c569e71c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c56a0f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c56a378a-94cc-11ec-8aec-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c56a5fa8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c56a8af0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c56ab534-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c56add7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c56b05b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c56b2e56-94cc-11ec-8aec-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c56b5688-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c56b7ec4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c56ba6d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c56bd068-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:c56bf890-94cc-11ec-8aec-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c56c20b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c56c48f4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c56c722a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c56c9b7e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c56cc3b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c56cec64-94cc-11ec-8aec-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c56d1496-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c56d3cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c56d64dc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:c56d8d90-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:c56db5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c56dddf4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c56e0612-94cc-11ec-8aec-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c56e2fe8-94cc-11ec-8aec-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c56e5a4a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:c56e8358-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:c56eab62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c56ed420-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c56efc34-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c56f2466-94cc-11ec-8aec-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c56f4c98-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c56f7588-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c56f9dba-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c56fc5e2-94cc-11ec-8aec-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:c56fee00-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:c5701970-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c5704184-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c57069b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5709238-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:c570ba6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:c570e292-94cc-11ec-8aec-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c5717cc0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c571aa6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c571d47c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:c571fd26-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c572256c-94cc-11ec-8aec-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c5724db2-94cc-11ec-8aec-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c5727670-94cc-11ec-8aec-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c5729e98-94cc-11ec-8aec-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:c572c6d4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c572f1ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c5731aee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:c5734320-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c5736b48-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c5739370-94cc-11ec-8aec-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c573bdb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c573e5e6-94cc-11ec-8aec-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:c5740e22-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:c5743640-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c5745eea-94cc-11ec-8aec-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:c5748708-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c574af3a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c574d816-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:c5750048-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:c575285c-94cc-11ec-8aec-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c575508e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c5757a14-94cc-11ec-8aec-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c575a26e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:c575ca96-94cc-11ec-8aec-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:c575f2d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:c5761b40-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:c5764368-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:c5766b9a-94cc-11ec-8aec-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:c57693f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c576bcda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c576e5fc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:c5770e1a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c57736e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c577619e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c5778b42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c577b388-94cc-11ec-8aec-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c577dbc4-94cc-11ec-8aec-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c578046e-94cc-11ec-8aec-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c5782c96-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c57854c8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c5787ce6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c578a5c2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c578ce08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c578f78e-94cc-11ec-8aec-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:c5792100-94cc-11ec-8aec-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:c579495a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:c57971b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:c57999f0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c579c286-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c579eab8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:c57a12e0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:c57a3b08-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:c57a63ee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c57a8c16-94cc-11ec-8aec-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c57ab448-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:c57add38-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c57b079a-94cc-11ec-8aec-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:c57b2fcc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c57b57ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:c57b801c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c57ba8c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c57bd102-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:c57bf92a-94cc-11ec-8aec-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c57c2152-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c57c4a92-94cc-11ec-8aec-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:c57c72b0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c57c9aec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c57cc31e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c57cebf0-94cc-11ec-8aec-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:c57d142c-94cc-11ec-8aec-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c57d3c54-94cc-11ec-8aec-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:c57d64f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:c57d8d26-94cc-11ec-8aec-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:c57db544-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c57ddde4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:c57e06b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c57e2ee8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:c57e5706-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c57e7f2e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:c57ea904-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c57ed334-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c57efb70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c57f23ac-94cc-11ec-8aec-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c57f4c4c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:c57f749c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:c57f9cc4-94cc-11ec-8aec-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:c57fc51e-94cc-11ec-8aec-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:c57fee04-94cc-11ec-8aec-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:c580164a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:c5803e72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:c58066c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P51957 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:c5809282-94cc-11ec-8aec-0242ac110003 UniProtKB:Q58F21 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Unclassified (Bromodomain testis-specific protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c580babe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96PY6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c580e2dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:c5810b54-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c581337c-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c5815bd6-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:c581841c-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c581ad02-94cc-11ec-8aec-0242ac110003 UniProtKB:P26433 biolink:molecularly_interacts_with DrugCentral:5349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenapanor targets Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:c581d548-94cc-11ec-8aec-0242ac110003 UniProtKB:P48764 biolink:molecularly_interacts_with DrugCentral:5349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenapanor is inhibitor of Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:c581fd7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c58225a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:c5824f0a-94cc-11ec-8aec-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c5827750-94cc-11ec-8aec-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:5351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasmiditan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:c582a0a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c582c8cc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c582f162-94cc-11ec-8aec-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c5831a7a-94cc-11ec-8aec-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c58342ac-94cc-11ec-8aec-0242ac110003 UniProtKB:G1C775 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:c5836afc-94cc-11ec-8aec-0242ac110003 UniProtKB:A6T4V3 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:c58393ce-94cc-11ec-8aec-0242ac110003 UniProtKB:H4I819 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c583bbf6-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A0W8ASI8 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:c583e432-94cc-11ec-8aec-0242ac110003 UniProtKB:A6T4M7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c5840c78-94cc-11ec-8aec-0242ac110003 UniProtKB:G3XD46 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:c58437ca-94cc-11ec-8aec-0242ac110003 UniProtKB:D0CCM7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:c584601a-94cc-11ec-8aec-0242ac110003 UniProtKB:A0A5E6DR09 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:c584884c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanubrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:c584b09c-94cc-11ec-8aec-0242ac110003 UniProtKB:P13196 biolink:molecularly_interacts_with DrugCentral:5354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 givosiran is antisense inhibitor of RNA (aminolevulinate synthase1 (ALAS1) mRNA) DrugCentral uuid:c584d644-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c584fea8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c5852702-94cc-11ec-8aec-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:c5854f52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:c585789c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:c585a0d8-94cc-11ec-8aec-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:c585c91e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:c585f2f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Transporter (hemoglobin subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:c5861e50-94cc-11ec-8aec-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 golodirsen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:c586427c-94cc-11ec-8aec-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c5866ac2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:c586943e-94cc-11ec-8aec-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:c586bc66-94cc-11ec-8aec-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:c586e4ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c5870cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:c58735f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:c5875e5a-94cc-11ec-8aec-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:c5878740-94cc-11ec-8aec-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:c587af9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:c587d9e8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99572 biolink:molecularly_interacts_with DrugCentral:5359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brilliant Blue G is antagonist of Ion channel (P2X purinoceptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c588021a-94cc-11ec-8aec-0242ac110003 UniProtKB:P37840 biolink:molecularly_interacts_with DrugCentral:5359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brilliant Blue G targets Transporter (Alpha-synuclein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c5882a42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c5885288-94cc-11ec-8aec-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c5887b5a-94cc-11ec-8aec-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c588a3b4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubrogepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:c588cbf0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9BQB4 biolink:molecularly_interacts_with DrugCentral:5362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romosozumab is binding agent of Glycoprotein (Sclerostin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.7']} DrugCentral uuid:c588f44a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brolucizumab is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c5891d3a-94cc-11ec-8aec-0242ac110003 UniProtKB:O95390 biolink:molecularly_interacts_with DrugCentral:5364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.13']} DrugCentral uuid:c589459e-94cc-11ec-8aec-0242ac110003 UniProtKB:O14793 biolink:molecularly_interacts_with DrugCentral:5364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.69']} DrugCentral uuid:c5896dee-94cc-11ec-8aec-0242ac110003 UniProtKB:P16109 biolink:molecularly_interacts_with DrugCentral:5365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizanlizumab is inhibitor of Adhesion (P-selectin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c589b5d8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:c58a2950-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96NY8 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Nectin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:c58a5222-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab deruxtecan is binding agent of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c58a7a9a-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab deruxtecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:c58aa2d6-94cc-11ec-8aec-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 botulinum toxin type A is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:c58ac6f8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:c58af02e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c58b1860-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c58b4088-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:c58b68ba-94cc-11ec-8aec-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elexacaftor targets Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:c58b91d2-94cc-11ec-8aec-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c58bba18-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine is inhibitor of Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) DrugCentral uuid:c58bde1c-94cc-11ec-8aec-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine is inhibitor of Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) DrugCentral uuid:c58c02b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:5376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remdesivir is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c58c2b42-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c58c5388-94cc-11ec-8aec-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:c58c7bb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P05532 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:c58ca46e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:c58ccca0-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:c58cf4dc-94cc-11ec-8aec-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c58d1d04-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92800 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:c58d464e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15910 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c58d6f3e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimegepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.56']} DrugCentral uuid:c58d9770-94cc-11ec-8aec-0242ac110003 UniProtKB:P53396 biolink:molecularly_interacts_with DrugCentral:5382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bempedoic acid is inhibitor of Enzyme (ATP-citrate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c58dc092-94cc-11ec-8aec-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c58de90a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:c58e1146-94cc-11ec-8aec-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:c58e3978-94cc-11ec-8aec-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c58e61a0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c58e8a54-94cc-11ec-8aec-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:c58eb27c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:c58edaa4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:c58f02c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P30099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:c58f2d24-94cc-11ec-8aec-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c58f556a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:c58f7db0-94cc-11ec-8aec-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isatuximab is binding agent of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c58fa736-94cc-11ec-8aec-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.82']} DrugCentral uuid:c58fcfe0-94cc-11ec-8aec-0242ac110003 UniProtKB:P10092 biolink:molecularly_interacts_with DrugCentral:5386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:c58ff830-94cc-11ec-8aec-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teprotumumab is antagonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c590204e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:c590492a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c5907206-94cc-11ec-8aec-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:c5909a92-94cc-11ec-8aec-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:c590c2b0-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:c590efba-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c590efba-94cc-11ec-8aec-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:c5912304-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:c5914b2c-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c5917444-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:c5919d02-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:c591c53e-94cc-11ec-8aec-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is antibody binding of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.71']} DrugCentral uuid:c591edde-94cc-11ec-8aec-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is binding agent of Enzyme (DNA topoisomerase 1) DrugCentral uuid:c592120a-94cc-11ec-8aec-0242ac110003 UniProtKB:P09758 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is antibody binding of Tumour-associated antigen (Tumor-associated calcium signal transducer 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.58']} DrugCentral uuid:c5923b04-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capmatinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.88']} DrugCentral uuid:c592634a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selpercatinib is inhibitor of Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:c5928b86-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selpercatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:c592b3c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c592df14-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:c5930732-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:c5932f50-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:c5935796-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5938036-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:c593a872-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoroestradiol F 18 is binding agent of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.07']} DrugCentral uuid:c593d0ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:5396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flortaucipir F 18 is binding agent of Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:c593f9b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inebilizumab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c59421f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inebilizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:c59451dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c59451dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c59451dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:c5949994-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c5949994-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c5949994-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:c594e5a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c594e5a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c594e5a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:c5952ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:c5952ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:c5952ce2-94cc-11ec-8aec-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595828c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:c595ee8e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:5401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostemsavir is inhibitor of Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:c59616de-94cc-11ec-8aec-0242ac110003 UniProtKB:P32320 biolink:molecularly_interacts_with DrugCentral:5402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inqovi is inhibitor of Enzyme (Cytidine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:c5963f24-94cc-11ec-8aec-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5966814-94cc-11ec-8aec-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c596928a-94cc-11ec-8aec-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:c596bac6-94cc-11ec-8aec-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c596e302-94cc-11ec-8aec-0242ac110003 UniProtKB:P51685 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c5970bd4-94cc-11ec-8aec-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafasitamab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c597344c-94cc-11ec-8aec-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:c5975cb0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12314 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (High affinity immunoglobulin gamma Fc receptor I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:c5978532-94cc-11ec-8aec-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c597af4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02223 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Tumour-associated antigen (Tumor necrosis factor receptor superfamily member 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:c597d7a8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c597ffda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c598283e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:c5985282-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:c5987cda-94cc-11ec-8aec-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:c598a50c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c598cd34-94cc-11ec-8aec-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine is agonist of GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:c598f5f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c5991e74-94cc-11ec-8aec-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viltolarsen is binding agent of RNA (exon 53 of dystrophin pre-mRNA) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:c5994b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c5994b2e-94cc-11ec-8aec-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c5997f5e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clascoterone is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c599a7a4-94cc-11ec-8aec-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copper dotatate Cu-64 is binding agent of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:c599d148-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:c599f984-94cc-11ec-8aec-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c59a23dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c59a4d62-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:c59a75b2-94cc-11ec-8aec-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c59a9de4-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c59ac68e-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:c59aeed4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:c59b1710-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:c59b3f6a-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:c59b694a-94cc-11ec-8aec-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somapacitan targets GPCR (Growth hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:c59b91ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c59bb9f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c59be208-94cc-11ec-8aec-0242ac110003 UniProtKB:P01111 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase NRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c59c0c38-94cc-11ec-8aec-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c59c346a-94cc-11ec-8aec-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:c59c608e-94cc-11ec-8aec-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c59c608e-94cc-11ec-8aec-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:c59c9464-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UJM8 biolink:molecularly_interacts_with DrugCentral:5415 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumasiran is antisense inhibitor of RNA (Hydroxyacid oxidase 1 (HAO1) mRNA) DrugCentral uuid:c59cb872-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c59ce0cc-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c59d0930-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c59d31ee-94cc-11ec-8aec-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:c59d5a20-94cc-11ec-8aec-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:c59d8252-94cc-11ec-8aec-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:c59daab6-94cc-11ec-8aec-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:c59dd586-94cc-11ec-8aec-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:5417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bulevirtide is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:c59e0934-94cc-11ec-8aec-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:c59e0934-94cc-11ec-8aec-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:c59e0934-94cc-11ec-8aec-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:c59e0934-94cc-11ec-8aec-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:c59e4aca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c59e7374-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c59e9b92-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c59ec3c4-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c59eebec-94cc-11ec-8aec-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:c59f15c2-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:c59f3f2a-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:c59f6766-94cc-11ec-8aec-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:c59f9060-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:c59fb89c-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:c59fe0f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:c5a00950-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:c5a0324a-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c5a05a72-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c5a0831c-94cc-11ec-8aec-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:c5a0ab62-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8N543 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Prolyl 3-hydroxylase OGFOD1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c5a0d42a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:c5a0fc52-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:c5a124b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.93']} DrugCentral uuid:c5a14cf2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:c5a1774a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:c5a19fa4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:c5a1c7fe-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:c5a1f03a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:5422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 borofalan (10B) is substrate of Transporter (L-type amino acid transporter 1) DrugCentral uuid:c5a21538-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c5a23e78-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c5a266a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c5a28f68-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:c5a2b862-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:c5a2e094-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:c5a309c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:c5a331f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:c5a35c90-94cc-11ec-8aec-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c5a384b8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:c5a3acd6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tepotinib is inhibitor of Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:c5a3d54e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tepotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:c5a3fd9e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c5a425c6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:c5a44dee-94cc-11ec-8aec-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:c5a476ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:c5a49efc-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:c5a4c710-94cc-11ec-8aec-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:c5a4ef56-94cc-11ec-8aec-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:c5a5195e-94cc-11ec-8aec-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c5a541b8-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:c5a56a30-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:c5a5928a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c5a5bb70-94cc-11ec-8aec-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:c5a5e3ca-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:c5a60c1a-94cc-11ec-8aec-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofpironium bromide is inhibitor of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:c5a6310e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07288 biolink:molecularly_interacts_with DrugCentral:5429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallium (68Ga) gozetotide is binding agent of Surface antigen (Prostate-specific antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:c5a659fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5430 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 berotralstat is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:c5a68258-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:c5a6aa80-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c5a6d2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:c5a6fcec-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:c5a7251e-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:c5a74d50-94cc-11ec-8aec-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:c5a775a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:c5a79e54-94cc-11ec-8aec-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ansuvimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:c5a7c6ae-94cc-11ec-8aec-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 margetuximab is antagonist of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.55']} DrugCentral uuid:c5a7ef26-94cc-11ec-8aec-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 margetuximab is antagonist of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:c5a817a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atoltivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:c5a8405c-94cc-11ec-8aec-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atoltivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:c5a868b6-94cc-11ec-8aec-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maftivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:c5a8912e-94cc-11ec-8aec-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 odesivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:c5a8ba82-94cc-11ec-8aec-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 odesivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:c5a8e32c-94cc-11ec-8aec-0242ac110003 UniProtKB:P20595 biolink:molecularly_interacts_with DrugCentral:5439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:c5a90b5e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:5439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) DrugCentral uuid:c5a92f4e-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5a9582a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5a98070-94cc-11ec-8aec-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:c5a9a8a2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c5a9d0f2-94cc-11ec-8aec-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:c5a9f988-94cc-11ec-8aec-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:c5aa2264-94cc-11ec-8aec-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:c5aa4aaa-94cc-11ec-8aec-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c5aa7340-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c5aa9d16-94cc-11ec-8aec-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c5aac642-94cc-11ec-8aec-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c5aaefb4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:c5ab17f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:c5ab40f4-94cc-11ec-8aec-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:c5ab693a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:c5ab9180-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6ZWH5 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Serine/threonine-protein kinase Nek10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.57']} DrugCentral uuid:c5abb9e4-94cc-11ec-8aec-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:c5abe2ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:c5ac0ade-94cc-11ec-8aec-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casimersen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:c5ac2eec-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9NZB8 biolink:molecularly_interacts_with DrugCentral:5444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosdenopterin targets Enzyme (Molybdenum cofactor biosynthesis protein 1) DrugCentral uuid:c5ac52d2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:c5ac7db6-94cc-11ec-8aec-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c5aca89a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:c5acd0e0-94cc-11ec-8aec-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:c5acf8fe-94cc-11ec-8aec-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:5447 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasiglucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:c5ad2216-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9Y5C1 biolink:molecularly_interacts_with DrugCentral:5449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evinacumab is inhibitor of Secreted (Angiopoietin-related protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:c5ad4a70-94cc-11ec-8aec-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:c5ad72b6-94cc-11ec-8aec-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:5450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:c5ad9b9c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dostarlimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:c5adc3f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loncastuximab tesirine is antibody binding of Surface antigen (B-lymphocyte antigen CD19) DrugCentral uuid:c5ade804-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5453 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bamlanivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:c5ae104a-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etesevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:c5ae39a8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casirivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.34']} DrugCentral uuid:c5ae61f8-94cc-11ec-8aec-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imdevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.33']} DrugCentral uuid:c5ae8a5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P01024 biolink:molecularly_interacts_with DrugCentral:5457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegcetacoplan is inhibitor of Unclassified (Complement C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:c5aeb414-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04609 biolink:molecularly_interacts_with DrugCentral:5458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piflufolastat F-18 is binding agent of Enzyme (Glutamate carboxypeptidase 2) DrugCentral uuid:c5aed8ea-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5af0108-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5af294e-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c5af5180-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c5af7a16-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c5afa23e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c5afca5c-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c5aff28e-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c5b01cbe-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c5b04766-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b06f98-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c5b097c0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c5b0c1f0-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c5b0ea18-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c5b1124a-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b13a86-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5b16312-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c5b18b44-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c5b1b376-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c5b1db94-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c5b2079a-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b232e2-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c5b25b78-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c5b28472-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c5b2ad9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c5b2d5da-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c5b2fdf8-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c5b32684-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b34ec0-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c5b376fc-94cc-11ec-8aec-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:c5b39f1a-94cc-11ec-8aec-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5b3c86e-94cc-11ec-8aec-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:c5b3f0a0-94cc-11ec-8aec-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b418be-94cc-11ec-8aec-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:c5b44154-94cc-11ec-8aec-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:c5b46a26-94cc-11ec-8aec-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:c5b49258-94cc-11ec-8aec-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:c5b4ba9e-94cc-11ec-8aec-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b4e2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c5b50b48-94cc-11ec-8aec-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c5b53370-94cc-11ec-8aec-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:c5b55b98-94cc-11ec-8aec-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:c5b583ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:c5b5af4e-94cc-11ec-8aec-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:c5b5d78a-94cc-11ec-8aec-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:c5b5ffc6-94cc-11ec-8aec-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:c5b628ac-94cc-11ec-8aec-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:c5b650ca-94cc-11ec-8aec-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:c5b679f6-94cc-11ec-8aec-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:c5b6a354-94cc-11ec-8aec-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:c5b6cbcc-94cc-11ec-8aec-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:c5b6f408-94cc-11ec-8aec-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:c5b71c30-94cc-11ec-8aec-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:c5b7446c-94cc-11ec-8aec-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:c5b76e6a-94cc-11ec-8aec-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:c5b79822-94cc-11ec-8aec-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:c5b7c054-94cc-11ec-8aec-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) DrugCentral uuid:c5b7e462-94cc-11ec-8aec-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:c5b8091a-94cc-11ec-8aec-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) DrugCentral uuid:c5b82d32-94cc-11ec-8aec-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) DrugCentral uuid:c5b85136-94cc-11ec-8aec-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:c5b87990-94cc-11ec-8aec-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:c5b8a23a-94cc-11ec-8aec-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is partial agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:c5b8ca80-94cc-11ec-8aec-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotorasib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:c5b8f2bc-94cc-11ec-8aec-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:c5b91b84-94cc-11ec-8aec-0242ac110003 UniProtKB:Q6FTN8 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:c5b945dc-94cc-11ec-8aec-0242ac110003 UniProtKB:P87204 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral